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ABSTRACT 
Advances in genomics research have brought forth a number of psychosocial concerns. In 
Africa, in particular, one of the concerns relates to the potential impact of genomics research 
on stigma experienced by specific population groups. Using a mixed-methods approach, this 
study sought to explore how genetic causal explanation relates to the internalised stigma 
experiences of a sample of South African Xhosa people with schizophrenia (n= 36) and 
rheumatic heart disease (n= 46). Additionally, a pilot study was conducted with another sample 
of schizophrenia (n= 65) and rheumatic heart disease (n= 55) patients to translate and adapt 
an internalised stigma of mental illness scale into isiXhosa. The aim of the study 
was operationalised into three research questions, namely;  1. What causal attribution 
models do Xhosa people with schizophrenia and rheumatic heart disease employ to explain 
their illness and to what extent do genetic explanations play a role in these causal models? 2. 
What are the internalised stigma experiences of Xhosa people with schizophrenia and 
rheumatic heart disease? 3. How do the genetic causal explanations of Xhosa people with 
schizophrenia and rheumatic heart relate to their internalised stigma experiences, if at all? 
Through focus-group discussions participants were introduced to non-genetic and genetic 
causal explanations and then asked a series of open-ended questions eliciting their 
perceptions of disease causation, genetic causation and the possible implications these 
perceptions may have on internalised stigma they may have experienced. Next, an 
internalised stigma of mental illness scale (ISMI) was translated through a mixed-methods 
translation approach into Xhosa and adapted for use in both disease groups. Insights from 
this translation were used to gain an understanding of how the Xhosa language supports 
particular descriptions and conceptualisations of stigma experiences. Psychometric 
results provided further insights into particularly relevant internalised stigma items 
for each disease group. Findings from the FGDs and translation process suggested that 
firstly Xhosa people with schizophrenia and those with rheumatic heart 
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disease have a general understanding of genetics and genetic attribution to disease. Secondly, 
and not withstanding this knowledge, these participants hold a multitude of disease 
explanations. In consideration of the alternative causal explanations, and the factors these 
participants are exposed to, the genetic explanation did not appear to relate to their internalised 
stigma. While there was evidence of stigma in the two disease groups – schizophrenia patients 
reporting more stigma than the rheumatic heart disease sample – this stigma was not often 
related to a genetic attribution of disease. Findings suggest that the link between genetic 
attribution and stigma is complex. Due to the variable nature of the evidence derived from the 
study we cannot conclude that a genetic attribution is not related to stigma, however the 
findings provide clues as to why this is an unlikely implication for Xhosa people in these 
disease groups. This finding is different to empirical research which has been conducted in 
North American and European contexts. Although research in Western and European contexts 
suggests that attributing a disease to genetics may have an impact on disease-stigma, there have 
been minimal efforts to explore that assumption in the African context. This study, being one 
of the first to explore that assumption in an African population group, did not find consistent 
evidence to support it.  
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ISISHWANKATHELO 
Ukukhula kwamanyathelo athe athatyathwa ngocwaningo ngezofuzo kuye kwazisa 
ngaphambili inxalabo malunga nemo yokuziphatha. Kwilizwekazi iAfrika ingakumbi, 
ezinxalabo zinxulumene kakhulu negalelo lophando kwezofuzo kwakunye nechaphaza abanye 
abantu ekuhlaleni abaye bazifumane benalo. Ngokusetyenziswa kweendlela ezixubeneyo, 
olucwaningo luzama ukuqwalasela ngokubanzi ukuba ingaba lengcaciso inxulumene njani na 
nechaphaza elithi libe ngaphakathi kulowo uziva enalo kwiqela labantu boMzantsi Afrika 
kubantu abangamaXhosa abanesifo sengqondo (aba=36) kwakunye nabanesifo sentliziyo 
(abanga=46). Ukongeza kolucwaningo, kuthe kwenziwa izifundo zokugelesha (pilot study) 
kwelinye iqela labantu abagula ngengqondo (abayi=65) kwakunye nabanesifo sentliziyo 
(abayi=55) ukuze kucaciswe ngokubanzi ukuba ingaba londele kangakanani na ichaphaza 
elingaphakathi kubantu besiXhosa abanezizifo. Injongo zolucwaningo zithe zohlulwa-hlulwa 
kwimibuzo emithathu eyile: 1. Ingaba abantu besiXhosa abanesifo sengqondo nesentliziyo 
basebenzisa  eyiphi na imifanekiso ukuze bacacise izigulo zabo kwaye ingaba ingakanani 
indima edlalwa lufuzo kwezingcaciso? 2. Ngawaphi amava echaphaza elingaphakathi abantu 
abangamaXhosa abanesifo sengqondo nesentliziyo abanawo? 3. Ingaba ingcaciso zofuzo 
kubantu besiXhosa abanesifo sengqondo kwakunye nesentliziyo zinxulumana luhlobo luni na 
nechaza elithi libe ngaphakathi, ukuba kukhona ukunxulumana? Ngokusetyenziswa 
kweengxoxo zamaqela akhethiweyo abathabatha inxaxheba kolucwaningo bathe bachazelwa 
ngengcaciso zofuzo kwakunye nezo zingezizo ezofuzo bandula ukubuzwa imibuzo evulekileyo 
esiphelweni khonukuze kulandelwe eyabo imicamango ngabona bonobangela bezizifo, 
negalelo lofuzo, kwakunye nendima enokuthi lemicabango ithi ibenayo kwichaphaza 
elingaphakathi abaye bazive benalo. Ukusukela apho kuyekwathatyathwa isikali sesifo 
sengqondo (ISMI) sacalucalulwa ngeendlela ezixubeneyo siguqulelwa esiXhoseni ukuze 
kulungiselelwe ukusetyenziswa kwaso ngamaqela anazo zombini ezizifo. Imibono ethe 
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yafunyaniswa kulenguqulelo ithe yasetyenziswa ukuze kulandeleke ukuba ingaba ulwimi 
lwesiXhosa luzixhasa kangakanani na ezingcaciso kwakunye neengcaciso-banzi ngamava 
abanawo ngokuba nechaphaza. Iziphumo zengqondo ziye zanika ingcaciso ngokubanzi 
ngechaphaza elingaphakathi kubantu besifo ngasinye. Iziphumo ezifunyenweyo kolucwaningo 
(FGDs) kwakunye nenguqulelo zithe zabonakalisa okokuqala ukuba amaXhosa anesifo 
sengqondo nalawo anesifo sentliziyo anenkolo yawo ngezofuzo kwakunye nezinto ezibalelwa 
kwezizifo. Okwesibini, lungajongelwanga phantsi njalo olulwazi, abathabathe inxaxheba 
banengcaciso eziliqela ngezizifo. Xa kuqwalaselwa ezinye ingcaciso kwakunye nezinye izinto 
(abo bathe bathabatha inxaxheba badlula kuzo ebomini), ezingcaciso ngezofuzo azikhange 
zibonakalise kunxulumana nechaphaza elithi libe ngaphakathi kubo. Njengokuba kuye 
kwafumaneka ubungqina bechaphaza kwezizifo zombini, izigulana zesifo sengqondo zibe 
zezona zichatshazelwa ngakumbi lichaphaza kunezigulana zesifo sentliziyo kwaye elichaphaza 
alibonwanga linxulumene nofuzo lwezizifo. Iziphumo zibonakalisa ukuba unxulumano 
phakathi kofuzo nechaphaza yinto enobuzaza kakhulu. Ngoko ke ngenxa ye- antlukwano 
yobungqina obuthe bafunyaniswa kolucwaningo kunzima kakhulu ukugqiba ngokupheleleyo 
ukuba ufuzo lungabalelwa ekubeni lube kanti lunegalelo kwichaphaza, kodwa ke iziphumo 
zisinika umkhondo wokuba kungokuba kutheni lombono uphikisana namaXhosa akwezi zifo. 
Eziziphumo zahlukile kucwaningo oluthe lwagqitywa kuMantla Melika kwakunye neYurophu 
Njengokuba ucwaningo eNtshona kwakunye naseYurophu lubonakalisa ukuba ukubalela 
ezizizifo kufuzo kungaba negalelo kwisifo nechaphaza, imbalwa kakhulu imizamo 
ethatyathiweyo ukuqwalasela lombono kwizwekazilaseAfrika. Olucwaningo njengokuba 
ilolokuqala ukuqwalasela lengqikelelo kumaqela oluntu lwezwekazi laseAfrika alukhange 
lufumane bungqina buphangaleleyo bokuluxhasa. 
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CHAPTER 1: INTRODUCTION 
1.1.Background 
The adoption of the Human Genome Project (HGP) in 1990 has led to an increasing interest in 
genomics research with the hope that it may positively influence the advancement of treatments 
for diseases across the globe (Flowers, Froelicher & Aouizerat, 2012). Increased funding 
available for genomics research has meant an upsurge of studies conducted in this field. 
However, advancements in the field have raised awareness of associated ethical, legal and 
social implications (ELSI) which need to be addressed.  
 
Considering the expectations that genomics research could possibly reduce global health 
inequalities, it is concerning to consider that population groups from the African continent have 
minimally been represented in the genomics arena (Munung, Mayosi & de Vries, 2018; 
Popejoy & Fullerton, 2016). Over the past few years there has been a push towards enabling 
genomics science to expand on the African continent and involving different population groups 
in order to better understand disease causes in diverse groups. This is partly motivated by 
Africa’s rich genetic diversity and the increased disease burden on the continent (Munung, et 
al., 2018). 
 
With the introduction of genomics research in Africa, a particular concern arises as to whether 
it is possible that receiving genetic information about disease may cause any harm to African 
population groups (de Vries et al., 2012). This concern was first raised soon after the inception 
of the HGP by researchers in the United States of America (USA) who questioned the 
possibility of stigma as a consequence of obtaining genetic information (Beckwith, 1991). 
More than 15 years later, USA researchers Khoury, Gwinn, Burke, Bowen and Zimmern (2007) 
postulate that this concern is still important to investigate as it is not yet clearly understood. 
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Most of the research on this topic has been conducted in North American and European 
contexts and has revealed conflicting evidence of whether genomics could create or increase 
stigma for individuals who have diseases with a known genetic or hereditary basis (Sankar, 
Cho, Wolpe & Schairer, 2006). Currently, there is limited literature exploring this concern in 
genomics research conducted in non-Western countries.  
 
In Africa, ELSI researchers and ethics committees have questioned whether harm in the form 
of stigma may be a consequence of genomics research (de Vries et al., 2012). This assumption 
is made routinely for all genomics research studies and is raised particularly often in research 
that focusses on either (1) a known stigmatised population group, or (2) when conducting 
research with a population that has been marginalised or discriminated against (de Vries et al., 
2012). Since genomics research is only just advancing on the African continent, it is pertinent 
to explore how African population groups understand genomics and whether or how a genetic 
disease causal explanation may relate to their stigma experiences. Importantly, the concern that 
genomics research could increase stigma is made regardless of whether the condition under 
study is stigmatised.  
 
This study involves Xhosa patients with schizophrenia (a known stigmatised population group) 
and Xhosa patients with rheumatic heart disease (a group which has experienced 
marginalisation and discrimination). The goal of this study is to explore what causal 
attributions are held by Xhosa people with SCZ or RHD, how genetic explanations are 
understood by these population groups and whether a genetic attribution may relate to their 
internalised stigma experiences.  
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1.2. Genomics in Africa: Human Heredity and Health in Africa 
Genomics research has recently been introduced in Africa. Despite the increased burden of 
infectious diseases, along with non-communicable diseases (WHO, 2002), Africans have 
participated minimally in genomics research (H3Africa, 2014; Munung et al., 2018; Popejoy 
& Fullerton, 2016). Thus, most of what is known in relation to genetics is based on individuals 
from European ancestry, e.g. in 2016 over 80% of participants in genome-wide association 
studies (GWAS) were from Europe and North America (Popejoy & Fullerton, 2016).  
 
One of the first group of scientists to conduct genomics research in Africa fall under the Human 
Heredity and Health in Africa (H3Africa) Consortium which was established less than a decade 
ago, in the year 2010 (Adebamowo et al., 2017). The H3Africa Consortium aims to investigate 
genomic and environmental determinants on common diseases relevant to African populations 
through African leadership. With funding received from the National Institutes of Health in the 
USA and the Wellcome Trust in the United Kingdom (UK), the consortium aims to facilitate 
the advancement of genomics research on the continent (H3Africa Consortium, 2014). This 
initiative supports a wide range of genomics projects as well as four biobanks, a bioinformatics 
network, as well as a series of ELSI projects (one of which this research project falls under). 
The purpose of the establishment of the ELSI projects is to address the aforementioned 
potential ethical, legal and social implications arising from genomics research. Notably, the 
H3Africa Consortium has also collaborated with another group of genomics researchers, 
namely the African Society of Human Genomics group (AfSHG) that was founded in 2003. 
The aim of the AfSHG group is to equip the African scientific community and policy-makers 
with information and practical knowledge to contribute to the field of genomics research. 
Furthermore, it also aims to attract global attention to the efforts of African scientists (Diallo 
et al., 2017). When conducting genomics research in Africa, it is pertinent to consider the 
P a g e  | 4 
 
 
possible implications of this work on the lives of Africans living with the diseases investigated 
through a genomics methodology.  
 
This research is part of a larger H3Africa ELSI project entitled “Stigma in African genomics 
research on Schizophrenia and Rheumatic Heart Disease”.  It was a three-year collaborative 
study between investigators in South Africa and the USA, funded by the National Institutes 
of Health (NIH) under Grant number: 5U01HG008226-03. That project had two phases. 
Through the use of Focus Group Discussions (FGDs), phase one aimed to explore the possible 
relation between a genetic attribution and disease stigma within SCZ and RHD patient 
population samples. Through the use of semi-structured interviews with caregivers or family 
members of patients with SCZ and RHD, phase two explored the effects of disease-related 
stigma on caregivers or family members and the likely effect of genetic attribution on stigma 
experienced by these stakeholders.  
 
1.3. Thesis outline 
This thesis is structured as follows: 
 Chapter 1 serves as an introductory orientation by providing a brief contextual 
background to genomics research and ELSI concerns that arise in it. The chapter then 
introduces the reader to genomics research in Africa. This chapter also describes the 
broader project which this study falls under and concludes with a presentation of the 
structure of the thesis.  
 Chapter 2 discusses what causal attributions are. This is followed by a discussion on 
causal attributions held globally and in Africa. A discussion on how which causal 
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models African cultural groups attribute to disease are discussed. Then I provide a 
background on the Xhosa culture, language and translation of biomedical terminology. 
 Chapter 3 starts by defining genetics and genomics as it is understood in this study. The 
chapter also describes the concept of a genetic causal attribution. The concerns 
highlighted in the global context in relation to how genetic information may influence 
individuals, family and community relationships as well as having serious possible 
future planning implications are presented.  
 Chapter 4 describes the concept of stigma, the stigma conceptual framework applied in 
this thesis and the possible effects of stigma, as cited in the literature. Next, literature 
on mental illness and stigma as well as cardiovascular disease and stigma are discussed. 
The chapter ends with a discussion on how genetics may relate to stigma experienced 
by people with SCZ and RHD.  
 Chapter 5 describes the theoretical frameworks employed in this study, namely the 
Attribution Theory (AT) and the Modified Labelling Theory (MLT). The chapter ends 
with a summary of how these frameworks are integrated in this study to inform the 
epistemological underpinnings.  
 Chapter 6 outlines the research methodology employed in this research. It contains the 
problem statement, research aim and research questions guiding the study. The chapter 
documents the data collection methods followed and provides a description of the 
participants enrolled. The chapter also contains a discussion on the data analytical 
framework employed in this study, as well as a reflection on the process of data 
collection and my role as a researcher in this process. Lastly, I discuss the ethical 
considerations.   
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 Chapter 7 presents the socio-demographic characteristics of the participants. It then 
provides a description of the qualitative data that articulates the participants’ disease 
causal explanations.   
 Chapter 8 documents the qualitative data that presents evidence of stigma experiences 
and the coping mechanisms employed to mitigate the stigma in the two disease groups 
investigated in this study. 
 Chapter 9 describes the translation and adaptation of a psychometric tool to measure 
internalised stigma, the Internalised Stigma of Mental Illness scale in isiXhosa 
(ISMI/ISRHD-X). I also discuss insights of the items which were most relevant for the 
two disease groups based on the endorsement rates. I also discuss the limitations of the 
translations and end the chapter with a summary of the overall findings in this study.  
 Chapter 10 provides a discussion on the findings of the research in relation to the 
conceptual and theoretical frameworks employed. It also discusses how the results 
emanating from this study add value to the genomics ELSI literature and can inform 
arguments about the possibility of genomics research playing a role in increasing stigma 
among people from a South African population group. The chapter also includes some 
considerations researchers ought to make when conducting genomics research with 
African populations. The chapter concludes with an outline of the limitations of the 
study and some recommendations for future research. 
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CHAPTER 2: DISEASE CAUSAL ATTRIBUTIONS 
2.1. Introduction 
As described in the previous chapter, this thesis focusses on exploring the causal attributions 
held by Xhosa people with schizophrenia (SCZ) and rheumatic heart disease (RHD) and 
specifically sought to understand the possibility of a genetic attribution influencing their 
internalised stigma experiences. An important starting point for this work is to explore what 
causal attributions are. Therefore, I begin the chapter by describing causal attributions. This is 
followed by a discussion on generally held causal attributions for mental illness and 
cardiovascular disease. I then discuss disease causal models held globally and in African 
cultures, with a specific focus on the Xhosa culture and language. The challenges of language 
and the use of biomedical terminology are also discussed. Lastly the background of the social 
context - South Africa - of the research participants is discussed.  
 
2.2. Causal attributions  
Generally speaking, people tend to understand illness in a variety of ways. In social science 
research, the term for how people understand illness is “causal attribution”. A number of causal 
models of disease have been proposed and previous research suggests that people generally 
perceive the causes of their disease to be multifactorial (Condit et al., 2009; Davison, Davey, 
Smith & Frankel, 1991). The causal attributions people make about a disease may be shaped 
by their culture and/or experience of living or caring for an individual with that disease. 
Moreover, societies may differ in the way in which individuals from different cultural groups, 
with differing sensitivities or historical backgrounds, make attributions to illness (Gaskell, 
Bauer, Durant & Allum, 1999). Broadly, disease causal attributions may be influenced by 
biomedical, environmental, psychological, behavioural and cultural factors (Swartz, 1998). In 
many instances, individuals may hold a number of these explanations simultaneously. This 
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study seeks to understand what causal models Xhosa people with either SCZ or RHD hold, as 
well as how a genetic model may play a role in their understanding of disease causation, and 
in turn their internalised stigma experiences.   
 
2.3. Causal attributions for mental illness and cardiovascular disease globally 
As is true for other conditions, mental disorders are also often attributed to a range of causes 
including, biological, psychological and cultural. For instance, medical professionals variably 
attribute the cause of mental illness to be biological, psychological or both. Luhrmann (2000) 
articulates the two perspectives eloquently by saying: 
 
“Sometimes [psychiatrists] talk about mental anguish as if it were cardiac disease: you 
treat it with medication, rest, and advice about the right way to eat and live… 
Sometimes, though, psychiatrists talk about distress as something… that involves the 
kind of person you are: your intentions, your loves and hates, your messy, and 
complicated past” (p. 6) 
 
Beliefs around a variety of causes for mental illness may suggest that researchers – including 
genomics researchers – ought to prioritise gaining an understanding of these causal beliefs, 
many of which may vary across different contexts and cultural groups (Radua et al. 2018). In 
a recent review of the literature, Radua et al. (2018) report that there is mixed evidence on the 
aetiology of SCZ. These researchers document that a model which has gained much traction 
recently for the cause is the genetic and environmental risk factors interaction (van Os, Rutten 
& Poulton, 2008). While other scholars such as Howes and Murray (2014) denote that the 
influence of social factors on causing SCZ is also been well supported in the literature. In 
Brazil, with first year college students, Gericke, Carver, Castéra, Evangelista, Marre & El-Hani 
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(2017) for instance investigated the relationships among belief in genetic determinism, genetic 
knowledge and social factors for various diseases, and found evidence for SCZ being largely 
equated to genetics. These authors found that the association between knowledge of genetics 
or genomics and genetic determinism (i.e. the belief that a disease is primarily caused as a 
result of genetics despite what scientific evidence suggests) was low. This could also be 
understood as evidence that higher knowledge of genetics may counteract genetic determinism.  
 
In Greece, Economou, Richardson, Gramandani, Stalikas and Stefanis (2009) conducted a 
study with patients who have SCZ, investigating their causal disease models. Eighty percent of 
their sample reported their causal explanations. Of those who indicated a cause, 18.5% 
identified biological and genetic causes, while the most common attribution cited by these 
participants was psychosocial-environmental explanations with 34%, and the rest (27.7%) 
attributed their disease to a combination of psychosocial, genetic and environmental factors 
(Economou et al., 2009). This study also found that the attribution of SCZ only to biogenetic 
causes increased with socioeconomic status (SES) and education level, which is in contrast to 
Gericke et al. (2017). Therefore, individuals who had a higher SES and education level were 
more likely to attribute their disease to a biogenetic cause, than those who had lower education 
levels (Economou et al., 2009). This explanation is in support of Naanyu (2009) who found 
evidence that black South African males with low-levels of education held non-biological 
causes for mental illness.  
 
Shifting to Africa, there is a robust amount of research on the causal attributions of mental 
illness (Adewuya & Makanjuola, 2005; Adewuya & Oguntade, 2007; Patel, 1995; Seedat, 
et al., 2002). Much of the mental illness literature - documenting the perspectives of the 
general public, traditional healers, health care practitioners, patient carers and some 
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patients - suggests that individuals from a variety of African cultural groups primarily 
attribute their disease to cultural or supernatural causes (Bantjes, Swartz, Cembi, 2017; 
Cheetham & Cheetham, 1976; Mbanga, 2002; Motlana, Sokudela, Moraka, Roos & 
Snyman, 2004, Naanyu, 2009; Ngobe, 2015; Sorshdahl et al., 2010). This is similar to the 
findings by scholars in other LMICs such as India (Saravanan et al., 2007) and Malaysia 
(Thornicroft et al., 2009).  
 
From the perspective of patient relatives in the South African context, Mbanga et al. (2002) 
conducted research with 100 relatives of Xhosa patients diagnosed with SCZ. Essentially, the 
findings of their study indicate that caregivers of patients with SCZ tend to more commonly 
attribute mental disorder to a complex variety of causes, many of which are related to 
psychosocial stresses, as opposed to a biomedical explanation. When symptoms are obvious 
and observable, as in psychotic symptoms of SCZ, this behaviour tends to be commonly 
attributed to witchcraft or possession by evil spirits (Mbanga et al., 2002). Naanyu (2009) 
reiterates this finding in her research by reporting that in South Africa and most African 
communities in general, magical aetiologies are regularly cited causal models for mental 
illness.  
 
Shifting to cardiovascular disease global beliefs of causes, in the US, Bates et al. (2003) 
conducted research among the general public to understand how individuals understood a 
genetic explanation to heart disease. Through the use of FGDs with participants from rural, sub 
rural and urban areas, the scholars sought responses to the question “what does a gene for heart 
disease mean?”. They found that participants understood a gene for heart disease to mean that 
genetics and the environment both played a role in the onset of heart disease. This interpretation 
by the lay public is supported in other international studies (Davidson et al., 1989; Hunt et al., 
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2000 & Ponder et al., 1996) that have found that individuals in the US general public 
consistently understand heart disease to be caused by behavioural, environmental and genetic 
(in relation to family history) factors. In the US, heart disease is recorded as the second highest 
preventable cause of death, and it affects ethnic minorities disproportionately (National Heart 
Lung and Blood institute, 2000 as cited in Bates et al., 2003; Smedly et al., 2000). African 
Americans have been found to provide different estimates for the role of genetics in causing 
heart disease (Bates et al., 2003). Again, this is in support of a robust amount of literature, 
suggesting that people may hold multi-causal models for disease (Senior, Mateau & Weinman, 
2000). With growing evidence, these multi-causal explanations held by people with disease 
may provide valuable insights into treatment acceptance and adherence. Given that genomics 
research aims to provide advanced treatments for genetically affiliated diseases, these causal 
beliefs may be pertinent to consider in the process.  
 
Cardiovascular disease (including heart disease and stroke), type 2 diabetes, cancer, chronic 
lung disease, depression and schizophrenia are some of the major documented non-
communicable diseases (NCDs) in low and middle-income countries (LMIC) of the world 
(Daar Singer, Persad et al., 2007; Sorshdahl, Flisher, Wilson & Stein, 2010). Mayosi, Flisher, 
Lalloo, Sitas, Tollman and Bradshaw (2009) postulate that in present day South Africa, NCDs 
are increasingly common in both rural and urban areas of the country. In poorer areas of South 
Africa, these scholars predict the burden of NCDs to increase substantially (Mayosi et al., 2009) 
and the same is predicted for the broader sub-Saharan Africa (SSA) (Dalal, Beunza, Volmink 
et al., 2011). In their systematic review of common diseases in SSA, Dalal et al. (2011) found 
that external factors, including environmental factors such as polluted air, may play a role in 
cardiovascular disease onset. Other factors cited were diet, lack of exercise, alcohol use, 
psychological and physical abuse.  
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Although these are the cited general possible causes of heart disease in African contexts, it is 
not yet well understood what individuals in local societies believe to be the cause of their 
cardiovascular disease (Mshana et al., 2008). In a study investigating the explanatory models 
held and treatment seeking attitudes by patients with stroke in Tanzania, Mshana et al. (2008) 
found that the attribution of illness in African aetiologies can be characterised by biomedical 
explanations and/or spiritual explanations. In the South African context Hundt, Stuttaford and 
Ngoma (2004) investigated the conceptualisations of illness causation held by individuals with 
stroke-like symptoms in a rural population in the Limpopo province and found that patients 
cited both physical environment and social causes. Bham and Ross (2005) found cultural 
explanations a strong focus among South African Indian Muslims, hence their conclusion that 
faith and religion feature strongly in the aetiology beliefs held by Muslim patients with 
cardiovascular disease. A pertinent reason for understanding the explanations held by patients 
is the concern that the explanations may fuel stigma which could negatively inform their help-
seeking practices, selection of pathways to care and adherence to treatment.  
 
In Africa, and many non-Western cultures, causal attributions for illness are often also 
understood in relation to traditional cultural belief systems (Alem, Jacobsson, Araya, Kebede, 
& Kullgren, 1999; Mshana, Hampshire, Panter-Brick, & Walker, 2008; Saravanan, Jacob, 
Johnson, Prince, Bhugra & David, 2007; Swartz, 1998). The African belief system often 
informs the manner in which many Africans perceive their world and impacts their 
understanding of illness (Matoane, 2012). It is difficult to speak of a single African viewpoint, 
since many Africans have shifted to establishing a variety of belief systems influenced by 
different cultures including Western views. Mkhize (2003) suggests that cultural groups in SSA 
may hold similar beliefs and a unique consciousness about the world. In addition to biological 
explanations to illness, which are often cited as dominant causal models in European 
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population groups (Jayaratne et al., 2009), Africans generally also emphasise external 
factors such as relationships with family, the environment, sorcery, bewitchment, ancestors 
and ancestral spirits (Mkhize, 2003; Naanyu, 2009; Nwoye, 2015).  
 
2.4. African cultural beliefs 
 
In many traditional belief systems in Africa, including South Africa, mental health problems 
may be attributed to the influence of the aforementioned ancestors or bewitchment factors 
(Sorsdahl, Flisher, Wilson & Stein, 2009). The “Africentric approach” to research is 
documented by authors such as Bangura (2012) and Mazama (2001), who posit that this 
paradigm relates to an ideology that guides the essence of research and practice in 
contemporary African-centred scholarship. Crossman (2004) postulates that the principal 
message of this paradigm is that research conducted in the African context should take into 
account the worldview and philosophical assumptions held by people in Africa. More 
specifically, in the context of mental illness, Nwoye (2015) describes the difference 
between biomedical and biogenetic models of illness in Africa, which tend to see an illness 
in relation to the abnormality of a patient’s anatomy, genetics and nervous systems, and 
the African paradigm which sees an illness as “symbolic” with a hidden message from 
external spiritual forces (i.e. ancestors). For instance, some Africans go beyond the clinical 
information provided by a clinician, and seek to find “who” is speaking through the patient’s 
physical manifestations (Nyowe, 2015). The differences between the biomedical 
understanding of illness and the African paradigm undoubtedly influences treatment and 
help-seeking behaviour. While belief in the aforementioned results in patients seeking help 
from Western medicine practices, the latter for instance results in a patient and their family 
seeking guidance from traditional healers to provide clarity on what they should do in 
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order to determine “who” is speaking through the illness and what is expected of them in 
order to effect healing for the patient (Bantjes et al., 2017; Mzimkulu & Simbayi 2006; 
Nwoye, 2015). Other scholars such as Connell et al. (2015) and Campbell et al. (2017) attest 
that Xhosa people often hold a diverse range of spiritual beliefs, including African traditional 
healing systems, traditional medicine, ancestral worship, magic and witchcraft, along with 
Christian, Islamic, atheist and agnostic beliefs. With the presence of a multitude of disease 
causal explanations often held in conjunction with one another, scholars such as Kabir, Iliyasu, 
Abubakar & Aliyu (2004) suggest that many Africans have poor knowledge, understanding 
and acceptance of a biomedical explanation to disease. Moreover, in relation to mental illness, 
Ilechukwu (1998) proposes that a large number of African people do not know the cause of 
their illness. Overall however, cultural aetiologies are highly prevalent in African cultural 
groups, even though individuals also consider other potential factors, including biomedical and 
genetic explanations to illness.  
 
Kleinman et al. (1978) propose that cultural beliefs are prominent in the development of 
individuals’ causal models for disease. There are many definitions for the term “culture”. In 
this study culture is understood as defined by Mkhize (2003:6), stating “culture refers to 
meanings, values and behavioural norms that are learned and transmitted in the dominant 
society and within its social groups”.  He further describes culture as a complex system of 
symbols which include values, feelings and ideals as well as beliefs, traditions and behaviours 
governed by societal laws and rituals. Scholars such as Vaughn, Jacquez and Baker (2009) and 
Swartz (1998) also attest that people’s beliefs about disease causation, treatment and health 
practices are influenced by their culture. Globally, there is much debate about the influence of 
culture on the biomedical explanatory models for illness. Authors such as Kohrt et al. (2014) 
express concerns with not considering culture in biomedical research. For instance, where 
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many studies have been conducted on schizophrenia, very little has been done to alter 
conceptualisations or treatments of this disorder in consideration of the commonly held cultural 
beliefs.  
 
A particular question to investigate is whether it is possible that a disease (presenting with 
similar symptoms across different contexts) is understood in the same way by people in 
different contexts. An African psychiatrist, T. Adeoye Lambo, (who joined international 
psychiatry research networks in the 1950s and 60s) expressed that the content of the symptoms 
of mental illness presented differ cross-culturally. Furthermore, T. Adeoyo Lambo believed 
that it is critical for psychiatrists to be sensitive to the cultures they worked with, in order to 
make accurate judgements on illness. The same argument can be made for physical diseases 
and physicians treating physical diseases among African population groups. In the South 
African context, scholars such as Drennan, Levett and Swartz (1991) and Swartz (1998) have 
raised important questions about the transportability and relevance of western biomedical 
constructs of disease in African settings.  
 
Typically, in the 21st century, research indicates that attributional styles differ cross-culturally. 
However, the argument holds that most studies have been aligned to the World Health 
Organisation (WHO) and World Mental Health tools, which are mostly conducted based on 
Western culturally developed biomedical diagnoses that lack the inclusion of cultural concepts 
(Kohrt et al., 2014). Vaughn et al. (2009) asserts that individuals from diverse cultural 
backgrounds typically make different attributions of illness, health, disease, symptoms and 
treatment.  
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In the US for example, African Americans are reported to more likely attribute a disease to 
external factors such as destiny or the will of God, along with a firm belief in the healing power 
of prayer (Landrine & Klonoff, 1994). Moreover, ethnic minorities in the US (i.e. Anglo 
Americans) are more likely to hold traditional Western health beliefs involving individual 
responsibility for health and illness (Landrine & Klonoff, 1992; 1994), as well as more 
“empirical” explanations of illness. These authors explain that because of the emphasis on 
micro-level and natural causes of illness, many Caucasian Americans believe that illness can 
be treated without reference to family, community or deities, as it holds an intrinsic element.  
 
According to the Western biomedical model, a disease originates inside the body due to a 
specific, identifiable “medical” cause or pathogen (viral, bacterial, etc.). Yet, whilst people in 
Western countries tend to attribute the cause of illness to the individual or the natural world, 
individuals from non-Western or European countries are more likely to explain illness as a 
result of social and supernatural causes (Naanyu, 2009; Vaughn et al., 2009). These findings 
are consistent with another study by McCabe and Priebe (2004) who investigated the 
exploratory models of illness among people with schizophrenia in the UK by comparing four 
ethnic groups (Caucasian, Bangladeshi, African Caribbean and West African). These scholars 
found that the white population cited genetic causes more prominently, while the three non-
white groups cited supernatural causes as being more prominent.  
 
2.4.1. The Xhosa culture 
 
For the purposes of this thesis (involving Xhosa people with SCZ and RHD) it is critical to 
provide some information about the Xhosa people (amaXhosa) and their culture. Hence, it is 
vital to have some knowledge of their culture, customs, language, as well as their worldview 
and philosophy of life. This is especially relevant as Emsley et al. (2001) point out that thus far 
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health researchers have paid scant consideration to the ways in which the cultural norms of the 
Xhosa people may inform opinions on disease and the politics about causation. Although 
culture can be a complex arena that constantly changes over time, there is reported value in 
explaining the cultural backgrounds of individuals involved in a study.  
 
The Xhosa people fall within the previously racially segregated populations stipulated during 
the apartheid era in South Africa (Buhrmann, 1977). This group was restricted to the Eastern 
Cape Province of South Africa, thus the majority of Xhosa people continue to reside in the 
Eastern Cape (Steele & Edwards, 2008). In 2008, Steele and Edwards reported that over 90% 
of the population in the Eastern Cape Province are isiXhosa-speaking. The Xhosa language is 
associated with the Nguni group of African languages, which encompasses isiXhosa, SiSwati 
and isiZulu (Buhrmann, 1977). Xhosa people are divided into various clan groups (the clan 
group name which one belongs to is called isiduko). These clan groups derive from the 
patrilineal lineage of an individual and are very crucial for the individual’s identity. They are 
unchangeable, and exclude a number of potential marriage and sexual partners (namely, those 
who belong to the clan groups of all four grandparents) (Hirst, 2005).  
 
The Xhosa cultural belief system places great value on the role of the ancestors in individuals’ 
health and wellness (Hirst, 2005). It is the ancestors who are believed to either expose 
individuals to witchcraft and possession by evil spirits or protect them from these sources 
(Buhrmann, 1984; Connell et al., 2015; Hirst, 2005; Mbanga et al., 2002). In order to treat 
illnesses that may arise based on the presumption of bewitchment, Xhosa people often consult 
“traditional doctors (inyanga), diviners (izangoma), faith healers (umprofiti or umthandazi) or 
a birth attendant” (Sodi et al. 2011; p. 102). Although terms for the healers do vary across 
different ethnic groups, they are often similar in many African cultural groups (Truter, 2007). 
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Healers and practicing herbalists are often skilled to provide natural herbs as treatment, 
however no amount of treatment can be efficacious if appropriate traditional life-cycle rituals 
are neglected. Healers also provide some guidance on the particular rituals that ought to be 
performed by the ill individual and/or their family in order to appease the ancestors so that they 
can provide protection (Hirst, 2005). The main source of guidance from the ancestors is through 
dreams. Most Xhosa people follow the Christian religion. They believe that the ancestors pay 
a mediatory role between living beings and the Christian God (named, uThixo), therefore the 
cultural and religious beliefs are held alongside one another.  
 
In particular, many Xhosa individuals have upheld purity of the language and traditional 
practices, including ancestor worship and traditional treatment (Buhrmann, 1977; Buhrmann, 
1984). It is important to note however that there are subtle differences to the beliefs upheld by 
Xhosa people in the Eastern Cape Province – province which most Xhosa people reside in rural 
villages - and Xhosa people in the Western Cape Province where most Xhosa people reside in 
townships.  
 
Generally, in the Xhosa culture, Hirst (2005) emphasises that the nosology of diseases is 
often believed to be linked to witchcraft, ancestors or both. Overall, Xhosa people often 
focus on dual systems of illness causal explanations (where their relationships with 
ancestors, family and environment are all connected) therefore understanding of illness 
causation takes all of them into consideration in addition to other explanations (Mkhize, 
2003; Nwoye, 2015). This finding is of particular relevance because African cultures 
typically do not consider the individual in isolation, but in the context of a greater collective 
of factors (Mkhize, 2003; Nwoye, 2015). The cultural beliefs of African people are often 
underappreciated in genomics studies (Adebamowo et al., 2017). The limited consideration 
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of cultural norms may in itself have implications for stigma. Botha, Koen and Niehaus (2016) 
provide preliminary evidence that cultural differences contribute to the way in which disease 
causation beliefs manifest and how a disease is stigmatised. Cultural awareness is one strategy 
which has been proposed by African genomics researchers, in order to efficiently conduct 
genomics research with African population groups (Munung et al., 2018). 
 
2.5. South African context 
 
South Africa is a middle-income country, yet there are large disparities in access to resources 
(Petersen et al., 2016). South African cities and towns have been shaped by a range of 
discriminatory laws following the apartheid era (Nqwela & Lewis, 2012), which has resulted 
in persisting inequalities (Mayosi & Benatar, 2014). Considering that apartheid intentionally 
promoted separate and unequal development of the different racial groups in South Africa, 
there are many people, particularly black African people still living in poverty with limited 
access and barriers to healthcare and education. These communities are similar to the 
communities of African American participants in the study by Collins et al. (1998), which are 
unfavourable in terms of safety, friendliness, delivery of facilities such as health, education and 
municipal services. These areas are also often loud, unclean and distanced from cities and may 
also be called townships.  
 
Since 1994 there have been significant advances in primary healthcare initiatives and a stern 
focus on improved healthcare delivery (Mayosi, van Niekerk, Bradshaw, Karim & Coocadia, 
2012). Low-income communities in underdeveloped areas of the country, however, are still 
largely occupied by black African people who, alongside other population groups that are poor 
in the country, suffer the most in terms of accessing adequate healthcare and other resources 
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(Vergunst, Swartz, Mji, MacLachlan & Mannan, 2015). Most of the participants in this study 
come from these communities. These low-income communities are challenged with a high rate 
of crime and poverty (Ngqela & Lewis, 2012). This contextual background is important to 
acknowledge, as Lund et al. (2018) maintains, that poverty is consistently related to increased 
prevalence of disease in low-income, middle-income and high income countries. Other 
scholars, such as Folb et al. (2015), conclude that socioeconomic disadvantage among mental 
health patients in the Western Cape province of South Africa, may not only be a cause of 
depression, but also a barrier to accessing treatment. Lund et al. (2010) extensively reports on 
the implications of poverty in exacerbating the presence of mental health conditions in low-
income communities, with some of his research conducted in the context of South African 
townships. It is not uncommon for individuals in these areas to witness or experience violent 
behaviour such as stabbings, assaults or gunshot encounters. Nqwela and Lewis (2012) 
maintain that tensions from the experience of poverty are part of the reasons for the internal 
violence in these communities.  
 
Growing global evidence indicates that health, poverty and stigma are intertwined in a negative 
cycle (Lund et al., 2010; Turan et al., 2019).  These elements are all intertwined in the concept 
“intersectional stigma” (Turan et al., 2019). While disease causes may vary, the social 
circumstances of individuals in low-income communities in South Africa may certainly 
account for their residents being the most vulnerable to disease onset. Zuhlke (2015) supports 
the above by stating that the inequalities in these communities translate into continued high 
prevalence of diseases of poverty in the population, mentioning RHD and tuberculosis.  This 
view was extended by Vergunst et al. (2015) and more recently, supported by Lund et al. 
(2018), who included the increased vulnerability to mental illness onset among individuals in 
these communities.  
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Employment is seen as a protective factor for acquiring disease. For example, having financial 
income provides one with greater opportunities to have access to better health care, such as 
access to good hospitals and clinics, healthier food and exercise facilities, safer neighbourhoods 
to live and work in (i.e. suburban areas with less crime, pollution and noise), as well as 
increased access to education facilities. Unfortunately, unemployment in South Africa is a huge 
burden, especially among black South Africans (Statistics South Africa, 2013). Notably, the 
Stats SA 2018 report documents that unemployment in black African population groups is 
extraordinary high at 30.5% (2018). Stats SA (2013) reported that black South Africans 
constitute 80% of the population. However, the majority of blacks continue to experience 
poverty, homelessness and unemployment (Statistics South Africa, 2013). This is a concern, 
considering researchers such as Lund et al. (2018) report that employment is also associated 
with better social functioning, less severe symptoms and a higher quality of life for people 
living with a physical or mental disease.  
 
In low-income communities in South Africa the transportation system is a challenge. Lucas 
(2011) documents that the majority of South African families do not have steady access to any 
form of transport, which impacts on their capability to contribute to important financial and 
societal activities (Vergunst, Swartz, Mji, MacLachlan & Mannan, 2015). The lack of transport 
experienced by South Africa’s low-income populations has been a persistent and prominent 
problem in both its pre-and post-apartheid eras (Khosa & Zwane, 1995).  Thus, the people who 
comprise the vast majority of South Africa’s urban population struggle to access reliable, safe 
transport in order to reach employment or even health facilities. This is critical to highlight as 
Potgieter, Pillay and Rama et al. (2006) indicate that transport has been recognised as a main 
factor in the monetary and societal growth process because it facilitates the movement of 
individuals and goods, thereby encouraging trade and improved standards of living through 
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access to employment, health, education and communal facilities. Also, Potgieter et al. (2006) 
emphasis the concept of transport poverty (which is associated with a lack of provision of 
transport infrastructure and motorised services), the monetary cost of travel and the amount of 
time people spend accessing and waiting for transportation, which all serve as barriers to 
accessing the aforementioned services. The lack of transport may also be the reason why many 
individuals in rural areas go to local traditional healers as first point-of-care when they become 
ill (Ngobe, 2015). These transportation barriers often shape the reality of outpatients in low-
income communities who attend health facilities in urban areas. The challenges to access safe, 
reliable and convenient transportation not only affects their ability to hold and maintain jobs in 
urban areas but also affects their ability to seek help and treatment from health facilities.  
 
Evidence reports that many Xhosa people are juggling the combined effects of 
transgenerational poverty, inequality and discrimination. The realities of many individuals 
residing in low-income communities in South Africa are extremely difficult, even more so for 
people living with a disease. As a result, these factors cannot be overlooked when considering 
disease causal explanations and stigma.  
 
2.5.1. Access to healthcare in South Africa 
In the South African constitution, section 27 documents the right to access health care for all 
South Africans. In reality the country’s healthcare is divided between private and public 
healthcare. Private healthcare is payed for by individuals who can afford it (servicing only 16% 
of the population). Public healthcare thus holds the responsibility of servicing the remaining 
84% of the population. This heavy burden on the system has resulted in challenges to access 
adequate healthcare in the country (Petersen et al., 2016). Challenges to access health care 
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remain a huge problem for many South Africans, one reason being the distribution of resources 
and staff in different facilities (Coovadia, Jewkes, Barron, Sanders, & McIntyre, 2009).  
 
Many people living in low-income communities in South Africa increased barriers to accessing 
adequate healthcare. Their challenges to accessing health care are fuelled by the inadequate 
infrastructure, housing and limited access to basic services in township communities. Access 
to health care is therefore affected by these notable barriers: (i) poverty and inequality, (ii) 
transport and distance to travel to access a clinic/hospital, (iii) resources and staff capacity of 
the health facility, and (iv) traditional beliefs regarding illness held by members of different 
cultures (v) violence in their communities and (vi) stigma and discrimination (Coovadia et al., 
2009).  
 
Issues related to accessing health care are especially important to highlight for SCZ and RHD 
patients, who need to frequently collect medication for their illness. In terms of minimising 
stigma and discrimination, Zuhlke (2015) explains that patients with physical and 
psychological diseases prefer going for treatment in cities as this maintains a sense of privacy 
and anonymity. It distances them from the stigma experienced when attending local 
community-based healthcare facilities because frequent visits to the clinic are often associated 
with the collection of HIV treatment, which is a highly stigmatised disease in these 
communities (Stein, 2003; Vincent, 2008).    
 
Another challenge is the limited available resources at local clinics. For instance, in one 
township in Cape Town, individuals queue for 6 hours before getting medical attention (Nteta, 
Mokgatle-Nthabu & Oguntibeju, 2010; Zuhlke, 2015). This is due to the high volume of people 
who visit these facilities on a day-to-day basis. It is not uncommon for people to return home 
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without having been attended to and having to return to the clinic the following day to queue 
again in the hope that they will be attended to. Their necessary periodic visits to the health 
facilities, which take a significant amount of time, are a further reason why many people living 
with disease experience barriers to accessing healthcare (Nteta, Mokgatle-Nthabu & 
Oguntibeju, 2010; Vergunst et al., 2015), subsequently exerting further pressure on the costs 
incurred by the state if or when they are admitted to hospitals for disease complications 
(Zuhlke, 2015).  
 
Furthermore, another barrier to accessing healthcare for people in low-income communities is 
the influence of the cultural belief systems held by people of the community. Cultural causal 
attributions may influence pathway to care in various ways (Burns, Jhazbhay & Emsley, 2010). 
Many Africans consult alternative healers in their communities who provide traditional 
medication (Bantjes et al., 2017 Mzimkulu & Simbayi, 2006; Sorsdahl et al., 2009).  Generally, 
these healers have varied levels of experience and avail their services to the tradition-bound 
members of the community (Bantjes et al., 2017; Mzimkulu & Simbayi, 2006; Vergunst et al., 
2015).  This could also pose various problems, as in many cases this leads to the late detection 
or diagnosis of diseases in health facilities, which can result in further complications (Zuhlke, 
2015). Burns et al. (2010) indicate that for patients with a first episode psychosis who first 
consult traditional healers, there is a longer duration of medically untreated psychosis, thereby 
negatively impacting prognosis of the mental condition.  Based on these barriers, among others, 
it is evident that contextual factors may influence causal explanations of individuals with 
physical or mental diseases. 
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2.6. Language and biomedical information 
South Africa currently has 11 official languages. The Xhosa people are the second largest 
population group in South Africa (Steele & Edwards, 2008). As it has been found in other 
African contexts, having population groups who speak various local languages can create a 
language barrier between the patients and health professionals (Drennan & Swartz, 2002; 
Swartz, Kilian, Twesigye, Attah & Chiliza, 2014). Tindana et al. (2012) document that in a 
genomics study conducted in Ghana, research staff clearly struggled to explain scientific terms 
to participants in their local languages. This challenge is echoed by South African scholars 
(see, Campbell & Young, 2016; Drennan & Swartz, 2002; Levin, 2016; Swartz et al., 2014) 
stating that amongst the general public, there is often difficulty understanding and interpreting 
biomedical information and constructs, which is particularly challenging for black Africans as 
this information is predominantly communicated to them in English and not their home 
language. The primary reason that communication is conducted predominantly in English and 
sometimes Afrikaans is the historical and current realities of the country having mostly only 
white healthcare practitioners (with the exception of black nurses) who relay health information 
(Drennan & Swartz, 2002). Secondly, very few of the white general practitioners can speak 
any black African language (Drennan & Swartz, 2002) 
 
Because of the past discriminatory system in South Africa, a large majority of black Africans 
in the general public have low levels of education, which means that receiving genetic 
information (often communicated by the available medical practitioners in English/Afrikaans) 
can be even more difficult to comprehend (Drennan & Swartz, 2002; Levin, 2016; Steele & 
Edwards, 2008). In addition, Levin (2016) maintains that the general practitioners themselves 
often have limited training and knowledge of genetics, which makes it even more difficult for 
them to relay the information to patients. 
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The difficulty for practitioners to find isiXhosa words to describe genetics aggravates the 
challenge for health staff or researchers in relaying genomics and biomedical information to 
many black African people. This is elaborated on by Levin (2016) who investigated 
misunderstandings encountered by doctors communicating with Xhosa-speaking patients in the 
Western Cape, South Africa. In his research Levin (2016) revealed gaps in communication and 
discovered that most isiXhosa words were not in the doctors’ vocabulary and some common 
English words were not in patients’ vocabulary. Additionally, in situations where words were 
common to the vocabulary of both groups, significant differences existed in the number and 
range of definitions, with many significantly different interpretations being apparent. Hence, 
for Africans, in addition to the complexity of the scientific terms, a further layer of challenge 
in conveying this explanation is the language barrier between healthcare practitioners and 
patients. The continuing institutional failures to adequately bridge the language gap in 
healthcare systems in South Africa fuels the stereotypes held about certain diseases and 
disregards the importance of all people understanding the health information provided to them 
(Drennan & Swartz, 2002).  
 
That said, it is of no surprise that experts in the social sciences and humanities fields in Africa 
are concerned about ordinary people having misconceptions and misunderstandings about 
genetics. One particular misconception which may occur is the reported belief that an 
individual acquires an illness solely as a result of their genes. Furthermore, people may be more 
prone to believe that one is defined by their genes in the present and future, thus making it 
predictable and unchangeable – even by health promoting behaviour – which can result in 
increased stigma and discrimination (Lynch et al., 2008). This may relate to what King et al. 
(2002) calls “genetic illiteracy”. Given the lack of knowledge on what Xhosa people with SCZ 
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and RHD understand about genetics, this study hopes to better understand their genetic literacy 
and how it may influence stigma.  
 
2.7. Chapter summary 
 
This chapter provided a discussion on what causal attributions are. It also provides a brief 
description of disease causes often cited globally and in African literature. The chapter ends 
with a general background of the culture of the research participants (the Xhosa culture and 
language), the South African context, as well as how language informs the understanding of 
genomics research information among African participants.  
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CHAPTER 3: GENOMICS RESEARCH 
 
3.1. Introduction 
Interest in genomics research has increased substantially in the past three decades. The 
enthusiasm of the possibilities of genomics providing tangible improvement in diagnosis, 
treatment and prevention of disease can not be ignored. Alongside the enthusiasm, there are 
also real ethical, legal and social implications which have been highlighted for consideration 
by researchers (Catz et al., 2005). Genetic explanations have long held a strong view of being 
a dominate explanatory model for human characteristics in Eurocentric contexts (Garrison, 
Brothers, Goldenberg & Lynch, 2019). The field has moved from focussing on genetics, to 
genomics. In this chapter I start by defining the difference between genetics and genomics. I 
then discuss the concerns raised by ELSI researchers regarding genomics research. I explain 
how genomics information can influence individuals and communities, as well as future 
prospects. The discussion in this chapter is helpful in drawing out the main assumptions guiding 
the backdrop of the research questions explored in this thesis. I end the chapter with a summary.  
 
3.2. Genetic attribution 
The field of genetics largely focusses on single genes, genomics describes the study of the 
entirety of an individual's genetic material (the genome) which includes interactions of the 
genes with each other and the individual's environment (non-genetic factors) (Flowers et al., 
2012). Genetic attribution (Tygart, 2000) refers to a perceived genetic cause of a trait or 
behaviour and is related to deterministic thinking (Dar-Nimrod & Heine, 2011). Deterministic 
thinking attests to the idea or belief that differences in people (such as physical appearance, 
health outcomes, characteristics and life experiences, etc.) are largely due to genetics and 
therefore can never be changed. According to Phelan, Cruz-Rojas and Reiff (2002), when an 
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individual believes an illness is genetic, then s/he may be more likely to believe that the disease 
cannot be avoided through a change in behaviour or environment.  
 
Tygart (2000) suggest that genetic attribution, how people perceive the influence of genetics 
on an individual trait, depends on the types of traits. Therefore, as emphasised by Gericke et 
al. (2017) it is important to explore how this perception may influence a diversity of traits. 
Given the concern of a pessimistic attitude to disease onset or prognosis, holding solely a 
genetic explanation to a disease trait raises some serious questions around how it may fuel 
consequences which may influence stigma for different diseases. How genetic attribution 
impacts the lives of various people with different diseases, and from different social contexts 
and cultural groups is yet to be discovered (Catz et al., 2005).   
 
Data from multiple studies using different methodologies and focussing on different traits 
revealed results suggesting that individuals understand that even if genetics may play a role in 
disease causation, it is not an overwhelming role and there may be other factors which influence 
disease onset (Condit et al., 2018). For instance, Parrott, Silk and Condit (2003) who conducted 
FGDs investigating genetic attribution for traits such as talents, mental abilities, lung/prostate 
cancer, weight and height, found that individuals believe that whilst genes do play a role in 
most of these traits, the effect is not overwhelming.  
 
In the US, Jayaratne et al. (2009) asked individuals what they think about genetics, environment 
and choice, which allowed for a comparison across the causal models. In their study, black and 
white Americans indicated their beliefs in attributions for athleticism, intelligence, tendency 
towards violence, drive to succeed, and sexual orientation. For most of the traits individuals 
were below the midpoint (less than 2 in a 1-4 point Likert scale), with white respondents 
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the highest traits reported closer to genetics. As Condit (2018) suggests, individuals vary in 
how they think about disease causation (which may be different for physical and mental 
diseases) and often hold a multifactorial causal model, rather than just a genetic deterministic 
perspective.  
Condit et al. (2009) conducted a study with individuals who have physical and mental 
conditions. Through the use of interviews, these researchers asked participants what they 
think causes their disease? Then they prompted individuals with other causes not 
mentioned (i.e. behaviour and personal choice). Additionally, they provided vignettes with 
causal models (including genetics and gene-environment causes). These scholars found 
that individuals provided a variety of responses and in some instances these responses 
seemed contradictory. During the discussions individuals changed, adapted or modified their 
causal models to include factors not previously mentioned. In another study in the US, 
Parott et al. (2004) found that there was uncertainty about the role of personal behaviours, 
social environments, and religious faith on genes’ impact for human health. In their study, 
some participants reported believing that God plays a critical role in how genes are 
expressed and impact health. This provides further evidence that individuals may attribute 
the cause of their disease to multiple factors simultaneously. It also may suggest that 
introducing participants to particular causes may be likely to shift their original beliefs to 
some extent accommodate the new information they receive to their disease model. 
Globally, there is robust evidence reported over the past 20 years, suggesting that individuals 
from different contexts have complex causal accounts for disease and genetic explanations 
are just one of them (Condit, 2018). Most people seem to fluctuate between causal models 
based 
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on genetics, the environment (including physical, social and cultural), supernatural factors, 
individual will and chance.  
 
3.3. Concerns regarding genomics research 
 
Clinical and research institutions around the globe are generating enormous amount of genetic 
and genomic data through enrolling thousands of patients in large-scale studies (Garrison et 
al., 2019). Accompanying this increased interest in the field, Kong, Dunn and Parker (2017) 
propose that, it is critical to investigate the possible ethical, legal and social issues that such 
research raises. Scholars such as Munung et al. (2015); Marshall et al. (2014) and Tindana et 
al. (2012) comment on some of the important considerations when conducting this research in 
Africa. Munung et al. (2015) for instance discusses issues relating to the difficulty that 
genomics research participants (across numerous countries and cultural groups on the African 
continent) may experience in understanding genomics informed consent documents. Marshall 
et al. (2014) also highlights (in the context of Nigeria) the importance of investigating the 
comprehension of informed consent documents utilised for genomics research among African 
cultural groups. These authors suggest that it is important for researchers to consider various 
qualitative (Catz et al., 2005; Kinney, DeVellis, Skrzynnia & Millikan, 2001) and quantitative 
(Bottorff et al., 2002) strategies to examine the knowledge of research participants in genomics 
research, particularly because biomedical studies often employ complex terminology (Catz et 
al., 2005; Levin, 2016).  
 
In Ghana, Tindana et al. (2012) refers to the challenges of comprehending the implications of 
participating in genomics research (specifically in terms of long-term storage, sharing and re-
using of data and samples). These authors urge researchers to consider guidelines for the 
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protection of participants who may not fully understand the implications of genomics research 
and what it would reveal in relation to their personal genetic make-up as well as that of their 
family or community members. Situated amongst these ethical considerations is a concern 
about potential stigma arising from genomics research. De Vries et al. (2012) and Tekola et al. 
(2009) describe the potential of ethnic stigmatisation among African population groups 
enrolled in genomics research. The most pertinent issue they raise is the potential for genomics 
research to highlight particular cultural groups as being more susceptible to particular diseases.  
 
More importantly, Sabatello and Juengst (2018) report that a critical concern in genomic 
information about specific populations, is that it may trigger a negative response in societies. 
As mentioned before, this is especially pertinent when conducting research with already 
stigmatised or marginalised population groups (de Vries et al., 2012). In relation to the latter, 
there is a concern that a genetic focus on disease could increase stigma relating to the disease 
(Kong et al., 2017). This concern is arguably rooted in concerns over eugenics ( Savulescu, 
& Kerin, 1999) and in early experiences with genetic screening for conditions such as sickle 
cell disease in the US (Duster, 2003; Phelan, 2002). Taking a closer look at the concerns of 
stigma and genomic research, this phenomenon could run two ways: genetic information could 
reduce stigma by reducing some degree of personal responsibility for developing the condition 
(Angermeyer et al., 2011; Mehta & Farina, 1997; Phelan, 2005; Phelan, Cruz-Rojaz & Reiff, 
2011), or it could increase stigma by placing emphasis on conditions perceived to be 
fundamental and unchangeable, with little possibility for recovery or treatment (Angermeyer 
et al. 2011; Kong et al., 2017). In the context of mental illness, Kong et al. (2017) put forward 
that an increased focus on genetic causes for disease may contribute to deterministic thinking 
and essentialist views, which may increase the already present stigma of mental illness. 
Furthermore, these authors also postulate that a focus on genetic causes may distract 
P a g e  | 33 
 
 
researchers from attending to nonbiological causes. Contrastingly, Appelbaum (2017) attests 
that while this is possible, genomic research is not likely to be the main cause for increased 
stigma experienced by people with mental diseases.  
 
The hypothesis that genetic information may increase stigma is built on t h e  Attribution 
Theory for stigma, which hypothesises that disease-related stigma and associated 
characteristics like blame, rejection and anger are greater if the person suffering from the 
condition carries greater personal responsibility (Phelan, 2005; Phelan, 2006). This hypothesis  
has been empirically tested only relatively recently, with some of the first studies conducted 
just over a decade ago (Phelan, 2006; Rusch et al., 2010). The most systematic attempts at 
understanding the implications of genetic attribution on disease stigma have been made in the 
context of mental health research (Kvaale et al., 2013(1); Kvaale et al., 2013(2); Phelan, 2005; 
Sabatello et al., 2015; Shostak et al., 2009). In the US, Phelan (2005) examined how attributing 
SCZ to a genetic cause affects stigma (for this condition) in a series of quantitative and 
qualitative projects (Meiser et al., 2005; Shostak et al., 2009). It was found that while 
respondents were less likely to attribute blame for their condition to patients when a genetic 
cause was known – which could reduce stigma – they were less likely to think that the 
person’s condition could improve with treatment. These findings were echoed by Kvaale et al. 
(2013) in a meta-analysis of studies on the effect of genetic attribution on disease stigma 
(Laegsgaard et al., 2010). Phelan and colleagues also found some evidence that the social status 
of participants could be important in understanding the perceived importance of genetic 
information in understanding health outcomes (Meiser, Mitchell, McGirr, Van Herte & 
Schofield, 2005). Furthermore it was suggested that stigma may be extended to family 
members where a disease is attributed to a genetic factor (Shostak et al., 2009).  
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A US-based study investigating this relation on physical diseases included people with either 
breast cancer, deafness, cystic fibrosis or sickle cell disease (Sankar et al., 2006). These 
authors found that identifying a genetic cause for a disease or condition does not in itself 
increase or decrease stigma associated with a particular disease. Rather, they suggest that a  
genetic cause is interpreted in the context of patients’ “lived experiences with a particular 
condition” (Sankar et al., 2006). Based on their research in Brazil, Gericke et al. (2017) extend 
this suggestion and state that genetic attribution is influenced by education and personal 
experience. In New Zealand Breheny (2007) investigated genetic attribution and social 
distance (as a measure of stigma) in relation to schizophrenia, depression and skin cancer, and 
she also found no main effect for genetic attribution in relation to participants’ willingness to 
interact with an individual who has one of the three diseases. Hence, de Vries et al. (2012:11) 
suggests that genomics research may not cause stigma, however it may “feed into stigma 
where it is already present”. Furthermore, it could enhance other forms of harm (i.e. 
disadvantages from the family, community or governmental structures) to participants 
enrolled in this kind of research.   
 
Contrastingly, in the context of the US, Lebowitz and Ahn’s (2012) study involving patients 
experiencing depression found that a biogenetic attribution could help alleviate some of the 
guilt and shame associated with this mental illness. Another US-based qualitative study 
involving family members of people with bipolar disorder found that family members thought 
that genetic information could reduce stigma by taking away personal responsibility (Meiser 
et al., 2005). Phelan et al. (2006) also put forward the hope that genetic explanations of illness 
may influence public perceptions, which may decrease stigma and increase help-seeking 
behaviour among mentally ill patients. In contrast Sabatello et al. (2015), investigating the 
effects of genetic attribution on stigma related to epilepsy in a US sample, found that 22% of 
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their recruited participants (who were outpatients) reported an increase in stigma related to 
having received genetic information about their illness. Also, scores were increased among 
those who were unemployed, older, and who reported discrimination related to their disease 
(Sabatello et al., 2015).  
 
Shifting from the US context, a qualitative study in Denmark involving people diagnosed 
with depression found that patients had an expectation that genetic information about their 
disease may decrease stigma (McGregor, 2010). On the other hand, having a biomedical 
attribution of the disease could remove personal blame for patients. Kvaale et al. (2013), who 
compared attitudes to genetic attribution between mental health patients and members of the 
general public, found that the former tended to assume greater personal responsibility for 
their condition. Dietrich et al. (2006) found evidence that attributing mental illness to genetics 
may reduce desire for social contact from the general public towards the individual living with 
the disease. While in the review by Angermeyer et al. (2011) it was found that a biogenetic 
explanation has a positive association with stigma in relation to SCZ, but not necessarily other 
diseases.  
 
In summary, studies conducted on various diseases, mostly mental illness, present inconsistent 
evidence of whether or not genetic attribution to disease may increase or decrease stigma 
(Tekola et al., 2009). Because of the uncertainty of this possible implication on African 
populations and given the increase in genomics research in Africa, it is pertinent to at least 
explore whether there is a possibility that this kind of research may influence disease-related 
stigma experiences of Africans.  
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3.4. Discussions in the global context 
3.4.1. How people utilise genomic information 
3.4.1.1. Individual (Micro-level) 
In North American and European contexts - where much of the genomics research has been 
conducted - the implications of genomic information have been proposed to influence each 
level of society, including the individual, family, community and future social categories. At 
the individual level/micro-level (particularly for young people who are still developing their 
identity), the concern is that informing individuals about a genetic predisposition for a 
particular disease, may result in them developing fatalistic views about the onset of the disease. 
Concurrently, Sabatello and Juengst (2018) explain that this may impact on their beliefs of 
identity, self-worth, current and future plans in terms of career aspirations and having children 
of their own. Furthermore, Sabatello and Appelbaum (2016) attest that the distribution of 
adolescents’ genomic information may lead to personal and social consequences (including 
stigma and discrimination). Anderlik and Rothstein (2001) describe this as a violation of a 
child’s “open future”. These scholars further suggest that relaying information about a 
predisposition for a disease may also influence an individual’s subsequent behaviour (i.e. some 
may part-take in risky behaviour based on fatalistic views), in addition to it influencing their 
views on self-blame.  
 
One of the assumptions of genomics research, is that genetics informs on who we are, and who 
we can be. This idea that biology ultimately rules our individual fates (Petersen, 1998) remains 
a dominant understanding today, despite the greater acknowledgement from many geneticists 
in the 21st century that environmental and social factors may act as “triggers” that influence the 
manifestation of a genetically related disease. Based on the abovementioned assumption that 
genetics determines one’s ‘fate’ or future, scholars such as Anderlik & Rothstein (2001) and 
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Bates et al., (2005) report that some researchers’ express concerns in relation to the use of 
genetic information for genetic stigmatisation and discrimination; e.g. when obtaining medical 
insurance (by insurance companies who may access their genetic information) and employment 
(if employers access their genetic information). In the US, it is this fear which lead to the 
implementation of the Genetic Information Non-discrimination Act (GINA), which became 
effective in 2008 (Department of Health and Human Services, 2009). This act was established 
to protect Americans from discrimination based on their genetic information when accessing 
health insurance and employment. The NIH reported that GINA also has implications for 
individuals participating in genomics research. Hence, Hellman (2003) argues that genetic 
information is special, and warrants special protection for discrimination. Therefore, in the US, 
genomic research projects are scrutinized by ethics review boards to ensure that researchers 
have considered the guidelines outlined by this act when designing their studies (Department 
of Health and Human Services, 2009). Aside from GINA there are other laws focussing on 
protecting US citizens from discrimination based on genetic information. On the African 
continent no known similar laws exist yet for the protection of Africans, although South Africa 
has very robust discrimination legislation that equally prevents discrimination on genetic 
grounds.  
 
3.4.1.2. Family, Community and Public (Macro-level) 
Revealing a genetic predisposition to an individual often goes beyond the individual, as it also 
provides information about people they may share genetic ties with (e.g. biological relatives). 
The NIH National Human Genome Research Institute explains that genetic information 
includes;  family history, the manifestation of a disease in a family member and information 
regarding individuals and family genetic tests (Department of Health and Human Services, 
2009). Thus, if there are any possible implications based on the disclosure of genetic 
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information, there may be implications at the family and community level. Sharing genomic 
information may have implications on family dynamics (including fuelling tensions between 
parents, parent-child relationships and sibling-sibling relationships) (Anderlik & Rothstein, 
2001; Sabatello & Juengst, 2018). For instance, Sabatello and Juengst, (2018) maintain that 
blame may be shifted between the parents on who is responsible for causing the disease in the 
offspring or within parent-child relationships, there may be favouritism, or treating children 
differently (i.e. treating the child with a genetic predisposition more kindly, being 
overprotective over them or “labelling them” as the child with the gene to the disease). This 
may create conflict among the siblings as feelings of “othering” may emerge.  
 
Additionally, the psychosocial consequences of providing genetic information to an individual 
may shift from the individual to extended family members (i.e. through ‘associative/courtesy 
stigma’), further complicating the family dynamics and processes of blame, discrimination and 
stigma within families and communities. Revealing this information to the individual, family 
or community directly impacts the level of privacy (about one’s own genetic-make-up) that 
individuals have. Anderlik and Rothstein (2001) and Bates, Lynch, Bevan and Condit (2005) 
support the above by reporting that some US citizens who participated in their research were 
concerned that divulging genomic information may impact society as a whole. Anderlik and 
Rothstein (2001) elaborated that genetic information is connected to the individual and their 
population group’s identity. It may be easier to anonymise individual data, however it may be 
trickier to anonymise population groups. Therefore, protecting their privacy (by not sharing 
genetic information) may be as important for the individual as it is for their population group.  
 
In the media – which is a source often used to share genetic information - Bates et al. (2005) 
and Lynch et al. (2008) also indicate that, among others, concerns of the psychosocial 
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implications of genomics research include increased determinism and discrimination, 
positioning their argument particularly in relation to the public. It is important to note that 
projects such as the HGP and those employed by other health researchers have used media 
platforms to engage the public on human genetics. The impact of this type of broadcasting has 
also raised concerns among ELSI researchers. One reason for this concern being around the 
kind of platforms on which genetic information is relayed, as well as the content, as it can 
create a negative shift in how ordinary people may use genetic explanations to justify 
discrimination and determinism (Condit, 2010; Lynch et al., 2008). The definition of genetic 
determinism employed in this study is, “genetic determinism identifies genes as the sole 
relevant causal feature of an individual’s characteristics and life courses” (Condit, Parrott, & 
O’Grady, 2000, p. 558) 
 
Reydon, Kampourakis and Pattrinos (2012) and Sabatello and Juengst (2018) note that the 
manner in which genomics research is communicated to the general public (which often 
consists of people who typically have a poor understanding of genetics, genomics and its 
impact in society) creates distinct differences to what lay people know about genetics (Condit, 
2010). Which is understandable given Kerr, Cunningham-Burley and Amos’ (1998) view that 
the general public’s involvement in dialogues about genetic research is skewed, as these 
conversations are often controlled by more educated individuals who have been exposed to 
contexts where genetic attribution to disease may have been discussed. This is not common for 
many black South Africans, as many of them reside in small townships away from cities or 
rural areas and a smaller number in urban areas. Most of them have no access to an easy 
exchange of genomic information and education resources.  
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3.5. Chapter summary  
This introduced genomics research. It provides a short, yet valuable discussion on the concerns 
raised by scholars, primarily ELSI researchers, regarding the potential psychosocial 
implications of genomics research. The chapter describes how people may use genomic 
information, and how the information may affect the individual,  family and community levels. 
The next chapter describes the concept of the stigma construct, the stigma theory framework 
used in this study and how genetics may influence disease related stigma. 
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CHAPTER 4: STIGMA  
4.1. Introduction 
Stigma is a concept which is understood in different ways in different studies. This chapter 
provides an overview of stigma research, how it has evolved and describes the common 
concepts related to stigma which are discussed in the literature. The chapter also describes the 
stigma theory conceptual framework applied in this study. It also discusses mental illness and 
stigma, cardiovascular disease and stigma and concludes by considering how genetics may 
relate to stigma among African people with SCZ and RHD.  
 
4.2. Defining stigma  
Stigma, and later the concept of prejudice that has been incorporated into stigma research, stem 
from the works of Goffman (1963) and Allport (1954) who are pioneering authors in the field. 
Initially, the concept of stigma was associated with diseases such as mental disorders and later 
HIV, and the concept of prejudice and discrimination to status characteristics such as race, 
gender, poverty or sexual orientation (Pescosolido & Martin, 2015). In contemporary literature, 
scholars have begun to merge these concepts into one stream of stigma research due to the 
overlap of the conceptualisations (Phelan, Link & Dovidio, 2008). Dembling, Chen and 
Vachon (1999) note that there is, however, variation in the use of terms often discussing the 
same social phenomena. 
 
According to Goffman (1963), stigma is a mark, condition or status that is likely to lead to 
devaluation. Phelan et al. (2014) attest that primary consequences of stigma include status loss 
and discrimination, which often result in long-term social and economic inequality between 
those who stigmatise and those who are stigmatised. Although the majority of stigma research 
focuses on stigma in illness (Cocker, Bown & Henderson, 2016), disability or behaviour 
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(Phelan et al., 2005), there has been some work focusing on conditions, traits or situations such 
as poverty, sexual orientation and ethnicity (dos Santos, Kruger, Mellors, Wolvaardt & van der 
Ryst, 2014; Parker & Aggeleton, 2003; Simbayi et al., 2007). A more nuanced conceptual 
definition of stigma is provided by Link and Phelan (2001) as well as Byrne (2000).   
 
Stigmatisation is the social process whereby the mark affects the lives of those associated with 
that mark, condition or status (Link & Phelan, 2001). In their recent research, Link and Phelan 
(2014) propose a concept they identify as “stigma power”. This concept suggests that stigma 
is a process where stigmatisers aim to keep others (the stigmatised) down or away. This aim is 
often achieved by processes which are indirect, generally effective and disguised as taken-for-
granted cultural circumstances (Link & Phelan, 2014). These authors drew on the work of 
Bourdieu (1987) and Phelan et al (2008) to describe “stigma power” as the disguised, taken-
for-granted cultural circumstances that enforce or reinforce stigma processes.  
 
The “stigma power” process is the transference of particular characteristics through a social 
process. This process builds on existing social and power relations and dominant cultural 
beliefs about similarity and difference (Link & Phelan, 2001; Yang et al., 2007). According to 
these scholars, the stigmatisation process requires four aspects (a) distinguishing and labelling 
differences, (b) associating human differences with negative attributions or stereotypes, (c) 
separating “us” from “them,” and (d) experiencing status loss and discrimination. Pescosolido 
and Martin (2015) postulate that stigmas is “shaped and reshaped in particular cultural 
configurations that arise in social context, i.e., depending on time and place” (p. 91).  
 
Contemporary research differentiates between perceived stigma, endorsed stigma, anticipated 
stigma, felt/received stigma and enacted stigma. Perceived stigma is the belief that “most 
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people” will devalue or discriminate against the stigmatised (Pescosolido & Martin, 2015). It 
has been associated with a lower quality of life, low self-esteem, low quality of work or role 
functioning, as well as a decreased uptake of social activities (Alonso et al., 2009). Endorsed 
stigma can be understood as the agreement with commonly held stereotypes about the condition 
or disease. According to Pescosolido (2013) this is the most researched type of stigma. 
Anticipated stigma is defined as an individual or group expecting that others will devalue or 
stigmatise them (Pescosolido & Martin, 2015). Felt/Received stigma focusses on the 
stigmatised individuals, establishing their recollections of discriminatory or stigmatised 
behaviour acted towards them (Pescosolido & Martin, 2015). Enacted stigma refers to the 
experience of discrimination that a stigmatised individual is subjected to by others (i.e. 
members of the family or community) (Gray, 2002).  
 
The action-oriented stigma concepts often cited are internalised/self-stigma, 
courtesy/associative stigma, public stigma and structural stigma. Internalised/self-stigma 
involves an individual experiencing shame and an expectation of discrimination when being 
open about living with a condition that is vulnerable to stigma (Corrigan & Watson, 2002; 
Gray, 2002; Lee, 2002; Livingston & Boyd, 2010). Therefore, it can be viewed as the 
internalisation of negative attitudes, stereotypes and perceptions of people who belong to a 
devalued social group (Corrigan, Markowitz & Watson, 2004). Associative/courtesy stigma 
relates to the stigma experienced by caregivers or family members of an individual with a 
particular disease (Catthoor, Schrijvers, Hutsebaut et al., 2014). Public stigma refers to the 
reaction that individuals in the general public have to persons with an illness (Corrigan & 
Watson, 2002). Structural or institutional stigma, refers to the policies of private and 
governmental institutions that intentionally or unintentionally restrict opportunities available 
to people who have a particular disease (Corrigan et al., 2004; Lukachko et al., 2014).  
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Table 1 below lists the most commonly used terms in stigma research, many of which are used 
in this thesis (adapted from Pescosolido & Martin, 2015). This list is not exhaustive, however, 
to better understand how stigma is described in the literature, it tries to provide the conceptual 
definitions often used in stigma research.  
 
Table 1: Theoretical building blocks of stigma research 
Basic concepts 
Stigma A deeply discrediting attribute; “mark of shame”; 
“mark of oppression”; devalued social identity 
Stigmatisation A social process embedded in social relationships that 
devalues through conferring labels and stereotyping 
Labels Officially sanctioned terms applied to conditions, 
individual, groups, places, organizations, institutions, 
or other social entities 
Stereotypes  Negative beliefs and attitudes assigned to labelled 
social entities 
Prejudice Endorsement of negative beliefs and attitudes in 
stereotypes 
Discrimination Behaviours that act to endorse and reinforce 
stereotypes, and disadvantage those labelled 
Target variants 
Perceived Belief that “most people” will devalue, discriminate 
the stigmatised 
Endorsed Expressed agreement with stereotypes, prejudice, and 
discrimination 
Anticipated Expectations of experiencing prejudice and 
discrimination among the stigmatised 
Received/felt Overt behaviours of rejection and devaluation 
experiences of negative interactions 
Enacted Behaviours of differential treatment by stigmatisers 
Action-oriented 
Internalised/self-stigma Internalised acceptance of stereotypes and prejudice 
Courtesy/associative 
stigma 
Stereotypes, prejudice, and discrimination by 
association with marked groups 
Public stigma Stereotypes, prejudice, and discrimination endorsed 
by the general population 
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Structural stigma Prejudice and discrimination by policies, laws, and 
constitutional practice; also called institutionalized 
Stigma 
Table 1 adapted from Pescosolido & Martin (2015) 
 
4.3. Stigma Theory conceptual framework  
This study is guided by the Stigma Theory conceptual framework of mental illness stigma, 
which is used in this research to position the discussion of internalised stigma and attribution. 
Exploring whether internalised stigma related to disease is particularly prevalent within certain 
populations is an important consideration for health promotion and prevention strategies 
(Livingston & Boyd, 2010). For this study, internalised stigma is the focus because it is a risk 
for increasing negative outcomes for persons living with a physical or psychological disease. 
These outcomes may include non-adherence to medication and decreased help-seeking. 
Theorists Corrigan and Watson (2002) distinguish between public and internalised stigma. 
These two types of stigma have three components, namely: (1) negative associations with 
particular human characteristics or disease (stereotypes), (2) beliefs in the negative associations 
(prejudice) and (3) the social consequences of these negative associations (discrimination) 
(Corrigan & Watson, 2002). Thornicroft, Rose, Assam and Sartorius (2007) and Thornicroft, 
Brohan, Kassam, Lewis-Holmes (2008) propose that the first is related to problems of 
knowledge or misinformation (ignorance), the second is about attitudes (prejudice) and the 
third is associated with action or behaviour (discrimination). The concepts of stereotypes, 
prejudice and discrimination have been used by various other authors (e.g. Heatherton, Klerk, 
Helb & Hull, 2000; Levin & Laar, 2006). Whilst Corrigan and Watson (2002) apply these 
concepts to the context of mental illness, other scholars such as Parker and Aggleton (2003) 
have applied this framework to stigma research on other diseases like HIV for example. 
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For this particular study, this framework was selected to position the discussion for three 
reasons: (1) this is the framework which is most cited in mental health stigma research (which 
is where a robust amount of research has been conducted on disease stigma), (2) this framework 
closely relates to the concepts of stigma described by the well-established stigma theorist 
Thornicroft in the area of stigma research, and (3) this framework has been applied to studies 
involving both mental illness and ones focussing on physical diseases. Figure 1 below presents 
the schematic presentation of the conceptual framework. 
 
 
 
 
 
 
 
 
 
 
Figure 1: Stigma’s two dimensions (Internalised and Public) and three components 
(Stereotypes, Prejudice and Discrimination) (Corrigan & Watson, 2002; Corrigan et al., 2004). 
 
3.2.1. Components of Stigma Theory: Stereotypes, prejudice and discrimination 
Stereotypes  
Angermeyer and Dietrich (2006) describe stereotypes as commonly held beliefs about a group 
of people that are used to categorise the group members and anticipate their behaviour. In 
relation to internalised stigma (which this study focusses on), negative stereotypes are 
Stigma 
Internalised Public 
Stereotypes Prejudice Discrimination 
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internalised by individuals belonging to the “categorised” or “devalued” group. This means 
that the individual believes the negative stereotypes to be true of themselves and others who 
have the same condition (Quinn, Williams & Weisz, 2015). Corrigan and Rao (2012) describe 
the consequences of the internalisation of stereotypes as leading to fears of rejection, 
discrimination and a lowered self-concept experienced by individuals living with the disease. 
For example, much research has reported people with SCZ to be more dangerous, unpredictable 
and weak (Angermeyer & Dietrich, 2006). These beliefs about people with SCZ may lead to 
particular stereotypes. People with RHD have in some form or another been suggested to be 
weak, especially women because they are viewed as having fewer chances to obtain 
employment (Faure, 2018) or bearing their own children (Chang et al., 2018). These negative 
beliefs or stereotypes have been reported to have an impact on self-concept and self-esteem. 
Thachuc (2011) for example reports that stereotypes can be more disabling than the illness 
itself because they create a set of held beliefs which influences action/behaviour. For instance, 
negative stereotypes held by health professionals (see Adewuya & Oguntade, 2007; Li, Li, 
Thornicroft, & Huang, 2014; Thornicroft, Rose & Kassam, 2007) may prevent people with 
SCZ from seeking medical treatment for their disease (Angermeyer & Dietrich, 2006; Boyd, 
Katz, Link & Phelan, 2010; Rusch, Angermeyer & Corrigan, 2006; Pescesolido et al., 2010). 
Furthermore, Chang et al. (2018) report that women with RHD not only often refrain from 
consulting with health professionals about their reproductive decisions, but many of them 
ignore the opinions of health professionals and take “risks” by becoming pregnant without 
consultation because of the negative or judgemental responses they receive from health 
professionals when they articulate their desire to bear children. Not being children results in 
judgement from members in their family and community (Chang et al., 2018), which can 
further fuel internalised stigma.   
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Prejudice 
Corrigan and Watson (2002) describe that a person is prejudiced when they believe a stereotype 
or perception. Thornicroft et al. (2007) describe that prejudice is more likely to lead to 
discrimination than stereotypes themselves. This is based on the knowledge that prejudice does 
not only result in negative thoughts about the stigmatised persons, but also results in negative 
emotions towards them, such as anxiety, anger, disgust, resentment, distaste or hostility, which 
may all influence behaviour (Corrigan & Watson, 2002; Thornicroft et al., 2007; Phelan et al., 
2008). Experiencing emotions of disgust for instance, may result in the action of social 
distancing from a person forming part of a “devalued” group. If individuals are prejudiced 
about people who have a particular disease, they tend to endorse actions that discriminate 
against those people (Phelan et al., 2008). It is worth noting here that prejudice is often cited 
as a common concept in research related to race and racism, and similarly so, the action of 
discrimination is also often associated with issues of race and racism (Dovidio, 2001). This 
may be because these issues relate to the internalisation of negative beliefs (prejudice) and the 
actions linked to them (discrimination).  
 
Discrimination 
Discrimination is described as a behavioural response to the negative stereotypes and prejudice 
described above (Corrigan & Watson, 2002). Discrimination can result in the “harm” or 
oppression of a stigmatised group of people. For example, discriminatory behaviour toward 
people who have SCZ would be to refuse them employment opportunities, decent healthcare, 
housing and sometimes falsely accusing them of violent crimes (Corrigan & Watson, 2002; 
Phelan & Link, 2005). For instance, in a study done in the UK, black Caribbeans and mixed 
ethnicity patients who had a mental illness reported higher rates of discrimination than their 
white counterparts (Hatch et al., 2016). Similarly, in a study measuring anticipated and 
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experienced discrimination among people with schizophrenia, bipolar and depression in the 
UK, it was found that 87% experienced discrimination. In that study, higher levels of 
experienced discrimination were reported by individuals belonging to ethnic minority groups 
(Farelly et al., 2014). A multi-centre study in 27 countries found high experiences of 
discrimination among patients with a mental illness (Thornicroft et al., 2009). 
 
Du Plessis et al. (2004) refers to research by Zerwech (2000: 54) and Mhaule & Ntswane-
Lebang (2009) who describe the experiences of Xhosa people with SCZ with a mental illness. 
These authors suggest that this group of people maintain a level of secrecy about a mental 
condition of a family member. These authors also highlight that the individual with the illness 
themselves, are often encouraged to or choose to isolate themselves from social engagements, 
leading to limited exposure to situations where they may experience discrimination.  Hence, 
Zerwech (2000: 54) comments that the consequence of a lack of understanding and support 
from family and community members results in self-isolation by the person with a mental 
illness.  
 
In Uganda, women with RHD reported being discriminated against in obtaining employment 
and anticipated of discrimination regarding their reproductive prospects (Chang et al., 2018). 
Faure (2018) found that mixed-ancestry RHD patients in the Western Cape reported 
discrimination experienced by women because of not being able to do as many household 
chores or engage in physical activities as they did prior to their diagnosis, which sometimes 
resulted in being excluded from community activities which were meaningful to them. An 
anticipation of discrimination can also result in people not participating fully in certain aspects 
of their lives, which can create negative feelings and reactions.  
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Jones (1997) defines discrimination as repeated indignities that deny people in the stigmatised 
group benefits that are available to those who do not fall part of that group. The nature and 
expression of prejudice and racism, however, depends on a number of dynamic processes 
closely relate to structural stigma (Dovidio, 2001). The Xhosa population enrolled in this study 
may therefore experience layers of discrimination based on: (1) racial categorisation, (2) 
disease label, and (3) socioeconomic status. Because of the possible real-life consequences of 
stigma, if there is any possibility that genomics research could increase the stigma they 
experience, then it is essential to understand better when and how this may occur and could be 
prevented.  
 
4.4. The implications of stigma 
Stigma has a significant negative impact on individuals living with disease, consequently 
affecting many aspects of their external lives, including relations with friends, family, 
communities, employers, healthcare services and the justice system (Mental Health 
Commission of Canada, 2009, p.90). Internalised stigma has been found in people with mental 
diseases, however research investigating internalised stigma in people with physical diseases 
is rare (Corker et al., 2016). Ritcher, Otilingam and Grajales (2003) conclude that internalised 
stigma impacts the self-esteem of people with the illness. Individuals labelled with a disease 
label who live in a culture with dominant stereotypes about the disease may anticipate and 
internalise attitudes that are based on the discrimination they have received (Corrigan, Larson, 
& Ruesch, 2009). Corrigan et al. (2009). Ritcher et al. (2003) and Link, Struening, Neese-Todd, 
Asmussen & Phelan (2001) demonstrated the relationship between internalised stigma and low 
self-esteem. Low self-esteem may prevent individuals from seeking relationships, 
employment, decent housing and even healthcare services for the fear of rejection or being 
viewed as weak. The hesitancy to seek healthcare for the fear of being associated with the 
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disease label – i.e. in the public hospitals in South Africa where there are clear signs of wards 
for patients with mental illness – may influence adherence to medication and ultimately the 
recovery process.  
 
4.5. Mental illness and stigma  
SCZ is a highly stigmatised condition and has been defined as a psychiatric disease for over a 
century, but despite decades of research, a definitive set of biological markers for the disorder 
is still not available, nor are there any existing preventative or curable treatments (Abayomi et 
al., 2014).  Despite the fact that this disease is not curable, there are potential ways to improve 
lived experiences of people with a SCZ diagnosis with the help of pharmaceutical and 
psychotherapeutic interventions. However, in the South African context, as is reported in other 
LMIC, the majority of people living with mental diseases do not have access to adequate 
mental healthcare services (Lund et al., 2012). 
 
Lund and Fisher (2009) point out that many of the facilities providing mental healthcare in 
South Africa are chronically under-resourced. Barriers to accessing mental healthcare include 
among others: poverty, poor mental health literacy, stigma and the influence of cultural beliefs 
(Naanyu, 2009). Furthermore, due to the fact that mental healthcare services are mostly 
integrated into primary healthcare (i.e. the community clinics with clearly marked labels of the 
psychiatric sections), patients are potentially exposed to public scrutiny (Botha et al., 2006; 
Swartz, 1998).  With the exception of Botha et al. (2006) and Sorsdahl, Kakuma, Wilson, & 
Stein (2012), minimal research has been documented on the topic of internalised stigma in 
relation to mental illness (from the perceptions of patients) in South Africa. In their study, 
Botha et al. (2006) found a high level overall degree of perceived stigma reported by 
schizophrenia patients. Additionally, these authors suggest that their stigma may also be 
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influenced by contextual and cultural factors. As described by Satorius (2005) different fears 
and prejudicial judgments may be prevalent in relation to stigma in different cultural groups. 
Physical abuse as a demonstration of stigma due to having a mental illness was highly reported 
by male Xhosa-speaking patients who had frequent hospitalisations for longer periods in Botha 
et al’s (2006) study. Sorsdahl et al. (2012) found that internalised stigma is not always a 
consequence for people with depression. However, where it is present, it is significantly related 
to social withdrawal and discrimination.  
 
Generally, the South African public tends to be more stigmatising towards patients diagnosed 
with SCZ in comparison with patients diagnosed with other mental disorders (Mbanga et al., 
2002). In addition, caregivers and family members of patients with SCZ have demonstrated a 
tendency to perceive these patients as dirtier, weaker, more unpredictable, worthless, delicate, 
slow, foolish and more dangerous than the average person (Hughes & Huby, 2002; Mbanga et 
al., 2002; Sorsdahl et al. 2012). Anecdotal reports from traditional healers suggest that these 
patients are rejected and ridiculed by their communities (Pain, 2012). Hence their life 
opportunities are decreased and employment, suitable accommodation and suitable life care of 
people with SCZ may be negatively affected.  
 
There is much research on stigma and mental illness on African population groups (Adewuya 
& Makanjuola, 2005; Adewuya & Oguntade, 2007; Patel, 1995; Seedat, Stein, Berk, & 
Wilson, 2002). While evidence suggests that African people with SCZ are stigmatised 
(Naanyu, 2009), a gap in this literature is that the perceptions of the people living with SCZ 
themselves have been largely ignored. Much of the available research has included members 
of the general public, family members or traditional healers to the exclusion of patients 
themselves. This study is unique in that it explores the SCZ patients’ own perceptions. 
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Following Naanyu’s (2009) research on social context, attribution and stigma in South Africa, 
this study is one of the first to explore the possibility of a genetic explanation to disease 
influencing internalised stigma experienced by a South African patient population group.  
 
4.6. Cardiovascular disease and stigma  
The second disease focussed on in this study is RHD. This population group was selected for 
inclusion in this study for three reasons. Firstly, as mentioned before, ethics committees often 
highlight stigma as a potential concern when considering genomics research projects for all 
disease groups (de Vries et al., 2012; WHO, 2002). It is thus important to better understand 
whether this is a valid concern, and if so, how genetic attribution of physical, non-stigmatised 
conditions could possibly influence stigma. Secondly, this disease group was deemed suitable 
for inclusion due to fact that during the time when the study was developed, the Faculty of 
Health Sciences at UCT conducted the largest ongoing genomics project in Africa that 
enrolled patients with RHD (the Genetics of Rheumatic Heart Disease study). This provided 
a unique opportunity to recruit patients who had been involved in a genomics study, to enrol 
in this particular study that investigates a potential ethical or social implication of genomics 
research.  Furthermore, in similar ELSI genomics studies in the context of the USA for 
instance (see Condit et al. 2009) researchers have investigated the psychosocial implications 
of genomics research across very different diseases (e.g. Condit et al., 2009 focussed on heart 
disease, lung cancer and depression). Thirdly, focussing on a mental illness (which may be 
perceived as more stigmatised) and a physical disease (which may be perceived to be 
generally less stigmatised) may reduce the chances of mistakenly suggesting general 
conclusions relating to the concern that genetic attributions may influence stigma in similar 
ways across mental and physical disease groups based on the findings of one disease group, 
which is known from the literature to already be vulnerable to stigma. 
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RHD is a chronic heart condition caused by untreated infection with Streptococcus 
pharyngitis, also known as Strep A (Carapetis, McDonald & Wilson, 2005). In some patients, 
untreated Strep A sore throat can cause rheumatic fever, which in turn can cause an 
autoimmune reaction that attacks the tissue of heart valves. Repeated infection with Strep A 
can cause cumulative damage to the heart valves, leading to serious and potentially lethal 
heart damage (Carapetis et al., 2005) that can only be effectively mediated with surgery. 
Globally, RHD remains the most common cause of heart disease in children and young 
adults (Robertson, Volmink & Mayosi, 2006) with about 30 in 1000 schoolchildren affected 
in Sub-Saharan Africa (Robertson & Mayosi, 2008). 
 
RHD has been described as a disease of poverty that largely affects marginalised 
population groups (Barth, 2013; Chang et al., 2018; Engel et al., 2011; French & Poppas, 
2018; Zuhlke, 2015). It is a rare phenomenon in wealthy countries with incidences increasing 
under the influence of poverty (Robertson & Mayosi, 2008). In South Africa for instance, the 
prevalence of RHD runs parallel with a host of variables indicating poverty, such as crowded 
housing, poor nutrition and low levels of education (Barth, 2013). 
 
In a systematic review of published twin studies, Engel et al. (2011) estimated the 
heritability for developing rheumatic fever to be 60%. Ironically, the prevention of RHD is 
both affordable and effective ( Irlam, Mayosi, Engel & Gaziano, 2013), as primary care 
treatment of sore throat infections with penicillin prevents the development of RHD, whilst 
prophylactic use of penicillin in RHD patients prevents recurrent infections and further 
damage to heart valves. Concerning estimates suggest that there are 15.6 million prevalent 
cases of RHD worldwide, with 282,000 new cases and over 233,000 deaths per year (Zuhlke 
& Steer, 2013).  
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RHD is often detected at higher rates in women than men due to the physiological changes 
experienced by women during pregnancy, which includes increased blood volume and heart 
rates (French & Poppas, 2018). RHD may often only be diagnosed in pregnancy. If RHD is 
diagnosed at a young age, then women are usually discouraged from getting pregnant, because 
of the possible complications which may arise (Zuhlke, 2011). Due to the risks of 
complications for the mother and offspring (French & Poppas, 2018), women with RHD are 
often discouraged by medical practitioners to bear children. The social consequences of not 
bearing children, however, are often a cause for stigma among women in Africa living with 
RHD (Chang et al., 2018).  
 
The only other two known studies that explored the stigma experiences of people with RHD in 
an African population group (Chang et al., 2018 & Faure, 2018) used a similar methodological 
approach to the present study. Chang et al. (2018) conducted FGDs with 75 women living with 
RHD in Uganda (Chang et al., 2018). Fifty out of the seventy-five women completed a stigma 
questionnaire designed by the authors. Participants in their study reported considerable stigma 
in the domains of reproduction and financial limitations (Chang et al., 2018). The authors found 
that the stigma reported by the participants was often worse than the stigma reported by patients 
with HIV in their context (Chang et al., 2018). Faure’s (2018) study explored the impact of 
genetic attribution on stigma associated with RHD among mixed-ancestry patients in the 
Western Cape, South Africa. Eleven FGDs were conducted with 52 mixed-ancestry patients 
with RHD, 70% of which were women. Findings from that study suggest that RHD stigma is 
impacted by various contextual realities that are largely shaped by the historical racialised 
nature of marginalisation and structural inequality of the South African context (Faure, 2018). 
Despite the limited number of studies involving RHD patients and exploring stigma, we 
anticipated that Xhosa people with RHD would share similar disease stigma experiences, 
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particularly given that it is a disease of poverty, and in conjunction with the other stigmatising 
factors they face (i.e. social inequality, low-levels of education, lack of adequate healthcare 
services, high unemployment rates etc.).  
 
4.7. How genetics may relate to stigma 
DiMillo et al. (2015) define the concept of genetic stigmatisation as a negative label by virtue 
of membership to a particular group that has been described as being genetically deviant. These 
authors identify three types of stigmatisation associated with genetics, namely; (1) 
stigmatisation through anticipation, (2) stigmatisation through rejection, and (3) stigmatisation 
by affiliation (DiMillo et al., 2015).  
 
Reasons for genetic stigmatisation have been discussed as firstly, genetic illiteracy among 
health professionals, the public and policy-makers (King et al., 2002). One example is the 
genetic testing of African Americans for sickle cell disease in the US in the 1970s. During that 
time there was confusion among physicians, and subsequently the general public, in 
understanding the results between carriers of the disease and people who actually had the 
disease. The second reason may be what Markel et al. (1992) describe as the “quarantine 
mentality”, which refers to society attempting to keep people who carry specific genes “out” 
or “away” from the general or “normal” population who do not have those genes, as Link and 
Phelan (2014) allude to in their conceptualisation of the “stigma power” concept. These 
individuals are seen as inferior and “different” (i.e. othering). This may be done as an attempt 
to prevent the genes from being passed down to the next generation or as an attempt to keep 
the “normal” people “pure” (Sabatello & Juengst, 2018). Similarly, ethics committees often 
raise concerns about stigma as a result of genomics research, regardless of the disease under 
investigation.  
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The WHO (2002) report suggests that genetic stigmatisation can occur for any disease. In this 
research we enrolled participants who either had SCZ or RHD and were participants in one of 
the ongoing genomics studies in the Faculty of Health Sciences at UCT. These two parent 
projects are discussed in Chapter 6, section 6.6.  
 
4.8. How genetics may relate to stigma in SCZ and RHD genomics research 
Rotimi and Marshall (2010) propose a list of ten cultural and social factors to consider when 
compiling informed consent forms for conducting any genomics research in Africa. One of 
these ten factors is the potential for stigmatisation of specific population groups. These authors 
attest that the social and cultural meanings of disease held by the people in the population group 
under investigation should be considered with sensitivity prior to highlighting genetic 
attributions about their disease. A physical disease named Podoconiosis – a disease resulting 
in the swelling of the lower limbs of the legs of people exposed to red soil – is highly prevalent 
in some regions of Africa, such as in Ethiopia for instance. It is a physical disease that is highly 
stigmatised (Rotimi & Marshall, 2010). Researchers engaging in a genomics study focussing 
on Podoconiosis (Tekola et al., 2009) found that participants were afraid to participate in the 
research because they were fearful that receiving information about the genetic nature of the 
disease may contribute to an increase in social stigma.  
 
While this is a physical disease, and considering that genomics research on African populations 
has only just started over the past few years, it is unclear whether Xhosa people involved in 
schizophrenia and rheumatic heart disease genomics research may feel that genomic 
information about their disease in any way relates to their internalised stigma experiences. 
While we know that SCZ is a stigmatised condition, and there has been some stigma reported 
on RHD, if there is a possibility that providing genetic information as a cause may increase 
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internalised stigma, it is important to explore how that may be possible. This possibility is 
important to consider because, as Rotimi and Marshall (2010) propose, genomics researchers 
have a responsibility to investigate whether stigma is a potential risk for African population 
groups involved in genomics research. This study may contribute to gaining an understanding 
of the relevance of this concern amongst the Xhosa people with SCZ and RHD enrolled in this 
study. It may help the continuously evolving field of genomics and ELSI research to consider 
the ways in which genomics research could potentially relate to stigma of common physical 
and mental diseases in Africa, and thus insert measures to protect against that in future study 
designs.  
 
4.9. Chapter summary 
There is a robust amount of literature related to mental illness and stigma. However, there is 
not much literature focussing on cardiovascular disease and stigma, both globally and in Africa. 
Most research on stigma and disease has been conducted in North American and European 
context. This chapter provides a description of the concepts often used in the literature to 
explore stigma. Given that Africa has a unique context with diverse population groups, these 
concepts are applied in this study with caution and openness to the conceptualisations of stigma 
that may emanate from this African population group.  
 
 
 
 
 
 
P a g e  | 59 
 
 
CHAPTER 5: THEORETICAL FRAMEWORKS 
5.1. Introduction 
In this chapter I discuss the theoretical frameworks that are utilised in the current study. The 
research in this thesis is guided by the Attribution Theory (Weiner, 1986) and the Modified 
Labelling Theory (Link & Phelan, 2001). The constructs of the theories, synergies between the 
constructs and how they could relate to the research findings are explored. 
 
5.2. The Attribution Theory   
The first theory this study employs is the Attribution Theory (Weiner, 1986; 1995). Attribution 
Theory (Weiner, 1986; 1995) refers to a collection of models and theories that focus on creating 
an understanding of the process that involves people forming inferences about the cause of 
events or disease (i.e. causal attributions) and the consequences of these causal explanations 
(Fiske & Taylor, 1991). Attribution Theory was selected as one of the suitable theoretical 
frameworks for this research for two reasons. First, this theoretical framework is useful because 
it specifically focusses on perceptions of causation rather than the actual cause or the accuracy 
of these causal beliefs. Dovidio, Major and Crocker (2000) articulate that attributions typically 
involve explanations about beliefs on causes, actions, or conditions. Perceptions of causes of 
disease are thought to influence subsequent cognitive, affective and behavioural responses.  
 
Secondly, we found the Attribution Theory a suitable model to guide this research because, in 
his later work Weiner (1995; 1998) suggests that the Attribution Theory can also be used to 
describe whether or not an attribution can lead to stigmatised perceptions and discriminatory 
behaviours. Concurringly, Corrigan (2000) describes attribution theory as a cognitive 
emotional process whereby individuals make attributions about the cause and controllability of 
the individual’s disease. 
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Many attribution theories report that people are motivated to make causal attributes in order to 
firstly, gain an understanding of their world and past events, and secondly, to guide future 
behaviour and enable greater predictability and control over their environments (Harvey & 
Weary, 1984). Weiner (1986; 1998) puts forward that by identifying the cause of the disease, 
an individual may have the ability to assess which actions may be taken, if any, to minimise 
the reoccurrence of negative outcomes in the future, as well as maximise the probability of a 
desirable outcome.  
 
Being one of the first theorists to classify Attribution Theory and coin the attribution theory of 
motivation and emotion, Weiner (1986) identified three main dimensions, namely locus, 
stability and controllability. Each of the dimensions has predictable psychological and 
behavioural consequences (Corrigan, 2000). An internal locus of causality suggests that the 
disease onset is a result of dispositional factors originating from the individual, while an 
external locus of causality implies that contextual factors constrained the individual to the 
extent that they developed the illness. Furthermore, where there is an internal locus of causality, 
it is not always under the individual’s control. An example of this might be that while an 
individual’s genetics can be considered to be internal, genetic composition is not considered as 
being within the individual’s control. Also, Weiner (1986) defines stability and controllability 
by proposing that the stability of a cause refers to its perceived degree of permanence over time 
(some illnesses remain stable over time, while others increase or decrease), as opposed to 
controllability, which refers to the degree the cause is believed to be under the individual’s 
control. An example of controllability may be an individual choosing to abuse substances, eat 
unhealthy food and not exercise, which may influence the onset and stability of a disease. On 
the contrary, one cannot control something like blindness.  
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Essentially, it is possible that there is more than one factor that makes one susceptible to 
developing a disease. These factors may be located differently in terms of Weiner’s (1986) 
three dimensions. Furthermore, perceived causality may vary between individuals living with 
the same disease diagnosis. It may also vary within a single individual at different times, both 
for the cause and the location of the cause on the three dimensions. Hence Weiner (1986) 
suggested that each causal dimension is related to a specific set of emotions that emanated or 
is enhanced because of the disease onset.  
 
Fundamentally this study draws on the Attribution Theory’s process to associate causal 
attributions and likely responses to the disease onset. Corrigan and Watson’s (2002) conceptual 
framework of stigma (as described in Chapter 4, section 4.3) and Weiner’s (1986) Attribution 
Theory have been used in this study in order to better understand the process of a potential 
genetic attribution to disease and its potential influence on stigma experienced by SCZ and 
RHD Xhosa patients. Next, the Modified Labelling Theory will be discussed, which is also 
used in this study to inform the epistemological underpinnings (Link, Cullen, Stuening, Shrout 
& Dohrenwend, 1989).  
 
5.3. The Modified Labelling Theory 
The Labelling Theory views the label, rather than the outcomes of having the label as shaping 
the fate of mentally ill persons (Rosenfield, 1997). A label of a mental illness is believed to 
create negative attitudes (held by others and the person with the illness) (Link, 1987; Link et 
al., 1989). This theory maintains that the label creates a state of chronic illness through 
compromising the opportunities afforded to the person with the label (Scheff, 1966; as cited in 
Rosenfield, 1997).  
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The theory has received considerable critiques from the medical model of mental health due to 
the disagreement between the importance of the behaviour and the label assigned to it resulting 
in the negative social response (Link et al., 1989). One of the main criticisms being that the 
Labelling Theory places less importance on factors such as stigma and stereotyping. Link et al. 
(1989) therefore draw on the Labelling Theory (Scheff, 1966) and extend it into what they call 
a Modified Labelling Theory (MLT). Like Scheff (1966), step one of their proposed theory lies 
in that individuals internalise social conceptions of stereotypes related to having a mental 
illness. This is when individuals begin to distinguish and assign labels to individuals with a 
stigmatisable attribute or disease (Link & Phelan, 2001). These conceptions are guided by two 
elements: first, the extent to which people (with and without the label) believe that persons will 
be devalued, and second, their perceptions of these individuals experiencing discrimination. 
Step two involves official labelling through treatment contact, for instance in whether or not 
people maintain social distance from a person with an illness. An example of this component 
is described by Link and Phelan (2001) regarding a vignette experiment conducted by Link 
(1987) where when the vignette described a person with mental illness, the response from 
participants in general were “dangerous” and an increased desire for social distance, while 
when it described a person with back pain the participants did not express a relation to 
dangerousness and/or an emphasis on social distancing. Step three focusses on patients’ 
responses to their stigmatisation process. Link and Phelan (2001) describe the labels to connote 
a separation between “us” and “them”. These authors maintain that in extreme cases, 
individuals falling in the “them” group are treated horrifically. Step four includes the 
consequences of stigma process on the patients’ lives. At this stage, individuals with the label 
experience consequences of status loss and discrimination (Link & Phelan, 2001). Using the 
Modified Labelling Theory together with the Attribution Theory, this study aims to understand 
the relation between attributing a labelled disease (in this case SCZ and RHD) to a particular 
P a g e  | 63 
 
 
causational model and how that could influence the stigmatisation process experienced by 
individuals with that disease. This study applies these theories bearing in mind that they were 
developed in very different contexts and that different cultures have been reported to assign a 
variety of attributions to disease onset (Naanyu, 2009). 
 
5.4. Chapter summary 
This chapter outlined the theoretical paradigms used in this study. These theoretical 
frameworks were used in the research with the hope to elucidate the relation or association 
between attributions, disease labels and stigma experienced by Xhosa people with SCZ and 
RHD. The Attribution Theory and the Modified Labelling Theory are integrated in the study 
in order to better understand the constructs they explore. In support of Phelan et al.’s (2008) 
position that stigma is contextual and the unique social milieus important when trying to 
understand the stigma process of different population groups, the research methodology 
employed in this thesis will be discussed in the next chapter.  
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CHAPTER 6: RESEARCH METHODOLOGY 
6.1. Introduction  
In this chapter I will first outline the problem statement and the focus of the study. I then 
provide an explanation of the research aims and research design. I also provide an overview of 
sampling strategies, the study setting, samples, data collection and data analysis. Furthermore, 
I detail the development of the research instruments and how they were utilised in the study. 
In the chapter I provide a detailed account of the development use of the instruments used in 
the FGD process. I also briefly mention the translation of the Internalised Stigma scale (an 
extensive elaboration of which is discussed in Chapter 9 of this thesis). In this section, I also 
reflect on my own position as researcher. The chapter concludes with a discussion of the ethical 
considerations pertinent to the study and a chapter summary. 
 
6.2. Problem area and focus 
Problem area: The adoption of the Human Genome Project, the increasing interest in genomics 
research and associated increase in funding this research agenda led to a number of ethical and 
social concerns. Implications of genomics research, particularly within specific population 
groups, need to be taken into account by researchers. One concern is that the results of 
genomics research could create or increase stigma for individuals who have diseases that are 
known to have a genetic or a hereditary basis (Sankar et al., 2006). Although the concern about 
stigma is identified broadly for all medical genomic projects including those investigating 
illnesses that do not have a clear genetic basis (WHO, 2002; Yakubu, Tindana, Matimba, 
Littler, Munung, Madden … de Vries, 2018). The concern of stigma has been identified as 
particularly important because genomics research is only just advancing on the African 
continent, and it is important to recognise that studies may involve participants who have 
different language and cultural backgrounds governed by different belief systems. Some 
P a g e  | 65 
 
 
participants may be from populations which are marginalised or already stigmatised (Yakubu 
et al., 2018). These nuances ought to be considered sensitively. Much of the research 
investigating this potential implication has been conducted in North American and European 
contexts on diseases that are already stigmatised like schizophrenia. Whether or not the same 
risk of stigmatisation is apparent in an African contexts and with populations which are not yet 
known to experience disease-related stigma remains unexplored to date.    
 
Focus: The general aim of this study is to explore how genetic attribution of disease may relate 
to the internalised stigma experiences of South African Xhosa people with schizophrenia and 
people with rheumatic heart disease.  
 
This research project focussed on exploring how a genetic attribution to disease relates to 
internalised stigma experiences of South African Xhosa people with schizophrenia and people 
with rheumatic heart disease.  
 
6.3. Research aims  
This study aims to explore how genetic attribution to disease relates to the internalised stigma 
experiences of South African Xhosa people with schizophrenia or rheumatic heart disease.  
 
6.4. Research questions 
1. What causal models are employed by Xhosa people with schizophrenia and people with 
rheumatic heart disease to explain their illness, and to what extent do genetic 
explanations play a role in these causal models?  
2. What are the internalised stigma experiences of Xhosa people with schizophrenia and 
rheumatic heart disease?  
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3. How do the genetic disease causal explanations of Xhosa people with schizophrenia 
and rheumatic heart relate to their internalised stigma experiences, if at all? 
 
6.5. Research design 
The research design is one of the most important aspects of a research study as it provides 
guidance for the research process, and the interpretation of the results (Gobo, 2008). The 
present research is explorative and descriptive in nature and through the use of focus-group 
discussions (FGDs) a mixed-methods (inclusive of a qualitative and a quantitative 
component) approach was utilised. We chose this method to elicit thorough and nuanced 
information from our participants. This method has also been used in previous studies 
investigating stigma and RHD (Chang et al., 2018) and stigma and SCZ (Atkins, 2016). 
Furthermore, a mixed-methods approach has also been employed in studies investigating 
ethical and social implications of genomics research (i.e. Sabatello et al., 2015 in the context 
of mental illness and Condit et al., 2009 across physical and mental diseases). As found in 
previous ELSI genomics studies (Condit et al., 2009), a focus-group format allowed us an 
opportunity to engage with participants to explore and probe on their perceptions around 
genetics as disease causation and how it may relate to any stigma experiences they may have. 
Conducting FGDs has been reported as an effective method to explore disease causal 
attributions (see Condit et al. 2009 and Sankar et al. 1999 for example). Condit et al. (2009) 
conducted focus-group discussions with eighty participants from the US, Australia and 
Europe. During their FGDs, individuals answered questions like (what do they know about 
their illness and about genetics) and completed questionnaires to indicate estimates of genetic 
influence on their disease.  
 
P a g e  | 67 
 
 
The first component of this study sought to translate and adapt the ISMI scale into isiXhosa for 
use among both SCZ and RHD participants. For use among RHD participants, the term ‘mental 
illness’ was replaced with ‘heart disease’. This was a specific methodological decision 
informed by previous adaptations of the ISMI for use in other disease groups in health-related 
research, and correspondence with the ISMI scale developer about the extent of adaptation of 
the scale for use in the RHD sample. A discussion of the advantages and disadvantages of this 
decision, and the resultant limitations of the Xhosa scales that were ultimately produced are 
presented in Chapter 9, section 9.5. In the context of FGDs (7 for RHD patients and 6 for SCZ 
patients), I hoped to use the newly translated and adapted scale to quantify some of the 
internalised stigma experiences of the Xhosa samples with RHD and SCZ. However important 
limitations within the translated scales were revealed during the investigation of psychometric 
properties which made the use of the data generated from the scales problematic. Instead 
important insights about the conceptualisation of internalised stigma in the Xhosa language 
and particularly relevant internalised stigma items identified in each disease group from the 
translation design of the study were used to inform the second research question: What are the 
internalised stigma experiences of Xhosa people with schizophrenia and rheumatic heart 
disease?  Additionally, I qualitatively explored what disease causal models these individuals 
hold and how a genetic explanation may influence any potential disease stigma. I used the 
context of FGDs based on the guidance of Liamputtong (2011) who describes that, “focus 
groups involve 6-8 people who come from similar social and cultural backgrounds or who have 
similar experiences or concerns” (Liamputtong, 2011, p. 3). Morgan (2002) on the other hand 
reports that FGDs may even have a minimum of 5 people.  
 
Following a mixed methods approach, data collection took place in one session for each group 
(Creswell, 2009; Collins, Onwuegbuzie, & Johnson, 2012). Not only was that efficient, but it 
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also ensured that all the data for each participant was collected without the threat of difficulty 
in follow-up. A series of 13 focus group discussions were held. This process allowed 
participants’ to articulate themselves and explain their perceptions, while I as the researcher 
had an opportunity to listen and gain an understanding of their viewpoints (Cresswell & Plano 
Clark, 2011). A mixed method approach to translation of the internalised stigma scale 
component was preliminary to the focus groups and involved an investigation of psychometric 
properties of the translated internalised stigma scales in Xhosa, to inform understandings of 
how the constructs of internalised stigma (i.e. alienation, social withdrawal, discrimination 
experiences and stereotype endorsement) were supported in the Xhosa language in these two 
population groups.   
 
Each FGD was roughly 90 minutes long. Interviews took place at a boardroom in a public or 
psychiatric hospital that participants were outpatients to and thus were familiar with because 
they received their treatments at these facilities. Upon completion of the FGD questions, 
participants were thoroughly debriefed to ensure that they understood that the FGD videos 
involved hypothetical scenarios, and that at present there were no existing evidence for 
exclusive genetic attribution for these two diseases. As the researcher, I conducted these FGDs 
in isiXhosa alongside the recruited home-language isiXhosa-speaking co-facilitator (who at 
the time, was pursuing a Master’s degree in Medical Anthropology) who had some experience 
in conducting empirical research. During the first FGDs with each disease group, one of my 
supervisors was present to assist and provide guidance where necessary.  
 
6.6. Sampling strategy and gaining access to the study sample 
Onwuegbuzie and Collins (2007) view sampling which involves selecting a portion or segment 
representative of a whole, as an important part of the research process. The authors explain that 
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this is because careful sampling informs the quality of the conclusions made by the researcher 
based on the research findings. For the purpose of this research, purposive sampling was used 
(Bryman, 2012). The research sample was based on people living with RHD and those with 
SCZ who were available and willing to participate in the study and who had met the inclusion 
criteria. The inclusion criteria for this study was that prospective participants had to have been 
enrolled (as patients) in one of two ongoing genomics research projects, namely the “Genetics 
of Rheumatic Heart Disease project” also referred to as the RHD Gen project (FHS016/2013, 
PI: Bongani Mayosi, Grant number: WT ME060838MA) and the “Genomics of Schizophrenia 
in Xhosa-speaking South Africans project” (FHS049/2013, PIs: Dan Stein; Ezra Susser & 
Mary-Claire King, Grant number: NIH1U01MH096754-01A1). At the time, these studies were 
both ongoing in the Faculty of Health Sciences at UCT. Because the latter study only enrolled 
individuals of Xhosa origin, in order to ensure an adequate comparative sample, we decided to 
include a second inclusion criterion which was that we would only enrol patients of Xhosa 
origin. The two parent genomic studies provided a unique opportunity to engage with research 
participants who had enrolled in those genomic studies.  
 
6.6.1. The Genetics of Rheumatic Heart Disease (RHD Gen) Project 
The RHD Gen project aims to build a clinical and laboratory network for the phenotyping of 
RHD patients and controls in Africa; identify genes affecting susceptibility and resistance to 
RHD as well as train scientists and clinicians in genomics research while also addressing ELSI 
issues relevant to Africa (h3africa.org). The RHD Gen study enrols participants irrespective 
of their ethnic background, but due to factors stemming from South Africa’s apartheid legacy 
which created significant differences in socio-economic levels (RHD being a disease affecting 
mostly the poor) in the RHD Gen study cites in South Africa, research participants are either 
of mixed-ancestry or Xhosa background. 
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6.6.2. Genomics of Schizophrenia in the South African Xhosa people (SAX) Project   
The SAX project is a multisite project, which aims to identify gene mutations associated with 
SCZ in Xhosa people in South Africa. This study is the first of its kind to investigate genomics 
of SCZ in specifically Xhosa-speaking people (h3africa.org).  
 
6.6.3. Focussing on RHD and SCZ 
We chose to focus on RHD and SCZ for a two reasons. Firstly, the fact that these diseases are 
distinctly different (i.e. a physical disease vs a mental disease) provides an opportunity to 
explore how disease stigma may be influenced in a condition which is not currently known to 
carry much stigma (RHD) and one which is well-known to carry stigma (SCZ). This was 
important because concerns around stigma in African genomics arise regardless of whether the 
disease under investigation carries stigma or not.  Secondly, we hope that choosing these very 
different diseases may provide some preliminary evidence as to whether and for which types 
of diseases stigma should be a concern, as often assumed by ethics committees (de Vries et al., 
2012 & WHO, 2002) when reviewing proposals for genomics studies. It is important to note 
however, that RHD is strongly poverty-related (in fact, it is often described as a “disease of 
poverty”) and so could carry negative associations and some stigma.  
 
6.6.4. Focusing on the Xhosa-speaking patient population 
Due to the fact that the research design is comparative between patients from both the RHD 
Gen and SAX studies, working with the same population (Xhosa people) proved to be more 
practical in facilitating the research. The SAX study focuses exclusively on the Xhosa 
population. Therefore, for the purpose of this study, only people of Xhosa origin were 
enrolled.  
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6.6.5. Study sites  
Participants in the study were recruited from various sites. RHD participants were recruited 
from a public hospital located in the southern suburbs of Cape Town, in the Western Cape, 
while SCZ participants were recruited from two public psychiatric hospitals (one in the 
southern suburbs and another in the Cape Flats region in the Western Cape). Additionally, 
some SCZ participants were recruited at a public hospital (within a psychiatric ward) located 
in a low-income community in East London, in the Eastern Cape. All these sites are in South 
Africa. 
 
6.6.6. Recruitment process  
Xhosa-speaking RHD patients who were enrolled in the RHD Gen study, were re-contacted 
telephonically and invited to participate in the current study. Those who agreed were invited to 
one of the 7 FGD sessions. Following a similar process, I also re-contacted SCZ patients who 
had participated in the SAX study and invited them to participate in the current study. All 
participants in both studies had signed consent documents which stipulated the possibility of 
being re-contacted. For the purpose of involvement in this study, participants also signed a 
consent form which was translated into isiXhosa (see Appendix E). The criterion for inclusion 
in this study was any male or female of Xhosa origin, who had been enrolled in the RHD Gen 
or the SAX studies.  
 
6.7. Procedure 
 
This study was conducted in three phases: 
Phase 1: Obtain permission and ethical clearance 
Phase 2: Translation and adaptation of the ISMI scale 
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Phase 3: Focus Group Discussions  
 
6.7.1. Phase 1: Obtain permission and ethical clearance 
 
The present study falls under a larger study in the Department of Medicine at the University of 
Cape Town (FHS HREC 204/2015 Stigma in African Genomics Research on Schizophrenia 
and Rheumatic Heart Disease, which is a sub-study linked to RHD Gen study: 016/2013 and 
the SAX study: 049/2013), and ethical clearance for the study had been granted before 
completion of data collection (see Appendix A). Through conducting this study, I committed 
to upholding all the conditions stipulated in the approval documents from the Human Research 
Ethics Committee, Faculty of Health Sciences at UCT.  
 
6.7.2. Phase 2: Translation of the ISMI scale 
 
The standardised ISMI scale used in the study was translated into isiXhosa using a five-stage 
translation design, which drew from methods recommended by Brislin (1970; 1986), and the 
WHO (Sartorius & Janca, 1996), and had proved effective in previous South African translation 
studies adapting psychiatric measures into Xhosa (e.g: Campbell & Young, 2016 and Steele & 
Edwards, 2008). Firstly, the measure was forward-translated independently by four isiXhosa-
speaking healthcare professionals. Secondly, these translation reviewers met as a committee to 
discuss the resultant translations;  particularly focussing on differences between the four 
translations and to select preferred translation choices for each questionnaire item. The 
resultant isiXhosa-translated scale (further referred to as ISMI/ISRHD-X) was quantitatively 
piloted by trained psychiatric nurses (under the SAX study) in a sample of 60 Xhosa 
participants with SCZ, while I piloted the ISRHD-X with a sample of 50 Xhosa-speaking RHD 
participants in the Western Cape.  Thirdly, I qualitatively piloted the ISMI-X and ISRHD-X 
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scales in a smaller sub-sample of 5 Xhosa-speaking SCZ and 5 Xhosa-speaking RHD 
participants by using cognitive interviewing. Fourthly, these newly developed isiXhosa tools 
were back-translated into English by an independent Xhosa-speaking psychiatric nurse. Lastly, 
the translation group collaborated to review the back-translation and the piloting results to 
resolve any discrepancies pertaining to the scale. There is some debate in the literature about 
the advantages and disadvantages of utilising healthcare professionals in the translation 
process. This critique is presented Chapter 9, section 9.2. As the researcher, I led every step of 
this process. A greater elaboration of the translation of the tools is described in Chapter 9 of 
this thesis. 
 
6.7.3. Phase 3: Focus group discussions 
 
I organised and facilitated 13 FGDs (6 SCZ and 7 RHD) with a total of 82 research 
participants consisting of 36 people with SCZ and 46 with RHD. The FGDs drew on 
vignettes to explore the potential relation between different disease causal models with a 
focus on genetic explanations and the resultant stigma they received. Causal explanations 
included genetic, partially genetic and non-genetic (environmental) attribution of disease.  
Each FGD was opened with a welcome address followed by a discussion of the consenting 
process, and collection of demographic information.  
P a g e  | 74 
 
 
 
Figure 2: FGD participants completing consent, demographics and ISMI/ISRHD-X scales 
 
 
Socio-demographic particulars of the participants, including age, sex and education were also 
collected at the beginning of the interview to gain a better understanding of the backgrounds 
of participants (see Appendix F).  Following this, video-vignettes (see descriptions on 
Appendix H) were shown to participants and during this session I facilitated the discussion 
based on the topic guides for the study.   
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Figure 3: Participants watching vignette  
 
During the group sessions, participants were presented with a video of one of three 
vignettes. Each vignette comprised a different disease causal explanation: genetic, mixed-
genetic and non- genetic/ environmental, for patient X (who was named Andile), who had 
the same disease as the individuals being interviewed. Each vignette had a voiceover 
presenting the storyline, along with questions at the end of each stage which were posed to 
the group for discussion.  
 
The discussions which followed were centred on beliefs and experiences of Andile, 
considering the disease causation that was presented in the vignette that the group had 
watched. For the SCZ group I conducted two FGDs per disease category (i.e. two genetic, 
two environmental and two non-genetic). For or the RHD group I conducted three FGDs with 
the genetic attribution vignette, and two for the environmental and the non-genetic 
explanations.  
 
The groups concluded with a thorough debriefing session where participants were informed 
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that the vignettes were staged and that the characters in these stories did not have the disease, 
but were in fact acting a story to facilitate engagement in the group. Many participants 
expressed that they thought the storyline was real and some had wanted to befriend the 
character and exposed sympathy to his situation. Following explanation, they understood the 
value for the vignette in the FGDs. Participants were also provided with the opportunity to 
express any feelings or contribute to the discussion after they had learnt of the nature of the 
vignettes and completing the session. Figure 4 below indicates a schematic presentation of 
the FGD process.  
 
Figure 4: Schematic representation of focus group discussions 
 
Topic guides for the vignettes are presented in Appendix H. Each FGD started with questions 
relating to the theme, “What do people know about genetics?” in an effort to explore 
participants’ associations with or understanding of genes, genetics and disease causation and 
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FGDs with RHD (n= 7 groups) and SCZ (n= 6 groups) to explore the 
impact of genetic attribution on internalised stigma 
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associations. This was followed by a discussion of the disease relevant to the group of people 
(RHD or SCZ) and examined topics like disease causation, consequences of the condition, as 
well as the impact of the disease on the person and their social lives (Lloyd, Jacob, Patel, 
St Louis & Bhugra, 1998). During this section of the FGD, I also explored beliefs in the 
likelihood that their condition could be remedied through treatment. Next, associative stigma 
was explored through eliciting participants’ feelings  about being friends with Andile or 
having him marry the participants sister. This component of the FGD topic guide explored 
questions such as,  “Would you be happy for Andile to marry your sibling”, “Would you be 
likely to be friends with Andile”, and so forth. Overall, I explored the consequences of the 
different disease explanations on the stigma experienced by participants.  
 
Ten participants were invited to each FGD resulting in group sizes ranging from 6 to 10 
participants, depending on the number of attendees. Participants from the same disease group 
were randomly allocated to one of the three vignettes (see Appendix H for topic guides and 
vignettes). Discussions were closely guided to ensure relevance to the applicable vignette 
topic per group.  As the researcher, I also explored respondents’ understanding of genetics 
and remained conscious of the fact that participants may be somewhat challenged in terms 
of differentiation along the lines of ‘DNA’ or related to ‘inheritance’ and genetics, for 
instance.  Thus, discussions were mediated based on my understanding of the concepts of 
genomics, stigma, as well as the Xhosa language and culture, in order to keep the structure of 
the discussions both meaningful and purposeful. This yielded some challenges in the 
discussion, for instance not having direct linguistic translations for terms meant having to 
make conceptual explanations in isiXhosa that were likely open to a range of different 
interpretations.  
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6.8. Development of the vignettes  
 
The short stories were developed by drawing from vignettes used in previous studies by the 
Department of Psychiatry at UCT (Pain, 2012) and by Dr Jo Phelan at Columbia University 
(Phelan, 2005) and consultation with the team of investigators on the FHS HREC 204/2015 
Stigma in African genomics of Schizophrenia and Rheumatic Heart Disease project at UCT 
(PI: Jantina de Vries). Separate vignettes for RHD and SCZ patients were developed. I 
identified and recruited individuals for particular characters for the vignettes (i.e. Andile, his 
mother, doctor, aunt, uncle, friends, neighbours) and locations (i.e. informal house structure, 
RDP house, clinic, doctor’s room and community) for the filming of the vignettes. Scenes from 
the different locations mentioned above were filmed by a professional videographer with 
myself alongside him in order to ensure that the videos were in line with the storylines 
produced. Following filming, the vignettes were presented in the form of short videos.  In 
total, the videographer produced two vignettes, each with three different explanations of 
disease causation, from genetic (e.g. “Andile is informed by his/her doctor that his/her 
condition is related to genetic”) through mixed-genetic to non-genetic.  
 
6.9. Demographics of Study Sample 
The FGD sample consisted of a total of 82 participants (36 SCZ and 46 RHD). The SCZ sample 
consisted of 34 males and 2 females, while the RHD sample consisted of 7 males and 39 
females. Notably, the SCZ sample had a younger age range from 20 to 48 years, with an average 
age of 33.91 years, while the RHD sample had an older age range from 19 to 76 years, with an 
older average age of 43.04 years (see Table 2). These differences in samples are illustrative of 
the same sex and age differences identified in the larger SAX and RHD Gen studies. One reason 
for this may be the recruitment strategies employed in these larger studies. For instance, a study 
investigating capacity to consent to research through a Xhosa language version of the 
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University of California, San Diego Brief Assessment of Capacity to Consent Questionnaire 
(UBACC)  among SCZ patients (n= 528) recruited for the SAX study, 89% were males and 
only 10% females (Campbell et al., 2017). The authors suggested that these sex-related 
differences may reflect a higher prevalence of males with schizophrenia in state psychiatric 
facilities where these patients were recruited. Similarly, as Zuhlke (2015) describes, there is a 
higher rate of older females who attend primary care clinics for RHD. In a smaller Msc study 
by Faure (2018) who recruited mixed-ancestry RHD patients (n= 52) enrolled in the RHD Gen 
study to conduct FGDs which aimed to explore genetic attribution and stigma found that 70% 
of the enrolled participants were female.  
 
Table 2: Socio-demographics of participants enrolled in the study 
 RHD (n=46) SCZ (n=36) 
Age                                                                     
Range 
Mean 
23-75 years 
43.04 years 
 
20-53 years 
33.91 years 
Sex                                                           
Male                                                              
Female  
 
7 (15.21%) 
39 (84.78 %)  
 
34 (94.44%) 
2 (5.56%) 
Highest education level 
>Grade 7 
<Grade 7 
Unknown 
 
7 (15%) 
37 (80.43%) 
2 (4.35%) 
 
6 (16.67%) 
30 (83.33%) 
0 (0%) 
Employment 
Unemployed 
Employed 
Unknown 
 
42 (91.30%) 
3 (6.52%) 
1 (2.17%) 
 
32 (88.89%) 
3 (8.33) 
1 
Government Grant  
Yes 
No 
Unknown 
 
27 (58.70%) 
18 (39.13%) 
1 (2.17%) 
 
22 (61.11%) 
14 (38.89%) 
0 (0%) 
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6.10. Data Analysis 
6.10.1. Qualitative Analysis: Transcribing and coding of FGD data 
FGDs were tape-recorded then transcribed and translated verbatim and texts were stored in a 
password protected computer. Participants’ names do not appear in the transcripts. A  
second year Master’s student in the Xhosa Language Department at the University of the 
Western Cape was recruited as a research assistant to help with the translation and 
transcription of the data. During the FGDs, in addition to myself, at least one other individual 
(who was the co-facilitator for the session) was present to take notes about speaker sequence, 
body language and other aspects of the interactions which we then discussed together at the 
end of each FGD.  
 
Overall, I transcribed 4 RHD and 4 SCZ group discussion transcripts, while the transcriber 
transcribed the remaining 5 recordings. Transcriptions done by the transcriber were checked 
by myself to ensure quality of the transcripts. Transcripts of FGDs were translated to 
English for analysis by myself and the recruited student. Both were used concurrently in the 
data analysis.    
 
English versions of the transcripts were imported into NVivo 11 which is a computer program 
for managing text data (NVivo qualitative data analysis software, 2015). FGDs were analysed 
using thematic analysis, which is a standard approach for conducting a qualitative analysis of 
text data (Braun & Clarke, 2006; Morgan, 2002). Notes taken by myself and the co-
facilitator, including the sequence of responses during the FGDs, were used to allocate 
passages to participants, in so far as possible, to be used in the analysis.  
 
Data were analysed in multiple rounds of coding which lead to the identification of general 
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themes in the data. The process began with a hierarchical coding scheme which was 
developed by myself and my supervisors. First, I and my primary supervisor coded three 
transcripts each (independently). Then we met to discuss the themes which emerged and 
agreed on an initial coding scheme. This coding scheme was applied to a subset of transcripts. 
Coded text was then analysed to develop a hierarchical coding scheme. Thematic domains 
were identified through a process of intense reviewing of transcript data with specific codes 
developed afterwards for conceptual categories. Various discussions were held between 
myself and my primary supervisor to resolve discrepancies, along with regular scheduled 
supervision meetings with both of my supervisors and collaborators on the larger project of 
which this study falls under (FHS HREC 204/2015 Stigma in African Genomics Research 
on Schizophrenia and Rheumatic Heart Disease). Lastly, comments by the international 
researchers based at institutions in the United States of America involved in the larger study, 
such as Prof Paul. S. Appelbaum from Colombia University and Prof Patricia Marshall from 
Case Western University, assisted me to build a robust data analysis strategy with repetitive 
reviews of the coding process. Through these meetings and based on their views, along with 
mine and my supervisors it was decided to analyse the FGD data as one big dataset (as 
opposed to comparisons between the different scenarios; genetic, environmental and genetic 
and non-genetic) as there were very minimal differences in the nature of the dialogues in the 
groups.  
 
6.10.2 Analysis of data from the translation of the internalised stigma scales   
Qualitative and quantitative insights from the translations of the scales were gained from 
examining the data generated during the translation process. I sought to further understand how 
the construct of stigma was supported in the Xhosa language and the relevance of individual 
internalised stigma scale items for Xhosa people with SCZ and RHD, illustrated through their 
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psychometric properties. Demographic data were recorded in an Excel worksheet, cleaned, 
saved and then analysed.  
 
6.11. Role of the researcher 
Reflexivity on methodology:  The mixed-methods approach required considerable expertise 
from myself as the researcher to be versed in both quantitative and qualitative research 
methods. Therefore, I had to equip myself with the necessary skills to facilitate the process of 
data collection, analysis and reporting as defined by a mixed-methods approach. This was 
achieved through familiarising myself with literature on mixed-methods research (Bryman, 
2012; Creswell & Plano Clark, 2011; Johnson, Onwuegbuzie & Turner, 2007), as well as 
having frequent discussions with my supervisors. Furthermore, to enhance my research 
capacity during the degree, I attended a Doctoral level Mixed-Methodology Course (held 
during the International Summer School at the University of Oslo, in Norway) which focussed 
on training PhD candidates on mixed-methods approaches in social research. In addition, 
considering that my background was in qualitative research, and I was therefore more versed 
in that approach than in a quantitative approach, I audited a Masters level semester course 
focussing on analysis of quantitative data in social science research at UCT. Lastly, I sought 
multiple opportunities to present my research at different meetings and conferences involving 
South African, African and international audiences - where I would get critical feedback which 
I incorporated into the work. These training opportunities allowed me to hone and craft these 
skills and conceptually think about employing a mixed-methods approach in a single research 
study, which ultimately made the data collection, data analysis, as well as documenting this 
thesis a practical and meaningful experience. 
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Researcher’s background: As the researcher, I hope that sharing my background will assist 
in illuminating the reasons for my observations and interpretations of this research. As Bryman 
(2012) suggests that qualitative research is often relatable to our contextual factors and as a 
result, the context and our relation to the context often inform the uniqueness of how we see 
the world. I am a 26 year old mother-tongue isiXhosa-speaking female, born in the rural village 
of eNqele, near the town of Alice in the Eastern Cape Province, South Africa. Despite living 
in the Western Cape Province for the past 20 years, my family and I continue to go ‘home’ to 
eNqele, about 934 kilometres (roughly 580 miles) from where we currently live, at least twice 
a year, sometimes more. Many of the times in which we go to the village, we attend or perform 
cultural ceremonies that form a significant part of our cultural values. Being raised, and 
attending schooling in a modernised (and primarily Westernised) setting in the Western Cape 
and being able to go ‘home’ to very rural surroundings in a context where life is largely guided 
by an African cultural worldview has been deeply meaningful to me. It is this background and 
reality which has allowed me the opportunity to gain a deeper understanding of both African 
and Western worldviews. Moreover, it is what has allowed me to make sense, as far as possible, 
to the realities of the participants in my study. As for my academic background, I completed 
an undergraduate in psychology from the University of the Western Cape, and then an honours 
and Master’s degree in psychology at Stellenbosch University.  
 
In my first year of the Master’s degree I applied and was appointed in a research assistantship 
position in the larger study which my PhD project falls under in the Department of Medicine 
at UCT. I took up the position part-time during my second year of my Master’s degree at 
Stellenbosch University. After completing my Master’s degree, my current supervisors 
suggested I pursue a PhD degree at UCT and in 2016 I enrolled for this PhD.  
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6.12. RHD Data collection 
RHD data collection took place from September to November 2016. During this time, 46 
people with RHD were recruited to participate in the FGDs. Inviting these individuals to attend 
FGDs for this purpose posed various challenges as many of them were elderly women who 
faced physical mobility issues which impacted on travelling (see demographics of respondents 
on page 59). Financial constraints of participants were also considered, hence the decision to 
provide reimbursements for travelling to data collection sites. All scheduled FGDs had between 
6 and 10 participants who attended while one of the FGDs only had 2 respondents of an initial 
10 invitees. This low response rate could possibly be attributed to the adverse weather 
conditions on that specific day, considering that most of the participants relied on public 
transport. This session was cancelled and the participants reimbursed for their travel costs and 
invited to join another scheduled group discussion. Overall, the process continued without any 
other difficulties and during the FGDs, participants were easy to engage with.  
 
6.13. SCZ Data collection  
SCZ group sessions occurred from February until May 2017. These FGDs proved to be more 
challenging to organise, not in the least because this patient group is more vulnerable. Specific 
aspects of this vulnerability are discussed in the subsequent paragraph to this section. This 
caused practical challenges, for example in relation to their ability to travel independently to 
the FGD venues. Coordinating these FGDs involved having various meetings with psychiatric 
nurses, as well as the project coordinator of the SAX study to resolve certain logistical issues 
(i.e. location, suitability of participants to respective group sessions and how to inform potential 
participants about scheduled sessions). This was particularly difficult for a number of reasons, 
some of which are discussed below. 
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Firstly, patients recruited in the SAX study were individuals who had at some point been 
admitted to a psychiatric hospital. Many of these participants reported negative experiences of 
being admitted to psychiatric hospitals as some of them were admitted by force and not 
voluntarily. This created a deep sense of fear and resentment for these facilities which 
consequently influenced their decision to attend a FGD held at the same location. In some 
cases, the people with a SCZ diagnosis’s parents or family members were strong motivators 
for their children to attend the sessions, however it was the individual with the condition who 
refused to attend. In these cases, potential participants were informed that their participation 
was voluntary and that they were under no obligation to participate. On the other hand, since 
the participants were outpatients and some of them had not been in a space with other 
individuals who had a SCZ diagnosis for some time, they were excited to attend the FGDs. 
This was mainly because it provided them with an opportunity to engage with other people 
who were living with the same condition.  
 
As detailed in the demographics of the participants on page 78, the population available 
included mostly men with an average age of 34 years. Being a younger female, facilitating 
these FGDs was more challenging, as issues of gender power did come into play. For instance, 
in the first FGD, male participants made derogatory comments during the group session. That 
experience however helped me to reflect on my position, and thus develop and employ a stricter 
approach (which included emphasising rules relating to respect of fellow individuals) during 
the FGDs.  
 
All FGD participants had previously enrolled in a genomics study (RHD Gen/ SAX) from 
which their contact details were obtained. However, the large amount of inconsistent contact 
details provided by individuals during their involvement in the SAX study posed another 
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challenge for recruiting these participants for the present study. Due to the fact that the contact 
details database for participants in the SAX study dated back to 2013, many of these 
individuals’ contact numbers had changed, or were incorrect or incomplete. These challenges 
made it difficult to invite potential participants to be involved in this study.  
 
6.14. FGD Data collection – General observations 
 
Many of the participants enrolled were born in the Eastern Cape and had moved to the Western 
Cape in search of better work or living conditions. Some of the participants also relocated in 
search of better medical treatment for their illnesses, in the reportedly better facilities available 
in the Western Cape. Being born and bred in a similar context to them, I had an understanding 
of participants’ backgrounds and to this effect, for the most part during the FGDs I experienced 
a sense of trust from participants that they felt comfortable sharing their experiences and 
perceptions with me, and the group at large. The FGDs were predominantly lively 
engagements.  
 
Due to the selection of exclusively Xhosa-speaking people, efforts were made to ensure that 
all material, including consent documents, the video vignettes and the guiding questions for 
the FGDs were translated into isiXhosa. This promoted comprehension and allowed 
participants to understand and engage more fully with the material. Throughout the study, 
participants were assured that all discussions would be facilitated in their mother-tongue. It 
was noted that participants appeared comfortable during these group discussions because they 
could converse and express themselves in their home-language – an experience that is not 
common in other similar research (i.e. Solomon et al., 2012) or in many clinical interactions as 
they are often not conducted in the patient’s mother-tongue. 
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 Essentially, the interviews afforded me the opportunity to identify and grasp the perspectives 
of people diagnosed with the two diseases. However, during the FGDs, participants would 
sometimes choose not to elaborate their thoughts in an in-depth fashion which brought me to 
the conclusion that this was based on the assumption that I would understand their perceptions 
based on our potentially shared and somewhat similar backgrounds. This was especially 
depicted in statements such as “you know”, “in our culture”, “for us” and many similar 
expressions frequently mentioned in these discussions. In addition, participants often made 
facial and hand gestures, hereby suggesting that I would be able to interpret such non-verbal 
actions.  In these instances, participants were encouraged to explain themselves in a more 
effective manner and by also emphasising my role as a researcher to fully comprehend and 
make sense of their views to ensure an accurate interpretation of the data.  
 
6.15. Ethical considerations 
Ethics approval for the study was sought from UCT’s Faculty of Health Sciences 
Human Research Ethics Committee prior to commencement of the study (see Appendix A). 
Research took place in accordance with South Africa’s Department of Health Ethics in Health 
Research Guidelines (2015), Declaration of Helsinki (Update 2013) and Good Clinical 
Practice (GCP) guidelines. I attended a GCP courses for during the period of completing the 
research. In addition, I considered the Code of Ethics of the American Sociological 
Association (issued in 1999). With regards to the FGDs, potential participants were contacted 
telephonically with a comprehensive explanation of the research project. Interested parties 
were invited to a group discussion at a hospital which they were familiar with due to their 
current outpatient status and them receiving treatment from these hospitals. Each participant 
was provided with an information sheet and after reading this, was asked to voluntarily sign 
an informed consent form before proceeding with the session (See Appendix D & E). Due to 
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low-literacy levels among some the participants, one-on-one support was provided to explain 
aspects of the study that were not clear, to answer questions and to assist during the signing 
of consent forms. Considerable debriefing was done after the FGD, in order to emphasise 
that these were hypothetical scenarios and make sure participants were eventually stable. 
During the consent process, it was also explained that confidentiality could not be guaranteed 
during and after the group discussion, and that individuals were not obligated to share any 
information which they felt uncomfortable to discuss. However, it was emphasised, and 
participants were assured that within the research documentation, confidentiality would be 
maintained. Participants were free to leave questions unanswered, or to stop and exit the 
session at any time, although none did. All interview transcripts were anonymised and all 
possible identifiers (such as name of the employer or hospital attending) were substituted with 
generic language. All transcripts were kept on password protected computers and were only 
shared on a need-to-see basis between myself, the assistant transcriber, my supervisors and 
the international advisory team.  
 
Lastly, all FGDs were conducted by myself in isiXhosa, unless the participants themselves 
preferred to use English which none did. Consent materials were translated into isiXhosa to 
ensure that all individuals understood the material and what they were consenting to. Each 
participant received R100 ($7) as reimbursement for transportation costs as well as 
refreshments and snacks during the FGDs.   
 
6.16. Chapter summary 
This chapter provided an outline of the research problem, the focus and aims of the study as 
well as the research questions. It also introduced the mixed-methods approach informing the 
study, as well as the, sampling strategies, data collection and data analysis methods used. By 
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reflecting on my subjective position as a researcher, I discussed my role as a researcher, along 
with data collection processes involving both patient groups. The chapter concluded with an 
overview of ethical considerations employed in this study. The next chapter presents the 
disease causal explanations identified by patients in this study.  
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CHAPTER 7: DISEASE CAUSAL ATTRIBUTIONS  
 
7.1. Introduction 
 
In this chapter I begin by presenting the sample characteristics and relevant descriptive 
statistics. These results are important for interpretation of the qualitative findings related to the 
study’s research questions. Next I present findings relevant to the first question of this study, 
which is “What causal models are employed by Xhosa people with schizophrenia and people 
with rheumatic heart disease to explain their illness, and to what extent do genetic explanations 
play a role in these causal models?”. I end the chapter with a summary of the aforementioned 
findings.  
 
7.2. Demographic details of FGD participants 
 
When conducting research, it is common for researchers to investigate certain characteristics 
of the sample in the study as these characteristics can often assist the researcher to gain a more 
nuanced understanding of the research findings. In this study the demographic details of the 
respondents relative to age, sex, highest level of education, employment status and government 
social grant receiver status were investigated. These results are provided in Table’s 4 to 7. 
 
Table 4: Distribution of participants’ age categories 
 Frequency (%) 
 
RHD (n=46) SCZ (n= 36) 
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A Chi-square test was performed to determine whether there was a significant age difference 
between the RHD and the SCZ groups. There were no significant differences with regard to 
age between the two groups: x² (4, n= 82) = 45, p = .081. While the age range was between 18 
to over 35 years, the RHD sample predominantly comprised of over 35-year-old patients (mean 
age being: 43.05 years) while the SCZ sample predominantly comprised of 25-35-year-old 
patients (mean age being: 33.92 years).  
 
Graph 1: Age of participants  
 
In terms of the sex variable in this study, it is notable that the RHD sample consisted mainly of 
females, while the SCZ sample comprised of mostly males. This was not too surprising as 
discussed in chapter 6 on page 78, this same trend is evident in the RHD Gen study (PI: Prof. 
Bonagni M. Mayosi) as well as the SAX study (PI: Prof. Dan Stein). A Chi-square test was 
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performed to determine whether there was a significant difference between the RHD group and 
the SCZ group with regard to sex. As anticipated the Chi-square test revealed that there is a 
significant difference with regard to sex between the two groups: x² (1, n = 82) = 50.71, p = 
0.01.  
 
Table 5: Distribution of participants’ sex 
 
The distribution of participants’ sex is visually presented in the graph below and shows the 
extreme disproportion enrollment of men and women in these two groups. The resultant 
findings would need to be considered in relation to these differences in sex and age of 
participants.  
 
Graph 2: Sex of participants  
 Frequency (%) 
 
RHD (n= 46) SCZ (n=36) 
Sex 
Male 
Female 
 
7 (15.21%) 
39 (84.78 %) 
 
34 (94.44%)  
2 (5.56%) 
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In addition to age and sex, the employment status of participants in this study was also 
investigated as a means to understand the participants’ standard of living. Below table 6 
presents the employment statuses of participants enrolled in this study.   
 
Table 6: Employment status of participants 
 
From the table above, it is evident that for the RHD sample 42 out of 46 patients (91.30% of 
the sample) reported being unemployed. While for the SCZ sample 32 out of 36 patients 
(88.89%) were unemployed participants. The Chi-square test revealed that there is no 
significant difference with employment status between the two groups: x² (1, n = 80) = 0.103, 
p = 0.75. A visual representation of the employment rates is displayed in Graph 9 below.  
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Unemployed 
Employed  
Unknown 
RHD (n=46) SCZ (n= 36) 
 
42 (91.30%) 
3 (6.52%) 
1 (2.17%) 
 
32 (88.89%) 
3 (8.33) 
1 
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Graph 3: Employment status of participants  
 
The high rate of unemployment observed across the two disease groups raises the question of 
how these patients financially provide for themselves and ensure that they can sustain 
themselves and their families. In the South African context, individuals who are unemployed 
and have a disability (a factor which disables them from getting ordinary employment easily) 
may apply to receive a government social support grant (of roughly 121 USD/ R1490) on a 
monthly basis. Below, Table 7 represents the number of people in this study who receive the 
social grant because of their unemployment and disability status across the two disease groups.  
 
Table 7: The number of participants who receive social grants 
 
 Frequency 
 
Government Grant  
Yes 
No 
Unknown 
RHD (n=46) SCZ (n= 36) 
 
27 (58.70%) 
18 (39.13%) 
1 (2.17%) 
 
22 (61.11%) 
14 (38.89%) 
0 (0%) 
0
20
40
60
Unemployed Employed Unknown
N
u
m
b
er
 o
f 
p
ar
ti
ci
p
an
ts
Employment status
Employment
RHD SCZ
P a g e  | 95 
 
 
Table 7 shows that 27 out of the 46 RHD patients (58.70%) and 22 out of the 32 SCZ patients 
(61.11%) receive government social grants, while just under 40% for each group does not 
receive social grant.  The Chi-square test revealed that there is no significant difference in the 
receiving of a government grant between the two groups: x² (1, n = 81) = 0.0103, p = 0.92. The 
high unemployment rate as well as the receiving or not receiving of social grants from the 
government and its implications for these patients is further explored in the reporting of the 
qualitative findings.  
 
Graph 4: Distribution of participants’ receiving social grants from the government 
 
Participants’ were also requested to report their highest level of education. This variable 
provided an opportunity to gain a sense of the education level of participants in this study. 
Table 8 displays the participants’ highest level of education. 
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Above 50% of the patients in both groups had either a Grade 11 or Grade 12 (the final year of 
secondary school in South Africa) or above. Evidence from the Chi square test suggests that 
there is no significant difference in education levels between the two groups. The chi-square 
statistic is 0.0083. The p-value is 0.93. The above 50% proportion of the sample having some 
secondary schooling suggests that the sample had a reasonable level of literacy to conceptualise 
and engage with the material used in this study. The levels of education of the participants are 
presented in Graph 5. below.  
 
Graph 5: Participants’ highest level of education 
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7.3. Disease causal attributions 
 
Next, this chapter provides the qualitative data related to the causal models held by participants 
in this study. The findings are discussed guided by specific themes. These themes were 
identified in the thematic analysis process proposed by Braun and Clark (2006). Focus-group 
interview transcripts of the 13 FGDs which were conducted in this study, collectively 
contribute to the pool of data used to identify thematic patterns that surfaced in the study. As 
described in Chapter 6, during the FGDs participants watched a short clip of a vignette about 
a character named ‘Andile’ who is living in a South African township and has been diagnosed 
with either RHD or SCZ. The vignettes provided participants with a causal explanation for the 
disease (which was either genetic, environmental, or a combination of genetic and 
environmental causation). The participants were then asked to respond to a series of questions 
relating to their experiences and opinions of disease-stigma. Participants replied to the 
questions in relation to themselves and in relation to the character ‘Andile’. Therefore, the 
results below refer to personal and external perceptions of disease-stigma raised in the FGDs 
in relation to the two diseases.  
 
The role of genetics and its influence on disease stigma is increasingly discussed in the context 
of ELSI research (Appelbaum, 2017; Kong et al., 2017). The concern is that placing an 
emphasis on genetic explanations to disease may influence the stigma associated with it in 
potentially harmful ways. Consequently, understanding beliefs of disease causation is of 
relevance and importance when investigating the stigma within different disease groups. As 
described in Chapter 6, this study aimed to explore the role of genetic attribution on disease-
stigma in relation to internalised stigma experienced by schizophrenia and rheumatic heart 
disease Xhosa outpatients. In this chapter I describe the qualitative findings which emerged 
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relating to the causal attributions reported by participants, with a particular focus on their 
articulation of genetic causes to disease.  
 
The causal attributions people give to disease are often shaped by their symptoms and their 
experience of living with that disease. Having a family history with someone who had the same 
disease may for example predispose people to associate their disease with a genetic cause. 
Conversely not having or knowing a person who has had the disease in the family or immediate 
social circle (and not having any genetic tests conducted) may lead to people attributing a 
disease to environmental, psychological, personal choices or cultural factors. 
 
The following section presents data related to question 1 of the research, which is;  “What 
causal models are employed by Xhosa people with schizophrenia and people with rheumatic 
heart disease to explain their illness, and to what extent do genetic explanations play a role in 
these causal models?” 
  
Table 9: Disease causal attribution themes  
MAIN THEMES SUBTHEMES 
1. Genetic causal explanation   
 a) Knowledge about genetics 
2. Alternative causal explanations   
2.1 Psychosocial explanations  a) Environmental causes  
 b) Psychological causes 
 
 c) Personal lifestyle choices 
            2.2 Cultural explanations  
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 a)  Bewitchment/ Supernatural causes 
 
7.3.1. Genetic attribution  
 
Genetic explanations may influence understandings of human behaviour and the stigma 
associated with their behaviours (Phelan, 2005). The two diseases investigated in this study 
have complex explanations in terms of relating the disease to heredity in general and a potential 
genetic causation specifically. For instance, there is conflicting evidence in the health literature 
about the extent to which SCZ could be considered a genetic disease (Schizophrenia Working 
Group of the Psychiatric Genomics Consortium, 2014). In addition, while 40% of RHD can be 
explained by genetic predisposition (Engel et al., 2011), a stronger causality has been found 
for infection with Strep A and environmental conditions.  The data in this study revealed that 
some participants are aware of a potential genetic attribution of their disease, while others may 
not have been. Notably, participants often spoke about genetics and heredity in similar ways 
and used these terms interchangeably (and this will be evident in the verbatim quotes which 
follow). 
 
7.3.1. Knowledge about genetics 
 
A critical component of this study was gaining an understanding of what participants know 
about genetics and heredity, as well as how they relate genetics to their disease. The question 
in the FGD guide which began to explore what participants understand about genetics is; 1. 
What do you know about genetics? This section presents the findings related to answers 
participants provided under the theme Knowledge about genetics. It is important to note that 
all our participants had previously participated in genomics research projects before, which 
may be why some of them are familiar with genetic terminology such as genomics, DNA and 
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heredity which are also terms used in the consent processes and community engagement 
activities they may have completed. 
 
SCHIZOPHRENIA 
In response to the first question participants in the SCZ sample displayed an understanding of 
genetics and genetic attribution to disease. When asked to explain genetics, many participants 
referred to heredity and in particular the inheritance of biological features and genes:   
“I think that… I think that genetics has to do with genes. So let’s say for example your 
father... Say you inherited a gene from your father, then you have that gene. Later you 
realise that that gene is related to the disease your father has. Then you end up having 
the same disease. So that is inheritance.” (P.7: FGD 2) 
 
“Genetics, what I know about genetics is like... if there is someone, like your father 
maybe, there are these things called chromosome networks, where if your father gets 
mentally disturbed you also end up falling in the same path. You would be aware that 
its genetics which caused that. That’s how I know it.” (P.1: FGD 2) 
 
The above explanations are a representation of how some participants in the SCZ FGDs 
understood genetics. It is notable that these two examples were shared by participants who had 
a tertiary education. Not all participants demonstrated the same depth of understanding. In 
describing genetics, other participants highlighted a range of traits that can be inherited. Some 
participants related genetics to the idea of passing down of a physical trait (like looks for 
example):   
“It’s like looking like your father or your mother… Like the things you have on your 
body, they may look like theirs.” (P.6: FGD 3) 
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“Yes, I was going to say perhaps the way you resemble a particular person. When you 
look like him or her, you have inherited those looks from your relative” (P.2: FGD 5)  
 
Others spoke about passing down behavioural attributes:  
“Hm. Okay, the genetics is like, say a child inherits something for example from the 
father. I am not sure if its genes or what. But then it is about a child inheriting attributes 
from their father. For example behavioural patterns. Say for example a child is 
disobedient and they do not listen to you at all, then people are able to say that ‘he 
inherited this behaviour from so and so’... I am talking about behavioural patterns, 
either of the father or of the mother.” (P. 6: FGD 2) 
 
Another participant referred to it in terms of inheriting a habit from a family member.  
“It’s like doing things that your parent used to do, like maybe you grow up to look like 
your parent a lot. And the things you do, people say you inherited those things from 
him” (P.5 FGD 3) 
 
In addition to the physical and behavioural traits and habits which were understood by 
participants to be passed down in families, participants were also able to explain that a disease 
may be passed down in the family. This was explained in particular through relating genetics 
to the chances that Andile may pass that disease on to his children:   
“If for example he has five children. Then two of the children may have the disease, 
because it can be understood that the one or two children who have it, got it through 
inheritance from Andile. So of the five children, two could have the disease and the rest 
may not.” (P.1: FGD 6) 
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“When it is genetic it means that he can still have a child or maybe a grandchild who 
may have the disease.” (P.10: FGD 4) 
 
“So if a person is genetically related to someone at home. Like if maybe someone in the 
person’s family has been sick before, then they too end up being sick because of having 
the same genes.” (P.6: FGD 6) 
 
Within the data, there was a great deal of association between genetics and relatives or family 
members. Exactly how traits are passed down amongst the relatives however was not clearly 
articulated in the FGDs but most participants were certain that they are passed down 
“somehow” in the family. Participants shared an understanding that a particular disease may 
be passed down in the family, and explained that a disease can skip a generation and be passed 
down to or express itself amongst grandchildren and not necessarily their parents. Moreover, 
some participants explained that other influences may trigger the disease onset, even if they 
have a genetic predisposition. For instance, 
“Uh, something that could also put his children at risk of getting the disease is their 
own decisions. For example if a child uses drugs too much, then it will be more likely 
for the condition to emerge if it is genetic. Or for example if he abuses alcohol, it could 
also emerge. You see. Or if he is really hurt. For example I have a niece whose mother 
has schizophrenia. I also am a schizophrenia. But for me, schizophrenia emerged 
because I was using drugs. Well I was using weed [cannabis] for a long time, then I 
stopped, and then the schizophrenia began. I thought, and the doctors thought it was 
withdrawal symptoms, but then it was schizophrenia. So I always advise my niece that 
if she has anything that is hurting her feelings, for example if she is having problems in 
a romantic relationship, she should speak to someone about that. I tell her that because 
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she is likely to get ill, because this thing is genetic. You see for me, maybe I would not 
be like this. Maybe I wouldn’t have been like this had I not used drugs. So as for Andile’s 
child, he/she could have the illness, even though the symptoms may not emerge. It 
depends on the decisions he/she makes and things he/she abuses”. (P.10: FGD 4). 
 
There are a few things worth noting about the participant’s quote above (P.10) firstly, he 
describes that he believes the disease is genetic. He has it, his niece has it and his mother’s 
niece has it. Secondly, he also describes that although it may be genetic, it requires a trigger 
for onset. His trigger was cannabis, while he thought his nieces trigger may be “thinking too 
much” or stress. Thirdly, he suggests that Andile’s child may have the disease gene passed 
down to him, but it may not express itself unless he or she engages in behaviours that may 
trigger it.  
 
The view that SCZ requires a trigger was also shared by other participants, suggesting that 
Andile’s children would be unlikely to develop this condition if they “treat themselves well” 
and avoid abusing substances which would put them in a position of being vulnerable to 
developing the disease. This alludes to the fact that in addition to the genetic causation 
explanation, personal lifestyle choices and decisions on behaviour are seen as having important 
implications to the development of the disease.   
 
RHEUMATIC HEART DISEASE 
While the SCZ participants began by discussing genetics in general and later related it to their 
disease, the RHD participants immediately described genetics in relation to their disease. For 
instance, when asked to share their understanding of genetics one participant described it as 
follows:  
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“I was told by the doctor that sometimes, you may have an illness because you have 
inherited it from someone in your bloodline. Someone in your family perhaps.” (P.1: 
FGD 2) 
 
“When there is a history in your family, perhaps there is a person who suffered from 
heart disease, for example your grandfather, it may be said that you inherited it from 
him.” (P.2: FGD 6) 
 
“I think heredity… I think it is something that is in the family. Let us say if my 
grandmother had a heart disease, her children and grandchildren can also have the 
heart disease.” (P.6: FGD 7)  
 
Many participants noted that genetics may have to do with something being passed down 
through relatives or in the family, for instance from parents or grandparents to children. While 
some participants described that disease can also be passed down from uncles and aunts in the 
family.  
“Me, it is said that there is my aunt [her mother’s sister] who had it. But I do not know 
how it connected with me.” (P.3: FGD 7) 
 
Similar to the SCZ sample, these participants were also aware that it may be passed down to 
some offspring, while other children may not have the disease.  An example of this was given 
by one participant who had a father with ‘RHD’. When asked whether any of her siblings have 
been diagnosed with the same disease, she responded by saying none of them had the disease 
(out of a total of six children born from her parents) (P.3: FGD 4). It is important to note here 
that the RHD participants did tend to conflate general heart disease and RHD. This may not be 
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altogether surprising considering that the term RHD does not exist in isiXhosa, therefore 
generally people with RHD refer to themselves as having a ‘heart disease’ (isifo sentliziyo) in 
the Xhosa language.  
 
In light of that knowledge, another participant, described that she had a brother who died of 
RHD. Among that participant’s siblings, there were two children born from her parents and 
both of them had heart disease. The above examples point to the observation that some children 
may have the disease passed down from someone in the family, while others may not. This 
observation is supported by a comment by a participant in another FGD who voiced that she 
believes that not all children of someone with RHD would necessarily get the disease. She said:  
“…but not all of them. Maybe there will be one who inherits the disease.” (P.7: FGD 
2) 
 
This understanding was commonly shared, see:   
“It would depend on the genes. If your genes are different from your mother’s but are 
similar to your father’s, you might have it, if your father had it. If you have identical 
genes with your father who has the same condition, then you will have it. It depends on 
whose genes of your parents is stronger.” (P.6: FGD 1)  
 
Although many RHD patients did recognise some contribution of genetics to their illness, many 
others had not thought about their disease in relation to genetics. However, many participants 
stated that they recalled having been asked by doctors before whether they knew anyone in 
their family who has had RHD before, and many described being the first person that they 
know of in their family who has the disease. See, 
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 “I will talk about my own experience, I’m the only one who has this heart disease in 
my family I haven’t heard of anyone who had it before me, and so I wouldn’t say it’s 
inherited.” (P.3: FGD 2) 
 
Five out of six participants in the first RHD FGD echoed the same sentiments as participant 3 
above, all stating that they are the first people (they know of) to have a heart disease in their 
family and therefore they do not think that RHD has a genetic origin. In the other RHD FGD’s 
there was always at least one or more participants who held the same perception. Most of these 
participants identified other diseases however which they felt had a genetic component, like 
cancer, asthma and hypertension. Some participants indicated that they had been informed that 
the disease was potentially genetic by health professionals (i.e. doctors). The information they 
took away from those discussions however seemed inconsistent and left some of them confused 
about the nature of the genetic explanation. See, 
“I was told by the doctor that my heart condition is genetic. He asked who has a heart 
condition in your family, and I told him that I don’t know anyone. Then he said, it is 
most likely genetic. But to my surprise, since he said it is genetic, there is no one in my 
family who has ever been ill with a heart condition. However, in my in-laws, my mother 
in-law has a heart condition. So I was confused about that, because even my daughters 
say that I have inherited the disease from her, but I am not sure how I could have 
inherited it from my in-law family.” (P.10: FGD 2) 
 
“He [the doctor] asked me yes, whether there is someone who has had the condition in 
my family. I said that when I grew up and started understanding things, there was no 
one I knew of.” (P.5: FGD 2)  
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Some participants seemed to not have thought of the disease potentially being genetic until 
their encounter with this explanation in the FGD they participated in, even though they had 
previously participated in (and consented to) a genomics study. For example:.  
 
“For me I do not have any knowledge about genetics and heart disease. I was never 
informed about genetics or inheritance. I just heard about it now, but I did not inherit 
this disease from anyone. But maybe my child will inherit it though as the time goes on 
but for now she does not have it.” (P. 4: FGD 4) 
 
When directly asked whether participants believed that they inherited the disease after they 
were diagnosed, many revealed that they did not consider that causal explanation until they 
reached adulthood. One participant said:  
“No. It is only now that I am old when I realized that I inherited heart disease from my 
mother….Otherwise back then, nobody said anything about inheritance.” (P.1: FGD 4) 
 
One observation from the FGDs is that some participants appeared to not take the genetic 
explanation seriously, which affected the way in which they responded to the proceeding 
questions. This may have been due to the fact that they had not really thought about the 
implications of their disease having a possible genetic cause. Moreover, some did not recall 
hearing this explanation before attending the FGD. Hence, their responses were based on the 
explanatory models which they held and strongly believed in as the cause of their illness. One 
participant however, generalised the perspectives of black Africans and said:  
“Sometimes, for us black people, he [Andile] could think that... Like we take 
things for granted. He could think that this is not something serious, it’s ‘just’ an 
inherited disease. Like we don’t take genetics as a serious thing. If you inherited 
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something, you just think ‘oh well, this is how we are at home’ and take it lightly.” 
(P.9: RHD FGD 3) 
 
It is the above mentioned general view of ‘taking things lightly’ that is evident in some 
responses provided by participants in the FGDs. For instance a participant said: 
“For example my daughter also has the disease, but she says she will not take 
treatment. She says, ‘I will take it the way that you did mom, only when I have a child 
as well’.” (P.7: FGD 3) 
 
The decision made by the child in this regard and the parent who is allowing it suggests that 
they may not see the illness as a serious concern which requires immediate attention. While 
one participant attributed the disease to a biological cause relating to one’s own blood, she said: 
“I think heart disease is a virus that is in the blood.” (P. 2: FGD 1) 
 
7.4. Alternative causal explanations 
 
The perceptions an individual has about a disease and its attribution is important as it influences 
on how these individuals understand disease and the stigma they experience related to the 
disease. Due to participants’ past involvement in genomics research many had some 
understanding of how genetics may play a role in the development of a disease. Some held this 
explanation alongside alternative causal models. The questions asked in the FGDs were 
specific in asking about the role of genetic knowledge on experiences of stigma (i.e. “whether 
knowing a disease is genetic may affect decisions on getting married/having children/getting a 
job etc.”). However, the data suggests many of the respondents described other non-genetic 
explanatory causal models which they believed may have played a more important role in 
P a g e  | 109 
 
 
causing their disease. These alternative explanations included psychosocial and cultural 
explanations which will be discussed in the sections below.  
 
7.4.1. Psychosocial explanations 
 
Psychosocial explanations about disease causation can be understood as pertaining to 
psychological and social factors which influence an individual’s mind, behaviour or 
experiences. The social and psychological factors influencing the health of an individual may 
be interrelated. For instance, living in poverty or not having being able to obtain sufficient 
means to survive, could create frustration and a sense of powerlessness. In this study, 
participants highlighted that a disease like SCZ or RHD is often attributed to psychosocial 
experiences (i.e. being influenced by their environment, psychological or their social relations 
and described these factors could have an impact on their physical and mental health). For 
instance, being in environments where it is not uncommon for people to witness situations such 
as shootings, stabbings, physical assault and gendered violence in households and the 
community may affect one’s psyche and play a role in disease causation.  
 
7.4.1.1. Environmental explanations 
Under the theme of psychosocial explanations, the environment was seen as a salient 
contributing factor to the onset of the two diseases.  The perceptions on how the environment 
can play a role in causing disease are discussed below.  
 
SCHIZOPHRENIA 
Amongst the SCZ sample, the environment within which one grows up was reported as having 
a considerable influence on the onset of the disease. To start off, participants noted that the 
house that Andile lives in could compromise his health. In the vignette, Andile is shown to live 
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in a RDP house in a township. A RDP house is a one-bedroom house (about 36 square meters 
in total) with a kitchen, small lounge and a bathroom. These houses are very small in size, do 
not have enough space, particularly for the large families who usually live in them, and often 
have poor ventilation. RDP houses are often situated in low resource areas requiring people to 
travel long distances to hospitals and clinics. Most participants in this study (from both the SCZ 
and the RHD groups) come from townships or low-income communities, some of them the 
very same township as the character, Andile. In these areas many of them live in these RDP 
houses which have been provided by the government since 1994 to demonstrably poor people. 
These houses are a means to replace the even poorer conditions many South Africans live in 
informal settlements with shacks. Although the aim of receiving these houses from government 
is to better their living conditions, these participants are suggesting that when one is ill with a 
disease, it is also unhealthy for them to be staying in such a small space with many other people.  
These problematic environmental challenges can even impact on help-seeking behaviours and 
medication compliance. For instance: 
“Another thing that I think may affect him, is the situation in which he lives under. His 
environment maybe, since they say that he lives in an RDP house. Which means that he 
may not have access to the medication which could be most effective for his illness. 
Then it could be more difficult for him to get better. But if he was in, in, in a developed 
place, he would be able to have access to facilities which can help him.” (P.3: FGD 2)  
 
The fact that the reason most people reside in those homes is because they are poor and can not 
afford to buy a house for themselves is another cause for concern, which is why participants 
motivated that it is important to try and find a way to move from this kind of housing structure.  
“Andile’s life could be affected in the sense that he may not have the ability to assist 
his mother, since they stay in an RDP house. He may not be able to assist her with 
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getting a house. In order for his mother to have a better house, other than the RDP 
house that they live in, because it makes them live a poorer life.” (P.9: FGD 2) 
 
For these participants both the structures for housing (RDP homes) and the township 
environment, associated with poverty, high rates of unemployment, high incidents of violence 
and drug abuse (Bähre, 2007; Ngqela & Lewis, 2012) were highlighted as not being conducive 
environments for an individual living with SCZ because they may have a negative influence 
on their physical and psychological well-being. This observation is highlighted by 
Mossakowski, (2008) who postulates that long-term exposure to poverty and unemployment 
significantly predicts the abuse of alcohol and other substances, especially between ages 27-35 
years.  
 
RHEUMATIC HEART DISEASE 
The RHD participants also highlighted that living in a small RDP house may affect Andile’s 
health. Based on that knowledge participants in the study suggested that Andile would need a 
“proper place” (it is assumed that they meant a bigger home) to live in. One participant said: 
“An RDP house has got a very small space and there is a lot of people.  Everybody is 
breathing under one roof which can cause problems. TB is also easily spread because 
others are not healthy. It was bound to happen to him as he is living under unhealthy 
conditions… The government also needs to intervene and give him a proper home so 
his health can improve.” (P.6: RHD FGD 1) 
Notably, living in poor, ill-ventilated housing is identified as a strong environmental factor 
causing the onset of RHD (Barth, 2013). Another participant related this view to her 
experience:  
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“For me at home, my mother received a small RDP house. I was sick with rheumatic 
fever and my brother had leukaemia. So my mother went to the hospital and reported 
that she has been given a small house while she has two sick children. She was given a 
letter to take to the committee and counsellors. From there on we received a bigger 
house with space.  We now have a bigger and spacious house which we grew up in.” 
(P.2: FGD 1)  
 
While the problem about the physical environment was discussed by participants, another 
participant also related the cause of their disease to the nature of the environment: 
“I grew with my grandmother smoking a cigarette called ‘Mrhameti’. When she was 
smoking the smoke would affect me badly to the point where I thought it would kill me 
because I did not feel alright when she smoked and I was around. So that resulted in 
me having difficulties in breathing. But she was my grandmother, so I had no choice.” 
(P.3 FGD 1) 
 
Some participants described their disease was caused by a germ or virus which is passed on 
through the environment they live in. One participant, in the 7th RHD FGD said she had 
received this explanation from her doctor. She explained that a germ creates an infection which 
then later develops into RHD. This explanation is supported by two other participants in 
another FGD who shared: 
“I also think like ‘P.1’, maybe you are in a village, and you drinking water from the 
streams you don’t even know where it comes from. So there might be a germ or virus 
in that water that is how I think it can cause the disease. Maybe the water from the river 
would cause you to cough, have short breath, loss of appetite, it might be that the germ 
formed all these things after that it becomes a heart disease.” (P.4: FGD 2) 
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It is commonly known in the health literature that RHD is a disease of poverty. It is rare in 
developed wealthier countries and has a higher incidence rate in contexts with more poverty 
(Engel et al., 2011; Zuhlke, 2015). Most of our research participants in this study are 
unemployed (see Table 2 in Chapter 6), and these RHD participants clearly linked the 
consequences of poverty to disease causation – in terms of their living conditions, but also in 
terms of how those realities have an impact on the stress they have and how that related to their 
illness. 
“Poverty is one of the difficult things that we go through and it can make you sick with 
stress. I am sure Andile is also thinking about how he and his family can get out of this 
poverty.” (P.4: FGD 4). 
 
7.4.1.2. Psychological explanations 
Under the psychosocial explanation, the psychological implications of past and present 
experiences of trauma, stress and emotional abuse also surfaced in the groups. There were 
many participants who reported that these experiences influenced their lives significantly and 
many of them felt that they may have caused the onset of their disease.  
 
SCHIZOPHRENIA 
Some participants in the SCZ FGDs suggested that experiencing a violent environment may 
trigger the onset of the disease. See for example,   
“It is not being happy because you live with being abused by people in your community, 
people in your home and just people around you”. (P.4: FGD 3)  
 
“What do I think causes it? I think it may be caused by being beaten up.” (P. 10: FGD 
1) 
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While another participant discussed the influence of negative perceptions held by people in 
their community, about mental illness and how that may affect them psychologically:  
“And it’s true my sister yey, when you are a mentally ill person living in the township, 
people often undermine you when it comes to a lot of things.” (P. 1: FGD 6) 
 
This undermining could be the result of a loss of social status in the community, which in turn 
results in some participants feeling inferior, and reporting a loss in their self-confidence. Living 
in the township and not having a job that provides a sense of income can also cause stress 
which may result in the onset of disease.  
“Not working means you can’t afford everything you need and want. When you are 
poor, you live in difficult circumstances”.  (P.4: FGD 3)  
 
In the literature review section of this thesis we discussed the quality of life in townships and 
went into detail about the challenges of living in a low-income community (see Chapter 2, 
section 2.7.3.) with high levels of unemployment, poverty violence and crime. It is no surprise 
that living in a low-income community can impact on one’s psychological health.  
 
This ties in with the earlier suggestion made by many of the participants that once diagnosed 
with the disease, Andile should try to move away from his environment. This move may allow 
him to enhance his resilience which they feel is needed in order for him to function to the best 
of his ability.  
 
In addition to the normalisation of violence, reported by many participants as a common 
occurrence in their community, the fear of being violently attacked was reported as a common 
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trigger of psychological distress amongst participants. Some participants feel that this constant 
sense of fear may also be the cause of their disease.  
“P.4: Being scared sometimes. Being scared can also disrupt ones thinking.  
I: Okay, being scared of what maybe? 
P.4: Being scared by things, for example the killing of people.  
I: Okay, so these would be things you would see where maybe? 
P.4: These are things you would see in the township.” (P.4: FGD 6) 
 
These concerns are unsurprising in the sense that in South Africa people are being killed in 
tarvens [informal shebeen’s] and other areas of townships or low-income communities in 
general almost on a daily basis. It is a common occurrence and for a mentally ill person who 
may struggle to control or defend themselves, it could be a cause for a deep sense of fear. This 
fear was mentioned by some participants as playing a role in developing the condition.  
 
RHEUMATIC HEART DISEASE  
For the RHD participants, psychosocial stress was described as having a prominent 
psychological implication on participants’ life experience. This feeling was echoed by many 
participants in this disease group and most of them felt strongly about the relation between 
stress, trauma and past negative experiences and the impact these may have on their psyche 
and heart. Many participants ascribed the cause of their disease to emotional stress, some of 
which was experienced during their childhoods and some during adulthood. Furthermore, 
many of the RHD patients described that the way in which you are treated at home, and the 
circumstance you live under whilst growing up may also have an influence on your health, 
which is similar to perspectives described by some of the SCZ participants. For example one 
participant in the RHD FGD said that:   
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“…to think too much, and being abused at home, it kills the heart…” (P.4: FGD 1)  
 
“So I thought that it might be caused by the stress that I used to have at an early age, 
and I did not speak about my stressful things. I kept all of them into myself… Therefore, 
I think what causes heart disease is stress and to take things too much into your heart.” 
(P.3: FGD 7) 
 
In relation to the stress, similar to the SCZ participants, some RHD participants also expressed 
experiencing abuse in their lives, and they attributed the cause of the disease to the stress of 
living through experiences of abuse. 
“Children at school used to abuse me because when they see me they think I would faint 
or do something weird so that they would laugh at me, these are some of the things that 
affected Andile’s life.” (P.2: FGD 1)  
 
“I think what causes heart disease is when maybe something happened, and you just 
ignore it, maybe someone hurt you or did something hurtful you will obviously think 
about that and then the minute you process it in your mind, your heart beats faster and 
starts pumping in a strange way. I think things like that affect the heart, because the 
heart pumps the blood. Even when you are overthinking maybe you are angry and you 
experience that the blood is not flowing well, the heart is beating faster and its paining 
before they do the operation at the hospital because you are angry.” (P.7: FGD 1) 
 
While another participant who shared with the group her experience of abuse as an adult said:  
“For me my husband mistreated me, he used to hit me always and he would not give 
me his salary at all claiming that he is the one who works for that money so he can 
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spend in whatever way... I have been abused emotionally, and for me the heart disease 
was caused by this abuse, because I did not have this disease when I was growing up 
and in my family, we have no history of the heart disease but abuse from my husband 
caused this illness.” (P.1: FGD 2)  
 
While abuse and stress were described as having psychological implications which in some 
way may have contributed to individuals getting the disease, there were some contrasting 
views. Some participants stated that they got diagnosed with RHD when they were children, 
and they therefore do not believe that the cause of the disease for childhood onset would be 
stress. For instance,  
“So my mother had this idea that a heart problem is only for older people, because they 
think a lot. Then, when I arrived at Red Cross Hospital, I realised that there are many 
children with heart diseases. That’s when I was told that this disease is not just for 
older people, because they have stress.” (P.1:  FGD 1) 
 
In support a few other individuals who were diagnosed with RHD at a young age did not believe 
that they developed the disease because of stress, but rather felt it was other causes which may 
have contributed to them getting the disease, for example the environment they lived in or the 
choices they made growing up.  
 
7.4.1.3. Personal lifestyle choices 
Personal lifestyle choices were also are important causal explanation which participants gave 
to their disease. Both groups of participants emphasised the importance of smoking, substance 
abuse, unhealthy foods and physical inactivity in disease causation with some voicing that they 
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believe that their inability to avoid engaging in those behaviours may have caused their disease. 
The different perspectives shared by the participants in the two groups are presented below.  
 
SCHIZOPHRENIA 
Many of the SCZ participants reported that lifestyle choices and an individual’s behaviour may 
have contributed to them developing SCZ. A majority of participants believed SCZ was due to 
them having abused substances at some point in their lives. Examples of statements shared 
when participants were asked what they thought caused SCZ included: 
“It is smoking too much drugs. It disturbs your thinking, then you end up robbing 
[stealing from] people, and you end up being beaten by people in your community 
because you are robbing them. Because your mind is not functioning as per usual, it is 
functioning in another way.” (P.9: FGD 1) 
 
While another participant supported the above view and said:  
“By using drugs maybe and also by using alcohol maybe where you find that you 
perhaps smoke and do everything and your brain does not come back to its proper state. 
And you end up losing your mind.” (P.5: FGD 5) 
 
When asked about whether the participants thought Andile’s child may have the disease, some 
participants suggested it would depend on the personal lifestyle choices that the child makes. 
These participants asserted that children needed to be aware that along with their agency in 
making these decisions came the knowledge that these may have health implications.  
 
The critical role of substance abuse in causing the onset of SCZ was only affirmed by the fact 
that some participants made the assumption that Andile uses drugs, which is interesting as this 
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is not mentioned or suggested in the vignette they watched.  However, considering that 
substance misuse is highly common in South Africa, especially amongst the youth – individuals 
between the ages of 16 and 34 years – it is understandable that these participants considered it 
to have an influence on the onset of the disease. The average age of these participants was 33 
years old, falling well within the age group with the highest risk of drug use. Many of these 
participants reported misuse of substances in the past, and the association they make between 
substance abuse and the onset of SCZ may be in relation to their own experiences.  
 
RHEUMATIC HEART DISEASE 
Personal lifestyle choices were discussed differently by the RHD patients. Whilst there was 
some mention that Andile should not take drugs or abuse alcohol, this group did not place the 
same amount of emphasis on this as the SCZ sample. One participant said: 
“Andile needs to change his ways. If for example he was drinking alcohol and smoking, 
and using other drugs, he needs to decide to change his old and wrong ways for the 
better.” (P.1: FGD 4). 
 
Again, similar to the SCZ participants, some respondents also made mention that he needs to 
stay away from people and situations (for example parties or shebeens) which would influence 
him to consume alcohol.  
 
This is also reflected in RHD FGD 6 where a participant said that Andile should be careful of 
the friends he chooses and monitor his alcohol intake. She said:  
“Alcohol and the friends. In terms of friends, he should choose the friends he mingles 
with, because if you will be getting drunk while you are sick it is not right… he should 
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try to change now… Even the kind of food he eats. He would have to stop eating 
amagwinya [Vetkoek / fat-cakes]…” (P.2: FGD 6)  
 
The above comment shifts from highlighting the need to reduce the consumption of alcohol to 
highlighting the need to reduce the intake of unhealthy food, which was a prominent topic 
discussed in the RHD FGDs. In fact, the kind of diet participants are or were on before the 
onset of the disease was suggested to have significant implications on their heart condition. For 
instance,  
“It because of the things that we eat daily, fatty foods, cooking oil consumption and so 
forth, they are the cause of heart disease because it’s not heredity.” (P.3: FGD 1) 
 
“I think overthinking and consuming too much salt are the things that caused heart 
disease in my life.” (P.3: FGD 1) 
 
The above extracts (about the food diet) relate to a different way in which personal lifestyle 
choices were discussed by group members. For example, as seen above, when it came to food, 
RHD participants were adamant that it is important that someone with RHD does not eat oily 
or salty foods, or too many green vegetables (which have a negative relation to Vitamin K in 
the blood system).  An example of an extract which describes the participants’ awareness of 
avoiding certain foods and substances is displayed below.  
“I avoid a lot of things, like cough syrup, raw food, and alcohol. I can’t have them, I 
must eat proper food and I must follow the right diet.” (P.3: FGD 4) 
 
For this group, the consumption of healthy food was a focus under this theme, and it was linked 
to both contributing to the cause of the disease as well as to the management of the condition 
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after diagnosis. In addition to maintaining a good diet, many participants emphasised the 
importance of exercise as it is known to also contribute to an individual living a healthy 
lifestyle. These findings again ought to be understood against the background of the 
participants’ environments and financial situations.  
 
7.4.2 Cultural explanations 
 
7.4.2.1. Bewitchment/Supernatural causation 
In African contexts most people are more prone to understanding the world and living their 
lives through traditional cultural belief systems. As it has been discussed in the literature 
(Mkhize, 2003; Swartz, 1998), mentally ill individuals from African settings often attribute 
part of the cause of their illness to cultural beliefs (for example bewitchment i.e.: being cursed 
or poisoned through supernatural ways). The results below illustrate how these two disease 
groups view the role of witchcraft and or supernatural causes like evil spirits in the onset of 
disease.   
 
SCHIZOPHRENIA 
Among the SCZ participants for instance, one participant describes how he thought his illness 
emerged due to a supernatural cause (bewitchment) before he gained better knowledge on what 
caused his disease. He said:  
“I used to think it was witchcraft, but then when I heard more about it I realised that 
it’s a blockage in the veins in your head.” (P.7: FGD 2) 
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Even though the above participant seemed to have changed or included an additional 
perspective to their own explanatory model, other participants stayed firm in their belief that 
their illness was caused by supernatural causes. 
“What I think is that it is caused by witchcraft. Because I have experience with those 
things when it comes to me and things that have happened to me. So I think that maybe 
it does happen that, there is Satanism, or witchcraft which is involved. No matter what 
may be the main cause of it but I do think that those things do play a role in triggering 
it.” (P.5: FGD 2) 
 
While another participant in the same FGD as the one above said: 
“….I relate this to what [she] said, that it is related to witchcraft. So the person who 
did that to Andile is like someone who practices witchcraft.” (P.1:  FGD 2) 
 
While two other participants acknowledge that some people who develop SCZ may feel this 
way because of their cultural belief system. See, 
“Other people start blaming neighbours of witchcraft, and they would start saying that 
as a family they need to move out of the neighbourhood because they are being targeted 
for bewitchment.” (P.3: FGD 2) 
 
“It may also be caused by the thing of believing in things to do with witchcraft. Maybe 
you could be bewitched perhaps, then you notice that you are not the same as you used 
to be.” (P.6: FGD 4) 
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When asked to articulate how bewitchment occurs, some participants explained that they 
thought of bewitchment in the form of being poisoned, which can happen through eating food 
with poison served by someone who has the intention to bewitch them.  
“Yes, poison food… Some people can give you food which is poisoned for you to be 
mentally ill. Then once you are ill. Once you start being mentally disturbed, then those 
people will start speaking to you on the side [which is when you hear voices]. That’s 
when they will say [to themselves or others], ‘hey, I have poisoned so and so’s child 
and I want them to go around picking up papers or eating from the bins.’ Ya.” (P.1: 
FGD 6).  
 
These extracts are in accordance with the literature which documents that within Xhosa 
communities, individuals indicate that psychotic symptoms related to mental conditions like 
SCZ are attributed to witchcraft and spirit possession (Mbanga et al., 2002; Swartz, 1998). This 
was eloquently discussed by Campbell et al. (2017) who investigated Xhosa patients with 
SCZ’s understandings of delusions. Echoing these previous studies, many of the participants 
in the present study reported their beliefs in a supernatural cause which may have triggered the 
onset of the disease. In African cultures, it is believed that this causal explanation is often 
viewed as prevalent alongside the other causal views explained by participants. Moreover, 
individuals often attribute this explanation as identifying the ‘root cause’ of an illness, while 
western medicine manages the symptoms of psychosis. Hence, these participants suggested 
that there could be a combination of causes and disease causation may not be limited to genetic, 
psychosocial or cultural causes exclusively.  
 
RHEUMATIC HEART DISEASE 
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It was intriguing but rather unexpected to note that in the first RHD FGD, participants 
suggested that the disease causation can be linked to supernatural reasons. One participant said:  
“My mother, when I told her about it she thought and believed that it was evil spirits 
that caused it.  I told her that it is a common sickness, there is a lot of people who are 
affected by it. She was hurting so it was not easy for her to accept it.” (P.4: FGD 1) 
 
Two participants in the sixth RHD FGD also suggested that the cause of the disease was related 
to supernatural powers such as evil spirits.  
“I am saying it is evil spirits.” (P.2: FGD 6) 
 
“Me, it is said that there is my aunt who had it. I do not know how it connected with 
me. I would say it is heredity, but no, I also say it is evil spirits. [Laughter]. So I also 
think maybe it is that is what caused the illness.” (P.3: FGD 6) 
 
Although P.3 above included the possibility of a genetic contribution to her illness, she also 
added to her explanatory model her belief in a supernatural cause. In the 7th RHD FGD 
participants also echoed the views expressed above by stating that RHD may be caused or at 
least enhanced by supernatural causes.  
“And that is true, evil things will get to you through something that you have. If people 
want to bewitch you they will use this heart disease, or use the illness that you suffer 
from.” (P.4: FGD 7) 
 
“…I mean I do agree that sometimes it would be evil spirits and it would enter through 
what you suffer from. If it is said that you suffer from heart disease, the evil spirit would 
use that heart disease. You see, it is things like that.” (P.1: FGD 7) 
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This suggests that cultural explanations of illness may also play critical a role in understanding 
RHD disease attribution.  
 
7.5. Chapter summary 
 
The above findings lead to what has been alluded to and sometimes stated by many of the 
participants in the study, that the disease causation can be linked to multiple causes all 
interacting to cause the disease. Many participants noted that even if genetic predisposition 
may be present, there would need to be another factor that would trigger the onset of the 
disease. Some participants referred to that factor as being the environment they are in or have 
been in, while others related it to psychological experiences they have encountered and some 
related it to the cultural beliefs that they hold. These participants therefore often attributed the 
disease they live with to multiple causes concurrently (including genetics).  
 
Chapter 6 presented evidence of the causal explanations held by the SCZ and RHD participants 
in this study. The chapter began by defining disease causal explanations. Secondly, it presented 
qualitative data of participants’ attributions of disease in relation to genetics, psychosocial and 
cultural explanations. The chapter demonstrated that for Xhosa people with SCZ and those 
with RHD, genomics as a causal explanation for disease, is considered in conjunction with 
other causal models. In the next chapter I discuss the findings of the study in relation to the 
stigma experiences revealed in the FGDs across both disease groups.  
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CHAPTER 8: EXPERIENCES OF STIGMA 
 
8.1. Introduction 
This chapter details the findings of the experiences of stigma reported by participants in this 
study. The following section draws on participant experiences of their illness specifically in 
relation to stigma as well as how they cope with their reality of having their disease. The 
responses were provided following exploring participants causation attributions. While it is 
acknowledged that it is impossible to gain an exact account of these participants realities, the 
discussion below is based on their own accounts. This chapter is divided into the categories 
presented in Table 10 below. For consistency, for each category I present evidence for the SCZ 
sample, followed by evidence from the RHD sample. Where relevant, within this chapter I have 
used quotes to communicate the voices of the participants in this study.  
 
Table 10: Categories and themes  
MAIN THEMES SUBCATEGORIES 
1. Knowledge about disease  
  
2. Evidence of existing stigma a) Family, friends and community 
 b) Marriage 
 c) Having children 
 d) Ability to earn an income/work 
  
3. Coping strategies to overcome 
stigma 
a) Social support 
 b) Acceptance, openness and 
transparency 
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 c) Sense of purpose 
 d) Health knowledge 
 
8.2. Knowledge about the disease 
Peoples’ knowledge about disease is undoubtedly influenced by their perceptions, belief 
systems, disease-causal explanatory models and their worldviews which have been discussed 
in the previous chapter (Swartz, 1998). Below is a presentation of the shared views of Xhosa 
people, living with SCZ and RHD, about what they know or understand about their disease.   
 
SCHIZOPHRENIA 
For the SCZ patients, when asked the question: ‘What do you know about schizophrenia?’ they 
often answered with examples of the symptoms that they remember experiencing when they 
became ill. In particular, people in these FGDs commonly described the illness in terms of 
positive (psychotic) symptoms. These included descriptions of experiences of hallucination, 
delusions, disorganised speech and behaviour to name a few. Describing their illness through 
symptoms is not necessarily the same as using the disease label – and describing an illness in 
this manner could be considered as distancing oneself from the illness label and its 
connotations. This is not unexpected, as in the Xhosa language, there is no term for 
schizophrenia, or even differentiations between different mental disorders. Individuals 
diagnosed with a mental disorder are often grouped by members in the cultural group in one 
term which is “ukuphazamiseka enqgondweni” meaning in English, “a disturbance in the 
brain”. This understanding has an implication on how the scientific label “schizophrenia” is 
received, acknowledged and internalised as referred to in the Modified Labelling Theory (Link 
et al., 1989). For example, one participant said: “It is hearing voices.” (P.6: FGD 1). Hearing 
voices is a common symptom which was highlighted by these participants. For instance: 
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“In my knowledge, the illness known as schizophrenic is a disease which attacks a 
person. For example I am sitting at home, and I hear something [a voice] which says 
go outside and run in the road. Run on the white line on the road. It’s like there is God. 
Or like there is a big god that is telling you to go outside and expose yourself to 
something.” (P.1: FGD 2) 
 
This is an example of one of the few participants who actually mentioned the label 
“schizophrenic” in their dialogue. Many participants indicated that they understood SCZ to 
relate with disturbances in the mind, although they did not specify what happens in the brain. 
They also theorized that there may be a particular trigger (which many respondents propose to 
be bewitchment, the environment, stress or substance use) which may cause the disturbance in 
the natural state of the mind.  
 
Another participant in FGD 4 highlighted the symptom of hallucination. He said, 
“Having schizophrenia means seeing things that other people do not see, or hearing 
things that other people cannot hear.”  (P.6: FGD 4) 
 
In addition to hearing voices, disturbances in the mind and hallucinations, many participants 
associated ‘being sick’ with the time when they are ‘dirty’ and did not have motivation or 
energy to wash or clean up after themselves. They explained this as the time when they struggle 
(because of lack of interest) to do everything they were used to doing in their daily routines. 
There are many similar examples of how the participants in this study (who are patients 
themselves) described a person living with SCZ as being ‘dirty’. For example in the fifth SCZ 
FGD participant 3 said: “When the illness starts, it makes him dirty, and he becomes darker.” 
And again in the sixth FGD a participant said: 
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“One person may be very sick, and you notice that they even go around picking up 
papers. Like dirty things. And they even eat from the bins.” (P.10: FGD 6) 
 
The association of psychiatric illness with being ‘dirty’ in relation to personal hygiene, eating 
from bins and other dirty behaviours has been well documented in the literature. For example 
Phelan and Link (2004) as well as Mbanga et al. (2002) write about the public’s tendency to 
ascribe the negative characteristic of being ‘dirty’ to mentally ill people. When relating this 
observation to the aetiology of the disease, this could be understood as the disorganised 
behaviour typical of a psychotic episode. That patients themselves also articulated these views 
in our FGD could be considered evidence of internalisation of these stereotypes.    
 
With dirtiness described in this study as an indication of a symptom related to SCZ, it is not 
unexpected that participants perceive an important step towards recovery to be getting 
‘cleaned-up’. The participants describe a range of strategies for ensuring people living with 
SCZ (for example Andile) become cleaned up. Starting with friendly conversations suggesting 
that he get cleaned up, to resorting to violence -which as discussed in the literature reviews, is 
a common act in South African low-income communities - to force him to clean-up, all in the 
name of friendship and care. But what counts as friendship in this group is contested. For 
instance, some participants emphasised that friends should be the ones who take the role of 
pushing Andile to take action.  
“… When you are Andile’s friend you should be the person whom he is scared of. So 
that when he refuses to wash himself at home, his family can go and fetch you. When 
you arrive you should be able to threaten him and say ‘look boss, I will kick you, I am 
not going to beg you, I will stab you, you must wash now’, and he should wash.” (P.9: 
FGD 6)  
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This quote is an example of the normalisation of violence within the township communities 
that these participants come from (Bähre, 2007; Ngqela & Lweis, 2012). Moreover, it suggests 
that the participants are used to violence as a form of communication and a behaviour 
correcting strategy. This is evident in that participants even anticipate that their family 
members would call on someone to enforce violence in the name of care. This violence was 
also reported by participants to be a solution for when they do not want to seek treatment for 
their disease. This may further suggest the internalisation of stigma, that people with SCZ 
perceive themselves to be so helpless and stuck that this behaviour is acceptable and perceived 
as helping. Importantly, not all participants felt that using violence was acceptable and some 
expressed a desire to have conversations that encourage Andile to take better care of himself.  
 
Although most participants knew the name of their disease, and were able to describe the 
symptoms they experienced when they became ill, many did not necessarily identify with the 
chronicity of the illness and therefore did not consider themselves to currently be ill. Even 
though they were open to describing their diagnosis, there was clear hesitance in labelling 
themselves as having schizophrenia and in thinking of themselves as ill. Participants also went 
to some effort to point out that they were not as ‘sick’ or as ‘bad’ as the character in the vignette. 
This is interesting because the video character was only very mildly depicted as hearing voices 
and experiencing hallucinations and otherwise clean and healthy.   
 
From the data, four important observations can be made in relation to their knowledge about 
the disease: 1) Participants associated SCZ with positive symptoms such as hearing voices, 
hallucinations, delusions and disorganised behaviour (i.e. ‘dirtiness’); 2) Participants described 
SCZ as an illness which has an influence on your mind, making a person living with it 
experience things which others around them do not experience, 3) Most participants in this 
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study often distanced themselves from the label of schizophrenia and its chronicity, and rather 
referred to “a time when they were ill” or had certain experiences – often referring to the 
symptoms they experienced and 4) Participants understand SCZ to be triggered by an 
individual’s personal lifestyle choices (i.e. abusing substances such as drugs for instance).  
 
RHEUMATIC HEART DISEASE 
In the RHD FGDs, individuals vividly recounted experiences of how they remember the 
symptoms starting and their journey to diagnosis. When asked ‘What do you know about 
RHD?’, participants discussed two primary aspects, namely the symptoms they experienced 
during the onset of their disease and the management of their symptoms (which for many 
included having a valve replacement operation). Despite the high prevalence of the disease in 
township communities in South Africa (Engel et al., 2011), many participants stated that before 
going to medical practitioners for a check-up of their symptoms, they did not have much 
knowledge of RHD. For instance,  
“I didn’t know about RHD, it was my first experience hearing about it when I went to the 
private doctor.” (P.6: FGD 1) 
 
One of the challenges to gaining information about the disease which participants reported was 
delayed diagnosis. Many individuals recalled having to go to local clinics multiple times, 
without receiving a correct diagnosis. Some, like P.6 above, resorted to going to a ‘private 
doctor’, which unlike the local clinic - which provides free health services - requires monetary 
payment for consultation, to get the necessary tests done resulting in the diagnosis (see the 
resource challenges in the public health care system in South Africa described in Chapter 2 of 
this thesis).  
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FGD participants described their illness in terms of symptoms like: a sore throat, previous 
diagnosis of rheumatic fever, swollen legs, shortness of breath and tiredness. For instance:  
“Me my first time to have RHD, I started by having shortness of breath, I’d be unable to 
breathe and when I was unable to breathe I’d not be able to walk a long distance, then I 
went to the clinic and when I got to the clinic, I asked the doctor for an X-ray. The doctor 
put me on the X-ray machine and he found that there is something in my heart similar to a 
clot.” (P.5: FGD 1). 
 
While another participant said:  
“When you are someone with a heart disease, you start off by having a tight chest. And 
with your tight chest, it’s not like someone who has a chest problem. It feels like there 
is something coming up your chest. You keep on getting swollen, and getting swollen… 
You get tired easily. (P.4: FGD 3) 
 
Many people in these group discussions echoed these symptoms, while some participants 
shared that their RHD started with a sore throat or what they now know was rheumatic fever. 
This is evident in the response of P. 2 (FGD 1) who explained that she recalled a period when 
she had rheumatic fever as child.  
“As a young child other children used to avoid playing with me because I had a heart 
attack. I used to tell them that I have not had a heart attack, I had rheumatic fever. Then 
they would ask me what rheumatic fever is…” (P.2: FGD 1) 
 
While P.2 above knew that she once had rheumatic fever, P.6 below was also aware of this 
previous diagnosis as the doctor had informed her mother, however she reported that her 
mother did not follow-suit with ensuring that she gets treatment.  
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“I was supposed to go to the clinic for injections for rheumatic fever every month, but 
that never happened. So my heart valves ended up leaking.” (P.6: FGD 1) 
 
Some participants did not recall having been diagnosed with rheumatic fever at a young age, 
but many of them did recall having a sore throat at some point in their lives as children and 
then they recalled no longer feeling the pain after a few days.  
 
A participant (P.4: FGD 6) shared how in her village when she had a sore throat it was believed 
to be mumps (which they called “qilkwana”). In order to cure the mumps (qilikwana) one had 
to sing a short song called “qilikwana”. After singing that song it was believed that the sore 
throat would go away. Therefore, that is what she did when she had a sore throat and it went 
away after a few days without being medically treated. This belief may be in relation to the 
evidence (Engel et al., 2011: Zuhlke et al., 2015) suggesting that after a few days of having an 
untreated sore throat the pain does indeed go away. A period later one develops rheumatic heart 
disease.  
 
From the discussions in the RHD FGDs, four important observations can be made: 1) 
Participants appeared to have minimal information about RHD prior to their diagnosis; 2) 
Participants associated RHD with having a sore throat or a rheumatic fever diagnosis when 
they were children; 3) Participants describe RHD in relation to the symptoms they experienced 
before diagnosis (such as shortness of breath, tiredness and swollen legs); and 4) Some 
participants highlighted a cultural understanding of the precursor to the disease (RF) which 
they articulated as being mumps (qilikwana).  
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The descriptions of illness amongst the two disease groups varied. While the SCZ group 
highlighted the disease’s relevance to disturbances in the mind (hearing voices and 
hallucinations) and dirty behaviour, the RHD group discussed their illness in relation to 
physical changes or pain which they experienced in their bodies (which is to be expected 
considering the psychological vs physical nature of the two diseases).  
 
8.3. Experiences of stigma 
Below is a presentation of the examples of accounts of stigma which the participants in this 
study experienced in their; 1) Family and Community, 2) Marriage, 3) Having Children, and 
4) Ability to earn an income/ work life.   
 
8.3.1. Family and community 
Diagnosis of an illness has the potential to change the way in which family and community 
members view a person living with a disease. Participants from both groups in this study 
expressed that they have experienced and anticipate experiencing more stigma, discrimination 
and abuse from people in their immediate environment because of their disease.  
 
SCHIZOPHRENIA 
Participants in the SCZ sample in particular expressed that they have experienced many 
instances of stigma and abuse by family and community members. They shared that following 
diagnosis, many people around them started looking down on them, treating them as ‘useless 
people’ who cannot contribute to decisions made in the family and in the community. This 
resulted in a strain on the relationships participants have with people around them.  
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At a community level, participants expressed that people tend to tease and bully someone who 
has SCZ, hence they anticipate that the patient in the vignette (Andile) will receive this kind of 
treatment from their community. Many participants expressed feeling that someone who has 
SCZ is often perceived as an inferior individual who is not liked by people in the community. 
In particular, the respondents felt that many people have prejudiced views when it comes to 
engaging with someone who has SCZ. For example, P.9 in FGD 1 said: “Others may say that 
they like him and act like they like him [Andile], however that may not be true… I think people 
may crucify him for his disease.”  
 
Other participants expressed that the vignette character may experience discrimination.  
Participant 7 said: “People may start abusing him, like friends, family or elders for instance.” 
(P.7: FGD 1).  
 
In relation to family, participant 7 (FGD 1) provided another view relating to the hope that 
family members ought to be the ones who empathise with someone who is diagnosed with 
SCZ.  
“I think that the family may change, in the sense that they would try and become closer 
to him and kinder to him as well. I think also the fact that he did not do it to himself, for 
example through the use of drugs. His family may then support him.” 
  
This latter view was highlighted by most of the SCZ participants, as they voiced that their 
families ought to be the people who support them and treat them with empathy. In addition, 
respondents revealed that an individual with SCZ should in fact aim to limit their engagement 
with individuals outside of the family as that may open them up to situations where they may 
be stigmatised or abused. Notably however, as mentioned earlier however, sometimes the 
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family members themselves also exert violence towards the person suffering from SCZ, 
possibly because they don’t know how else to treat them when they behave strangely.  
 
The reaction of the family and the community to an individual who is diagnosed with SCZ was 
largely tied to their belief of the cause of the disease. Participants expressed that if an individual 
inherited the disease from a family member or it is something which is passed down in the 
family, then the individual would likely be less stigmatised. Whereas, if the individual 
participated in a behaviour (such as smoking drugs or abusing alcohol) which the family and 
community believed may have caused the onset of the disease then participants suggested that 
the person living with the illness would be more stigmatised, as people may in some way blame 
them for bringing the disease on themselves.  
 
Overall however, although it was reported by many in the groups that some form of stigma 
would be prevalent in their families, it was acknowledged that family support is an important 
protective factor for both the SCZ and RHD participants in this study. Hence, this theme is 
further elaborated on in the Coping Mechanisms section of this chapter.  
 
RHEUMATIC HEART DISEASE 
Similar to the SCZ group, some participants in the RHD FGD’s felt that Andile may be looked 
down on by individuals in the community. For instance, 
“Yes, it can happen that people look down on him since he is sick. Some people can 
even go to an extent of keeping his plate and spoons separately from theirs as they think 
his condition might be contagious. Like I said people are different.  Some people may 
even call him names.” (P.1: FGD 4) 
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Concurring Chang et al. (2018) a few participants described the burden of collecting treatment 
each month and having to take pills everyday as an act which gave some people in the 
community the misconception that they are taking Antiretrovirals for HIV (which is highly 
stigmatised) rather than RHD. The stigma of having HIV is extremely strong in these 
participants’ communities, therefore some explained that they carry their clinic cards with them 
and if someone suspects them to have HIV, they take it out and show them their diagnosis of 
RHD which is written clearly on their clinic card.  
 
Similar to the SCZ participants’ views, many RHD participants felt that the family should be 
protecting the person living with the disease from stigmatising encounters, again emphasising 
the importance of family as a protective factor towards stigma in this cultural group. For 
example, one participant said:  
“If the family does not give Andile love, care and support then the outsiders will also 
treat him that way.” (P.6: FGD 1) 
 
Participants in this group also expressed that Andile may be perceived as an inferior individual 
in the community. For example, P.1 in FGD said, “…they can make him feel so small.”  
 
On the other hand, many participants described that family members may also treat Andile 
differently not because they want to offend him intentionally but because they perceive him as 
vulnerable and want to protect him. This could be evident in them treating Andile as a fragile 
person, and taking active steps to try and minimize any possible emotional or physical harm he 
may encounter, for instance by avoiding telling him bad news, “for example there is bad news 
about death in the family, then the family may not want to tell him” said P.9 in FGD 3. He 
proceeded to say:  
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“Yes, or if it comes to making decisions. Some people in his family may feel that they 
need to make decisions for him just because he has a heart condition and they think he 
cannot be told anything. Which will then make it his responsibility to always tell them 
that, ‘listen, even if there is bad news, don’t hide it from me because I have RHD, treat 
me as you do other people’. So Andile’s life might be affected by other people treating 
him differently because of his condition.” (P.9 FGD 3) 
 
Some people expressed that Andile may be treated more positively because he has the disease 
and because people feel pity for him. This was expressed in the comment below.  
“People will always feel pity of him, even when there is some work activities in progress 
[in the community], people will always be sympathetic towards him and ask him to sit 
down instead of taking part in the activities. Even, at work, if he was working, when 
workers are being reprimanded because of some delays in production he was going to 
be told not to worry and not to be alarmed because he is exempted from the scolding. 
So he will be discriminated in some way.” (P.4: FGD 6) 
 
This was supported by some participants who also expressed having similar experiences where 
they have been told (either by people in their family, community or in the work environment) 
to sit down and rest because they are excused from working due to their disease. Participants 
described that this was not something they appreciated, as they wanted to be treated as equal 
human beings to other people and not be given better or different treatment due to having RHD. 
Another participant shared how it affected her spiritual life  
“For example, in things that are connected with church. During the fasting times, it 
would not be accepted that I also fast. I would be reminded that I am taking a treatment 
and therefore I cannot fast. And I will be telling myself that I feel powerful and I would 
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be able to fast until I complete the period. But I will not be able to take part in the 
fasting activity because I will be prevented to do so due to the treatment I am taking”. 
(P.3: FGD 6) 
 
While in relation to Xhosa cultural activities, one male participant shared that people may not 
take Andile seriously:  
“For example, in the villages [in the Eastern Cape Province] in preparation of burial 
service, it is young men who perform the responsibility of digging the grave-hole. So 
when it comes to him, people will say ‘oh that one, he is useless’, you see those negative 
comments. He cannot even make a suggestion and say, ‘Let us go and dig’, no, because 
people know that Andile is someone who cannot dig and cannot even carry a shovel, 
because he might just fall with it on his hands.” (P.5: FGD 6) 
 
Described in this way, the inability to physically assist with activities which are deemed 
important and valuable based on cultural values held in the community may be a cause of 
stigma for at least some people with RHD. This is true particularly for those who reside in more 
traditional communities, like for instance villages in the Eastern Cape. And even though some 
people may be residing in the urban areas of the Western Cape, many RHD participants 
described going go to the rural areas of the Eastern Cape at least once a year (usually in the 
December holidays, over the Christmas break) and sometimes more (like for instance in 
March/April which are the Easter holidays and the June or September school holidays or for 
funerals). During those periods they would be exposed to spaces where they can potentially be 
stigmatised for not being able to part-take in culturally valued activities.  
 
P a g e  | 140 
 
 
Women in particular carry a heavier burden, as in the Xhosa culture they are expected to do a 
lot of the house work (including cooking, cleaning, washing etc.), all of which requires physical 
energy and strength. Another cultural expectation for women in the rural Xhosa communities 
is that they go to the river to collect water (usually in 25 litre buckets which they carry on their 
heads to and from the river) for the entire family to use each morning. When you are unable to 
do so, you are sometimes labelled as ‘lazy’ by people in your family and/ or community. 
Women in the group discussions made reference to the work needed to be done by a woman 
and some of them expressed how they struggle to fulfil those duties and often have to rest 
before completing them. Although acknowledging that some people may judge them for their 
inability to assist in this labour, some participants stated that their families understood their 
situation and would not ridicule them if they cannot complete these tasks. One participant said 
that when people know that you have a disease, and they know the cause of that disease, then 
they are more likely to be understanding and may not label you as being lazy. 
 
Another reason mentioned (particularly by men) for being stigmatised by members of the 
family and the community is the inability to contribute financially towards things that require 
financing in the family and community. Notably Andile is unemployed and so are many of the 
participants in this study. Participants expressed that his [Andile’s] views and opinions may 
not be considered equally because he cannot contribute to the family physically and financially. 
This relates to the cultural viewpoint that if an individual (usually a male in the Xhosa culture) 
does not contribute financially in the household, he loses the right to voice an opinion about 
important decisions made in the family and in the community. This suggests that at least 
sometimes, the cause of participants’ exclusion is not primarily their diagnosis but may rather 
be related to whether or not that individual can fulfil social expectations and contribute to the 
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family and community. Thus, the persons’ sense of respect and social status in society is often 
based on their ability to contribute financially.  
 
8.3.2. Marriage  
For many participants in the study, being diagnosed with their disease had considerable social 
implications, most notably with regard to marriage and having children. These two domains 
are discussed separately in this chapter as even though there may be some overlaps, some 
participants are married, while some are single but still had strong views on having children. I 
start with the domain of marriage. Of those who are married, many of them met their spouses 
before their diagnosis. Regardless of their marital status, respondents had contrasting views on 
whether or not they thought a person with RHD or SCZ could find a spouse who would want 
to marry them. The views on marriage expressed by participants in both disease groups are 
presented below.  
 
SCHIZOPHRENIA 
Two main views were dominant among the SCZ participants. Firstly many participants felt that 
it was not appropriate for a person with a mental illness to get married for different reasons. 
One of the reasons is that it would be difficult for the person to find a partner who would be 
attracted to them in the first place, primarily because of the perceived ‘dirtiness’ of a person 
with SCZ - described earlier in this chapter. Another reason given is that Andile’s partner would 
experience a loss of social status by marrying someone with SCZ. They anticipated that a 
spouse of someone with SCZ would also be teased and bullied in their community. Therefore, 
some respondents felt that it is better for a person with SCZ not to get married or preferably to 
get married to someone who also had SCZ and will understand what it means to live with the 
illness. One comment which emphasises this view is presented below: 
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“He [Andile] cannot get married when he suffers from schizophrenia. His wife could 
be laughed at or she may speak badly, even to other women about him. He cannot fit 
into marriage when he has a mental disorder. Even me I cannot fit into marriage 
because I have a mental disorder. I would be laughed at and even my wife would be 
laughed at. How could she marry a person with a mental disorder?!” (P.4: FGD 3)  
 
A few participants, however, felt that if the partner loves someone with SCZ and they are aware 
of it and understand the nature of the condition, then they may perhaps be able to support and 
live in a marriage with that person. These participants felt that a relationship would have a 
chance to grow into a marriage.  
 
In addition, on attractiveness, some participants expressed that a woman may not want to get 
married to someone who does not have a job because they would not be able to support them 
financially. For these participants it seemed that the ability to provide for one’s partner and 
family plays a critical role in gaining a partner who is willing to be in a relationship with that 
person, which again may have to do with the social status that person will have in the family 
and in the community.  
 
With regards to decisions about marriage, some participants felt that external individuals or 
sources should get involved when a person with SCZ wanted to get married, especially if they 
wanted to marry a person who does not have SCZ. One participant in addition said that the 
government should be involved in making the decision.  
“The government prefers a person with a normal mental state to get married, not that 
when you are not well you are not normal but you are still under other people’s care 
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and why would you now want to get into marriage, while you are not well.” (P.5: FGD 
3).  
 
He proceeded to say that the government might not be happy with allowing a person with a 
mental illness such as SCZ to get married. Two participants in this FGD felt this way. This 
thought is in line with historical restrictive marriage policies for people with SCZ in the US for 
instance (Phelan, 2002). Other participants in the same group however disagreed with such 
views. One person who was of the opinion that the government should not have the capacity to 
decide whom an individual should ‘love’ and whom they should marry:  
“As for myself, I do not see it that way. The government cannot decide for you who to get 
married to, it is up to you. You decide on that with your partner that you are getting married 
to…  Now there at ‘what-what’ [meaning at the court] they ask you, ‘do you know this 
person?’ And if you say you do, they ask ‘so you are going to marry him as he is?’ and if 
you agree, it is okay, it is your right. So they will make you sign those documents, the both 
of you and you would have agreed as well. So it is not a forced agreement, you agree on 
your own.” (P.3: FGD 3) 
 
As mentioned earlier, a few participants felt that a person with SCZ can get married to someone 
who also has SCZ. This seemed to cause less concern than someone who has SCZ marrying 
someone who does not have the disease. This difference in perspectives was based on the notion 
that a mentally ill person is more likely to meet another mentally ill person (who understands 
their situation) at a facility for mentally ill people.  
 
Many participants either laughed or shared that they would disapprove of Andile marrying their 
sibling. 
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“I would not agree for my sister to get married to someone who suffers from mental 
disorder. That would even make other people to laugh at my sister. People like her 
friends for example.” [Laughter]. (P.4: FGD 3) 
Again, the fear of loss of social status was highlighted by participants, hence the comment 
above relates to the fear of being ‘laughed at’, ‘teased’ or ‘bullied’ when associated (or in a 
relationship) with someone who has SCZ, and this was a common underlying fear which 
emerged in many of the SCZ focus groups. While in contrast, some participants felt that the 
decision depended on how Andile (or a person living with the disease) would treat the sister. 
If he treats her well and they are happy, then they would not have a problem with it or interfere 
in the relationship. If however he doesn’t, then they feel they would step in and advise the sister 
not to marry Andile. One participant related this decision to the chances of having children 
with the disease.  
“I also would not agree at all…since he is ill and my sister is well and you find out that 
even if he would have a family, he might have children that do not have good health, 
just like him.” (P.2: FGD 3) 
 
In summary, the evidence above suggests that the views of participants on marriage were 
strongly related to firstly, thoughts that a mentally ill person would not find someone who is 
interested in marrying them, secondly, the fear of loss of social status (i.e. being teased, bullied 
or looked down on) and thirdly, the possibility of having children with the same disease.   
 
RHEUMATIC HEART DISEASE 
In the RHD group, males and females presented very different views when it came to their 
opinions on marriage. Men were concerned with their ability to provide financially for a family. 
Women were concerned about the risk that pregnancy would impose for their lives. In relation 
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to the concern raised by men, a stark statement made by one of the participants in the RHD 
FGD 6 is:  
“Who is going to get married to an unemployed man? A man whom when you need 
sanitary towels he will go and ask from his mother…” (P.1: FGD 6) 
 
Another male participant (P.3) said: “Andile is in trouble, because when you are a man you 
need to have a wife. How are you going to be able to practice lobola?”. Lobola is bride price 
traditionally paid with cattle in African families, but in the 21st century it is paid with a high 
monetary value to the bride’s family.  The above examples relate to the gender role expectation 
in African families, where a man is expected to take care of his family, both physically and 
financially, which was a prevalent theme in both disease group discussions. Instead for women,  
conversations around marriage linked closely to views on having children. Many women 
verbalised intense emotions when speaking about their fear of not being able to have children 
in a marriage. This fear was triggered by the fact that they reported doctors discouraging them 
from having children as they state that this would compromise both their health as well as the 
child’s health (i.e. it would be too risky to carry a pregnancy). See: 
“Otherwise on his side he can continue dating because he is a man. For us women it 
can be difficult to date and to get married. We are always reluctant to get married. 
When you are married you are expected to bear children. While doctors say that it is 
difficult for us to carry children because of the disease. So you always ask yourself what 
is the point of getting married if you cannot have children.” (P.3: FGD 5) 
 
In the Xhosa culture, as in many African cultures, women are strongly expected to get pregnant 
and give birth to a child, hence, many women felt that their potential inability to reproduce 
could pose a threat to their current or potential future relationships. The fact that one is 
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diagnosed which may compromise that ability (physically or psychologically) is a challenge 
which many of the participants have had to negotiate. Not having children has implications for 
the social status of the couple in their community. In addition to this expectation from society, 
many women expressed their desire to give love to a child of their own, while also 
acknowledging that children would be helpful when they needed to send someone to the store 
close by to purchase small items, like bread for instance. Males did not strongly share this 
concern as participants observed that male RHD patients can physically continue to reproduce 
and therefore that is not a reason for them not to get married. This is echoed by one of the 
participants who said: “The man can get married. It’s a woman who may have a problem.” 
(P.10: FGD 3) 
 
One participant tearfully shared that when she was diagnosed with the disease, she made the 
decision not to have children. She told her then boyfriend that she does not plan to have children 
and that if he wants to have children he should leave her and look for someone else. The partner 
decided to stick with her and they got married and never had children. She acknowledged that 
it is possible to get married if your spouse understands your situation. Although acknowledging 
that people may stigmatise her and her husband, she reported that she does not take note of that 
as it is her health they are most concerned about. Contrastingly, P.1 in FGD 2 explained that 
her male partner abused and later left her, because she could not have children. By contrast, 
many of the older women who participated in the FGDs shared that they did manage to have 
children, and they did not see this as a barrier to getting married.  
 
8.3.3. Having children 
There are different views expressed by individuals in the two disease groups, however as 
discussed in the previous section there is an emphasis on how this ability to have children 
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affects decisions on aspiring to get married and it may have social implications for a married 
couple. One implication may be that the status of those two individuals may be tainted or 
compromised in society. An emphasis on concerns around having children with the disease  
were also raised by the participants in these groups, which informs the question of genetic 
attribution and possible stigma in a biological way. With that consideration, the domain of 
decisions of having children is discussed separately. This is done with the acknowledgement 
that there may be some repetition between the ensuing paragraphs and the immediately 
preceding ones.  
 
SCHIZOPHRENIA 
Participant responses on the possibility of a patient who has SCZ having children varied. SCZ 
participants differed in opinions in terms of whether or not (if an individual were to have 
children) his or her children would inherit the disease. One participant said: 
“…they may be like him, like it could get passed down to his children.” (P.4: FGD 6) 
 
While in contrast another participant spoke of the benefit of having children, as he said:  
“I say that he could get children, and his children would know that their father has this 
condition. They would understand the illness and when they are older they could look 
after him. That’s what I think.” (P.10: FGD 6) 
 
Putting these responses in context however, it is important to remember that most of the 
participants in the SCZ focus group discussions were male (only 3 females in a total of 36 
participants). Therefore, their responses were indicative of a male perspective. For instance,  
“I also agree that he could have children, because his sperms still works. As long as 
his sperm still works, he can have children.” (P.3: FGD)  
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The above comment about physical ability to reproduce is a similar argument brought forward 
in the RHD FGDs. When the participants were asked whether knowing the cause of the disease 
would affect his desire to have children, one participant said:  
“Uhm, wanting children is another thing… For example let’s say his children, they 
could help him after a certain number of years, when he cannot do anything for himself. 
They could be there for him.” (P.7: FGD 6) 
 
Again this participant reiterates a view which was expressed above, that having children may 
have some benefit for the patient as children have the potential to take care of the person living 
with a mental illness in the future.  
 
When asked whether participants think that Andile’s children would have the same disease, 
again the responses varied. Some participants felt that some of his children may have it, while 
others said none of his children would have it, but instead it may appear in his grandchildren. 
For instance:  
“Maybe one of his children may have the disease. If let’s say he has five children, or 
four children. Maybe one of them could have the disease and inherit it from his father.” 
(P.10: FGD 6) 
 
Other participants felt that Andile should not even consider having children as his children 
would be vulnerable to inheriting the disease and it would be irresponsible of him to take that 
risk.  
 
RHEUMATIC HEART DISEASE 
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The conversation around bearing children amongst RHD participants (contrary to the SCZ 
participants, considering the fact that most of the participants in this disease group were 
females) with RHD was very different. Some participants felt that they are no different to other 
people, or expressed that they already have children who don’t have the disease. However, 
there is a larger group of women who as mentioned before indicated that they have been 
discouraged by doctors to have children, as the pregnancy may be too risky for them because 
of their RHD. While for males (including Andile) it may be different. For instance, one 
participant shared: 
“No. he can have children if he wants to. Take for instance my father when he was 
affected by the heart disease, he only had two children. He made five more children 
after his operation. Now he has seven children. So it does not affect his decision to have 
children.” (P.4: FGD 1) 
 
While another participant (P. 5) supported this view and stated that Andile can have as many 
children as he wants as long as he can ‘produce’. This is similar to the response from one of 
the participants in the SCZ FGD. That if he can biologically produce children, then there is no 
reason that a male cannot have children. The concept of masculinity varies in different cultures. 
For Xhosa people, being a man is characterised by a high level of respect from people in the 
Xhosa community. A man has a right to marry, inherit land and take responsibility for his 
family (Vincent, 2008). This participant therefore alludes to this understanding when he 
explains:  
“As a man you would want to know about those things because we are producers. It 
might affect our manhood if our options are not explained to us.” (P.6: FGD 1) 
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While many women had different perspectives when it came to women and having children. 
Some comments are shared below. 
“…When I got the heart disease I only had my first born who is now going to university. 
So what happened was that doctors told me that you can never be able to have children. 
So I got married and I told my doctors that I am now married. They told me that it’s 
dangerous to have children in my condition, I might end up dying.  Every time you talk 
about having children they will tell you that it is not right to bear a child in your 
condition. So I used my gut instinct and just got pregnant.” (P.3: FGD 1) 
 
Participant 3 above mentioned that she had two healthy children following her diagnosis. There 
was quite a range of views on this issue. Whilst some felt that they would “risk it” and have 
children despite the advice of doctors who have told them not to. Others stated that they listened 
to the doctors and either never had any or would not have more children.  
 
8.3.4. Ability to earn an income/work 
People diagnosed with the two diseases which we investigated are not always able to find or 
return to work, even after their symptoms have stabilized. In this instance, in South Africa these 
individuals are able to apply for a social grant which is a monthly stipend provided by the 
government to assist with day-to-day needs. This grant is not much – about the equivalent of 
R1490.00 (USD 121) – but means that individuals can at least contribute to their living costs. 
Many of the participants in this study were unemployed and in receipt of such a social grant. 
Whilst these grants are considered helpful in many cases, participants also described feeling 
negative about the fact that they cannot work for themselves and have to rely on a “handout” 
from the government or money they receive from family members. The views shared by the 
participants in the two disease groups are described below.  
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SCHIZOPHRENIA 
The importance of being able to earn an income has already been touched on in some of the 
themes above. In this section I pay particular attention to how participants feel about (not) 
having a job and how it affects their overall standard of living. Participants described many 
reasons that would make it difficult for Andile to find or keep a job. These were to do with 
symptoms of the condition, side-effects of treatment, or even fears about being judged. See, 
“When Andile first got sick at the age of 26, it would be even difficult for him to have 
courage to look for a job. Firstly, when Andile is filling in an employment form there 
will be a part that says health status. Andile would be scared to write that he has 
schizophrenia because no employer would want to employ a person with 
schizophrenia… his CV would be thrown away because they see that he is mentally 
disturbed”. (P.1: FGD 2) 
 
Side-effects which included dizziness and tiredness were also observed by the researcher 
during the focus groups themselves. Two individuals (in two of SCZ FGDs) complained of 
these side-effects and requested to leave the group discussion in order to take a nap (as their 
concentration was compromised by the medication they had taken). It is likely that the limited 
concentration span of some participants with schizophrenia could affect individuals’ ability to 
keep a full-time job. Another participant’s view which supported the point that the side-effects 
of treatment may be a discouraging factor for Andile to find or keep employment is shared 
below: 
“P.9: It could affect him even if he is employed in the sense that the treatment we’re 
taking might not help him perform his duties properly, it might affect him physically 
and do things to his body. 
I: Things like what? 
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P.9: Things like feeling dizzy…” (P.9: FGD 2) 
 
Some participants however felt that Andile or a person with SCZ could possibly hold a job 
which requires more manual labour, like cutting grass (i.e. being a gardener) or cutting hair 
(being a barber). Some aspects which participants felt would be affected when he (Andile) 
works is his ability to think logically about situations he may encounter. Some participants 
expressed that the employer may be concerned about whether or not Andile would be able to 
think logically to solve issues related to his work. Participants also mentioned that Andile may 
be sensitive at work. He may take experiences personally or take offense when provided with 
criticism. One other reason is that Andile may not be able to keep a job because he may engage 
in strange behaviours while at work. These behaviours may compromise his and other’s safety. 
Others also felt that he may have negative habits like for instance being late for work often, 
which may also be because of the low motivation they may be feeling. Another factor identified 
is a question about how the condition may have affected Andile’s ability to obtain professional 
qualifications. Considering all of these factors, one participant simply concluded: “His life 
would be largely affected because he would never be able to work again.” (P.2: FGD 4) 
 
One participant related his experience where he transitioned from working (before his 
diagnosis) to not working (after his diagnosis). He described that when he told his employer 
that he has schizophrenia, he was dismissed from employment. He shared that it was difficult 
to move from a position of being able to take care of himself financially, to a position of not 
being able to do so and depending on others.  
 
Some participants acknowledged that they decided to resign from their jobs, because they could 
feel a change in their ability to think and reason in the workspace. As summarized in Table 2 
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in Chapter 6, 88.89% of the SCZ participants in this study were unemployed, which seems to 
validate the suspicion that Andile may not work again. In the vignette, Andile is described as 
struggling to find employment and living on the social grant he receives. Commenting on those 
aspects, some participants suggested that it could push Andile into a state of “learned 
helplessness”, where he expects other people to give him a hand-out, instead of learning or 
thinking of ways in which he can get money and support himself.  
“Andile is someone who gets a government grant. So it is clear that since Andile is 
getting the government grant, he has not yet had the mind-set that he should go out and 
work. So in life it will be difficult for him to be able to do things for himself. He will 
think that he always needs to have someone looking after him. At all times.” (P.7: FGD 
6) 
 
One participant (P.10: FGD 6) related this to himself, and shared that although he receives a 
government grant, he still goes out to the farms in the Western Cape to seek short-term 
employment to get money to support himself. This is supported by P. 1 (in FGD 2) who stated 
that the government social grant is not enough to live the life he desires.  
 
RHEUMATIC HEART DISEASE 
Similarly, the thought that Andile should not be dependent only on the social grant received 
from the government is echoed by participants in the RHD sample. One participant proposed 
that it is not necessary to be employed by an employer. Rather, Andile ought to think creatively 
about how he can become an entrepreneur and make an income through having his own 
business. One example given is starting a barbershop, where he could cut people’s hair as a 
means to have an income. This kind of work would be flexible enough for him to rest if he 
feels tired, or take a day off if needed without having to explain to an employer. Although this 
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kind of work was also brought-up in the SCZ FGDs (e.g. being a barber) the idea of becoming 
an entrepreneur and having one’s own business was not mentioned there.  
 
Many participants felt that employers may not be comfortable to hire someone who has RHD 
because they may feel that the individual would have limitations which would compromise 
their productivity at work. One participant for example shared that her boss noticed that her 
feet were swollen when she was at work one day, after which he then asked her to go home 
and rest. She now fears that if he notices her feet swollen again, the boss will say she should 
stop the job because her feet regularly swell which affects her ability to walk. Or if a person 
living with RHD has painful hands they may not be able to do the job they are employed to do. 
This would affect the company’s productivity and the person may be dismissed.  
 
Another participant shared that employers may not want the responsibility of having to take 
their employees to the doctor if they become ill while they are at work. So allowing someone 
who has RHD to work for them may be “too much trouble”. This may be emphasised by the 
general high levels of unemployment in South Africa, meaning that employers can easily find 
other healthy individuals to occupy vacancies. In reflecting on these kinds of challenges, one 
participant indicated that it may be better for Andile to not work.  
 
For many of the participants in this study, when they conversed about employment, they related 
it to manual work. Most people who live in the low-income communities (townships or rural 
villages) have low levels of education and are not professionally trained. Given this reality, 
participants often end up in jobs which require strenuous labour (e.g. construction work for 
men and domestic work for women like being a cleaner). These jobs are usually available in 
the suburban areas and considering the public transport challenges in South Africa (see Chapter 
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2, on the public transport system challenges in South Africa), individuals usually have to travel 
long periods (i.e. one to two hours one way) to get to and back from work. This may be why 
many of these participants expressed that getting a job may be too difficult for Andile, given 
the fact that he resides in a township (Langa) and given his lack of qualifications. This is why 
some RHD participants advised that he raises his ambitions and tries to find and access 
opportunities to further his education, which may assist him in terms of getting a better job in 
the future. This was emphasised by a participant who said: 
“What I can suggest for him is to get himself educated, as that way life would be much 
easier. He could get an office job. When he gets an office job, he will just sit in his office 
and not work hard physically. Otherwise, his life will be difficult in terms of getting a 
job. I wish he could get a grant [a government social grant] or something from the 
government and continue pursuing his education…” (P.3: FGD 4) 
 
Another participant agreed with the statement above and said that Andile should get educated 
and obtain a qualification in order for him to get a good job. She explains that if he is not 
educated, he is more likely to get a job which requires physical strength, like being a brick 
layer for example, which would be a problem because his body is not fit for that. This may 
result in him remaining unemployed (much like the over 90% of participants in this study who 
are unemployed, see Table 2, in Chapter 6). In relation to this example, P.4. (FGD 4) shared 
her experience of when she had a job at a grocery store. She explained that she worked 
nightshift and she struggled because the manager did not understand why she was slow or could 
not do the work properly. In response, she decided to resign from her job because she could 
not physically keep up working in that environment. She concluded by saying: “I could not 
change my situation. A sick person like Andile cannot work in such a working environment.” 
(P.4: FGD 4) 
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Within the RHD group, many participants felt that it was important for Andile to try and get 
means to further his education as they emphasised that getting a qualification would allow him 
to get a job that did not require a lot of physical strength.   
 
8.4. Coping Strategies 
Coping strategies could mitigate experiences of stigma. Effective strategies could also have a 
positive influence on the life of the patient. Participants in this study described a range of 
strategies that helped them cope with their condition, including:  social support; acceptance, 
openness and transparency; having a sense of purpose; and health knowledge. These strategies 
are discussed below. 
 
8.4.1. Social support 
SCHIZOPHRENIA 
Social support can be described as the support of family, friends and others around the 
individual. For the SCZ participants, friends were viewed as less important figures in their 
lives. Although opinions about having friends varied, most people felt that friends would abuse 
or manipulate a person with SCZ, therefore they were to be protected from such persons. For 
instance, 
“People may start using him, like friends… They may see him as dumb and useless. 
And some of his old friends may not understand him anymore.” (P.7: FGD 1) 
 
Many other participants had similar views about having friends as a mentally ill person. For 
example, 
“So I think that Andile yey, Andile yey, he may be fine if he lives under his mother’s 
guidance [family support]. Ja, and he should forget about friends. Because friends yey, 
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they may always be disturbing him or calling him by names he may not like… Ja. Or 
let’s say that Andile wants to do something, and then his friends prevent him from doing 
the thing he wants to do because they undermine him simply because he is mentally ill. 
And it’s true my sister yey, when you are a mentally ill person living in the township, 
they like to undermine you when it comes to a lot of things. (P.1:  FGD 6) 
 
This was evident in a comment made by one of the participants where they expressed feelings 
of undermining Andile because of his disease, even though they have the same diagnosis.  
“I could be friends with him, but I couldn’t for instance, uhm be in contact with him 
every day. I could end up getting hurt as his friend. I can sit with him, but not every 
time. And the thing is I am young, and he is also young. But to me if I experience certain 
things I can handle them well, however for him because he has a disability, he will 
struggle to handle those things. Also he can’t be free out there, yet I can go out and do 
things that young people do. He is basically like an old person, he cannot do the things 
young people like to do. So in that way, I cannot be his friend. (P.7: FGD 1) 
 
This can be considered as a form of discrimination expressed by someone who also has a mental 
illness and is likely to have been exposed to such stigma, similar to the stigma power concept 
described by Phelan and Link (2015). On the other side, there were also a few participants who 
felt that friends may also provide support and encouragement to a mentally ill person. See, 
“It is important to have friends because it is where you will seek assistance sometimes 
you see… there are some friends who will offer you help.” (P.4: FGD 5)  
 
Both these opinions feed into the ways in which different people cope and think about the 
disease.  These participants seem to consider family as the most important source of support 
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for a person living with SCZ. Participants expressed that they would expect family members 
to play a huge role in supporting them in all avenues of their lives, from financial support, 
encouragement to take treatment, and to protect them from insults of people in the community. 
For instance one participant in the FGDs said:  
“I think that the family may change, in the sense that they would try and become closer 
to him and kinder to him as well. I think also the fact that he did not do it to himself, for 
example through the use of drugs. His family may then support him.” (P.7: FGD 1) 
 
This participant touches on an underlying theme in the discussions: the causation of the disease 
and how that influences a person’s experience of stigma. This is further elaborated in the next 
chapter. However, for the purposes of this section the above participant says that his [Andile’s] 
family would support him if he did not do it (the disease) to himself. Some participants 
mentioned that they think abusing substances (which can be considered as an individual’s 
choice to do so) can be one of the causes of the onset of the disease. Thus, if an individual did 
not participate in this behaviour, or they did however they learn that the disease is linked to 
genetic causes, this removes some of the blame from the individual and in that instance the 
family is more likely to be supportive.  
 
Two other participants alluded to the fact that some of the blame may be shifted from him to 
the family because of the genetic relation They commented that this may change the way in 
which the family relates to a person with SCZ (i.e. they could be more sympathetic and 
‘kinder’) simply because they believe the cause of the disease is not attributed to his behaviour. 
“It may change it, because it is maybe something that is passed down in the family.” 
(P.10: FGD 1) 
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“It may change because it is known that someone in the family has had the disease 
before. And knowing that he knows that he is not the first one to get it.” (P.8: FGD 1) 
 
These quotes may contribute to alleviating the blame posed towards the patient with the 
disease, however it may shift the blame to other family members.  
 
Contrastingly, P.3 in FGD 2 disagreed and said: “I would say that knowing the cause of your 
disease is not helped by blaming others in your family.” Instead this participant went on to 
express the value of accepting one’s disease. This acceptance is further elaborated on in the 
next theme. 
 
RHEUMATIC HEART DISEASE  
Contrary to the SCZ group, RHD participants placed great value on having friends as a source 
of support. Most of these participants felt that friends would not look down on a person with 
RHD, instead if they are well informed about the condition, they may be equipped to provide 
support. One participant described, 
“As far as my understanding goes, my friends never looked down on me. Some of them 
have passed on now, but they used to treat me normally. If one has true friends, then 
they will not look down on you. They will always be the ones to comfort him [Andile] 
and uplift him. If they care about him they will treat him normally. They will give him 
the support he needs so that he does not feel isolated. … Friends must always show love 
and support towards you. You must be free and happy when you are around them.” 
(P.6: FGD 1) 
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Many other participants echoed the same feeling about having friends for support. Participants 
especially said that it would be important for someone with RHD to have friends with the same 
illness, as they would then have the space to share their experiences of living with the disease. 
They would also have an opportunity to share their different coping strategies for living with 
the disease.   
 
Although a majority of people felt that it would be helpful to have friends, there were a few 
participants who expressed that friends may look down on a person diagnosed with RHD.  
“They can look down on Andile when he tells them about his condition. Especially if 
they are not fully informed about the disease and how it came about…” (P.3: FGD 1) 
 
Hence, similar to the SCZ participants, these respondents also highlighted the importance of 
family support. In fact participants stressed that when one is diagnosed with RHD it is expected 
and common that their family change the way in which they relate to that person by showing a 
greater sense of support and encouragement. “Yes… They also need to support him more.” 
(P.3: FGD 4) 
 
In agreement with the above, one participant shared how her family shows their support for 
her.  
“Support is really needed from the family when you have a heart disease. Sometimes 
you feel tired and do not feel like doing anything. Especially for me after the operation, 
I often feel tired. When I feel tired I just do not want to do anything. My mother just 
says I must go and rest if I do not feel like doing anything.” (P.4: FGD 1) 
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“…getting care from other people like your family can help put him at ease with his 
disease. Feeling cared for, will make him feel better… Even his extended family can get 
involved, like for example by taking Andile out for dinner some nights at their homes. 
This will help him feel loved and cared for and at a later stage he will make the decision 
to live a full life. He must be around positive people.” (P.1: FGD 4) 
 
8.4.2. Acceptance, openness and transparency 
 
SCHIZOPHRENIA  
Across the SCZ FGDs the acceptance of the illness was brought up frequently by participants. 
For instance one participant shared that he had trouble accepting his disease.  
“Another problem we face is that most people who have schizophrenia face a challenge 
of not being able to accept their condition for the first few years. For example I also 
had difficulty accepting it myself… What I’m trying to say is you find it hard to accept 
it.” (P.3: FGD 2)  
 
While another participant said:  
“…he needs to accept his condition. He needs to acknowledge that he is not well. He 
has schizophrenia.” (P.6: FGD 4)  
 
“I think that Andile would be fine. What I can suggest for him is that he must talk about 
his condition from the word go…” (P.5: FGD 5) 
 
Despite it being challenging for some people, many participants suggested that if one fully 
accepts their illness they are able to be open and share it with other people which results in 
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people being more understanding. Acceptance and openness were important subthemes as they 
were often related to participants receiving support from different sources. However, secrecy 
about their disease was seen as a contributing factor to fuelling the assumptions people in their 
community made about their disease. Although there were a few participants who felt that it 
was not necessary to tell people about their diagnosis, a large majority of the group felt that it 
is important to be open and transparent about their illness. For instance, in response to a 
participant’s comment about not telling people about their illness, one participant said:  
“You see, this illness, you do not have to hide it. There are lots of illnesses out there, 
and illnesses are not meant to be secrets. No matter what kind of illness you might 
happen to have, an illness is not something that is meant to be hidden.” (P.6: FGD 5) 
 
Furthermore, some participants expressed that if you are open and transparent about your 
disease, it allows people an opportunity to understand your illness which could mean that they 
become more supportive.   
“So for example they would have a better idea of whether they need to encourage him 
[Andile] to collect his medication at the clinic if he cannot do that, for example. Also if 
he has a job, they can be supportive and come up with ideas on how he can manage his 
condition. That could change the way they relate to him in a positive way you see. 
Especially if they know that it is not by choice that he has the mental illness. If they do 
research about it and find out the causes of the illness, that it is caused by circumstances 
you grew up under and so forth. For example if you have stopped taking the drugs, you 
are just like other normal people. If they look at you as a normal person, then at least 
that reduces the stigma. I mean, you could also reduce the stigma by telling yourself 
‘ag I am going to live with this illness’.” (P.1: FGD 4) 
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Like many other participants, P. 1 above suggests that acceptance is an important step in 
dealing with one’s illness. This is contrary to another coping mechanism which participants 
also mentioned, which involves isolating oneself from people and their natural environment. 
This is expressed in the dialogue below. 
“P.3. Oh! Andile stays in Langa? 
I. Yes.  
P.3. Does he not have any other place which he can relocate to maybe, so he can be 
able to fix himself for a while? Like maybe in the Eastern Cape or to his family 
relatives? 
I. So do you think… let us talk about that, so do you think other people do what you are 
saying, they leave their homes and maybe relocate to the Eastern Cape for instance?  
P. 3. Yes, maybe he can heal in the Eastern Cape, maybe this place where he is, it is 
not good for him. Another place could be better for him, he could come back well and 
having gained a little bit of weight.” (FGD 5) 
 
This was supported by a personal experience of another participant who said that he had taken 
some time and temporarily moved to the Eastern Cape (which is a less urbanised province in 
South Africa where the majority of Xhosa people in the country are originally from, see Chapter 
2, page 45 for more details on the origins of Xhosa people) during the course of his illness. He 
explains that being in a rural, calmer environment (as opposed to life in the urban areas) helped 
him get better. SCZ participants who were interviewed in the Eastern Cape also suggested that 
even if you are in the Eastern Cape, moving to a very rural village or another village than the 
one a person is originally from (i.e. different environment) may help a person with SCZ. See,  
“Another thing I think that can change his [Andile’s] life is a change of environment. 
Moving from where he is to a new environment with new people and starting a new life. 
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If he can get a quiet place which will allow him time to deal with his sickness, that 
would be good. Moving from one place to another has helped me a lot. Not that there 
was a problem where I lived before, just that the change of environment helped me a 
lot and that could help him too.” (P.5: FGD 2) 
 
“I fully support what P.5 is saying, that change of environment makes the sickness 
better. For example moving from the township to the villages.” (P.3: FGD 2) 
 
To the contrary, some people felt that changing environment symbolised “running away” from 
reality, and they felt that leaving their natural environments and going to another space would 
not help them. For example, 
“The thing is, you cannot run away. One cannot run away from his or her life. You must 
accept what you are facing at a particular time… Running away will not help you. This 
place that you are running away to is the same as the one you are running from. There 
will be no difference.” (P.10: FGD 5) 
 
In relation to acceptance, participants often mentioned that a source which may help them 
accept their condition is their religious beliefs, mentioning their faith in God or Allah. There 
were countless examples where participants expressed that a mentally ill person should go to 
church, and that they should put their faith in God.  
“That all depends on God, the creator…It is the Creator who knows, you will never 
know.” (P.1: FGD 3) 
 
When referring to Andile, one participant said: 
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“They don’t know that God still loves Andile, and can support Andile to at least improve 
in the things he does in life.” (P.1: FGD 6) 
 
Although it was not mentioned in the video clip which participants assumed Andile was a 
Christian. Some said that he should go to church as that will help him. This suggests the 
importance placed on religion amongst these participants.  The importance of going to church 
and keeping faith was discussed in four out of the six SCZ focus groups.  
“For example, me I am a church going person, so if I am attending church during the 
day, that keeps me busy. So Andile should also try something that will keep his mind 
busy.” (P.5: FGD 5) 
 
Many other participants across the SCZ FGDs insisted that Andile (or a person living with 
SCZ) should go to the church. Going to one of these places was viewed as having the potential 
to assist an individual to accept and cope with the disease. The value of accepting and believing 
in God’s will was viewed as very important amongst participants with SCZ. It also allowed 
participants to have hope for a better future. There were many examples of participants 
expressing the value of religion and how praying and having faith can assist one in accepting 
their illness.  
 
RHEUMATIC HEART DISEASE 
A majority of the RHD participants also emphasised the importance of accepting one’s illness. 
These participants made particular reference to the fact that acceptance is the best strategy to 
ensure that one lives a peaceful life with minimal stress and sleepless nights.  
“You must accept whatever negative thing that you are experiencing. That is why you 
do not sleep. That is what happens to me, when I am experiencing a negative thing, it 
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will not affect me immediately but it will bother me at night. It stays on my mind and 
that is why I cannot sleep. I will just sleep five minutes then I am awake.” (P.6: FGD 1) 
“You need to accept the situation that God has put you in.” (P.3: FGD 3) 
 
Similar to the SCZ participants, religious beliefs were an important source of support for these 
participants. Like above, there were many inferences where participants mentioned putting 
their faith in God or Allah and that God or Allah would not forsake them. When referring to 
Andile, one participant said, “He must pray to God” (P.3: FGD 4), while another participant 
said: “…it would depend on God.” (P.1: FGD 5).  
 
Some participants in this group also felt it is important to be transparent about the illness. For 
example, 
“I think Andile is just like other people. The fact that he has RHD does not change him, 
or anything about him. It’s all about the way he shares that information with people 
and that will depend on how he accepts his condition first.” (P.1: FGD 3) 
 
Similar to the SCZ participants, these participants felt that the way in which the individual 
views themselves is the way in which other people will see and treat them. Hence it is important 
to behave the way you would like others to treat you. For example, if he does not think less of 
himself, then others would not treat him as inferior to them. Similarly, if one allows people in 
their family to constantly treat them as though they are ill, weak and unable to participate in 
family decisions, then that is how people will come to see them. It is up to them to inform their 
family members that they want to be involved in decision making and they want to be informed 
about things that are happening in the family.  
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“…because he has a heart disease they may feel that he should not be told any bad 
news. Or if it comes to making decisions. Some people in his family may feel that they 
need to make decisions for him just because he has a heart condition and they think he 
cannot be told anything. Which will then make it his responsibility to always tell them 
that, ‘listen, even if there is bad news, don’t hide it from me because I have RHD, treat 
me as you do other people’. So Andile’s life might be affected by other people treating 
him differently because of his condition... Yes, and because other people do not 
understand him.” (P.9: FGD 3) 
 
8.4.3. Sense of purpose 
SCHIZOPHRENIA 
Another strategy for coping with the condition, which was suggested by participants in the 
groups, is through developing a sense of purpose and having the will-power to proceed with 
life. For instance, many participants emphasised the fact that as a mentally ill person, it is 
important to keep busy and to do things which will involve getting out of the house and 
engaging with other people. For example, 
“P.5: It would be good that he even attends one of these educational institutions that 
are meant for people with mental disorders. 
I: You would send him to the educational institutions? 
P.5: Yes, for people with mental disorders, they would be there together and meet-up 
with him and they would study with him.” (P.5: FGD 3) 
 
Participants 1 and 2 in FGD 3 mentioned that another way to keep busy is to join an exercise 
group in the community (a group playing soccer for example), again alluding to the importance 
of meeting and surrounding oneself with other people. Additionally, participant 3 in FGD 3 
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suggested that Andile invests time in playing video games to keep him busy throughout the 
day. In particular, the participant called it a way to ‘kill time’ (P.3: FGD 3).  
 
Some participants had faith in Andile’s life and reiterated that one should not ‘give-up’ on their 
lives no matter what their condition. For example, one participant said: 
“I think, well, like I had said before, I think that even if Andile is sick, he should not 
give-up on himself. He should try and find jobs if possible, so that he can sustain 
himself.” (P.5: FGD 6)  
 
So, having will-power and the confidence to go out and engage with other people was 
highlighted as an important coping strategy. That being said, the many examples mentioned 
earlier in the chapter about people looking down on a person with a mental disorder, or seeing 
them as inferior may make this process that much more difficult. For example, one patient said:   
“Your confidence goes down when you know that you are ill. Even if you learn to cope, 
but your confidence is no longer on the level it was on before you were diagnosed with 
this disease.” (P.10: FGD 4) 
 
But whilst other respondents acknowledged that the level of confidence one has in themselves 
does decrease, they still reiterated that it is important to look beyond that and try to find a sense 
of will-power in order to continue living in a reasonable manner.  
 
RHEUMATIC HEART DISEASE  
RHD participants also felt that Andile has the potential of gaining a sense of purpose and living 
a fulfilled life. Something touched on but not fully elaborated in the SCZ FGDs was the hope 
that Andile has to create a better future for himself, through for instance getting a job that will 
P a g e  | 169 
 
 
allow him to better his living conditions. One way of doing that mentioned by the RHD 
participants is through Andile taking action and becoming serious about furthering his studies, 
as a way to ensure a better future for himself and his mother. They expressed that he has the 
potential to obtain a degree and practice in a profession of his choice. For instance,  
“He can also further his studies and be what he wants to be. I have a doctor I met in 
the Eastern Cape who also has a heart disease but he is a doctor today.” (P.2: FGD 1) 
 
In agreement another participant in the FGD said:  
“Andile can continue to pursue his dreams. He would also need good support from his 
parents and everyone around him. His life does not have to stop because he has a heart 
condition.” (P.5: FGD 1) 
 
The perception that someone with RHD can continue to pursue their dreams was highly 
supported by respondents in these FGDs. Many people felt that this diagnosis should not be a 
cause to give up on pursuing one’s dreams. However, they acknowledged that living in a 
poverty stricken environment can be a barrier towards achieving those dreams.  
 
8.4.4. Health knowledge  
SCHIZOPHRENIA 
As discussed above, being open about the illness and in the process educating other people was 
emphasised as an important strategy to cope with the disease. One participant explicitly said,  
“…since our friends in the townships are not educated about this sickness, it would be 
nice if the nurses would take time out and educate the community and talk about the 
sickness and how these people should be treated… So it would be nice if nurses would 
go and educate the community on how to treat mentally ill people.” (P.1: FGD 2) 
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Participants provided numerous examples about how people in their community do not 
understand mentally ill people. For instance,  
“…Some of his old friends may not understand him anymore.” (P.7: FGD 1) 
 
“People don’t understand you.” (P.1: FGD 2) 
 
While another participant said, 
“No, maybe if they thought that he is a drug addict but they find out that it is caused by 
heredity, they will treat him differently, because they now understand that it is not drugs 
that caused his illness” (P.3: FGD 5) 
 
These extracts demonstrate how participants expressed the lack of understanding about mental 
illness amongst people in their community. The participants in this study themselves had to 
travel vast distances to access services, like for example the psychiatric hospitals they attend 
to access treatment and psychiatric consultations. As reported by them, this kind of service is 
not available in their community, hence their community members are not exposed to 
knowledge of mental health. In addition, the psychiatric nurses and doctors in the hospitals 
they attend are often not Xhosa-speaking (but rather English speaking) and therefore the 
participants expressed that they do not usually have an opportunity to engage with people and 
gain knowledge about their disease in their mother-tongue. These elements presented as 
barriers towards creating a space for mental health knowledge in the township or rural 
communities that these participants are from.   
 
RHEUMATIC HEART DISEASE 
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Similar to the SCZ participants, RHD participants also highlighted the importance of informing 
other people about their illness as a means of educating them about the condition. Many of the 
participants felt that people in their communities are ill-informed about the nature of their 
condition and therefore it is their responsibility to inform them in order to avoid 
misunderstandings and people making judgements. For instance,  
“They can look down on Andile when he tells them about his problem. Especially if they 
are not fully informed about the disease and how it came about. They would not take it 
seriously. So he is the only one who can explain it better to them so they can understand 
him.” (P.3: FGD 1) 
 
While another participant said, 
“You must always explain to people. When I am sitting with friends usually they say I 
am sitting with a watch. I always tell them that there’s no watch. I explain to them that 
it is a heart valve that have inserted in me because mine has stopped working. I always 
make them understand.” (P.6: FGD 1) 
 
In relation to educating people about the illness they are living with, many participants shared 
similar sentiments as the ones expressed by people in the SCZ FGDs. The above mentioned 
coping strategies were highlighted as important to enhance resilience for living with their 
disease, and participants expressed that they played a helpful role in how they manage the 
disease and the stigma which is a result of their disease.  
 
8.5. Chapter summary 
This chapter has presented the findings which emerged in the focus group discussions with 
people living with SCZ and people living with RHD. The chapter has highlighted the recurring 
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themes which relate to the knowledge participants have about their disease, their opinions on 
existing stigma experiences related to the two diseases as well as the coping mechanisms they 
employ to deal with the disease they are living with. From these findings it is clear that these 
participants have experienced stigma in different ways. As anticipated and supported by the 
literature the SCZ group reported greater experiences of stigma. While it was not known 
whether the RHD group would report any stigma experiences, our results show that this group 
does report experiencing some milder forms of stigma because of their disease. The chapter 
detailed features of stigma relating to:  a) family, friends and community; b) marriage; c) having 
children; d) ability to earn an income/work. Furthermore, it discussed the coping strategies 
employed by people with RHD and SCZ to overcome stigma, including:  a) social support; b) 
acceptance, openness and transparency; c) sense of purpose and; d) health knowledge. In the 
next results chapter we provide another exploration of internalised stigma experiences guided 
by insights from translating the internalised stigma scale into isiXhosa.  
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CHAPTER 9: INTERNALISED STIGMA SCALE  
 
9.1. Introduction 
During the 19th and 20th century, ideas and conceptualisations about disease were consolidated 
in North American and European contexts (Mkhize, 2003). These developments led to a 
creation of an international system of diagnosis. Importantly, those involved in developing such 
classifications believed that they could be applied cross-culturally (Mkhize, 2003), without 
thoroughly considering the differences in the ways in which diseases manifest across cultures 
(Draguns & Tanaka-Matsumi, 2001).  
 
From as early as 1904, the field of cultural comparison in the context of psychiatry was initiated 
by Emile Kraepelin, in an attempt to investigate the dementia praecox (the original term for 
schizophrenia) in Java, which later progressed to comparisons among Native Americans, 
African Americans and Latin Americans (Heaton, 2013; Jikek, 1995). In the 1960’s and 70’s 
the International Pilot Study of Schizophrenia (IPSS) was formulated (Satorius, Shapiro & 
Jabalensky, 1974), which involved testing whether effective criteria for schizophrenia cross-
culturally could be determined by investigating the disease across nine different catchment 
areas globally (including Ibadan, Nigeria for the African context), these investigations all 
utilised a research instrument, which was developed following a Euro-American context. While 
there have been progressive results of these investigations the question still arises whether it is 
possible that a disease (whilst presenting with similar symptoms across different contexts) is 
understood in the same way by people of different contexts (Heaton, 2013). Heaton (2013) 
discusses the developments of transcultural psychiatry and the ‘new cross-cultural psychiatry’ 
during 1980s. He highlights the implications of considering a universal human psyche as a 
point of departure for mental health theorists. Since then, the field has largely evolved and 
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progressed in North American and European contexts. Scholars such as Patel and Prince (2010) 
report that there are core common symptoms of mental health globally. In the same breath, it 
is equally important to consider that presentations of mental illness differ in different contexts 
(Desjarlais, Eisenberg, Good, Kleinman, 1995; Swartz, 2014). While there is some literature 
on mental ill health in African contexts (Adewuya & Makanjuola, 2005; Adewuya & 
Oguntade, 2007; Patel, 1995; Seedat et al., 2002), most of the currently available psychiatric 
(and health) measures used in research were originally developed for North American and 
European contexts, in which a dominant biomedical explanatory model for illness is generally 
applied (Mkhize, 2003). Kohrt et al (2014) raised important questions about the 
appropriateness of the use of biomedically oriented measures of disease cross-culturally. This 
is an important question, however it is equally important to consider that some constructs may 
be universally relevant, others may be unique to the cultural or disease groups. Applying a 
measure like the Internalised Stigma of Mental illness scale can highlight the similarities and 
differences.  
 
In 1977, Kleinman critiqued the simple translation and application of such instruments 
developed in European contexts to non-European cultural groups. In 2014 however, Yang and 
colleagues conducted a systematic review investigating the advances in cross-cultural 
measurement of culture-specific stigma. These authors found that 77% out of the 196 articles 
included in their study utilised adapted stigma-measures which were originally developed in 
Western-European contexts (Yang et al., 2014). Being one of the first scholars to contribute to 
highlighting the significance of cross-cultural psychiatry, Kleinman (1977) emphasised the 
need to give greater attention to the nuances of culture in this process. Hence, he contributed 
to the introduction of the ‘new cross-cultural psychiatry’. ‘New cross-cultural psychiatry is 
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centred on the belief that it is problematic to solely import psychiatric instruments (largely 
developed in Western countries) without considering cultural differences of the intended 
context. This supports Draguns and Tanaka-Matsumi’s (2001) conclusion that culture and 
psychopathology ought to be studied in consideration of the individual’s personal experiences 
of the disease. Following a large body of literature conducted under cross-cultural psychiatry  
there was an initiation of the Global Mental Health (GMH) Movement (Patel & Prince, 2010). 
The GMH movement has a specific goal of improving the lives of all individuals with mental 
ill health (Patel & Prince, 2010). Kirnayer and Swartz (2013) describe that there are many 
reasons why cultural factors should be a central concern to global mental health. For 
researchers in particular, these scholars articulate that culture is critical for clarifying the role 
which social and cultural factors have in illness and treatment. For clinicians they highlight 
that it is important for interpreting symptoms and informing appropriate interventions 
(Kirmayer & Swartz, 2013).   
 
The WHO has provided evidence on lack of treatment for most people with diseases in low 
and middle income countries (WHO, 2011). Exploring the inequality in representation of 
different population groups in health research is of importance to all health researchers, 
practitioners and the broader society. Given that language barriers are considered as one reason 
for a lack of involvement of specific population groups in health research, the option of 
translating measures is often utilised by researchers (Yang et al., 2014). Simple translation of 
instruments however can produce misleading results (Kaiser, Kohrt, Keys, Khoury & Brewster, 
2013). The GMH movement has taken great strides in developing new methodologies for 
adapting tools to be appropriate for use in local settings (Braathen, Vergunst, Mji, Mannan & 
Swartz, 2013).  
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The WHO has encouraged the development of global psychiatric measures, as well as 
guidelines for their adaptation and translation across different contexts (Sartorius & Janca, 
1996). However, translating health measures well is a laborious task which, when done 
thoroughly, utilises considerable resources and time (Steele & Edwards, 2008) leading some 
critics to question whether it is worth the effort. For instance, Keiser et al. (2013) translated the 
Beck Depression Inventory and the Beck Anxiety Inventory – for use among Kreyól-speaking 
individuals in Haiti and in the end found some items in the scales were non-equivalent due to 
a lack of specificity, interpersonal interpretation or conceptual non-equivalent. As evident from 
the literature (Smit et al., 2006; Yang et al., 2014), translating a measure investigating a 
construct developed in one context (i.e. a European context) to a distinctly different context 
(i.e. an African context) is very challenging and may not produce as accurate description of 
concepts relevant to the target population’s realities (Keiser et al., 2013). Hence, scholars from 
the Global Mental Health movement propose a local, emic approach to develop measures 
which are locally relevant and largely guided by qualitative methods.  
 
We sought in this study to find a way of quantifying the internalised stigma experiences of 
Xhosa people with SCZ and RHD. One approach would be to draw from a global mental health 
perspective guided by qualitative methods to develop a local internalised stigma measure 
specific to our target populations. The advantages of this include having a culturally relevant 
scale which is locally valid and comprehensible, however disadvantages include extensive 
time, effort and costs involved in developing a new measure. Furthermore, another 
disadvantage is that the resultant measure would not be comparable with data from other 
settings.  A second approach was a more traditional translation design that sought to adapt an 
already well-researched and established internalised stigma scale. The advantages of this 
approach included less need for extensive resources, the possibility of comparisons with other 
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international samples within the same disease groups (for example the extensive research 
conducted globally on internalised stigma experienced by patients with schizophrenia), 
however disadvantages included the possibility of missing local conceptualisations of stigma 
and internalised stigma experiences for the two disease groups. Moreover, another important 
disadvantage may be the challenge of adapting a scale for mental health for use among people 
with a physical disease (i.e. rheumatic heart disease) as it would likely exclude internalised 
stigma experiences unique to those patients. Considering our budget, the fact that this 
quantitative data would be adding to additional qualitative data generated from FGDs on 
internalised stigma experiences, and engagement with the original ISMI scale developer who 
explained that the scale had been translated and adapted for use among many psychological 
and physical diseases / conditions we decided on the more traditional translation approach.  
 
There are at least two additional reasons why we embarked on the translation process of the 
ISMI scale. First, the absence of a psychological resources measuring internalised stigma for 
African language speaking South Africans meant that contributions to the development of 
meaningful internalised stigma measures would be a valuable contribution to the field. Second, 
the acknowledgement that many Xhosa-speakers have limited knowledge of the English 
language (Steele and Edwards, 2008), which is the source language of the ISMI tool, and 
simply applying this tool in English to our participant population groups would not necessarily 
give us real insight into their unique understanding of internalised stigma. This study’s 
translation design and findings therefore provide valuable insights for future researchers 
conducting genomics and stigma research, and particularly those adapting standardised tools 
developed in western contexts for use among African population groups. 
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We opted for a comprehensive translation design that generated data about how the construct 
of internalised stigma was supported in the Xhosa language in terms of psychometric 
properties, and the relevance of internalised stigma items with each of our Xhosa patient 
disease groups. This information provided a foundation for future development of internalised 
stigma scales for Xhosa people with SCZ and specifically RHD.   
 
A number of challenges occurred during the translation process which suggested that the scores 
of the scales had some limitations. These limitations led to an inability to compare internalised 
stigma scores across the RHD and SCZ samples. Recognising these limitations we chose not 
to use the scale in collecting data during the focus group discussions. Instead in this chapter we 
discuss the translation process, piloting of the translated tools and the frequency of 
endorsements of items to understand the relevance of these stigma experiences in each of these 
disease groups.  
 
Importantly, in this chapter we focus on sharing the insights gained through this process in 
relation to how the concept of stigma is understood in the Xhosa language. This is important 
particularly in the context of this study which is centred on the concerns raised regarding the 
increase in genomics research with African population groups. As mentioned before these 
population groups have not frequently been included in genomics research. Even where they 
have, the research is often conducted by English speaking researchers, either by collecting data 
in English or through the use of an interpreter (Solomon et al., 2008), however, Drennan and 
Swartz (1996; 2002) identify some of the challenges of using interpreters in research. The 
translation design process followed in this study, which was led by the researcher who is first-
language isiXhosa speaker may provide valuable insights for future researchers developing or 
translating standardised instruments for use among South African population groups. 
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9.2. Approaches to understanding culture and health 
Measuring disorders with standardised tools across different contexts is controversial (Smit et 
al., 2006). There are different perspectives (Relativist vs Universalist) in global debates in 
consideration of language, culture and translation of health measures (de Jong & Ommeren, 
2002; Smit et al., 2006; Swartz, 1998; Swartz, 2012). The universalist/empiricist approach 
maintains that language refers to things and serves the purpose of articulating a ‘reality out 
there’. Thus different languages have different sets of labels for realities which are common 
across the world (Smit et al., 2006; Swartz, 1998). This approach is centred in biomedical 
science and focusses on labelling of symptoms or experiences. The approach brings forth 
multiple discrepancies between universal science and experiences of individuals in local 
communities (de Jong & Ommeren, 2002). Translation of instruments according to this 
approach is often increasingly difficult as it is about finding applicable labels in two languages 
which are referring to the same thing, despite coming from completely different historical, 
social and cultural contexts (de Jong & Ommeren, 2002; Swartz, 1998). Researchers such as 
Brislin (1980) and Hambleton, Merenda and Spielberger (2004) have commented on the 
frustration of attempting to translate instruments from one language to another. As Steele and 
Edwards (2008) maintain, unfortunately translation of tools is not just about finding equivalent 
words in a dictionary, since words often gain meaning from their context and cultural 
background of the language.  
 
The relativist perspective puts an emphasis on culture and language, by recognising that they 
are so intertwined that it is difficult to differentiate between the two. Language plays an integral 
role in the construction of meaning (Swartz, 1998). This position maintains that social 
construction plays a critical role in terminology used by individuals to describe disorders. 
Language plays an integral role in the construction of their meaning making (Swartz, 1998). 
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Therefore, thoughts, feelings and emotions are governed by the words we use and the 
vocabulary and sentence structure available in our language (Swartz, 1998). This alludes to the 
perception that we evaluate ‘reality’ through the words we use. Thus people living with a 
disease, from a particular cultural group somewhat create their own language for talking about 
and understanding their illness, hence it is important for researchers and clinicians to 
comprehend and acknowledge their perspectives. This approach argues that translating tools 
across different languages is a complex process and not solely about finding appropriate words 
to use in the target language. Both perspectives have their implications and there have been 
many debates regarding which is most useful (Swartz, 2012). One of the main reasons the 
universalist approach is still often applied (Yang et al., 2014) is that it can access large samples 
of people and results can be compared with other contexts, yet studies employing a relativist 
perspective generally enrol smaller samples and generally can not be compared across contexts. 
 
The hermeneutic/ constructionist approach maintains that translation is a complicated process 
as it does not only involve changing labels for things in the world, but also considers the role 
language plays in influencing emotions (Swartz, 1998). For instance, while the English 
language is comprised of a large variety of emotive descriptions, there is evidence that the 
Xhosa language has far less emotive terminology, but rather tends to draw on a broader range 
of somatic descriptions of illness (Campbell & Young, 2016; Steele & Edwards, 2008; Swartz, 
1998). This has an influence on the linguistic translation process and the way in which 
individual questionnaire items are then understood across language versions of a psychometric 
tool. Which is why many scholars (Adewuya et al., 2011; de Jong & Ommeren 2002, Lock, 
1987, Kleinman, 1997, Swartz & Drennan, 2000) emphasise that translated instruments do not 
necessarily measure one reality, but rather a cultural understanding of illness (typically 
biomedical) that is context specific. With this in mind we understood that translating the 
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Internalised Stigma of Mental Illness Scale into Xhosa would provide insights into how the 
construct of internalised stigma, as conceptualised in the ISMI, was supported in the Xhosa 
language. This was demonstrated through the psychometric properties of the resultant 
internalised stigma scales, and the relevance of the ISMI questionnaire items for Xhosa people 
with SCZ and RHD as evident from their endorsements of these items.  
 
9.3. Internalised stigma and disease 
As discussed in greater depth in chapter 4 of this thesis, Corrigan (1998) defines internalised 
or self-stigma as involving an individual devaluing themselves, experiencing marginalisation, 
living in secrecy, shame and intentional social withdrawal. Some of the effects of internalised 
stigma include hopelessness, low self-esteem, disrupted social adaptation, and often results in 
reduced adherence to medication (Link & Phelan, 2001; Livingston & Boyd, 2010). 
Considering that internalised stigma impacts on how patients live with their illness and their 
attitudes towards help-seeking and adherence to medication (which has implications for their 
recovery), this study sought to understand how causal explanations, specifically interested in 
how a genetic explanation to disease may relate to internalised stigma of SCZ and RHD.  
 
To date few studies have provided empirical data on the internalised stigma experiences in 
African populations. Those who have include:  Assefa, Shibre, Asher, & Fekadu, (2012) in an 
Ethiopian population of outpatients with SCZ; Adewuya et al. (2011) in outpatients with mental 
illness in Nigeria and; Botha et al. (2006) in schizophrenia patients in South Africa. These 
authors all report degrees of internalised stigma in their participant groups. As a result, a 
quantitative indication of internalised stigma experiences in the Xhosa people with the two 
diseases enrolled in this study, is helpful for informing the second research question of this 
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study (What are the internalised stigma experiences of Xhosa people with schizophrenia and 
rheumatic heart disease?).  
 
Given that there is strong evidence that internalised stigma is associated with a range of 
negative outcomes (Corrigan, 1998; Livingston & Boyd, 2010), the lack of conceptual clarity 
on how different cultural groups understand the concept of internalised stigma is concerning. 
In the South African context, in particular, there is currently no standardised tool developed to 
measure internalised/self-stigma for non-English speaking population groups. Botha et al. 
(2006) utilised an English version of the ISMI tool across three home language groups, namely:  
English (n= 17), Afrikaans (n= 77) and isiXhosa (n= 6). The authors did not disclose whether 
and how they translated this scale. Interestingly, 34 participants in their study (more than 50% 
of the sample) reported to not have completed primary school. In the UK, Corker, Brown and 
Henderson (2015) conducted a study using the original ISMI scale and an adapted version of 
the ISMI for rheumatoid arthritis (RA) (in which case the only adaptation they made to the 
scale for use with a RA group was to change the term mental illness to rheumatoid arthritis - 
they called it the ISMI-Rheumatoid Arthritis scale) to compare levels of internalised stigma in 
patients with a mental illness and physical disease (RA). Overall the authors found that the 
patients with a mental illness had higher levels of internalised stigma (2.5 vs. 2.2, p < .01) 
(Corker et al., 2015). In India, Stevelink, van Brakel and Augustine (2011) adapted the ISMI 
scale for use among people with HIV and people with Leprosy (an infectious curable physical 
disease). These authors created two versions of the tool and again made only one adaptation to 
the scale for use with the HIV and Leprosy groups: replacing the term mental illness with HIV 
and Leprosy. The mean scores on the ISMI for the two disease groups was 2.3 for people with 
HIV and 2.2 for people with Leprosy (p = 0.056) which is above the midpoint of 2 set by the 
scale developer (Ritcher et al., 2003; Stevelink et al., 2011). In relation to RHD, Chang et al. 
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(2018), who used a set questionnaire they developed to investigate the impact of stigma among 
Ugandan women with RHD, found that RHD related stigma was comparative to HIV stigma 
in their context. These authors however did not disclose where and how they acquired the 
questionnaire they used in their study. Additionally, they did not disclose the translation 
process they followed as their questionnaire was also translated into Luganda (a local language 
in Kampala, Uganda) (Chang et al., 2018).  
 
What seems apparent from these studies above is that the extremely influential role of 
internalise stigma scale preparation, translation and adaptation for use across languages and 
disease groups is not well recognised, nor does it seem to feature in the interpretation of results 
quantifying internalised stigma experiences.  Currently, there is no known standardised Xhosa 
scale measuring internalised stigma. UK researchers Brohan et al (2013) who developed the 
Discrimination and Stigma scale for mental illness, have recommended additional work to be 
done to develop relevant stigma measures. Additionally, both in the African context and 
globally, there is no known standardised scale measuring stigma among patients who have 
heart disease.  
 
Scholars such as Campbell & Young (2016), Drennan, Levett and Swartz (1991), Steele and 
Edwards (2008), Smit, van der Berg, Bekker, Seedat and Stein (2006) identify the lack of 
psychiatric instruments available for use by people who speak African languages such as 
isiXhosa as a concerning matter in the South African context. This is especially concerning, 
when considering that the Xhosa people account for the second largest population group in the 
country, 16%, while isiZulu (which is similar to isiXhosa) accounts for 22% of the population. 
These two languages are followed by 13.5% of the population who are first language Afrikaans 
speakers and 9.6% who are first language English speakers 
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(https://www.brandsouthafrica.com/people-culture/culture/languages-of-south-africa). 
Considering these percentages, it is disturbing to note that most standardised health tools 
available in South Africa are in English and Afrikaans, which means that available tools are 
not adequate for use by large parts of the South African population which serves as a barrier 
for a large proportion of the South African population from utilising health tools in their mother 
tongue. It is important that we address this gap, but do so in a manner that recognises the 
limitations of a translation approach, and interpret findings from scales produced through 
translation designs within the context of these limitations.   
 
9.3.1. The Measure: Internalised Stigma of Mental illness scale 
A number of measures have been developed to assess stigma experiences of people living with 
a mental illness. A literature review conducted by Wu et al. (2012) found that two of the most 
widely used stigma scales are: the Internalised Stigma of Mental Illness (ISMI) scale (Ritsher 
(Boyd), Otilingam, & Grajales, 2003) and the Self-Stigma of Mental Illness Scale (SSMI) scale 
(Corrigan et al., 2006). The ISMI scale was selected for this study because it potentially could 
provide a quantitative measure of internalised stigma experiences for our two disease groups, 
drawing on Corrigan and Watson’s (2002) theoretical framework of stigma which was 
discussed in Chapter 4 of this thesis. The scale has demonstrated consistently high 
psychometric properties across contexts in the USA, Europe and the UK, and different 
languages (Wu et al, 2012) which suggests good transportability to a South African setting. We 
sought permission from the scale developer (Jennifer Boyd) to translate and use the ISMI scale 
in this study. 
 
The large spread of use of the ISMI scale in the literature is demonstrated by the number of 
different languages, cultures, conditions and situations it has been adapted for use in, globally. 
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There are more than 55 versions of the scale in languages such as: Arabic, Armenian, Bengali, 
Bulgarian, Chinese (Mainland, Taiwan, Hong Kong), Croatian, Dutch, English (USA, South 
Africa), Estonian, Farsi, Finnish, French, German, Greek, Hebrew, Hindi, Japanese, Khmer, 
Korean, Lithuanin, Lugandan, Maltese, Polish, Portuguese (Portugal, Brazil), Romanian, 
Russian, Samoan, Slovenian, Spanish (Spain), Swahili, Swedish, Tongan, Turkish, Urdu, and 
Yoruba (Boyd, et al., 2014). This evidence suggests that the tool appropriately captures the 
broad concept of internalised stigma in mental illness across such different contexts. That the 
scale has been adapted for use in diseases which are not mental illnesses (i.e. Leprosy and 
Rheumatoid Arthritis) (Corker et al., 2015; Rensen, Bandyopadhyay, Gopal & Van Brakel, 
2011) also supported the potential use of the scale to measure internalised stigma experiences 
in our RHD sample. However as mentioned earlier, these studies did not adequately account 
for the limited adaptation of the tool for use in these other medical illnesses and internalised 
stigma experiences unique to our RHD group will likely be overlooked by the ISMI. Boyd et 
al. (2014) also emphasises that further work is necessary to establish the extent to which culture 
influences the experiences of internalised stigma. Within this study, this aspect is also 
considered with sensitivity to the particular cultural background of the Xhosa culture.  
 
In the studies which this instrument has been used in, the ISMI scale demonstrates high internal 
consistency across all subscales with cronbach’s α ranging from 0.74 to 0.92 (Ritsher (Boyd) 
et al. 2003; Boyd, Adler, Otilingam, & Peters, 2014; Ersoy & Varan, 2007; Kira, Lewandowski, 
Templin, Mohanesh & Abdulkhalek, 2011), except the Stigma Resistance subscale (which as 
Lysaker et al. 2007 describes, measures a different construct). As a result, Boyd et al. (2014) 
notes that most of the studies which used the ISMI, opted not to include the Stigma Resistance 
subscale in their analysis, as this subscale resulted in lower reliability scores.  
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Fewer studies report validity, nonetheless, the most common type of validity reported is 
convergent and divergent validity, where the ISMI compared favourably with other instruments 
measuring similar constructs, such as the Devaluation-Discrimination Scale and Self-esteem 
scale (Ritcher et al., 2003). These authors also report that with identical methodology, the ISMI 
indicated low correlations with scales measuring different constructs such as the Personal 
Empowerment scale which demonstrated a good indication of divergent validity (Ritcher et al., 
2003). Overall, the psychometric properties of the translations, as reported by Boyd et al, 
(2014) suggest that the tool transports well into different languages, cultures, conditions and 
situations in European and North American contexts. 
 
The transportability of the tool in different languages has demonstrated good psychometrics in 
various European studies, for instance, in Ocisková, et al. (2014) the Czech translated version 
of the ISMI for use in people with mental illness demonstrated good reliability in the form of 
high internal consistency (α =0.91) and convergent validity with the Beck Depression 
Inventory-II (BDI-II) (Ocisková, et al., 2014). Increasingly, it has also been adapted for use in 
low and middle income countries, for instance a version adapted and translated into Yoruba by 
a Yoruba-speaking psychiatrist and a Yoruba linguist was used with Yoruba-speaking people 
in Nigeria to measure internalised stigma of outpatients with mental illness. The Yoruba 
version of the ISMI demonstrated high internal consistency (α= > 0.84) and test re-test 
reliability, a measure of stability over time (rkk=0.86).  
 
In the South African context, the ISMI English language version has been used in a preliminary 
study investigating internalised stigma reported by people living with schizophrenia (Botha et 
al., 2006). Within their study, Botha et al (2006) describe that the original English tool is a 
validated measure. However, as observed before, these authors did not discuss whether and 
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how they translated the tool (given that their participants’ home languages were English, 
Afrikaans and isiXhosa). Following modifying the ISMI to include 6 items measuring abuse 
as a form of self-stigma, an important finding by Botha et al. (2006) which is further explored 
in this study, is that experiences of abuse were highly reported by the Xhosa people in their 
study. Based on their recommendation, in this study we included 6 items in the ISMI scale 
which tap into experiences of abuse in this population group. The psychometric properties of 
these items are assessed independently of the items included in the original ISMI scale. The 
items are: 
 Item 30: “People call me names because I have …”;  
 Item 31: “People have been physically abusive towards me because I have …”;  
 Item 32: “People have been verbally abusive towards me because I have …”;  
 Item 33: “I find it difficult to attend clinic appointments because people will know that 
I have…”;  
 Item 34: “I think the media has a negative influence on the way people perceive …”  
 Item 35: “I find it difficult to take my tablets every day because they remind me that I 
have…”.  
 
As highlighted in this chapter, most psychiatric tools are developed for use with individuals of 
European descent. This is critical to emphasise, as these individuals come from a different 
cultural context and often have a different socioeconomic status which has an influence on their 
ability to access education and health information. Moreover, they often have a different 
cultural worldview, which influences their perspectives on illness experiences (Mkhize, 2003). 
It therefore becomes necessary for researchers in contexts such as Africa, to sensitively 
translate and adapt these tools for use among local population groups (Drennan, et al., 1991; 
Steele & Edwards, 2008; Swartz, 1998). One of the well acknowledged challenges of the 
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translation of tools developed in the Western contexts for local population groups, is the 
different conceptualisations of illness explanations expressed by individuals in non-European 
contexts (Swartz, 1998). Moreover, Lund and Swartz (1998) discuss the absence of a 
‘psychological’ language within the Xhosa language. These authors emphasise the 
complexities of discussing psychological concepts in an African language. As an attempt to 
confront this challenge, this study used a 5-stage translation design, drawn from methods and 
suggestions from the literature on the translation of instruments (Campbell & Young, 2016). 
The resultant Xhosa language version of the Internalised Stigma of Mental Illness (ISMI-
X)/and Internalised Stigma of RHD (ISRHD-X) scales were used to better understand how the 
concept of internalised stigma was supported in the Xhosa language (through psychometrics of 
the scales) and the relevance of these individual internalised stigma scales items within each 
disease group using frequencies of item endorsements. Below I describe the translation and 
validation process used to inform the second research question of the study (What are the 
internalised stigma experiences of Xhosa people with schizophrenia and rheumatic heart 
disease?).  
 
9.3.2. Structure scoring and psychometric properties of the ISMI scale 
The original ISMI scale is a 29 item tool comprised of 5 subscales namely, 1. Alienation (6 
items), 2. Stereotype Endorsement (7 items), 3. Discrimination Experience (5 items), 4. Social 
Withdrawal (6 items) and 5. Stigma Resistance (5 items). The first four subscales measure 
internalised stigma experiences, while the fifth subscale measures stigma resistance (or 
resiliency towards stigma). Based on suggestions from Botha et al., (2006) about the prevalence 
and potential impact of abuse on internalised stigma in South African Xhosa people, in this 
study we have included a sixth subscale measuring experiences of abuse (6 items).  
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According to Ritcher et al. (2003), the alienation subscale measures an individual’s experience 
of feeling less than an ordinary member of society or being excluded from society due to their 
condition. The stereotype endorsement subscale investigates the extent to which the patient 
agrees with widely accepted stereotypes about people with an illness. The discrimination 
experience subscale measures the individual’s perception of the way other people treat him or 
her assuming they know about his or her condition. The social withdrawal subscale is 
concerned with the extent to which individuals avoid contact with others based on the 
perception that they do not want to burden them with their health issues or based on the fear of 
rejection if people learn that they have a specific disease. Lastly, the stigma resistance subscale 
determines the extent to which an individual is able to be resilient towards internalised stigma 
(Ritcher et al., 2003). The included abuse subscale measures the individual’s experience of 
physical and verbal abuse in relation to having a disease label.  
 
Total scores and subscale mean scores are calculated for each participant. Each item is scored 
on a Likert scale ranging from 1 =strongly disagree, 2= disagree, 3= agree to 4 = strongly agree. 
A total mean item score is obtained by dividing the total score by the number of completed 
responses (excluding the Stigma Resistance items as suggested by Lysaker et al. 2007 and in 
this study excluding the six items in the added Abuse subscale), usually 24 (if all items on the 
scale are completed). The first four subscales are scored in accordance with the Likert scale 
values, but the fifth subscale (Stigma Resistance) is reverse scored and analysed independently 
of the total scale. A mean score for each subscale is obtained by calculating the total for the 
subscale and dividing it by the number of completed items in the subscale. 
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9.4. Translation Method  
As described previously, translation of instruments from Western to non-Western languages 
has been reported as a challenging process (Bravo, Canino, & Rubio-Stipec, 1991; de Jong & 
Ommmeren, 2002; Steele & Edwards, 2008). It is difficult to assess to what extent the 
psychological terminology often used in health instruments can be translated with confidence 
across different cultures (Van de Vijver & Leung, 1997). Hence, scholars such as de Jong and 
Ommeren (2002) propose the use of qualitative methods (including focus group discussions 
and individual interviews) as a primary approach to investigating the illness experiences of a 
population before developing a scale which is informed by these experiences. In agreement, 
Kleinman (1977) denotes the importance of investigating how individuals in local cultures 
experience health problems.  
 
While acknowledging this perspective as particularly important, developing an instrument 
emanating from qualitative research is a lengthier and more extensive process, requiring more 
resources and capacity. One challenge to following this approach is that it often makes it 
difficult to compare the results of the newly developed scale with those employed cross-
culturally (Van de Vijver & Leung, 1997). Hence, many researchers prefer translating 
instruments which have shown evidence of good psychometric properties and transportability 
across cultures and contexts, for the intended target group (Yang et al., 2014). Although the 
process of scale translation itself is difficult, using a combination of previously suggested 
methods is an important step to attempt to provide the best possible version of the scale (de 
Jong & Ommeren, 2002; Van de Vijver & Leung, 1997). Hence, this study attempted to use a 
combination of methods from various authors (i.e. Brislin, 1970; Campbell & Young; 2016; 
Evans et al. 2002; Satorius & Janca, 1996; Swartz, 1998; Steele & Edwards, 2008) to develop 
a Xhosa version of the internalised stigma scale for use among people with RHD and SCZ.    
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Steele & Edwards (2008) propose that the translation process requires a rigorous design in 
order to adapt scales in a culturally relevant and comprehensible form while staying true to the 
meaning of the original items. In this study the translation and adaptation of the ISMI scale 
followed a five-stage mixed-methods design to attempt to develop as thorough a Xhosa 
translation as possible. The stages included i) Forward-translation; ii) Committee Approach iii) 
Back-translation iv) Quantitative pilot and v) Qualitative Pilot.  
 
Prior to beginning the translation process, we composed a team of bilingual translators who 
were suitable to assist in the translation process (Brislin, 1970). Below, I discuss how we went 
about identifying suitable individuals for this task, before proceeding to discuss the various 
stages in greater detail.  
 
9.4.1. The selection of the translation team 
The WHO Guidelines suggest that it is important to ensure that the translation of a standardised 
tool considers linguistic, psychological, and cultural differences in the intended populations by 
choosing experts with relevant skills (Satorius & Janca, 1996). We looked at the suitability of 
translators beyond their knowledge of the two languages involved in the test adaptation. 
Following Steele and Edwards (2008), we considered it important that translators were first-
language isiXhosa-speakers, having knowledge of the culture, adequate knowledge of the 
English language and were directly involved in health research conducted with people who 
have one of the two conditions (SCZ and RHD).  
This study selected translators based on the following criteria: 
i) Have knowledge of the two languages involved as they are home-language isiXhosa 
speakers and  
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ii) Have completed health courses in the source language which is English, 
iii) Have knowledge of the Xhosa culture,  
iv) Have experience in doing health research with one of the two patient groups. 
 
In accordance with these inclusion criteria, four bilingual translators were invited to be 
involved in the translation process. The translators included two male isiXhosa speaking 
psychiatric nurses working with SCZ patients in the Department of Psychiatry at UCT, as well 
as one female and one male healthcare worker who work with RHD patients in the Department 
of Medicine at UCT. An external female isiXhosa speaking retired psychiatric nurse and 
research coordinator from the Department of Psychiatry at Stellenbosch University was invited 
to assist in facilitating the translation process. The reason for inviting an external individual is 
that, as Steele and Edwards (2008) maintain, in group meetings, it is possible for dominant 
individuals to strongly influence the discussion, in the process leaving more reserved 
individuals’ opinions unacknowledged. The external individual was senior (in age and 
professional status) to the other group members and had much experience in translating scales 
therefore was very familiar with the translation process and could manage dominant 
personalities with confidence, while encouraging more submissive group members to make 
valuable contributions.  
 
This resulted in a team of three males and two females (excluding the researcher). All of these 
individuals, as well as myself the researcher, are first-language isiXhosa speakers and three 
had acquired tertiary education training at English language institutions. All individuals 
involved had experience in administering health measures with patients from one of the disease 
groups, in both English and isiXhosa. This team allowed for an exchange in views about the 
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scale items, based on the individual expertise of members of the team, in training, education 
and their cultural background (Brislin, 1970). 
 
9.4.2. Translation design 
i) Step 1: Forward-translation 
Forward-translation is defined as translating an instrument from the original language, also 
referred to as the source language, to the target language (Brislin, 1970; Wild et al., 2005). As 
done in previous studies (Corker et al., 2015; Rensen et al., 2011) prior to forward-translation, 
the term mental illness was replaced with heart disease in the English version of the scale 
adapted for use among people with RHD and was provided to the two of the translators who 
would forward-translate the version into Xhosa. The ISMI scale was forward-translated, from 
English to isiXhosa, independently by four members of our translation team (2 for the SCZ and 
2 for RHD). Each translator was given a month to complete the translations and then send the 
Xhosa translation of the scale back to the researcher. Once I had received all four forward-
translation versions of the scales, I tabulated the individual scale item translations for each 
comparison. This step is important as it allowed for similar forward translations to be compiled 
for discussion in the committee meeting (Campbell & Young, 2016; Wild et al., 2005).  
 
ii) Step 2: Committee approach 
The committee approach included all the translators involved in the translation design, myself 
and my supervisors coming together for two meetings. The committee met twice during the 
translation process. In the first meeting (which took place on a Saturday from 8:30am to 
3:00pm) the four forward-Xhosa translations of the internalised stigma scale were presented in 
a table format for discussion and comparison. Translators were requested to select and decide 
upon the most appropriate Xhosa translation for each item, suitable for use by isiXhosa-
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speaking participants across different areas of the country, including urban and rural contexts. 
The translators selected one Xhosa translation for each item, changing only the disease name 
for the two disease groups. Towards the end of the first meeting the team had developed two 
versions of the tool. One targeted individuals with mental illness where the term “mental 
illness” was translated into two terms used interchangeably in the items on the scale, in 
consideration of linguistic and grammatical syntax. These Xhosa words are: “uphazamiseka 
engqondweni” and “isigulo sengqondo”. For the scale which targeted individuals with 
rheumatic heart disease the term “mental illness” was replaced by heart disease which was 
translated to the Xhosa term “isifo sentliziyo”. Due to the absence of the term “Rheumatic” in 
isiXhosa, the word was dropped and substituted by “heart disease”, this was deemed fitting, 
given that the original tool also uses the broad term mental illness and not a specific mental 
condition. This process resulted in a preliminary Xhosa version of the internalised stigma scale 
for both the RHD and SCZ population groups. This version was electronically reviewed and 
commented on by all members a week after the translation team met. It was important to 
facilitate this step in the translation design as the risk of not implementing this step may result 
in an instrument which contains too much of one person’s style of writing and 
conceptualisations (Drennan, et al, 1991; Rabie, & Naidoo, 2018; Wild et al., 2005).   
 
iii) Step 3: Back-translation 
Back-translation involves the translation of the new language version tool back into the source 
language (Brislin, 1970; Brislin, 1986; Steele & Edwards, 2008; Wild et al., 2005). This is 
usually carried out by an individual who is a first-language speaker of the target language and 
fluent speaker of the original instrument language and had not seen the original tool (Campbell 
& Young, 2016). In this study an independent psychiatric nurse involved in the SAX study 
(who had not seen the original English ISMI scale), blindly back-translated the isiXhosa 
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versions of the tools to the English language. The psychiatric nurse was given two weeks to 
translate the two scales from isiXhosa back to English.  
 
There is some debate in the literature about the advantages and disadvantages of using 
healthcare professionals as back translators in a translation team. On the one hand the 
advantage of using a psychiatric nurse in the back-translation is that the individual may be 
familiar with the dialect used by patients given their experience in administering various 
psychological instruments in English and isiXhosa to isiXhosa-speaking patients in different 
South African psychiatric hospitals. However, there are also limitations such as that the 
healthcare professionals may back-translate scales into clinical terminology which is different 
from patient understanding as they may not be able to separate their conceptual knowledge of 
the constructs measured in the scale from the back-translation they produce. Ultimately we 
decided that the advantages of using healthcare staff - familiar with the source language and 
the target language, familiar with these two patient groups and how they describe their 
condition and having knowledge of the common questions they may ask about their illnesses 
and typical challenges they faced in their treatment and recovery - out-weighted the 
disadvantages inherent in their familiarity with the constructs measured. To compensate for the 
limitations in using a psychiatric nurse for back-translation, we included a cognitive 
interviewing component in our translation design to explore how Xhosa-speaking patients from 
the two disease-groups (n= 10) were understanding each item on the internalised stigma scale. 
Based on recommendations from these steps we adapted the scales to ensure conceptual clarity 
and ease of meaning for the target population.  
 
Upon back-translating the tool to English the nurse returned the back-translations to me and I 
combined the original version of the scale (in the source language, English), the Xhosa versions 
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of the scale (as developed by the translation team in the first committee meeting) and the back-
translation version of the scale in a summary table for discussion and comparison by the 
translation team during a second translation team meeting, as suggested by Campbell & Young 
(2016). This summary assists in highlighting any discrepancies which were evident, and helps 
facilitate discussion around more appropriate translation choices. The back-translation process 
raised some important discrepancies which were debated and explored in the second committee 
meeting which consisted of all the translators, myself and my supervisor. The second 
translation meeting took place eight months after the first meeting. It also took place on a 
Saturday from 8:30am to 3:00pm. A sample of the discrepancies identified during the back-
translation are presented in Table 11 below.  
 
Table 11: Examples of the review of the back-translation of the ISMI/ISRHD-X  
 Original items     ISMI-X / ISRHD-X items            Back-translated items 
1 I feel out of place in the 
world because I have a 
mental illness 
 
 
I feel out of place in the 
world because I have a 
heart disease                   
Ndiziva ndingamkelekanga 
emhlabeni kuba 
ndiphazamisekile 
engqonweni 
 
Ndiziva ndingenandawo 
ehlabathini kuba ndinesifo 
sentliziyo   
Due to my mental instability, I 
don't feel welcome in the world. 
 
 
 
I feel like I don't have a place on 
earth due to my heart disease 
5 I am embarrassed or 
ashamed that I have a 
mental illness    
                                                       
 
I am embarrassed or 
ashamed that I have a 
heart disease                                                             
Ndiziva ndinodano okanye 
ndinentloni kuba 
ndiphazamisekile 
engqondweni 
 
Ndiziva ndinodano okanye 
ndinentloni kuba ndinesifo 
sentliziyo 
I feel embarrassed or ashamed 
because I suffer from mental 
illness. 
 
 
I feel embarrassed or ashamed 
because I suffer from heart 
disease. 
16 I am disappointed in 
myself for having a 
mental illness    
                                                         
I am disappointed in 
myself for having a heart 
disease                                                                   
Ndiziva ndinodano ngesiqu 
sam kuba ndiphazamisekile 
engqondweni 
Ndiziva ndinodano  
ngesiqu sam kuba ndinesifo 
sentliziyo
I feel ashamed of myself as a 
person due to having a mental 
illness. 
 
I feel ashamed of myself as a 
person due to having a heart 
disease. 
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29 Stereotypes about the 
mentally ill apply to me  
 
 
Stereotypes about people 
with heart disease apply 
to me                                                   
Iingcamango ngabantu 
abagula ngengqondo ziquka 
nam 
 
Iingcamango ngabantu 
abanesifo sentliziyo ziquka 
nam 
I am included in the opinions 
society has on people with a 
mental illness 
 
I am included in the opinions 
society has on people with heart 
disease 
 
The back-translation step revealed some difficulty in finding linguistically and conceptually 
equivalent terms across the two languages for some concepts related to internalised stigma 
experiences used in the scale items (see complete document with back-translations on 
Appendix H).  For example, as evident in the table above, items 5 “embarrassed” translated to 
“ndinodano” and in item 16 “disappointed” also translated to ndinodano”. These are good 
examples of the English language having a greater selection of emotive terminology (i.e. 
embarrassed and disappointed mean different emotional states, but in the Xhosa language they 
are labelled as one term). Items 1 and 29 are good examples for presenting the difficulty in 
achieving conceptual equivalence between the English and Xhosa language. In item 29 
“stereotypes” have been lightened in Xhosa to “opinions / iingcamango”, but in English the 
term “stereotypes” holds more negative consequence and association than “opinion”. This 
choice of language does change the intensity of the sentence and associated meaning. As a 
result, it may change the way individuals endorse these items across the two languages. 
Similarly, item 1 “I feel out of place” is a common idiom in the English language relating to 
feelings of “not belonging”, which is not common idiom in the Xhosa language and as 
presented in the back-translation, could be interpreted in a slightly different manner by 
participants who complete the scale. Within this same example, the reference to mental illness 
in the original English statement and the interpretation of the back-translator to “mental 
instability/ ndiphazamisekile engqondweni” changes the degree of intensity in the question, 
arguably with the second seeming more severe. This however can also be viewed as an example 
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of a literal rather than a broad translation of the words from the perspective of the back-
translator.  
 
Key proposed changes to the translation included paying attention to the items highlighted in 
the back-translation, i.e. item 1: “I feel out of place in the world because I have a mental illness 
/ Ndiziva ndingamkelekanga emhlabeni kuba ndiphazamiseke ngokwasengqondweni” 
changed to “Ndiziva ndingamkelekanga ehlabathini kuba ndiphazamiseke 
ngokwasengqondweni”. The word for “world” was changed because emhlabeni can have two 
meanings, “world” and “soil”, while ehlabathini is only used when referring to the “world”.  
 
Item 17: “Having a mental illness has spoiled my life” was initially translated to “Ubomi bam 
bonakele ngenxa yesigulo sokuphazamiseka engqondweni” which translates to “My life has 
been ruined because of having a mental illness”. In the second meeting, the degree and sentence 
order of this item was changed to “Ukuba nesigulo sengqondo kubuphazamisile ubomi bam” 
which states, “Having a mental illness has disturbed my life”. This is an example of difficulty 
finding an equivalent word for “spoiled” in the Xhosa language, because “ruined” could be 
considered as having a more intense meaning, yet the alternative “disturbed” seems subtler.  
 
Item 5: “I am embarrassed or ashamed that I have a mental illness” / “Ndiziva ndinodano 
okanye ndinentloni kuba ndiphazamisekile engqondweni” which was change to “Ndiziva 
ndiphoxekile okanye ndinentloni kuba ndiphazamisekile ngokwasengqondweni”. The word 
embarrassed was now changed to ndiphoxekile meaning “ashamed” as opposed to “ndinodano” which 
means disappointed, as it has a slightly different meaning from embarrassed. This is also an 
example where the sentence was reordered in consideration of syntax, i.e. the Xhosa statement 
can be back translated to “I am ashamed or embarrassed that I have a mental illness”.  
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Item 29: “Stereotypes about the mentally ill apply to me / “Iingcamango ngabantu abagula 
ngengqondo ziquka nam” which was back-translated as “Opinions about the mentally ill apply 
to me” was then changed to “Iingcamango ezingezizo zabantu malunga nesigulo sengqondo 
nam ziyandichaphazela” which translates to “Negative opinions about mental illness apply to 
me”.  
 
Following the forward-translation, quantitative and qualitative piloting and the back-
translation of the ISMI/ISRHD-X scales, the committee met again eight months later to discuss 
the results and discrepancies which emerged during the first four steps of the design. The 
second committee meeting also aimed to establish semantic, idiomatic and conceptual 
equivalence. Semantic equivalence relates to whether, after translation, the meaning of the 
item has remained the same (de Jong & van Ommerman, 2002). This was aimed for through 
the changes made to the items (i.e. items 1, 5,16 & 29). Idiomatic equivalence refers to 
ensuring that idioms or words ordered in a particular way, of which the meaning is reliant on 
knowledge of the culture (Steele & Edwards, 2008), are translated as far as possible to mean 
the same or similar thing in the target language. For instance, item 1 of the ISMI includes the 
idiom, “I feel out of place in the world, because I have a mental illness / heart disease”.  This 
idiom refers to feeling like ‘one does not belong’ in the world and not necessarily what these 
words may seem to mean when focussing on the literal sense (i.e. literally feeling out of place). 
This example was translated to “Ndiziva ndingena ndawo emhlabathini, kuba 
ndiphazamisekile engqondweni/ ndine sifo sentliziyo”. Which was back translated to “I feel 
like I don’t have a place in the earth because of my mental illness / heart disease”. Conceptual 
equivalence relates to a construct having the same meaning across language or cultural groups 
(Harchi, Choi, Abbot, Catalano & Bliesner, 2006). Within the committee meeting, translators 
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were requested to decide on translations of items in the scale, word for word, however, as 
found in Steele & Edwards (2008), they often opted to translate items based on the broad 
meaning of the statement. This may be a threat for linguistic and grammatical-syntactical 
equivalence however, it increases the conceptual equivalence. For example, item 23’s sentence 
structure changed subtly from “I can’t contribute anything to society because I have a mental 
illness / heart disease” to “Andikwazi kuba negalelo ekuhlaleni nakweyiphi na into kuba 
ndiphazamisekile engqondweni / ndinesifo sentliziyo” which is “I can’t contribute, in anything 
in the community, because I have a mental illness / heart disease”. As done in previous studies 
by Drennan (1998) and Steele’s (1996) translation as cited in Steele and Edwards (2008), at 
this stage translation of some of the items changed and other options for translating statements 
and sentence structure were proposed. These changes were made in the attempt to provide as 
close a conceptual translation to the English version as possible. During the meeting the senior 
group member read both translated versions (for SCZ and RHD) of each item, following which 
the group discussed and agreed on the selected translations. 
 
These challenges in obtaining linguistic and conceptual equivalence are well documented in 
the South African literature (i.e. Campbell & Young, 2016; Swartz & Drennan, 2000; Steele, 
2003; Steele & Edwards, 2008). These authors caution that in some instances these challenges 
hinder the production of a high-quality tool that holds the same meaning or measures the same 
construct across the two languages. It is therefore likely that the final translation produced in 
this study will only provide a general or broad impression of some of the internalised stigma 
experiences of Xhosa people with SCZ and those with RHD, and that more culturally specific 
experiences, uniquely supported by the Xhosa language and culture, as well as the specific 
disease group, will remain unaccounted for unless qualitatively explored. It is also unlikely that 
we will be able to replicate the same psychometric structure as the original tool, hence there 
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may be some limitations regarding the transportability of some subscales and items. This is 
further investigated by examining the psychometric properties of the Xhosa tools (i.e. through 
measuring the reliability and validity of the translated tools).  
 
iv) Step 4.1: Mixed methods piloting 
o Quantitative pilot 
The ISMI/ISRHD-X scales resulting from the first committee meeting were then quantitatively 
piloted which allowed us to assess the psychometric properties. This pilot involved 
administering the tool in a subsample of patients with SCZ (n= 60) or with RHD (n= 50) in 
order to establish preliminary psychometric properties of the translated Xhosa versions. I 
recruited the RHD patients (who were already enrolled in the larger RHDGen study) when they 
attended a check-up at a hospital in the Western Cape Province, South Africa. I first explained 
the present study to potential participants, then if they volunteered to participate, I proceeded 
to explain the informed consent documents (specific for this process, see Appendix E). 
Following completion of the informed consent form, participants completed a demographic 
form which requested their age, highest level of education, area where they reside, date of 
disease diagnosis, and a question which asked whether they have had a heart operation and if 
so when it was conducted (see Appendix F). Next, the participants went through the scale and 
completed the items, while checking whether they believe the isiXhosa translations of each 
item are an equivalent of the English language item on the scale (both the English and Xhosa 
language versions were on the scale, with one below the other). As far as possible, patients also 
reviewed the scale for spelling and grammatical errors in the Xhosa versions.  
 
For the SCZ subsample (n=60), participants completed the ISMI-X as part of a battery of 
psychological measures that were administered during their participation in the SAX study, 
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following completing of an informed consent process, as well as the Structured Diagnostic 
Interview for DSM-IV Axis I Disorders (SCID) (First, Spitzer, Gibbon & Williams, 2012). 
Importantly, these patients also completed the Xhosa version of the Discriminations and Stigma 
Scale (DISC) scale as part of this battery. The DISC is an internationally established measure 
of discrimination and stigma experiences of people with SCZ and the English version of the 
tool has been used as a measure of convergent validity with the ISMI in a preliminary study by 
Brohan et al. (2013). Patient recruitment, consent, the SCID interview and subsequent 
psychometric battery were completed by trained psychiatric nurses at psychiatric hospitals in 
both the Western and Eastern Cape provinces South Africa. A total of 60 SCZ patients were 
enrolled. An important difference to note here is that the RHD participants only completed the 
ISRHD-X scale, while the SCZ participants completed the ISMI-X scale after a lengthy 
psychiatric interview and additional psychometric measures, with many reporting fatigue when 
they got to completing the last scale which was the ISMI-X scale.    
 
o Qualitative pilot 
The qualitative pilot of the tool was carried out through cognitive interviews (Miller, 2003). 
Cognitive interviewing was originally developed for survey research but has subsequently been 
adapted for use in psychometric tool development (Miller, 2003). Within this study, cognitive 
interviewing was conducted with a small sample of patients (five in each disease group) to 
ensure conceptual equivalence of item wordings in the Xhosa versions of the scales.  During 
these cognitive interviews RHD and SCZ participants were asked to complete the scale 
independently, while also verbally answering two questions to the researcher, namely;  
 
1. What did the question make you think of?  
2. Why did you respond in that way? 
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These cognitive interviews were audio recorded and transcribed. The themes which emerged 
from their responses to these questions were tabulated and prepared for comparison as they 
were analysed thematically. The patient responses and interpretations of the Xhosa version of 
the scale were then further used to provide evidence for the usability of the Xhosa scale.   
 
iv) Step 4.2: Mixed methods piloting results 
o Quantitative pilot results 
For the quantitative pilot, the completed scales from both samples were used to investigate 
psychometric properties of reliability and validity in the ISMI/ISRHD-X scales. In addition, 
the Xhosa version of the DISC was completed by a small sample of the SCZ respondents (n= 
32) and was used as a measure of convergent validity.  
 
Socio-demographic characteristics of participants 
Prior to presenting the psychometric properties, the socio-demographics of the pilot sample 
participants is presented to highlight important differences between groups that may account 
for differences in results of the scale development. The demographics of participants in the 
piloting of the ISMI/ISRHD-X scales are presented in table 10 below. This table reveals that 
the RHD sample (n= 50) is over represented with female participants (n= 41, 82%) while the 
SCZ sample (n= 60) is over represented with male participants (n= 57, 95%). In addition, a 
younger age range is observed (mean age: 30.30 years, the age ranging between 20-53 years) 
in the SCZ sample as opposed to a 42.26 years mean age (ranging between 23-75 years) in the 
RHD sample.  
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Table 12: Demographics of RHD and SCZ samples 
 RHD (n=50) SCZ (n=60) 
Age                                                                     
Range 
Mean 
23-75 years 
42.26 years 
 
20-53 years 
30.30 years 
Sex                                                         
Male                                                               
Female  
 
9 (18%) 
41 (82%) 
 
57 (95%) 
3 (5%) 
Highest education level 
 Completed tertiary studies 
 Some secondary school 
 Some primary school 
 No school 
 
1(2%) 
40 (80%) 
8 (16%) 
1 (2%) 
 
4 (6.67%) 
45 (75%) 
10 (16.67%) 
0 (0%) 
 
All the participants who completed the ISMI/ISRHD-X are first language isiXhosa speakers 
and the education level between the two samples is relatively similar, with 75% or more 
participants in each sample with at least some secondary schooling. The assumption may be 
that people with schizophrenia would have lower levels of education because of the cognitive 
impairments associated with the illness. Yet RHD is closely associated with poverty which 
may explain reduced education levels in this sample. 
 
9.5. Psychometric properties 
 
As opposed to simply using instruments developed abroad in the South African context, 
Foxcroft (1997) highlights the importance of investigating psychometric properties and 
providing evidence of the standard requirements for reliability and validity of a tool before 
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using it in a different cultural group. This study aims to adhere to that call by presenting the 
psychometric properties of the ISMI/ISRHD-X scale.    
 
This is also in line with Wild et al. (2005), who maintain that the best way to ensure usefulness 
of a scale in a local context is to assess the validity and conceptual equivalence of the newly 
translated tool through psychometric validation. Quality assurance of measures is however 
heavily dependent on the methodology used (Sartorius & Janca, 1996). In this study we 
investigate the psychometric properties of the ISMI/ISRHD-X scales using measures of utility, 
reliability and validity across the RHD and SCZ samples. Following capturing the data on the 
Excel computer programme, utility of the scale was considered in relation to the number of 
completed scales in each group. To determine the reliability and validity of the tool we used 
the computer programme SPSS.25 (IBM SPSS, 2017). Reliability indicators included internal 
consistency of the total scale and subscales, which was measured using Cronbach’s alpha (α) 
(Cronbach, 1951). Validity was established for the ISMI-X subscales using evidence of 
construct and convergent validity with the Xhosa version of the DISC using Spearman’s rho.  
 
a) Utility 
Utility relates to the quality of data as assessed by the completion rates of data and the score 
distributions (Lamping et al., 2002). In order to access whether the ISMI/ISRHD-X is 
acceptable to the Xhosa patients with SCZ and RHD, we examined the completion rates 
(number of scales completed per group), while also investigating the number of scales with 
missing items. Within the RHD sample a total of 50 questionnaires were administered of which 
47 (94%) were completed in full, while 2 (4%) had one omitted item, 0 (0%) had two items 
omitted, and 1 (2%) had three or more omitted items. Within the SCZ sample a total of 60 
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questionnaires were administered. Of these questionnaires 47 (78.33%) were completed in full, 
9 (15%) had one item omitted, 0 (0%) had two items omitted, while 4 (4.66%) had 3 or more 
items omitted. These figures demonstrate that the completion rates are high across the two 
disease groups, suggesting good readability and ease of use of the ISMI/ISRHD-X measure in 
both samples. These results are summarised in Table 13. below. 
 
Table 13: Utility of RHD and SCZ ISMI/ISRHD-X scales  
ISMI-X Pilot 
Samples:   
Utility (scale items completed) 
SCZ sample   
n=60  47 (78.33% completed all items) 
9 (15% omitted 1 item) 
4 (6.66% omitted 2 or more items) 
RHD sample  
n=50 47 (94% completed all items) 
2 (4% omitted 1 item)  
1 (2% omitted 2 or more items) 
 
In the RHD sample, these omitted items included items 2 (1 omission), 3 (1), 7 (1), 18 (1), 24 
(1) and 29 (1). While in the SCZ sample the items omitted included items 1 (2 omissions), 2, 
(1), 4 (1), 9 (1), 15 (1), 18 (1), 19 (1) and 26 (3). There were more items omitted in the SCZ 
sample in comparison with the RHD sample, yet neither group demonstrated a single item 
omitted more than 3 times, suggesting further evidence for the utility of these items.  
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There was a marked difference in completion rates between the RHD and SCZ group. This 
difference is likely the result of differences in how the instrument was administered in each 
disease group. Participants in the RHD group completed only the ISRHD-X, while for the SCZ 
group, participants completed the ISMI-X scale after completing the SCID and a series of other 
measures (which usually took about 2 hours to complete). As mentioned before, it is likely the 
lower completion rates were indicative of fatigue within the SCZ group.  
 
Within the SCZ and RHD samples, the questionnaires with 2 or more items omitted were 
considered unusable and removed from further analyses, leaving a total sample size of 56 for 
the SCZ sample and 49 for the RHD sample. The reliability results presented below are based 
on the 56 valid SCZ questionnaires as well as the 49 RHD questionnaires.  
 
b) Reliability 
Reliability assesses whether a measure consistently reflects the construct that it is measuring 
(Field, 2013). Reliability of the ISMI/ISRHD-X scales was investigated using internal 
consistency applying Cronbach’s α which is the most commonly used measure of reliability 
(Cronbach, 1951). Kline (1999) maintains that a level of 0.7 is a desirable representation of 
reliability, while other authors suggest that values as low as 0.5 are acceptable in the early 
stages of research (Nunnally, 1978). Empirical research has reported a high degree of internal 
consistency for the ISMI scale original English version, used in other studies with outpatients, 
with internal consistency scores ranging from 0.80 to 0.92 for the overall scale (Assefa et al., 
2012; Boyd et al., 2013). In studies where the stigma resistance subscale was not included in 
the total scores, similarly internal consistency ranged from 0.81 to 0.92 (Boyd et al., 2013). 
Table 12. below reflects the Cronbach’s α values of the total ISMI/ISRHD-X scales and 
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subscales thereof across the SCZ and the RHD samples in the present study, along with the 
original scores obtained in the original English version study (Ritsher et al., 2003).  
 
Table 14: Internal consistency coefficients reported for the ISMI-X scales 
Internal consistency Original 
English version 
(Ritcher (Boyd) 
et al., 2003) 
ISMI-X SCZ  ISRHD-X RHD 
 Cronbach’s α Cronbach’s 
α  
CI: 95% Cronbach’s 
α 
CI: 95% 
Total ISMI scale (24 
items)  
0.91 0.90 (0.76-
0.910) 
0.89 (0.759-
0.856) 
Alienation (6 items) 0.79 0.73 (0.596 - 
0.827) 
0.64 (0.455-
0.775) 
Stereotype 
endorsement (7 items) 
0.72 0.82 (0.737-
0.884) 
0.70 (0.554-
0.813) 
Discrimination 
experience (5 items) 
0.75 0.78 (0.669-
0.859) 
0.70 (0.540-
0.813) 
Social withdrawal (6 
items) 
0.80 0.86 (0.788-
0.907) 
0.80 (0.704-
0.878) 
Stigma resistance (5 
items) 
0.58 0.57 (0.362-
0.732) 
0.76 (0.637-
0.856) 
Abuse (6 items) - 0.78 (0.675- 
0.860) 
0.86 (0.788- 
0.913) 
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Internal consistency for the total scale was high in both the SCZ and RHD (α =0.90 and 0.89), 
and commensurate with the internal consistency of the original ISMI English language version 
(α =0.91). In addition, acceptable internal consistency is demonstrated across all of the 
subscales ranging from 0.57 to 0.86 in the SCZ sample and 0.64 to 0.80 in the RHD sample. 
The Abuse subscale also demonstrated adequate internal consistency at 0.78 for SCZ sample 
and 0.86 for the RHD sample. 
 
c) Validity 
Terre Blanche and Durrheim (1999, p. 83) as cited in Bhana (2006), attest that validity relates 
to an examination of whether the instrument provides a good degree of fit between the 
conceptual and operational definitions of the construct, as well as whether the measure is usable 
for the intended purpose. There are various types of validity, for the purpose of this study we 
investigate construct and content validity within both disease groups as well as convergent and 
divergent validity within the SCZ group.  
 
 Construct Validity 
Construct validity examines the extent to which an instrument behaves in a theoretically sound 
manner. It is measured by investigating the correlations between subscales within a scale that 
are expected to measure the same construct. Keszei et al. (2010) maintains that internalised 
stigma is a construct which cannot easily be measured through physical attributes. Numerous 
tools have been developed, primarily in North American and European contexts, consisting of 
experiential attributes to measure this theoretical construct. In psychological and social 
sciences these abstract experiential variables are called hypothetical constructs. The original 
English ISMI scale developed by Jennifer Ritcher [Boyd] and colleagues (2003) has five 
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subscales (i.e. Alienation, Stereotype Endorsement, Discrimination Experience, Social 
Withdrawal and Stigma Resistance) which are developed based on evidence from a substantive 
literature review (largely based on research conducted in the USA, UK and European contexts) 
that reports that these are important associated components of the construct, internalised 
stigma. In the South African context, Abuse was also viewed as a construct related to 
internalised stigma (Botha et al., 2006). In this study we included an additional subscale of 
abuse as an indicative measure of internalised stigma experienced by Xhosa people with the 
study diseases (Botha et al., 2006).  To measure whether the aforementioned subscales are in 
fact related to the internalised stigma construct among this African population group, a 
correlation of the subscales and the total tests was considered. The correlation between the 
scales assesses the degree to which they measure related aspects of the construct. We 
hypothesised that all the subscales (with the exception of the Stigma Resistance subscale – 
which measures a different construct) would show significant positive correlations with the 
total ISMI-X score, in the moderate range (r= 0.30 – 0.50), in accordance with criteria 
suggested by Brohan et al., (2013).  
 
Table 15: Within-scale correlations RHD sample (n= 49) 
 Total 
ISRHD-
X 
A SE DE SW SR AB 
Total 
ISRHD-
X 
1.000 
. 
r= 0.748** 
p= 0.000 
r= 0.882** 
p= 0.000 
r= 0.784** 
p= 0.000 
r= 0.841** 
p= 0.000 
r= 0.057 
p= 0.696 
r= 0.653** 
p= 0.000 
A  1.000 
. 
r= 0.662** 
p= 0.000 
r= 0.478** 
p= 0.001 
r= 0.390** 
p= 0.006 
r= 0.160 
p= 0.271 
r= 0.304* 
p= 0.034 
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SE   1.000 
. 
r= 0544** 
p= 0.000 
r= 0.676** 
p= 0.000 
r= 0.161 
p= 0.270 
r= 0.561** 
p= 0.000 
DE    1.000 
. 
r= 0.566** 
p= 0.000 
r= -0.029 
p= 0.844 
r= 0.539** 
p= 0.000 
SW     1.000 
. 
r= -0.068 
p= 0.643 
r= 0.674** 
p= 0.000 
SR      1.000 
. 
r= 0.111 
p= 0.446 
AB       1.000 
 
Table 13. Correlation with subscales in ISMI-X for the schizophrenia sample. (A= Alienation, SE= Stereotype 
Endorsement, DE= Discrimination Experience, SW= Social Withdrawal, SR= Stigma Resistance, AB= Abuse).  
p < 0.05*;  p < 0.01** 
 
For the ISRHD-X scale, indeed strong positive correlations were found between the ISRHD-
X total and subscale scores (n= 49). In correlation with the total, all of the subscales (excluding 
the stigma resistance subscale) demonstrated at least moderate positive correlations (0.3) and 
most subscales displayed a strong correlation. Within-scale analysis presents moderate to 
strong correlations, with the exception of the Stigma Resistance subscale (which is measuring 
a different construct). For the SCZ sample, the within-scale correlation results are presented in 
Tables 16 below.   
 
Table 16: Within-scale correlations SCZ sample (n= 56) 
 Total 
ISMIS 
A SE DE SW SR AB 
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Total 
ISMI-
X 
1.000 
. 
r= 0.777** 
p= 0.000 
r= 0.792** 
p= 0.000 
r= 0.706** 
p= 0.000 
r= 0.850** 
p= 0.000 
r= 0.415** 
p= 0.000 
r= 0.637** 
p= 0.000 
A  1.000 
. 
r= 0.493** 
p= 0.000 
r= 0.460** 
p= 0.000 
r= 0.509** 
p= 0.000 
r= 0.307* 
p= 0.021 
r= 0.479** 
p= 0.000 
SE   1.000 
. 
r= 0.311* 
p= 0.019 
r= 0.598** 
p= 0.000 
r= 0.506 
p= 0.270 
r= 0.495** 
p= 0.000 
DE    1.000 
. 
r= 0.530** 
p= 0.000 
r= 0.183 
p= 0.177 
r= 0.367** 
p= 0.005 
SW     1.000 
. 
r= 0.288* 
p= 0.031 
r= 0.630** 
p= 0.000 
SR      1.000 
. 
r= 0.175 
p= 0.197 
AB       1.000 
 
Table 8. Correlation with subscales in ISMI-X for the schizophrenia sample. (A= Alienation, SE= Stereotype 
Endorsement, DE= Discrimination Experience, SW= Social Withdrawal, SR= Stigma Resistance, AB= Abuse). 
p < 0.05*; p < 0.01** 
 
For the ISMI-X scale, strong positive correlations were found between the ISMI-X total and 
subscale scores (n= 56). In correlation with the total, all of the subscales (including the stigma 
resistance subscale) meet the threshold (0.3) and most subscales displayed a strong correlation. 
Within-scale analysis presents mostly moderate correlations. It’s interesting to note that the 
Stigma Resistance subscale shows moderate correlations with the overall scale as well as with 
the Alienation and Social Withdrawal subscales within the SCZ sample. In support of the 
qualitative data in chapter 8 under the section coping strategies, and the literature (Du Plessis 
et al., 2004; Sorsdahl et al., 2012)  one explanation for these correlations may be the SCZ 
description of alienation and social withdrawal as a coping strategy to mitigate perceived 
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stigma and discrimination from the general public. Therefore, alienation and social withdrawal 
may be strategies for managing stigma and increasing stigma resiliency for this sample.   
 
  Convergent and Divergent Validity 
As described by Diamantopoulos and Schlegelmilch (1997) convergent validity was 
considered in relation to the extent to which the ISMI-X was positively related to other 
measures which investigate the same concept.  Preliminary literature suggests that stigma and 
discrimination are related constructs, for instance, Thornicroft et al., (2007) explain that stigma 
is a mark or sign of disgrace which usually brings forth negative attitudes. For a person with a 
mental illness, this stigma can also contribute to discrimination for example when applying for 
a new job or maintaining a current job. This study utilised a comparison scale which measures 
discrimination (the Discrimination and Stigma scale) that has recently been translated for 
isiXhosa-speaking patients with a mental illness. Previous research in the UK has utilised the 
ISMI and the DISC English versions (i.e. Brohan et al. 2013) and indicated adequate 
correlations between the two scales. Evidence of convergent and divergent validity of the 
ISMI/ISRHD-X scales was examined in comparison with the DISC Xhosa version scales 
completed by the subsample (n= 32) of the SCZ participants in this study. Prior to presenting 
the scores, I present the demographics of the smaller sample of SCZ participants who 
completed both the ISMI-X and the Xhosa version of the DISC in totality (n= 32).  
 
Table 17: Demographics of SCZ sample that completed ISMI and DISC scales  
n= 32  
Sex 
Male 
Female 
 
32 (100%) 
0 (0%) 
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Age 
Average  
Range 
 
30 years  
21 – 50 years 
Highest level of education 
Some primary schooling 
Some secondary schooling  
Tertiary qualification 
 
 
4 (12.5%)  
26 (81.25%) 
2 (6.25) 
 
As noted in the table above, a total of 32 participants completed all items on the ISM-X and 
the DISC. All of these participants are male with a mean age of 30 years. Of these respondents 
2 (6.25 %) have tertiary qualifications while 26 (81.25%) have some secondary schooling and 
4 (12.5%) have some primary schooling.  
 
Only participants who completed both the Xhosa versions of the ISMI and the DISC scales and 
had less than 3 items omitted in each scale were included in the analysis of convergent and 
divergent analysis (n= 32).  Subscale scores of the ISMI-X and DISC were compared using 
Spearmans rho (Field, 2013) which is used for ordered or categorical data such as the data 
elicited from Likert scales utilised in the ISMI and DISC Xhosa version response scales. 
Results are presented in Table 12 to follow.  
 
We also investigated divergent validity following Diamantopoulos and Schlegelmilch’s (1997, 
p. 34) definition of divergent validity, which refers to measuring the extent to which an 
instrument is not related to scales/subscales of different concepts which have no expected 
theoretical relationship. We aimed to achieve this by investigating the relationship between the 
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ISMI-X Stigma Resistance and DISC Treated Unfairly subscale, as these two scales are 
expected to measure different theoretical constructs (Brohan et al., 2013).   
 
The convergent and divergent validity of the ISMI-X was investigated as per the hypotheses 
below. Only the DISC Treated Unfairly subscale was used for comparison based on Brohan et 
al. (2013) recommendation that this is the most relevant subscale which in their study proved 
to meet the psychometric requirements. A significant moderate to strong correlation (0.3 or 
greater) was considered as the criterion. Based on the establishment of a relationship between 
stigma and discriminatory behaviour, we hypothesized that we would see the following 
relationships in our sample.   
 
1. the ISMI-X Total will have a positive significant relationship with the DISC 
Treated Unfairly subscale 
2. The ISMI-X Discrimination Experience will have a positive significant 
relationship with the DISC Treated Unfairly subscale 
3. ISMI-X Stigma Resistance subscale will have no association with the DISC 
Treated Unfairly 
 Table 18: Results for correlations with the ISMIS-X and DISC (n= 32)  
* p < 0.05 ** p < 0.01 
 DISC Treated Unfairly 
ISMI-X total (excluding SR) 
- Alienation 
- Stereotype Endorsement 
- Discrimination Experience 
- Social Withdrawal 
- Stigma resistance   
r= 0.097, p= 0.60 
r= 0.229, p= 0.104 
r= - 0.083, p= 0.325 
r= 0.337*, p= 0.030 
r= 0.082, p= 0.328 
r= 0.127, p= 0.244 
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The ISMI-X total score (excluding the Stigma Resistance subscale) showed no association with 
the DISC Treated Unfairly subscale (r= 0.097, p= 0.60) within the SCZ group. The Alienation, 
Stereotype Endorsement, Social Withdrawal, Stigma Resistance all showed no association with 
the DISC Treated Unfairly. Only the ISMI Discrimination Experience subscale and the DISC 
Treated Unfairly subscale demonstrated a moderate positive correlation and thus met the 
threshold (r= 0.337*, p= 0.030).  
 
These results could be for a number of reasons: firstly, these results could suggest problems 
with the Xhosa translation of some of the ISMI and DISC items. Secondly, it could be related 
to the assumption that internalised stigma and discrimination are highly correlated in this 
population group. This assumption is not supported by these results in this study, as the 
Discrimination Experience subscale only showed a moderate positive correlation. This is 
supported by Brohan et al. (2013) who describe that while discrimination and stigma may be 
related, there is evidence to suggest that the relationship is not strong and that there may be 
some variation between the two terms (Dembling, et al. 1999). In this context, considering that 
for many generations, history attests that Xhosa people have been subjected to discrimination 
in many aspects of their lives (Khosa & Zwane, 1995; Salo, 2003), based in many instances on 
race, discrimination may not necessarily be specifically associated with increased experiences 
of internalised stigma in Xhosa people with SCZ. Because the ISMI-X scale did not meet the 
threshold for convergent validity with the DISC Treated Unfairly subscale as found in Brohan 
et al. (2013), it can be argued that the ISMI/ISRHD-X scale warrants further investigation of 
the tool prior to recommending it for use in future studies. For the purposes of this study 
however, we did not have a large enough sample to perform factor analysis, therefore this is a 
recognised limitation of this scale.   
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As a measure of divergent validity, as hypothesised, the ISMI-X Stigma Resistance subscale 
did not show a significant association with the DISC Treated Unfairly subscale (r= 0.127, p= 
0.488). This result is commensurate with the work of Ritcher et al. (2003), Lysaker et al. 2007 
as well as Sibitz, Unger, Woppaman, Zidek, & Amering (2009) who explain that the Stigma 
Resistance subscale measures a different construct.  
 
 Content Validity 
Content validity refers to the relevance of each item for the particular cultural and disease group 
(Smit et al., 2006). One method is to examine items which are most frequently and highly 
endorsed by participants for each disease group across each subscale. This is an attempt to 
detect items which are relevant and meaningful in relation to the life experiences of the 
participants (Flaherty et al., 1988). In each of the subscales therefore, all of the “agree” and 
“strongly agree” items are tallied up and presented in the form of graphs below. 
  
Within the Alienation domain, over 40% of participants within the SCZ sample endorsed items 
5, 17 and 21 which refer to internalised stigma experiences of shame or embarrassment about 
their illness, feeling as though the illness had ruined their lives and that others without the 
illness could not understand them. These items appeared to be the most relevant and meaningful 
internalised stigma descriptions for the SCZ group within the Alienation domain. In 
comparison 30% or less endorsed items 1, 8 and 16 relating to feeling out of place in the world, 
inferior and disappointed in themselves because of their illness. These lower, less frequent 
endorsements suggest these were not as meaningful or relevant internalised stigma experiences 
with the SCZ group.  
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Within the RHD group only two items (17 and 21) received high and frequent endorsements 
while the remaining 4 were endorsed by less than 20% of the RHD group. These results suggest 
that most of the internalised stigma items in the alienation domain were not particularly 
relevant to the RHD group with the exception of items relating to experiences of the illness 
ruining their lives and that others without the illness couldn’t understand them.  
  
Graph 6: Comparison of endorsements of the Alienation subscale within the RHD and SCZ 
groups 
 
The Stereotype Endorsement domain was poorly endorsed across both the SCZ and RHD with 
the exception of item 29. This is an interesting finding in that item 29 refers to stereotypes 
about the illness relating to the participant. While both RHD and SCZ participants seemed to 
endorse this experience in theory, when practical examples of stereotypes were presented in 
items 2,6,10,18,19 and 23, participants did not frequently endorse these experiences. One 
reason for this may be how the broad concept of stereotypes was translated into Xhosa. The 
word ‘stereotypes’ does not exist in the Xhosa language, but the translation team in this study 
decided to keep this item and thus translated the word ‘stereotypes’ to “iingcamango”, which 
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can be directly translated to “opinions” in the English language. In the English language there 
is a difference between stereotypes and opinions, with the aforementioned holding a greater 
degree of negativity. This may have contributed to how participants endorsed items with this 
term. The difficulty in using the term was also discussed by Adewuya et al.’s (2011) as they 
reported that Yoruba-speaking patients with mental illness did not understand this word.   
 
Graph 7: Comparison of endorsements of the Stereotype subscale within the RHD and SCZ 
groups 
 
Generally, the Discrimination Experience subscale presented low endorsements. The items 
which are most endorsed (but by less than 40% of participants) are items 28 and 15. These 
items specifically relate to other people thinking the person with an illness can not achieve to 
the same potential as other people and therefore demonstrating that believe that by treating the 
patient like a child. The rest of the items, 3, 22 and 25 were poorly endorsed with less than 30% 
in both samples endorsing each of the items. These items relate to acts of people discriminating 
against them, ignoring them or not wanting to be close to them because they have their SCZ or 
23
16
11
16
11
20
38
12
6
16
8 6
14
63
0
10
20
30
40
50
60
70
80
90
100
2. ...people
tend to be
violent
6. ...people 
shouldn’t get 
married 
10. People
with...cannot
live a good,
rewarding life
18. People can
tell that I have
... by the way I
look
19. Because I
have ... I need
others to make
most decisions
for me
23. I can’t 
contribute 
anything to 
society because 
I have …
29. Stereotypes
about ... apply
to me
STEREOTYPE ENDORSEMENT (PILOT)
SCZ RHD
P a g e  | 220 
 
 
RHD. This may be further evidence for the normalised discrimination which Xhosa people 
have generally experienced in history, therefore suggesting that these disease label may not 
largely increase those discrimination experiences. It is possible that these items may not be 
relevant descriptions of internalised stigma accounts in this population.  
 
Graph 8: Comparison of endorsements of the Discrimination Experience subscale within the 
RHD and SCZ groups 
 
For the social withdrawal subscale, the items which was endorsed above 40% for both the SCZ 
and RHD samples is item 11. This item relate to patients isolating or restricting themselves 
from talking about themselves to others in the fear of burdening others with experiences of 
their illness. The second most endorsed item is item 12, which relates to the influence of 
stereotypes held by others keeping patients from social engagements. This item however also 
uses the term stereotypes which may not be accurately understood in the Xhosa language, hence 
it was translated to the term ‘opinions’. This suggests that for these Xhosa individuals these 
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items are the most relevant descriptions of internalised stigma in this domain. The least cited 
items in this subscale are items 4, 9 and 20. These items are related to the fear of unpredictable 
behaviour causing embarrassment for the patient or the patient’s family. It is understandable 
that these items were minimally endorsed by RHD patients who may not have a marked change 
in behaviour because of their disease. Notably, more than a third of the RHD participants did 
endorsed item 20, which may relate to an issue of answering half the question, as discussed in 
the qualitative pilot results below. 
   
Graph 9: Comparison of endorsements of the Social Withdrawal subscale within the RHD and 
SCZ groups 
 
In the stigma resistance subscale, all items across both samples demonstrated poor 
endorsements. This may relate to limited accounts of experiences of discrimination (as evident 
in the discrimination domain endorsements) or stigma. It may also relate to the internalisation 
of stigma experiences to the point that participants do not consider themselves as resilient 
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towards them. The low endorsements may also be related to the translated versions of the items. 
For instance, with item 7, there was much confusion regarding two commonly used terms in 
English, which are ‘contributions’ and ‘society’. Coming from a background of having minimal 
financial resources (i.e. most participants in this study being unemployed) and having a 
condition which compromises physical ability, participants were unsure of what kind of 
contribution this item could be referring to. Whether it was financial or one which requires 
physical strength, they often felt like they were not in a position to do so. The term society was 
also challenging to translate, even for the translation team, hence it was translated to the term 
‘community’ which means something slightly different in English. Item 24 also contains an 
English idiom “being a tough survivor”. Translating that idiom to mean the same thing in 
isiXhosa was also difficult. These examples highlight the challenges in finding linguistically 
equivalent language across English and isiXhosa. Overall, across both samples the items on 
this domain (which as discussed earlier measures a different construct) were generally less than 
all the other subscales measuring internalised stigma, which could be because of the translation 
issues or because of items not resonating with the participants. See the stigma resistance 
subscale endorsements in graph 10 below.  
 
Graph 10: Comparison of endorsements of the Stigma resistance subscale within the RHD and 
SCZ groups 
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All items in the Abuse subscale demonstrated poor endorsements below 40%. The items most 
endorsed in the SCZ sample is item 30 and 32. These items specifically relate to being verbally 
abused by others because of having SCZ. Interestingly, although poorly supported, the RHD 
sample also endorsed these items most within this subscale. Generally however, the items in 
this subscale did not show evidence that these items are particularly relevant descriptions of 
experiences of internalised stigma in these two disease groups. More specifically items 31, 33, 
34 and 35 which relate to being physically abused, difficulty attending clinic appointments and 
taking treatment as they may reveal to others that these patients have the specific disease that 
they have and the influence of the media’s broadcasting of the illness were not perceived as 
relevant items regarding these patients internalised stigma accounts.   
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Graph 11: Comparison of endorsements of the Abuse subscale within the RHD and SCZ groups 
 
Summary  
In sum, the examination of utility of the internalised stigma Xhosa language version in the SCZ 
and RHD disease groups demonstrates high completion rates of the scale: 47 (94%) fully 
completed scales in the RHD sample and 47 (78.33%) in the SCZ sample. While reduced 
completion rates in the SCZ sample was likely due to performance fatigue, overall these results 
indicate good readability and ease of use of the ISMI/ISRHD-X tools in both samples. 
Reliability, in the form of cronbach’s α was acceptable to high for both scales across the total 
scales and subscales. In terms of construct validity, the instrument demonstrated good 
correlations across the subscales. All of the subscales, with the exception of the stigma 
resistance subscale, showed moderate to strong positive correlations (Brohan et al. 2013). 
Evidence of content validity was the most problematic with very few internalised stigma items 
being frequently and highly endorsed for both the SCZ group in the ISMI-X and the RHD 
group in the ISRHD-X. These findings suggest that many of the internalised stigma items used 
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in these scales are not as relevant and meaningful in the Xhosa language samples, and the 
disease groups we translated the scales for use in. This is a marked limitation of the Xhosa 
language versions of these scales.  Within the ISMI-X scale convergent validity with the DISC 
Treated Unfairly subscale was not significant for the ISMI total scale which may suggest 
translation issues in either or both the ISMI-X and the DISC Xhosa version or a less marked 
association between discrimination and internalised stigma in this sample due to a history of 
systematic discrimination based on race and not mental illness. Notably, the Discrimination 
Experience subscale of the ISMI did show a moderate positive significant correlation with the 
DISC Treated Unfairly subcale (r= 0.337*, p= 0.030). The divergent validity assessment was 
met as the Stigma Resistance subscale indicated no relationship with the DISC Treated Unfairly 
subscale.  
 
Table 19: Summary of the psychometric properties of the ISMI/ISRHD-X scales 
Psychometric 
Properties 
Constitute 
Parts 
Criterion Was criterion met? 
Utility 
 
Completion rate 
of the scales 
Following the 
Maximum 
Endorsed 
Frequencies 
criterion (Brohan et 
al., 2013), with a 
criterion of > = 
80% completed 
responses.  
RHD: Yes (94%) 
 
SCZ: No (78.33%)  
Reliability 
 
Internal 
Consistency 
α > 0.6                                                  RHD       SCZ 
 
Total Scale                              Yes          Yes 
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 Subscales 
Alienation                                Yes         Yes 
Discrimination Experience      Yes          Yes 
Stereotype Endorsement         Yes           Yes 
Social Withdrawal                   Yes          Yes 
Stigma Resistance                    Yes          Yes 
Abuse                                       Yes          Yes 
 
Validity 
 
 
Construct 
validity  
 
 
 
 
 
 
 
Content validity 
 
 
 
 
 
 
 
 
 
 
Convergent 
Validity 
 
r.>.30 (Brohan et 
al., 2013) 
 
 
 
 
 
 
 
>40% endorsed – 
considered 
meaningful items 
<40% endorsed 
suggest possibly 
problematic, not 
meaningful 
internalised 
experiences in this 
group 
 
ISMI total 
(excluding SR) 
will have a 
                                                RHD       SCZ 
 
Total Scale                              Yes          Yes 
Subscales 
Alienation                                Yes         Yes 
Stereotype Endorsement         Yes           Yes 
Discrimination Experience      Yes          Yes 
Social Withdrawal                   Yes          Yes 
Stigma Resistance                    No            No 
Abuse                                       Yes           Yes 
 
                                                  RHD       SCZ 
                                                 >40%   >40% 
Alienation items                       17, 21   5, 17, 21                                                
Stereotype Endorsement           29         29       
Discrimination Experience        NA       NA 
Social Withdrawal                     11         11 
Stigma Resistance                      NA       NA      
Abuse                                         NA       NA       
 
 
 
 
 
No (r= 0.097, p= 0.60) 
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Divergent 
Validity 
 
 
 
 
 
 
significant 
association with 
the DISC Treated 
Unfairly subscale 
 
The ISMI 
Discrimination 
Experience 
subscale will have 
a significant 
association with 
the DISC Treated 
Unfairly subscale 
 
ISMI subscale 
Stigma Resistance 
will have no 
significant 
association with 
the DISC Treated 
Unfairly 
 
 
 
 
 
 
 
 
 
Yes (r= 0.337*, p= 0.030) 
 
 
 
 
 
 
 
Yes (r= 0.127, p= 0.488) 
 
 
 
 
 
                    
 
 
Qualitative pilot results from the cognitive interviews 
Items that challenged both SCZ and RHD participants 
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Feedback from the cognitive interviews (n= 5 SCZ and n= 5 RHD) indicated that a number of 
items on the scale were difficult for patients to understand.  For both the SCZ and the RHD 
subsamples the following items were identified as particularly confusing:  
 Item 29 “Stereotypes about the mentally ill apply to me / “Stereotypes about people 
with heart disease apply to me” which in Xhosa was translated to “Iingcamango 
ngabantu abagula ngengqondo ziquka nam” and “Iingcamango zabantu malunga 
nesifo sentliziyo nam ziyandichapazela”,  
 Item 23 “I can’t contribute anything to society because I have a mental illness/ I can’t 
contribute anything to society because I have a heart disease” which was translated to 
“Andikwazi ukuba negalelo ekuhlaleni nakweyiphi na into kuba ndiphazamisekile 
engqondweni” and “Andikwazi kuba nagalelo ekuhlaleni nakweyiphi na into kuba 
ndinesifo sentliziyo”   
 Item 24 “Living with mental illness has made me a tough survivor/ “Living with heart 
disease has made me a tough survivor” translated to, “Ukuphila ndinophazamiseko 
engqondweni kundenze ndaphumelela kwimeko ezinzima” and “Ukuphila nesifo 
sentliziyo kundenze ndaphumelela kwimeko ezinzima” were identified as particularly 
confusing.  
 
One possible reason for these items being challenging relates to the recognised limited amount 
of descriptive words in the Xhosa language (Campbell & Young, 2016; Steele & Edwards, 
2008). In relation to that, participants reported challenges in understanding the term 
‘stereotypes’ used in the scale, (i.e. items 29 “Stereotypes about mentally ill people/ people 
with heart disease apply to me” “Ingcamango ngabantu abagula ngenqondo/ abane sifo 
sentliziyo ziquka nam”).  The word ‘stereotypes’ does not exist in the Xhosa language, but the 
translation team in this study decided to keep this item and thus translated the word 
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‘stereotypes’ to “iingcamango”, which can be directly translated to “opinions” in the English 
language. In the English language there is a difference between stereotypes and opinions, with 
the aforementioned holding a greater degree of negativity, meaning there may be a difference 
in how people endorse those questions. This challenge also arose for item 12 of this scale, 
which also uses the same term ‘stereotypes’.   
 
Another example is item 23 “I can’t contribute anything to society because I have a mental 
illness / heart disease” “Andikwazi kuba negalelo ekuhlaleni nakweyiphi na into kuba 
ndiphazamisekile enqondwendi / ndinesifo sentliziyo”. Through the cognitive interviews, two 
words in this item proved difficult for the patients (n= 3 SCZ and n= 5 RHD) to grasp. The first 
word was ‘contribution’. Some participants thought it related to financial donations or physical 
labour such as participating in building community facilities, both of which many felt they 
were not in a position to assist with. These acts are viewed as valuable and important social 
engagements in the Xhosa culture. Others attributed it to sharing knowledge about their disease 
with people in their community. The other difficult word in this item was ‘society’, which, for 
the lack of finding another word, was translated to ‘community’ which is also holds a slightly 
different meaning. These examples highlight the challenges in finding linguistically equivalent 
language across English and isiXhosa. The same challenge arose for item 7 of this scale, which 
also used this term ‘society’. 
  
Item 24 reads, “Living with a mental illness/ heart disease has made me a tough survivor” / 
“Ukuphila ndinophazamiseko engqondweni/ isifo sentliziyo kundenze ndaphumelela kwimeko 
ezinzima”, directly translating to “Living with a mental illness/ heart disease has made me 
overcome difficult situations”.  During the cognitive interviews, patients from both disease 
groups (n= 5 SCZ and n=4 RHD) reported difficulty in understanding the euphemism “tough 
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survivor” and this item generated much debate amongst the reviewers of the translation. 
Following consulting the English to isiXhosa Oxford Dictionary, the translation team reached 
the consensus that the phrase does not exist in the Xhosa language and it is therefore best to 
remain with “Living with a mental illness/ heart disease has made me overcome difficult 
situations”. This is an example of how an English idiom, is difficult to translate to carry the 
same meaning in an African language.  
 
Items that challenged the SCZ participants specifically 
Items that were highlighted as particularly difficult for SCZ participants included items 9 and 
4. Item 9 reads: “I don’t socialise as much as I used to because my mental illness might make 
me look or behave weird / Andisakonwabeli kakhulu ukuhlala nabanye abantu njengoko 
ndandiqhele ukwenza kuba isigulo sam sengqondo sindenza ndibonakale kwaye ndenze izinto 
ezingaqhelekanga”. Again this item may be difficult to engage with as the SCZ repeatedly 
reported their tendency to practice self-isolation and withdrawal from social spaces, as echoed 
by SCZ participants in Zerwech (2000). 
 
Item 4, I avoid getting close to people who don’t have a mental illness to avoid rejection / 
“Ndiyazikhwebula ukuba kufutshane kubantu abangaphazamisekanga engqondweni ukuze 
ndingaziva ndingamkelekanga”. For both items 9 and 4, the SCZ patients reported difficulty 
in answering these items based on their explanations that they relate to the first part of the 
question ‘avoid getting close to people’, in a general sense and not necessarily solely avoid 
people who are not mentally ill. Hence, throughout the study many voiced their beliefs in social 
withdrawal and self-isolation as a protective measure or coping strategy from experiencing 
stigma. This may be why there is evidence of the Alienation and Social Withdrawal subscales 
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significantly relating to the total internalised stigma scale for the SCZ sample. This is also 
described the in the coping strategies section (in Chapter 8) by the SCZ patients enrolled in the 
study.  
 
In summary some of the challenges that were highlighted through this qualitative pilot were 
that, first, these Xhosa patients struggled to understand items with idioms common in the 
English language, but foreign to their home language. Second, for the translators it became 
evident that English colloquial expressions were very difficult to translate into conceptually 
equivalent Xhosa terms – which is similar to what other scholars found (Campbell & Young, 
2016; Steele & Edwards, 2008; Swartz & Drennan, 2000). Third, an African language like 
isiXhosa does not have many labels for specific terms. This challenge was echoed by Adewuya 
et al. (2011) who used the ISMI to investigate self-stigma among Yoruba psychiatric 
outpatients in Nigeria. For example, as mentioned earlier, participants in Adewuya et al.’s 
(2011) study also described that they did not know what a stereotype is. In their research, they 
opted to remove items referring to stereotypes in the scale. 
 
Overall the translation design employed in this study provided very helpful insights into how 
challenging it was to begin engaging with the construct of internalised stigma in the Xhosa 
language, let alone in two very different disease groups. The resultant Xhosa translation of the 
ISMI for use with Xhosa people with SCZ and RHD demonstrated mixed psychometric 
properties, despite an extremely thorough translation design and the very best efforts by the 
research team. We had hoped to use the ISMI-X and ISRHD-X scales to quantify and possibly 
compare internalised stigma experiences across these two disease group, but our psychometric 
results raise questions about the reliability and validity of scores obtained on these translated 
scales. As a result, we chose not to use the scales with our FGD participants.  
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Discussion of the process 
The translation and adaptation of ISMI/ISRHD-X scales were completed within a period of 
nine months. This is a time and cost intensive exercise considering that the final Xhosa 
translation still demonstrated problematic items. In addition, it is likely that new factors 
associated with internalised stigma experiences, unique to the Xhosa language and how it 
supports experiences of stigma, as well as the unique illness experiences of the two disease 
groups (SCZ and RHD) may need to be integrated into these internalised stigma Xhosa 
language version scales in the future to ensure a more comprehensive appraisal of internalised 
stigma. This same finding has been noted in the literature (Campbell & Young, 2016; Steele & 
Edwards, 2008, Swartz, 1998).  One additional limitation of this tool is that, as was done in 
previous translation studies, this tool was not tested with the test-retest method (Brohan et al., 
2013) nor did we have a large enough sample to perform factor analysis. Piloting in a larger 
sample would allow for further investigation of the psychometric structure of the tool (Brohan 
et al., 2010a, 2010b, 2011, 2013). Hence, future studies should continue to expand on 
associated factors that may be meaningful to the construct of internalised stigma in Xhosa 
populations with SCZ and RHD, and continue to evaluate the reliability and validity of the 
current ISMI/ISRHD items and subscales prior to using it in their studies.  
 
Translations of the ISMI into other European languages like Croatian (Margetić, Jakovljević, 
Ivanec, Margetić & Tošić, 2010), Spanish (Mữnoz, Sanz, Pérez-Santos & Quiroga, 2011) and 
German (Sibitz, Amering, Unger, Seyringer, Bachmann & Shrank, 2011) have shown small 
psychometric differences with the original English ISMI version, suggesting good 
transportability of the measure across these different European contexts. In the African context, 
another translation of the ISMI scale was conducted in Ethiopia (Assefa, et al., 2012). For the 
Ethiopian context the Amharic version, which is the most widely spoken language in Ethiopia, 
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also showed good internal consistency and was thus utilised as a tool to measure internalized 
stigma of SCZ patients in their context.  
 
However, this was the first translation and adaptation completed for a South African language 
(isiXhosa). The translation of the ISMI scale from its source language (English) into isiXhosa 
proved to be more challenging. Even with the extensive time and resources utilised for this 
process, language and cultural differences proved very difficult to overcome in some items. If 
resources allow it may be a better use of time in future to develop scales measuring important 
constructs in the particular context from preliminary qualitative research, as they may be more 
relevant to the context (King et al., 2007).   
 
Limitations of the translation process 
Translations of scales developed in one context for use in another context have a number of 
limitations. This study’s translation process is no exception. Like most standardised scales 
(Yang et al., 2014) the ISMI scale was originally developed in a western context to measure 
mental illness stigma (Ritcher et al., 2003). Although there are 55 known adapted and translated 
versions of the ISMI scale, a number of adapted scales for different conditions (i.e. for 
conditions such as; Substance Abuse (Boyd et al., 2014), Eating Disorders (Griffiths, Costa, 
Boyd, Murray, Mitchison & Mond, 2016), Epilepsy (Boyd et al., 2014), HIV and Leprosy 
(Stevelink, van Brakel & Augustine, 2011) and Inflammatory Bowel Disease (IBD) (Taft, 
Ballou & Keefer, 2012) much like in this study, have followed the guidance of the scale 
developer and only replaced the term “mental illness” in the scale with the disease or condition 
they are aiming to investigate (Boyd, 2014).  
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Some scholars however, followed the same guidance and did not change the item wording but 
instead included other items they believed were relevant to the disease under investigation. For 
example, the Internalised Stigma of Depression version includes one other item which reads, 
“People often make fun of me because I have depression” (Boyd et al., 2014). In this study, we 
included six other items measuring abuse, which were cited as particularly relevant for 
investigating internalised stigma among South African Xhosa people (Botha et al., 2006).  
 
Other researchers did not change the majority of item wording in the scale but did change or 
omit one or more items which they believed were not relevant to the condition (either in the 
initial translation/ adaptation phase or later in their revised or brief versions) (Boyd et al., 2014). 
An example of the latter is the Inflammatory Bowel Disease version (Taft, Ballou & Keefer 
(2012), which changed “People with mental disease tend to be violent” to “People with IBD 
tend to be dirty” and the ISMI: Leprosy Version which completely omitted this item.  
 
Our experience from changing the disease name highlighted important limitations to consider 
when following that process for the Xhosa language and for the two disease groups. We 
therefore suggest that a more rigorous adaptation of the ISMI, applying qualitative methods, as 
suggested by King et al., 2007, in identifying the internalised stigma experiences unique to 
these two disease groups – particularly the RHD group, would have been a more effective 
approach.  
 
Development of the RHD version of the ISMI presented in this work, drawing from the 
psychometrics and qualitative feedback of internalised stigma experiences within the FGDs 
may be an interesting direction for future research. The translation process, small pilot study 
and the ISMI/ISRHD-X study results reveal which individual internalised stigma items are 
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largely supported by our samples of Xhosa people with SCZ and RHD, but many would require 
modifications or deletions. Results from the FGDs, presented in Chapter 8 of this thesis, 
highlight valuable internalised stigma experiences for each disease group that are not currently 
included in the ISMI. In particular, the physical manifestation of RHD (i.e. fatigue, decreased 
productivity, difficulty breathing, ability to perform manual labour, reproductive challenges - 
for women - and feelings of ‘inferiority’ due to the label of having the disease and social 
exclusion from activities) identified in this study should be considered.  
 
Notably, there would be challenges to conducting substantial changes to a standardised 
instrument. Firstly, for RHD patients for instance, it is would require an extensive amount of 
time, funding and resources to identify RHD patients’ experiences of stigma and then develop 
these into individual scale items that could be piloted in the development of a future scale. 
Second, the results of the newly developed instrument would not be comparable with findings 
in other studies in the literature. However, the data emanating from a newly developed scale 
starting with a qualitative component to identify themes and constructs held by the population 
and then including those into a scale, would yield highly relevant, context specific data that 
would make a valuable contribution to understanding internalised stigma experiences in 
different disease groups, in different languages. While this was beyond the scope of this thesis 
due to a lack of time and funding, we do hope that the data collected in this study provides an 
insightful starting point that would guide future researchers pursuing that specific endeavour.  
 
With these limitations in mind we decided not to use the ISMI-X and ISRHD-X with our FGD 
participants. Instead we drew from the psychometric results to inform our second research 
question: (What are the internalised stigma experiences of Xhosa people with schizophrenia 
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and rheumatic heart disease?) and these insights are considered in the discussion chapter 
(Chapter 10) of this thesis.  
 
9.6. Summary of the main findings of the study 
Chapter 7 of this study revealed the causal attribution models held by Xhosa people with SCZ 
and those with RHD. The attribution models which were identified in this study include 
genetic, environmental, psychological, personal choices and cultural explanations. While some 
individuals identified one of these explanations, many held a combination of two or more of 
these models concurrently, suggesting the relevance of a multifactorial model for these disease 
groups.  
 
Chapter 8 of this study revealed that the main stigma experiences reported by Xhosa people 
with SCZ are; a) experiencing bullying, b) experiencing violence or abuse, c) non-approval of 
marriage for a person with SCZ due to an anticipation of associative / courtesy stigma for 
spouse or children, d) fear of children having the disease, e) discrimination in obtaining and 
maintaining employment due to having the disease label. The main stigma experiences reported 
for people with RHD are; a) people tend to look down on them, b) reported experiences of 
social exclusion because of the disease label, c) experiences of negative labels assigned to 
patients (i.e. being ‘lazy’, d) employment limitations, e) limited chances of getting married 
were related to women with RHD, mainly due to reproductive risks associated with RHD and 
for men due to foreseen lack of employment/financial struggle and f) some related the frequent 
collection and taking of medication to people with RHD being mistaken by individuals’ in the 
community for an indication of having HIV/Aids. Internal acceptance of these stigma 
experiences may lead to increased internalised stigma among Xhosa people with an SCZ or 
RHD disease label. 
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Chapter 9 investigated the psychometric properties of the translated ISMI/ISRHD-X scale. 
Although the scale has been widely used across different contexts with different diseases, this 
study found minimal evidence that the constructs of the scale are well supported – as they are 
portrayed in the scale items – for the Xhosa language. The construct which appeared to be the 
most relevant for our participants was the alienation subscale, which had three items that were 
endorsed by more than 40% of the samples. This supports Sorsdahl, et al. (2012) finding who 
used the ISMI English version scale among mental health advocacy group members in South 
Africa, and found the alienation subscale to be endorsed the most. The items most endorsed in 
the alienation subscale for the Xhosa samples in this study are;  
 Item 17: “having … has spoiled my life”   
 Item 21: “people without … could not possibly understand me…”  
 Item 29: “stereotypes about … apply to me”  
The other item which was endorsed by more than 40% of participants from both the SCZ and 
RHD sample is under the social withdrawal subscale, this item is;  
 Item 11: “I don’t talk about myself much because I don’t want to burden others with 
my …” 
An additional item endorsed by more than 40% of participants in the SCZ sample is item 5 
which is (“I am embarrassed or ashamed that I have …”). Overall a large number of items in 
the scale across both samples revealed poor endorsement rates in the pilot, which is suggests 
that these particular items may not be relevant descriptions of internalised stigma experiences 
for Xhosa people who have SCZ or RHD. This is also a conclusion highlighted by Sorsdahl et 
al. (2012) who found that with the exception of the alienation subscale, individuals in their 
study reported low internalised stigma. The lack of evidence – based on the pilot process in 
this study – to support their relevance resulted in us making the decision not to use the scale 
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during the FGDs. Internalised stigma items specific to the disease and cultural groups would 
need to be investigated in future studies.  
9.7. Chapter summary 
First, the chapter discussed approaches to understanding culture and translation. Next I 
discussed the translation process employed in this study in order to translate and adapt the 
measure (Internalised Stigma of Mental Illness Scale) for use by Xhosa-speaking patients with 
SCZ and those with RHD. Then the chapter sought to present the psychometric properties 
(which included the utility, reliability and validity) of the newly developed ISMI/ISRHD-X 
scales. The limitations of the translation process are also discussed. Lastly, it ended with a 
summary of the main study findings identified in chapters 7, 8 and 9. Next, chapter 10 presents 
discussion based on the study findings.   
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CHAPTER 10: DISCUSSION, CONCLUSION, LIMITATIONS AND 
RECOMMENDATIONS 
10.1. Introduction 
This study used a mixed methods approach to explore how the causal attributions, particularly 
focussing on a genetic attributions held by Xhosa people with schizophrenia or rheumatic heart 
disease may relate to internalised stigma. The project was framed in the context of ethical 
concerns around how genomic research – which would likely lead to greater attribution of 
illness to genetics – could increase stigma associated with disease. This concern is often raised 
by researchers and ethics committees regardless of the condition that is being investigated. We 
sought to explore this concern through patients who participated in two ongoing genomics 
research projects at the University of Cape Town, one on rheumatic heart disease – not a 
traditionally stigmatised disease – and one on schizophrenia, for which there is considerable 
stigma.  
I explored participants’ views on causal explanations to disease by showing them video-based 
vignettes emphasising either (1) a genetic cause, (2) a gene-environment cause or (3) an 
environmental cause. I explored participants’ stigma experiences in the FGDs through a series 
of semi-structured questions. In the previous three chapters, I described our study results. In 
this chapter, I present my interpretation and discussion of these study findings. 
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This study sought to add to the limited literature on genomics research and its possible impact 
on stigma experienced by African patients with a psychological or a physical disease. The 
Attribution Theory, Modified Labelling Theory and Stigma Framework are used to guide the 
discussion which follows. The Attribution Theory specifically focusses on perceptions of 
causation rather than the actual cause or the accuracy of these causal beliefs. This theory can 
also inform behavioural responses or actions of individuals making inferences about a 
condition or disease (Weiner, 1998). The theory can also be used to understand whether or not 
an attribution could lead to psychosocial consequences, i.e. stigmatised perceptions and 
discriminatory behaviours. The Modified Labelling Theory was used in this study to better 
explore whether the disease labels under investigation could lead to expectations of devaluation 
and thus internalised stigma experienced by the patients. Corrigan and Watson’s (2002) Stigma 
Framework was used to position the discussion based on the constructs of stigma covered in 
their theory.  
10.2. Causal models of Xhosa people with SCZ and RHD 
Question 1: What causal models are employed by Xhosa people with schizophrenia and people 
with rheumatic heart disease to explain their illness, and to what extent do genetic explanations 
play a role in these causal models?  
To answer the first research question of this study, we asked patients what they attribute to be 
the cause of their disease, what they know about genetics and how they think genetics may 
have played a role in their disease onset. As described in Chapter 5, the Attribution Theory 
suggests that disease attributions are based on locus of control (internal vs external), 
controllability (controllable vs uncontrollable) and stability (stable vs unstable).   
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10.2.1 Genetic Attribution 
 
The first major finding of this study is that most participants with SCZ and RHD were able to 
define genetics, and some were able to link genetics to disease causation. Largely, participants 
articulated that a disease related to genetics can be passed down through inheritance, and that 
it is possible that it may skip a generation - suggesting they may be recessive (Condit, 2010; 
Henderson & Maguire, 2000). How the inheritance process occurs was not clear to them. With 
regard to inheritance, participants largely associated “genetics” with family members and 
discussed genetic attribution mostly in relation to a genetic predisposition. Some thought that 
inheritance of genetics could occur during the period when a woman is pregnant, while others 
said it may occur through the birth process. In both instances, participants referenced an 
exchange or mixing of blood between the mother and child at some point during pregnancy. 
Importantly, participants expressed an understanding that a predisposition for a disease may 
be passed down through either the paternal or maternal bloodline. 
 
Despite their general knowledge of genetics, the research participants did not frequently 
support solely a genetic causal explanation for their disease. Even though some participants 
were able to recall family members who had a heart disease or mental illness (without being 
certain of the exact diagnosis) or related that they had seen symptoms of the disease in their 
children, most participants were not convinced that genetics played a strong role (as suggested 
in the genetic determinism concern) in causing their disease. This finding suggests that these 
participants are not likely prone to deterministic and fatalistic thinking as cautioned by some 
researchers (i.e. Dar-Nimrod & Heine, 2011). The individuals who did consider a genetic 
explanation often did so in combination with other factors which may have “triggered” the 
disease.  
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For instance, many of the SCZ participants highlighted that if an individual has a ‘gene’ 
associated with the onset of SCZ, the development of the disease still required a particular 
trigger. Such triggers described by participants included stress (which they often called “over-
thinking” – as also defined in Lund & Swartz, 1998; Ngobe, 2015; Swartz, 1998), severe 
poverty, substance abuse or bewitchment. Similarly, the RHD participants placed much 
emphasis on the influence of emotional trauma, pain and anger (what they referred to as their 
“broken-heart”) as triggers for the onset of their disease. Such a perception was also described 
by Zuhlke, Perkins and Cembi (2018) and is understandable because the heart is often 
associated with being the centre of a person's thoughts and emotions. Overall, solely biogenetic 
attributions were minimally supported by the SCZ and RHD participants in this study. This 
finding is largely in line with other research on South African people’s conceptualisation of 
disease (Faure, 2018; Mbanga et al., 2002; Naanyu, 2009; Ngobe, 2015). Possible reasons for 
this finding are explored in section 10.3. of this chapter. The other causal explanations which 
were supported by individuals in this study are discussed below.   
 
10.2.2. Psychosocial Explanations 
 
10.2.2. a) Environmental Explanations 
A large number of RHD participants related the cause of their disease to either a gene-
environment explanatory model or solely an environmental model. This finding is supported 
in the RHD literature (Watkins et al., 2016) where high prevalence rates of RHD are often 
found in poverty-stricken environments, such as Africa, Asia, and parts-of Australia. In 
particular, in South Africa, the highest prevalence of RHD is among people living in low-
income communities. For instance, Engel et al. (2011) found a high prevalence of RHD in 
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Langa and Bonteheuwel townships. Notably, Langa is the community from which the fictional 
character in the vignettes (Andile) and many of the patients recruited in this study originated. 
  
In my study, RHD participants largely related the cause of their disease to environmental 
factors, or at least to an interaction of such factors with others - including genetics. This finding 
resonates with those from a study in the US, where Bates and colleagues used FGDs to explore 
people’s beliefs around the causation of heart disease. Participants in this study described that 
even if there were a “gene for heart disease”, both environmental and genetic factors would 
likely play a role in the onset of heart disease. Similar to this study, Bates and colleagues 
concluded that participants did not report a genetically deterministic view on disease causation.   
 
Another explanation described by RHD participants in this study included past personal 
lifestyle experiences, such as, unhealthy eating habits, food insecurity and no access to gyms 
(due to financial limitations) as well as abusing substances such as drugs and alcohol. Because 
heart conditions are popularly attributed to a poor lifestyle (where heart disease can be 
prevented by eating healthily and exercising), it is unsurprising that these participants cited 
poor past lifestyle decisions as a contributing cause of their disease. 
 
For the SCZ participants who come from a similar environment (i.e. low income communities), 
past personal lifestyle experiences were also highlighted as a contributory cause for their 
disease. The use of cannabis and other drugs was cited commonly as a past behaviour choice 
by many participants, whether during social engagements with friends or alone. One 
participant, for example, reported having used cannabis for 11 years prior to being diagnosed 
with SCZ. The influence of cannabis on the development of SCZ has been thoroughly 
investigated. Studies have found that individuals who use cannabis from an early age have a 
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higher chance of experiencing psychosis during their lifetime (Henquet, Murray, Linszen and 
van Os, 2005; Jones et al., 2018). This suggests that the attribution presented by participants in 
this study is plausible as a causal explanation. But, although evidence suggests that cannabis 
use is a risk for psychotic disorder onset as also acknowledged by some participants in this 
study, this is often only the case when combined with another factor such as genetic 
susceptibility (Henquet et al., 2005). In this study, participants echoed such a nuanced 
understanding and considered substance abuse as a trigger existing alongside other factors 
including a genetic predisposition. 
 
It was surprising to witness participants cite drug use as a factor influencing SCZ causation, 
since none of the vignettes used in the FGDs in the present study referred to this explanation. 
The assumption is therefore that it relates closely to personal experiences in the participants’ 
environment. The RHD participants who come from the same communities also highlighted 
the need to make an effort to avoid spaces where drugs are easily available. For them, it was 
regarded as a good practice to stay away from these spaces as it would otherwise adversely 
affect the management of their disease. This of course is well known regarding substance use 
in South African townships (Parry, 2005).  
  
9.2.2. b) Psychological Explanations 
Psychological explanations were also highlighted by participants in the study, relating them to 
stress and trauma. Stressful life events such as childhood trauma which included different forms 
of physical, sexual and emotional abuse and the loss of a parent or sibling at a young age, hold 
significant health implications. In South Africa, black people are disproportionately more 
exposed to stressful life events and psychological stresses due to higher rates of low 
socioeconomic status. In the low-income communities my participants come from, one 
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particular phenomenon is crime and violence (Ngqela & Lewis, 2012). RHD and SCZ 
participants in my study reported that high rates of crime and violence translated into a 
background fear of experiencing violence because of their disease. The knowledge of not being 
in a safe environment may affect mental wellness (Ngqela & Lewis, 2012).  
 
The hypothesis that stress affects the onset of SCZ is explained in the Traumatic 
Neurodevelopmental (TN) model of schizophrenia, discussed by Read, Moskowitz and 
Collony (2001). The TN Model documents similarities between the effects of traumatic 
occurrences on the development of the brain, as well as the biological abnormalities found 
in people with SCZ (Read et al., 2001). Read and colleagues argue that for some adults 
diagnosed with SCZ, traumatic life events or significant losses and deprivation may not 
only "trigger" SCZ but may also mould the neurodevelopmental abnormalities which 
underlie the heightened sensitivity to stresses which are often found in adults who are 
diagnosed with SCZ, if they occur early enough in the individual's life and/or are 
sufficiently severe. 
 
Applying the TN model, Read, Morrison and Ross (2005) describe that it is critical for 
researchers and clinicians to explore experiences of early traumatic events and stresses 
among patients with psychotic symptoms. For instance, many of the participants in this 
study highlighted experiences of child physical and emotional abuse, which is consistent with 
the literature on child abuse and psychosis in general as well as within SCZ (Read et al. 
(2005). These earlier traumatic experiences were echoed in this study. 
  
With the RHD sample we found that participants also expressed experiences which 
impacted them emotionally (such as emotional abuse and in some instances physical abuse) 
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which they also described as “triggering” their disease onset. In particular, for the RHD 
group, stress in relation to poverty and to childhood trauma were highlighted as a strong 
causal explanation for the onset of the disease. Similarly, for the SCZ group, stress enacted 
through “thinking too much” because of the circumstances they lived under was attributed 
to causing the disease.  
 
Although there is no known literature to support this causal effect in relation to RHD, there 
is general evidence that suggests that psychological stressors can "trigger" heart disease. 
Dimsdale (2016) and Skeptoe and Kivimaki (2013) for instance emphasise that there is 
evidence for the deleterious effects of stress on the heart. These authors further elaborate 
that vulnerability and resilience factors play a role in enhancing or reducing those effects. 
 
10.2.3. Cultural Explanations 
Cultural causes were cited by many participants in this study. Many of the SCZ participants 
supported cultural causes – which they described as bewitchment – for their disease. Given 
that over 90% of the SCZ participants are Xhosa males who have a low-level of education, 
this finding supports Naanyu (2009) who found that black South African males who have 
a low-level of education are more likely to endorse non-biogenetic explanations for mental 
illness. Currently it has been 25 years after the country became a democracy, yet black 
South Africans continue to be deprived of adequate educational facilities, which means 
that it is likely that they may not be as exposed to modern scientific knowledge about 
biological disease causation as they are to cultural explanations which may be held by 
members in their community.  
 
Understanding the cultural explanations held by different African cultures is a critical step 
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in understanding how the cultures develop their disease causal models. Attention to cultural 
understandings of physical and mental health has gained traction as an important element 
in mainstream medical literature (Stewart, 2003). Previous studies conducted in Ghana 
(Kyei, Dueck, Indart, & Nyarko, 2012), Ethiopia (Assefa et al., 2012),  Kenya (Mamah, et al., 
2012; Muga, & Jenkins, 2008) and South Africa (Mbanga et al., 2002; Swartz, 1998) report 
that a large number of African patients refer to cultural belief systems when considering 
disease causation. This finding is evident in my data for both RHD and SCZ participants. 
Many participants across both groups (although more so in the SCZ sample than the RHD 
sample) related the “root cause” of their disease to cultural explanations. In contrast to the 
US culture, which Sabatello (2018) describes as highly individualistic, the cultural 
explanatory model often held by Xhosa people considers multiple supernatural factors 
external to the individual having a collective role in causing a disease (Mkhize, 2003; 
Naanyu, 2009; Nwoye, 2015).  
 
Although, I did not intend to explore these cultural beliefs on disease causation, in the 
course of my FGDs it became evident that many participants cited witchcraft, evil spirits 
and sorcery as reasons for the onset of the two diseases. Congruent with previous research 
(Campbell et al., 2017), bewitchment was reported as a common causal explanation in the 
SCZ sample, but surprisingly also featured as a causal explanation for RHD. Participants 
describe bewitchment in one of three ways: Firstly, participants explained that it was 
possible for an individual who desires to bewitch another to consult with a witch doctor 
(traditional doctor) in order to obtain muti (traditional herbal medicine) which would allow 
them to poison the individual they wished to bewitch. Secondly, participants described 
the act of magically sending evil spirits (umoya omdaka) to the individual they wanted to 
bewitch. Finally, participants described that bewitchment could occur through a dream 
P a g e  | 248 
 
 
(ukuthakatha ngephupho).  
 
These definitions were consistent with those provided by traditional healers (Bantjes et al., 
2017; Mzimkulu & Simbayi, 2006). A primary reason for people to use witchcraft to bewitch 
another was reported by participants in this study to be jealousy. The desired outcome is 
to negatively affect a person’s wealth, mental health, or physical health. These participants' 
accounts of the cultural explanations of illness feed into a bewitchment framework 
(Campbell et al, 2017) which has been supported in research relating to mental illness in 
other African populations, such as the Sotho people with SCZ (Mosotho, Louw, & Calk, 2011) 
and depression (Mosotho, Louw, Calitz, & Esterhuyse, 2008) in South Africa and in the 
surrounding African countries such as Namibia (Maslowski, Rensburg & Mthoko, 1998).  
 
The evidence from this study suggests that this causal explanation is important to consider 
in genomics research conducted in African population groups, primarily because it plays 
a critical role in their health models. Particularly, for Xhosa people with SCZ and those 
with RHD, this explanation is identified as critical in relation to understanding 
conceptualisations around disease causal explanations.  
 
Naanyu (2009) denotes that African cultural groups may be drawing their causal 
attribution models based on beliefs passed down through generations; such in this study 
the example of a disease being associated with a genetic cause prevalent in a particular 
family that was suggested by some participants to having results of the entire clan group 
being associated with that disease. Africans may also have different cultural beliefs which 
may uniquely inform their perceptions on genetics having an influence in causing a disease 
(O’Neill, McBride, Alford and Kaphingst, 2010). Genetic and cultural attribution are 
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sometimes thought of as independent, however it is possible that these two causal models may 
interact and when conducting genomics research on African populations it may important to 
consider both.  
 
This study found that Xhosa people with SCZ and RHD attribute a multitude of casual 
explanations to their disease onset. How they decide on their held causal attributions is 
complex, and as found in Bates (2005), the transmission model of genetics information, in a 
linear and causal sense, does not hold up well with this population group. Scholars such as Dar-
Nimrod & Heine (2011) have suggested concerns around deterministic thinking, i.e. fears of 
individuals being exposed to information about a genetic cause to disease resulting in the belief 
that a disease is caused solely by their genes, therefore creating beliefs that it is fixed and 
unchangeable. This is also referred to as genetic fatalism (Bates, 2005). Evidence from this 
study is in contrast to that belief, as we found that individuals were open to considering a 
genetic cause for their disease – if aware of one – but they integrate that knowledge with their 
already held causal beliefs. The causal explanations these participants held, often concurrently, 
included both the biomedical model of illness, as well as alternative causal illness models. The 
alternative causal explanations included psychosocial causes (such as environmental, lifestyle 
choices, and psychological) and cultural explanatory causes. Even though there is no easy way 
to separate the causal explanations, in this study there was a definite emphasis on non-
biogenetic causes.  
 
10.3. Genetic causation vs other Causal Models 
 
There are at least three possible reasons why participants in this study predominantly 
highlighted environmental and cultural explanatory causes for illness, rather than biogenetic 
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explanations. Firstly, it is important to consider the participants’ sociodemographic 
backgrounds. The socio-demographic factors of participants in the study (see Table 2, Chapter 
6 page 78) indicate that the level of education of these participants is low, (roughly 50% of the 
RHD sample have a Grade 11-12 level of education and 33% of SCZ participants have Grade 
11-12), which is a low level of education when compared with, for instance, participants in 
genomics studies in North America (i.e. Sabatello et al., 2015). In the Sabatello et al. study 
(2015) which investigated the effects of genetic attribution on stigma related to epilepsy in a 
US sample, more participants had college degrees (52%). From other research (Naanyu, 2009) 
conducted in South Africa, we know that black South Africans with low-levels of education 
endorsed non-biogenetic causes for mental illness, which may be because of the lack of 
exposure to biological explanations through education curriculum. Given that exposure to 
scientific biomedical information is a known contributing factor to influencing causal 
beliefs (Condit, 2010) the lack thereof can explain the limited emphasis placed by these 
participants on that disease causal model. Other studies on physical diseases (Bham & Ross, 
2005 & Hundt et al., 2004) also found that black South Africans articulated environmental and 
cultural explanations for disease onset. Thus, individuals who have a higher level of education, 
may be more prone to accepting a genetic explanation to disease in comparison to those who 
may not as they may have been exposed to modern medical thinking. This would be consistent 
with Phelan et al. (2006) who propose that individuals who have had exposure to medical 
thinking are more likely to endorse genetic attributions to illness and seek biomedical 
treatment.  
 
Secondly, participants who identified other causes instead of a genetic explanation may have 
done so due to the complex nature of the science and of the genetic contribution in these two 
diseases. For instance, Muhammad (2018), who investigated the genetics of RHD through the 
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use of twin-studies, reveals that there is a shared genetic susceptibility in identical twins. In 
addition, Engel, Stander, Adeyemo and Mayosi (2011), as well as Muhammad (2018) report 
that there is an increased concordance in developing Rheumatic Fever (RF) in monozygotic 
twins in comparison to dizygotic twins.  Overall, regarding RHD, quantitatively, the heritability 
in twin studies has been estimated at 60%, with up to six-fold risk in monozygotic twins 
compared with dizygotic twins (Engel et al., 2011). Finally, Engel and colleagues (2011) 
document that familial and twin studies provide evidence of genetic susceptibility in RHD. 
However, the pattern of inheritance in RHD does not follow the simple mendalian single-gene 
inheritance, and in fact, is difficult to comprehend. Which is in support of Masiye (2015) who 
found that within the RHDGen study, there was difficulty in understanding scientific terms 
such as genomics, genetics and genes.   
 
Although data from those studies supplies critical evidence of possible heritability and genetic 
susceptibility of RF and RHD, precisely how this information can be thoroughly translated and 
understood by patients especially those with low-levels of formal education is not clear. 
Findings from Faure (2018) for instance indicate that RHD patients mostly do not consider 
their disease cause in relation to genetics, but rather to multiple factors including environmental 
and personal choices. Richards and Ponder (1998) note that, even in Western contexts, among 
lay people where there is an assumed higher awareness of genetics, the relationship between 
concepts such as “genes” or “DNA”, and inheritance of disease, are not clearly understood as 
they are too complex. This suggests that the challenges faced by health practitioners and 
researchers in explaining these terms, and the challenges faced by patients with low levels of 
education to fully understanding genetic explanations, may account for why Xhosa RHD 
participants were not certain of the role of genetics in the onset of their disease. This may also 
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be a reason why they attributed their condition to alternative causes which they find easier to 
access, understand and make sense of.  
 
Similar findings in the SCZ patients sampled for this study provides further support for this 
possible explanation. Research suggests that SCZ is highly heritable. In 2014, a systematic 
review was published by the Schizophrenia Working Group of the Psychiatric Genomics 
Consortium (PGC) on the biological insights of SCZ, relating to genetic loci (Schizophrenia 
Working Group of the Psychiatric Genomics Consortium, 2014). In their study, they provided 
findings for 128 independent associations covering 108 conservatively-defined loci that reach 
genome-wide significance. Although they provide novel findings (i.e. 83 conservatively-
defined loci that reach genome-wide significance, but which had not been reported) these 
associations do not necessarily imply genetic causality. How heritability translates into 
inherited genetic variants in the aetiology of schizophrenia is complex in itself (see, for 
example the Sullivan, Kendler and Neale, 2003). A lack of clarity in the scientific community 
makes the translation of these findings into accessible and meaningful explanations for SCZ 
patients, especially those with low levels of education, extremely challenging. Add to this an 
additional layer of language translation of these explanations into Xhosa, where the language 
simply does not have the linguistically equivalent vocabulary to support them, means 
researchers find themselves with considerable challenges in ensuring that genetic explanations 
are accessible, understandable and meaningful for these patients.  
 
Finally, the most obvious explanation for their condition for almost all of the participants in 
this study is the experience of poverty. Many diseases prevalent in South African low income 
communities are intimately related to the experiences of deprivation which can be understood 
based on the history of apartheid and segregation in South Africa (Swartz, 1998). Even though 
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it is 25 years following the end of the apartheid era, the consequences of it are still largely felt 
in township and rural communities. Black South Africans have mostly been disadvantaged and 
largely at the receiving end of marginalisation and discrimination. One past relevant example 
is the Group Areas Act in 1950, where black South Africans were moved from fertile to infertile 
land based on their racial profiles (Mesthrie, 1993). Xhosa people were moved to the Eastern 
Cape Province of South Africa. Most of them did and continue to reside in rural, 
underdeveloped areas in the Eastern Cape (Mesthrie, 1993). Some moved to more urbanized 
provinces, such as the Western Cape, where they mostly reside in townships. This is important 
to note, since Goffman (1963) documented that gaining an understanding of stigma requires an 
acknowledgement of the stigmatised group’s social structure. Culture, history, and present 
sociodemographic characteristics matter when one considers stigma. In this light, below I 
discuss the findings relevant to the second question of this study, which explores whether and 
how these Xhosa patients experience internalised stigma. 
 
10.4. Internalised stigma experiences of Xhosa people with SCZ and RHD 
 
Question 2: What are the internalised stigma experiences of Xhosa people with schizophrenia 
and those with rheumatic heart disease? 
 
This study found that Xhosa people with SCZ do experience internalised stigma. This finding 
echoes the findings of Botha et al. (2006) who investigated internalised stigma experiences of 
South African patients from diverse language backgrounds (including first language isiXhosa-
speakers) through the use of the Internalised Stigma of Mental Illness Xhosa scale. The 
uniqueness of this study lies in that it uses a mixed-methods approach, and draws on rich 
qualitative data shared by Xhosa patients living with SCZ or RHD. Patient perspectives, 
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particularly patients with a mental illness, have not largely been included in research studies in 
South Africa. Following the constructs discussed in Corrigan and Watson (2004) as well as 
Thornicroft et al’s (2007) (see chapter 4 of this thesis) descriptions of their framework of 
stigma, this study found that the participants in this study conceptualised their internalised 
stigma experiences in relation to: stereotypes (negative connotations); prejudice (ignorance or 
misinformation); and discrimination. While not using these direct terms, SCZ patients in this 
study described a range of these experiences in various domains of their lives. The Modified 
Labelling Theory by Struening et al. (1989) was also considered in order to understand how 
the label of the disease may produce different outcomes from participants, i.e. the theory 
proposes that some individuals will either be secretive about their disease, try to educate others 
or withdraw from social contacts due to the fear of rejection. Importantly, this study also 
provides evidence that the RHD patients in this study do report internalised stigma experiences 
which will be discussed below under the different disease labels.   
 
SCHIZOPHRENIA 
Stereotypes 
This study found that the stereotypes related to SCZ in this population group were that people 
with SCZ are perceived as ‘dirty’, ‘ugly’, ‘unpredictable’ and ‘violent’. These are commonly 
cited stereotypes about people with SCZ in preliminary research from the perspective of the 
general public (Angermeyer & Matschinger, 2004), family members (González-Torres, Oraa, 
Arìstegui, Fernandez-Rivás & Guimon, 2006) and health care professionals (Schulze & 
Angermeyer, 2003). Given that these are perspectives often held by members of the general 
public, caregivers and even health professionals (Harangozo et al., 2014; Ross & Goldner, 
2009; Schulze & Angermeyer, 2003), it interesting to see them echoed in this study by the 
patients themselves about other patients with the disease. This suggests that these participants 
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have internalised or are in agreement with the generally held stereotypes and views often 
associated with a person with a SCZ label. This is also evident in that the item which was most 
endorsed by SCZ patients in the ISMI-X pilot sample in the stereotype subscale which reads 
“stereotypes about … apply to me” (n= 38%). Participants also associated a person with SCZ 
as unable to communicate appropriately, hence some felt that having this disease meant they 
would not be able to attract and communicate with a potential spouse. Difficulty attracting a 
partner therefore led to feelings of limited chances of having children of their own. A decision 
to not have children was associated with; the fear of passing on the disease to offspring; the 
fear of not being able to take care of their children (physically and financially) because of their 
disease; and the fear of their partner and children experiencing stigma and discrimination 
because of their parent’s disease – what can be called “anticipated stigma and discrimination”. 
Based on the commonly held stereotypes about SCZ, many of these patients articulated an 
expected outcome of rejection. Based on the ISMI-X pilot data how these participants cope 
with this expectation is by practicing alienation and social withdrawal.   
 
Prejudice 
Participants described several ways in which the stereotypes about people with schizophrenia 
were internalised, and this affected their self-esteem. The feelings of “learned helplessness” 
and inferiority were articulated to affect their self-esteem. While the feelings of disgust and 
shame expressed by some patients about engaging with a person with SCZ suggest that these 
patients would even detach themselves from themselves if they could. This is depicted in one 
participant’s statement saying “who would want to be around someone who has 
schizophrenia”. This may be why many of them distanced themselves from the label of SCZ, 
and rather reflected on “when they were ill”, as though SCZ is not a chronic life-long disease. 
This is potentially the best way they can limit the feelings of not wanting to live with 
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themselves having that label. Again this finding is reflected in the ISMI-X pilot data results 
where 55% of SCZ participants endorsed the item “Having … has spoiled my life”, and 45% 
endorsed the item “People without … could not possibly understand me”. These are suggestive 
of the internalisation of society’s views on individuals with a disease label of SCZ.  
 
Discrimination 
Most of the stigma and discrimination mentioned was as a result of prejudice and stereotypes 
about people with SCZ, such as that they are ‘disabled’, unworthy of receiving the same human 
rights (i.e. marriage and having children) as “normal” people and that they are incompetent (for 
instance, in terms of employment). In the social context, the SCZ group highlighted three 
recurring stigma experiences regarding family, friends and community. Firstly, at the family 
level, most participants emphasised that they were subjected to discrimination (i.e. not being 
treated like their siblings or being treated as inferior, some even highlighting being introduced 
by family members to third parties as ‘the child with the mental problem’). This discrimination 
was thought to affect how external people (including those from their community) treated them 
which in turn affected how they felt about themselves. This is reflected in Link et al.’s (1989) 
description of the Modified Labelling Theory which describes that individuals internalise the 
social conceptions enacted by the people in their social networks in relation to their mental 
illness and this affects how they view themselves. This is evident in the ISMI-X pilot sample 
scale items endorsed most in the discrimination experience subscale, as 34% endorsed the item 
“Others think I can’t achieve much in life because I have …” and 32% of participants agreed 
that “People often patronise me, or treat me like a child because I have …”.  
 
SCZ participants also shared experiences of lost friendships and/or decisions to socially 
withdraw from friends since receiving the SCZ diagnosis, often because of the negative 
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attitudes (prejudice) and stereotypical beliefs held by friends and people in their community 
about mental illness (Hugo, Boschoff, Traut, Zungu-Dirwayi & Stein). Hence, some 
participants explained that they maintained social distance as a result of experiencing verbal 
and physical abuse.  Being in a community where violent behaviour is normalised and 
frequently reported as a behaviour-correcting “solution” by many of the participants in this 
study and others (Botha et al., 2006), the fear of violence as a reaction to stigma is a valid and 
understandable threat for people living in township communities in South Africa (Ngqela & 
Lewis, 2012).  For these patients, the fear of stigma itself could be so highly internalised that 
it leads to isolation as a protective behaviour in what Phelan (2005) terms as “anticipatory 
stigma” or anticipatory discrimination.  
 
While these experiences seemed to trouble the participants, they portrayed an understanding 
that the behaviour they received from others would be fuelled by family and community 
members’ ignorance and misinformation about mental illness. As a means to rectify such 
ignorance, some participants suggested that nurses and doctors should engage with 
communities and share knowledge about mental illness, to inform general public and their 
families and communities.  
 
In relation to finding and maintaining employment, as found in the UK by Dinos et al. (2004), 
disclosing a diagnosis of a mental illness to employers carries many disadvantages. Firstly, 
some participants reported being dismissed from their jobs or being undermined by employers 
– as if they were incompetent (Angermeyer & Matschinger, 2004). Secondly, they expressed 
being made to feel like an outcast by other employees (othering). For participants in these two 
disease groups, this resulted in a decision to refrain from applying or continuing with 
employment once diagnosed. While this created a sense of dependency – as the participants no 
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longer had a salary of their own – the discrimination and the ‘anticipated discrimination’ these 
patients believe they would receive in the employment environment proved too great for them 
to willingly engage in it.  
 
Others reported fear of disclosing their mental health condition on their résumé as that may 
influence employers to have negative views about employing them which further prohibited 
them from obtaining employment. With these examples the outcome enacted by the patients 
would often be secrecy. These findings would be important to consider in developing the work 
on an internalised stigma measure for Xhosa people with SCZ. 
 
RHEUMATIC HEART DISEASE 
Stereotypes 
The most commonly cited stereotypes about living with RHD reported in this study were that 
a woman with RHD cannot have children, and that if one has RHD they cannot maintain 
employment. The reproductive consequences were also described in Chang et al. (2018) and 
the limited employment prospects belief was described by participants in Faure (2018). 
Another stereotype which has been associated with RHD is the misconception that the 
individuals have HIV/Aids, which I found in this study but is echoed by Chang et al. (2018).  
 
Prejudice 
Negative attitudes related to the first stereotype were articulated by participants in this study. 
The reported negative attitudes were from members of the community, the family, medical 
practitioners, as well as from the individuals with RHD themselves. The community members 
may believe that a woman with RHD may not bear her own children, making her “less of a 
woman”. While it is true that pregnancy is a potentially lethal health challenge for females with 
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RHD because of additional pressure on the heart caused by greater blood volumes, there are 
measures which can be put in place to assist a woman with RHD to have a child of her own. 
Due to the real risks of pregnancy however, generally female RHD patients reported frequently 
being advised by medical professionals to not attempt pregnancy – especially in communities 
where there a minimal health resources to monitor their pregnancies (Chang et al., 2018). Most 
of the women with RHD in this study shared that they had been told by their doctor that their 
heart is not strong enough to support a pregnancy. These participants echo those from Chang 
et al. (2018) who reported that 100 percent of the Ugandan women with RHD in their study 
(n= 50) reported receiving the same information from medical practitioners. Internalising this 
real possibility – of not having children of one’s own – was deeply traumatic for many patients 
in this study, with some of them weeping in the focus groups. Chang et al. (2018) agreed that 
“society looks down on a woman who cannot have children due to a heart condition” and from 
the patients in this study’s reactions, this affects their sense of self. Additionally, RHD patients 
had negative preconceived attitudes and hopes regarding finding and maintaining employment. 
This was due to the physical limitations they have because of the disease (i.e. inability to carry 
heavy things or walk long distances). Due to their low-levels of education, the realistic 
possibility of finding employment often meant getting jobs which require manual labour (e.g. 
construction). There was a shared belief however that their physical limitations compromised 
their possibilities for obtaining such employment. For the Xhosa men who are often culturally 
expected to be breadwinners, this proved to be a difficult reality to bear. Financial reliance on 
others could result in males experiencing name-calling and negative attitudes from those in 
their family and community. This however was not the same for women. Furthermore, there 
seemed to be a public stigma experienced by some RHD patients due to the misconception that 
they have HIV/Aids based on their frequent collection of medication from the local clinics. 
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This resulted in some degree of distress for the patients and a desire to “prove” to people that 
they did not have HIV.  
 
Discrimination 
Many women in this study, voiced experiencing undesirable social moments including 
stigmatisation and emotional abuse by their partners and/or their partner’s family or the 
community because of their difficulty to fall pregnant and carry a child to full term. These 
incidents placed particular strain on marriages and relationships, especially because in African 
cultures there is the perception that a good marriage is one in which children are born (Cates 
et al., 1985). Marriage aside, single women also expressed a deep longing to have children of 
their own, some saying, “even if it is just to send them to the store to purchase small things like 
bread or milk”. Value was placed on having someone there who would be able to do those 
small tasks and be of company to the parent when needed.  
 
Overall, the internalisation of the psychosocial consequences of not being able to bear children 
have been studied broadly, and the incidents of anxiety, concern, depression and marital 
problems have been reported by scholars such as Berg and Wilson (1990), Downey and 
McKinney (1992) and Chang et al. (2018). Contrastingly, there were some women with RHD 
who had had healthy children of their own despite the advice from their doctors, which resulted 
in other women being very hopeful to also carry their own children one day. This however, 
was not the general view on this topic. Generally, it was a major concern which made decisions 
regarding marriage and child-bearing a deeply difficult topic to resolve for these participants. 
The difficulty finding employment resulted in some experiences of discrimination within the 
family and employment sector. The unfair treatment by people in these domains may be 
internalised by these participants. Some reported some discrimination in social gatherings, 
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where people related the patient taking treatment for RHD to taking ARV’s. Internalisation of 
these acts of discrimination could result in negative outcomes for the patient.  
 
Very few of these descriptions are internalised stigma experiences currently captured by the 
ISMI and would be extremely relevant in future developments of a Xhosa language version of 
a RHD internalised stigma scale.  Based on insights from the ISMI/ISRHD-X pilot data, the 
internalised stigma experiences which were commonly shared by participants in the two (RHD 
and SCZ) samples, albeit to somewhat different degrees, were that: 1. “Having … has spoiled 
my life” and 2. “People without … could not possibly understand me” ; 3. “Stereotypes about 
… apply to me” and 4. “A person with their disease would struggle to get employment”.  
 
The differences, identified through the qualitative findings, between the two samples is that 
many of the SCZ patients felt that it would be difficult for someone with the disease to find a 
partner for marriage due to the consequences of social distancing. The SCZ sample often felt 
that people would not want to associate with someone who has SCZ. Reasons given were that 
the person would decrease their ‘social status’, would be embarrassed by them because they 
would not be able to act in a socially appropriate manner. By contrast, the RHD patients thought 
that it is certainly possible to find a spouse when one has been diagnosed with the disease, on 
condition that it is someone who makes an effort to learn about the disease and thus support 
the partner with the disease. Many of these participants felt that they would gladly support 
another person with RHD, share experiences and encourage them to live a healthy lifestyle 
while maintaining their disease. With this group there were minimal accounts of social 
distancing reported due to the disease label. These important differences highlight why it would 
be important in future studies to carefully adapt internalised stigma scales to reflect stigma 
experiences unique to the disease group under investigation.  
P a g e  | 262 
 
 
 
10.5. How genetic attribution may relate to stigma 
 
Question 3: How do the genetic disease causal explanations of Xhosa people with 
schizophrenia or rheumatic heart disease relate to their internalised stigma experiences, if at 
all? 
 
The third question guiding this study was how genetic explanations of disease could relate to 
internalised stigma experiences. This question specifically takes issue with the often-repeated 
but ill-founded assumption in ethics literature on genomics research that it can lead to or 
increase stigma associated with diseases. This study found that stigmatisation related to 
genetics is complex and difficult to pinpoint, especially in the unique historical, environmental 
and cultural dynamics in South Africa. While many of the participants reported various forms 
of internalised stigma, these stigma experiences seemed to converge in a complex manner with 
the historical, cultural and environmental realities of their lives. Against a heterogenous and 
dynamic set of disease causal beliefs and stigma experiences that intersect with the realities of 
South Africa’s unequal society, genetic explanations of illness seem exceedingly unlikely to 
substantively influence internalised stigma experiences across the two disease groups.  
 
In accordance with the Attribution Theory, a genetic attribution may be considered internal, 
stable and uncontrollable. Furthermore, findings of this study suggest that blame, rejection 
and anger from external parties are not likely to be attributed to the patient when the disease 
is believed to have a genetic factor. Therefore, internal attributions present as more tolerated 
by the patients. This informs the argument by Phelan (2005; 2006) that details that disease-
related stigma and associated characteristics like blame, rejection and anger are greater if 
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the person suffering from the condition carries greater personal responsibility (Phelan, 2005; 
Phelan, 2006). Additionally, there is some evidence from this study which echoes Shostak et 
al. (2009) in suggesting that in instances of reduced personal blame and internalised stigma, 
stigma may be extended to family members where a disease is attributed to a genetic factor. 
Diallo et al. (2015) discusses this kind of genetic stigma as stigma by association – associative 
/ courtesy stigma. 
 
The lesser the external stigma towards the individual, the more tolerance the individual may 
receive from others which may result in less internalised stigma. The SCZ patients reported 
less tolerance and an anticipation of social distance from the vignette character and any 
individual who has SCZ. This was articulated mostly by individuals with SCZ, where they did 
not want to become friends or have the character marry into their family. In contrast, the RHD 
patients reported more empathy, support and tolerance for the vignette character and towards 
an individual with RHD – regardless of the cause. The RHD respondents had a completely 
opposite view, as they were willing to welcome and support another person with RHD.  
 
In keeping with the Modified Labelling Theory, one way of to better understand the possible 
relation between genetic attribution and internalised stigma, is through observing the responses 
of participants based on the disease label. Specifically, the responses in relation to the questions 
which asked participants if they anticipated changes in social distance and treatment of the 
fictional character following a diagnosis with SCZ or RHD and being told that it is caused by 
genetics. The kinds of responses of individuals who have internalised stigma are expected to 
present are secrecy and withdrawal (as suggested by Struening et al. 1989). The kinds of 
responses expected from individuals who demonstrate limited internalisation of stigma related 
to promoting health education about the disease and no social distance to the character. The 
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participants with SCZ in my study often offered responses of withdrawal and secrecy, which 
as defined in the MLT points to increased internalised stigma. Some of the participants 
acknowledged that education – about the disease and possible causes – to the general public 
may be one way to minimise external stigma and influence public perceptions in relation to 
common stereotypes, prejudice and discrimination which may influence their self-perception. 
Most of the participants with the RHD label rejected the response of secrecy and withdrawal. 
These participants affirmed the need for transparency and openness as a means of providing 
greater awareness and education about RHD in their communities. This outcome is in contrast 
to the MLT model’s proposed theory that individuals who internalise stigma would have an 
outcome of secrecy. This difference however, could be because this disease is not generally 
known as a stigmatised condition in communities. Therefore, patients with the disease may not 
be as prone to concealing their diagnosis. This however, does not necessarily mean that they 
have not internalised the stigma that they described. The suggested increased health education 
about their disease in their communities could be considered as a coping strategy to confront 
the reported prejudice, discrimination and stigma they receive due to having the disease. 
 
In relation to passing on genetic traits to children, SCZ participants who presented more 
descriptions related to internalised stigma, discussed that they would attribute blame towards 
themselves if they were to have offspring with the same disease because they fear that their 
children would be subjected to stigma in the same ways which they have been. This can be 
understood in relation to step 1 of the Modified Labelling Theory which affirms that individuals 
with internalised stigma internalise feelings of devaluation based on or in the fear of 
discrimination. Some of the RHD participants who reported having children with symptoms of 
RHD, did not seem to attribute the same feeling of self-blame and devaluation onto themselves. 
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This suggests that in this example RHD patients may not have internalised the stigma of passing 
on a potentially genetically related disease to their offspring.  
The three ways in which genetic stigmatisation is understood in the literature is through, 1. 
stigmatisation through anticipation, 2. stigmatisation through rejection and 3. stigmatisation by 
affiliation. The latter eloquently summarises the example of SCZ patients having a fear of 
having children or getting married, in the anticipation that these individuals may experience 
stigmatisation and rejection from society due to their affiliation with the patient (DiMillo et al., 
2015). This understanding of genetic stigmatisation was not shared by patients who have RHD 
in this study. The different behavioural responses mentioned above across individuals with the 
two different disease labels may provide insights on the importance of considering differences 
in diseases when suggesting claims about the possibility of intensifying stigma in genomics 
research. Additionally, when using internalised stigma scales, it is important to consider the 
nuanced differences of stigma shared by people with a physical or psychological disease. 
 
Based on the Attribution Theory, in reference to the finding of other causal explanations being 
prominent among Xhosa people with SCZ and RHD, contrastingly non-biogenetic causes (i.e. 
personal lifestyle choices) may be considered external, unstable but controllable by the 
individual, therefore more blame and stigma may be attributed to the individual. For instance, 
the examples provided in this study where some RHD participants attribute the cause of the 
disease to personal lifestyle choices they had made (i.e. unhealthy eating habits and a lack of 
exercise) may be seen as being in the individual’s control. A non-biogenetic explanation shared 
by SCZ participants is that they attributed the cause of their disease to substance abuse (i.e. 
using cannabis for an extended period of time). These decisions may also be viewed as within 
the individual’s control, unstable (as they are open to changing based on the individual) and 
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based on the external environment an individual is in and therefore may be more stigmatising 
than a genetic causal model. This however would need to be further explored in future research.  
 
Additionally, the environmental and psychological causes may also be perceived as external, 
unstable and uncontrollable. For example, participants who expressed being abused as children 
may not have had control over that situation, therefore even though they may have experienced 
external stigma, they may be living with less internalised stigma through the presence of low 
levels of self-blame or blame towards the individual. Rather, blame may be attributed to the 
immediate family members or those who afflicted the toxic environment the individual grew 
up in and may have perpetuated the psychological and physical abuse they experienced.  
 
The cultural explanation may be perceived as external, unstable and uncontrollable, also 
yielding less internalised stigma for the individual. The traditional beliefs of illness causation 
held by these participants related to bewitchment, which was reported to be a result of jealousy 
by the person bewitching them (Campbell et al., 2015). A genetic explanation may be held in 
conjunction with cultural beliefs. An example described by a participant (P.5 SCZ FGD 2) 
articulates that knowing that the disease is genetic may create anticipated stigma for not only 
the individual, but also those in their respective clan group – given the knowledge that genetic 
diseases run in families (this is with the understanding that individuals may share a clan name 
and not be biologically related or they may come from different families). In this example, 
individuals from those families may be rejected by others in the community based on the 
suspicion that there is “something in their blood” which people need to be safe guarded against. 
This may relate to the “quarantine mentality” described by Markel et al. (1992), which was 
described earlier in the thesis as a potential reason for stigma in relation to genetics because of 
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society trying to keep the general population “pure” from mixing with people falling in a 
stigmatised group.  
 
The lack of emphasis on a genetic attribution evident in this study could be due to the fact that 
a genetic explanation of disease causation’s influence on stigma may have been over-estimated 
(Racine et al., 2010; Appelbaum, 2017). This study therefore, in accordance with other studies 
(Lebowitz, Pyun, & Ahn, 2014; Lebowitz & Ahn, 2014) found difficulty in separating the 
genetic and nongenetic causes of disease and their possible influence on stigma.   
 
The main finding of the study is that Xhosa people with SCZ and RHD presented a multitude 
of factors that may have influenced their disease onset independently or concurrently. In 
agreement with Spiro (1991), who reports that a person can simultaneously be described as 
having SCZ (a label coined following biomedicine as a discipline), be bewitched according to 
African cultural models and be possessed by evil spirits according to religious structures (i.e. 
the church for Christians). This example is fitting for many patients in this study, as most, if 
not all, of them are aware of the biomedical term for their diagnosis but still hold other 
explanations for their illness simultaneously (i.e. “being bewitched”). Even though they have 
been exposed to genetic explanations – through the genomics studies they have been involved 
in – this exposure may not have been sufficient to completely shift their perceptions to those 
feared through deterministic thinking. As Weiner (1986) documented, it is possible to hold 
more than one causal belief for developing a disease and the factors which make an individual 
susceptible to developing a disease may vary across different individuals. It is also certainly 
possible that causal beliefs vary even within a single individual at different times.   
 
10.6. Conclusion 
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This thesis explored the causal models held by Xhosa people with SCZ and RHD. Through 
employing mixed-methods, the study focussed on gaining an understanding of the possible 
relation between genetic attribution and internalised stigma in these disease groups. Through a 
qualitative approach, the study used focus group discussions (FGDs) to explore first, the causal 
models held by Xhosa people with RHD and SCZ. Their responses were sought through 
presenting the participants with vignettes which focussed on a genetic, a combination of genetic 
and non-genetic, as well as non-genetic explanations and then noting their shared perceptions 
of their beliefs about these causes. These findings suggest that the SCZ and RHD participants 
attributed their disease causation to a multitude of explanations – some which were not 
presented in the vignettes, such as cultural causes – with minor reference to genetics. Other 
causal explanations, including psychosocial and cultural explanations, were more important 
explanatory models for these population groups. The second question of the study aimed to 
gain an understanding of the internalised stigma experiences of Xhosa patients with SCZ and 
RHD. In addition to probing responses to stigma encounters in the FGDs, the study also sought 
to quantify internalised stigma experiences within the two disease groups using a Xhosa 
translation of the Internalised Stigma of Mental illness scale (ISMI) (Ritcher et al., 2003). The 
study applied a five-stage translation design in order to adapt and translate the measure. 
Psychometric investigations demonstrated important limitations with the resultant translations 
which illustrated the challenges of exploring the construct of internalised stigma in African 
languages like Xhosa, and the uniqueness of internalised stigma experiences within different 
disease groups like SCZ and RHD.  
 
To answer the third research question as to whether and how a genetic attribution may relate 
to internalised stigma, despite the emphasis placed on a genetic causal attribution during focus 
group discussions, the lack of emphasis by participants on attribution when discussing stigma 
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experiences suggests genetic attribution may not have a strong influence on internalised stigma 
for these population groups. Findings from this research are valuable in that they reveal that it 
is critical for both researchers and clinicians to understand the explanatory models of disease 
held by patients as having a plausible influence on their beliefs on treatments that are acceptable 
to them. Additionally, an awareness of the different explanatory models also creates an 
opportunity for researchers or clinicians to negotiate the biomedical explanation for the specific 
disease, while simultaneously creating a common ground between the patient and researcher. 
As was found in previous studies (Naanyu, 2009) participants in this study did not emphasise 
solely a biomedical explanation (i.e. genetic attribution) to their disease onset. From this 
investigation, three things are apparent. Firstly, even though genetics are mentioned as a 
possible causal explanation, there is no evidence in this study to suggest that a greater emphasis 
on genetics in disease causation – which could be an outcome of genomics research – would 
likely play any role in increasing or decreasing stigma in this population group. This is a 
crucially important finding, not only because the concern that genomics could increase stigma 
is routinely made in discussions about the ethics of such research, but also because this was the 
first study purposively designed to explore this hypothesis on the African continent. Secondly, 
even though there were reported accounts of stigmatisation, these perceptions were reported as 
stigma relating to the disease label itself, rather than the belief of a genetic causation. This 
suggests that social realities, shared patterns of belief and attribution of disease to causal 
explanations play a collective role in people’s experiences of stigma.  
 
Moreover, it is critical to keep in mind that biomedicine is recognised as a cultural product 
developed in a Eurocentric context. For this reason, the use of the biomedical approach in 
relation to health in a non-Western context needs to be approached with sensitivity and a cross-
cultural difference awareness. Specifically, research has shown that work focusing on Africans 
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in particular, requires cognisance of African cultural beliefs. Thus, African cultural approaches 
have been described and discussed in this thesis and it is necessary to consider the differences 
between the explanatory models held by African people in the larger discussion of genetic 
attribution to disease. Culture and context play intrinsic roles in how people understand disease 
and therefore, cannot be disregarded when conducting genomics research.  
 
Furthermore, in the African context, historical discourses such as colonisation led to ideas and 
decisions made in the Western world being imposed on Africa. Based on experiences such as 
those and their influence on people’s perceptions, it is therefore necessary for biomedical and 
genomics researchers to consider both the political and historical underpinnings of the health 
system available for different individuals in African countries. For instance, exceedingly high 
levels of poverty in many African countries have resulted in substandard health care which 
could subsequently persuade individuals to enrol in genomics research (for monetary and 
special health care benefits). However, the question remains whether these individuals believe 
in the biomedical explanatory causal model. Building on other evidence in the literature, this 
study reveals that Xhosa people with SCZ and those with RHD, maintain complex explanatory 
models for their disease. In this regard, genetics prove to be one of multiple explanations that 
they hold.  
 
The distinct decision to place less emphasis on genetics as a concern for stigma amongst the 
population groups suggests that this causal explanation (in isolation) is not as pertinent for the 
Xhosa people in this study as is speculated in other populations. Moreover given the mixed 
evidence found in studies with other populations, it appears that the relation between genetic 
attribution and stigma may not be consistent across different population groups. In this study,  
a strictly biogenetic view of SCZ and RHD is not commonly supported by the Xhosa people 
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with SCZ and RHD in this study, therefore the concerns often raised in relation to this view are 
not evident to hold true for these participants. In fact, the aforementioned alternative causal 
explanatory models, including psychosocial and cultural views are more commonly held by 
individuals in these disease groups and therefore, need to be considered in African genomics 
research. This is important because these causal explanatory models were often held 
concurrently. Essentially, participants drew from a combination of genetic, psychosocial and 
cultural causal explanations. Hence, these models may potentially hold their own implications 
about the experiences of stigma for people with these diseases.  
 
10.7. Strengths and Limitations 
 
A major limitation of this study is that it is a cross-sectional study which does not use a pre and 
post intervention design, meaning it can not report on causality. The accounts of participants 
which are presented in this study are also not enough to make a conclusion on genetic 
attribution and stigma. Instead, these accounts provide us with a deeper understanding as to 
why, for these patients, genetic attribution may not directly influence their stigma. Although 
this thesis presents the views expressed by participants, it is acknowledged that due to its small 
sample, the views expressed do not capture the entire scope of patients’ beliefs of genetics 
(alongside other disease models) and the possible implications for stigma. Other limitations 
and strengths of the study are presented below.  
 
10.7.1. Bilingual researcher 
Being a bilingual, mother-tongue isiXhosa researcher with a master’s level English language 
educational background, it was easy to build rapport, to engage and to understand participants 
enrolled in this study. Although the research was conducted in the participants’ home language, 
some of the concepts explored (such as genetics) proved to be challenging to explain or engage 
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in discussions. Previous studies have documented challenges relating to the complexity of 
biomedical terminology (Tindana, Bull, Amenga-Etego & de Vries, 2012; Marshall et al., 2014 
& Marsh, Kamuya, Mlama, Williams & Molyneux, 2010). This is also emphasised in South 
African mental health literature (Campbell et al., 2015; Drennan et al. 1991; Steele & Edwards, 
2008; Swartz, 1998). Even though the study was conducted in isiXhosa, some of the 
participants would use English words for key terms like genetics or DNA during discussions, 
with occasional inconsistencies in how certain English words were interpreted in relation to 
their actual definition. An important challenge that this study grappled with was finding 
linguistically and conceptually equivalent terminology, particularly for the internalised stigma 
scale selected for use in this study. A real asset of this study is that it was conducted by a 
researcher fluent both in English and Xhosa, and with a conceptual understanding of the 
scientific nature underpinning the concepts under investigation. 
  
In terms of language, within the translation process of the ISMI tool, the translation of FGD 
vignettes (from English to isiXhosa) and the translation of the FGDs conducted in isiXhosa to 
English for analysis, it was found that there is often no single correct translation for every word 
(Muller, 1994). An example of this can be seen with the ISMI scale, where words were 
proposed by the translation team, debated and utilised, with some patients unable to grasp these 
concepts and the resultant low endorsements of items in the scales. This in itself suggests that 
amidst significant efforts to ensure the most accurate translations, there is a possibility of 
mistranslation in the final version of the tool, which is one of the reasons we decided not to use 
these tools in the FGDs. Fundamentally, the difficulties of finding appropriate terminology in 
the Xhosa language is well documented in the literature (see Drennan et al., 1991; Muller, 
1994; Steele & Edwards, 2008; Steele, 1997; Swartz, 1998). Thus, the study acknowledges this 
P a g e  | 273 
 
 
limitation of the newly translated isiXhosa tools, in terms of capturing the equivalent constructs 
as the original tool.  
 
10.7.2. Culture 
Despite the commonly known power-dynamics of the research process in this study, mutual 
and shared cultural backgrounds between the researcher and participants allowed for easy 
synchronisation and building of rapport. In this regard, adhering to cultural norms created a 
foundation of trust based on the assumption that most Xhosa people are deeply rooted in a 
cultural knowledge system. In this instance, gestures such as greetings, introductions and 
through patients sharing their clan names with which I was familiar, made it easier to create a 
sense of comfort and to establish rapport before and during the sometimes deeply personal 
dialogues shared during the research process. In essence, this study also reiterates the 
importance of having a researcher who understands not only the language, but also the culture 
of the target population.  
 
10.7.3. Sample 
A notable limitation of the study was the highly limited and greatly skewed sample population. 
For instance, the SCZ sample largely comprised of young males (94.44%, with an average age 
of 33years). Although this is representative of the sex difference in the larger SAX study, the 
resultant data may not adequately represent the views of older Xhosa people, as well as Xhosa 
women with SCZ. Similarly, the RHD sample (in accordance with the larger RHDGen study) 
consisted of mostly older females (84.78% with an average age of 43 years) and therefore, 
these views might not necessarily represent those of younger people and Xhosa males with 
RHD. The sex differences are a major limitation of this research and as a result any 
comparisons between the two samples should be made with caution.  
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10.7.4. Recruitment  
For both population groups, although I gained access to an extensive existing database with 
contact details of RHD and SCZ patients who had previously consented to being contacted for 
future studies, I still encountered significant challenges to accessing potential study 
participants. Multiple efforts were made to contact the participants enrolled in the study. 
Despite these efforts, the study still concluded with a smaller sample than I had aimed for.  
 
However, the fact that this specific study falls under two then ongoing genomics studies with 
available databases also contributed to its strength. In this regard, having access and being able 
to contact patients who had been previously enrolled in these genomic studies made it easier to 
expand on the foundation they had previously received, and in some instances the 
psychoeducation on genomics they had received. Consequently, this created a sense of 
openness from the participants to enrol in this study, simultaneously creating ease of discussion 
and reference.  
 
10.7.5. Focus groups  
Low levels of literacy amongst participants accounted for the fact that most of these individuals 
needed assistance from the researcher or the co-facilitator of the FGDs to complete the consent 
and demographic information forms. This resulted in a prolonged document completion time-
frame during the sessions. Additional assistance from the researcher was required based on 
literacy challenges faced by participants despite the fact that these documents were translated 
into isiXhosa for convenience. Consequently, this resulted in very long FGDs which may have 
led to participants being fatigued towards the end, thus influencing their responses. Fatigue 
may specifically have affected SCZ participants, who often had a shorter concentration span. 
This limitation may have affected the richness of the data yielded in the FGDs.  
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A mélange of factors such as differences in background, geographic location, households, as 
well as different coping mechanisms to living with their disease, posed various challenges on 
facilitating and managing the FGDs. Occasionally, participants were unaware of the behavioral 
skills required when participating in a group discussion (for example, participants did not 
understand why it was necessary to wait for their speaking turn instead of interrupting the other 
person). This often made hearing their responses and understanding the sequence of discussion 
in the group a somewhat difficult task (e.g. for the researcher when listening to the voice 
recordings and during transcription). Also, the tendency of some participants to interrupt and 
speak over others, sometimes discouraged others to respond to questions, thus resulting in 
numerous questions being answered either in agreement with the dominant speakers in the 
group, or individuals opted not to respond to the questions already extensively answered by 
others. Which may be a limitation to the voices and views expressed in the FGDs. 
 
Even though identifying, recruiting and involving Xhosa people living with SCZ in group 
discussions was not an easy process, essentially the uniqueness of this research resides in its 
ability to document patients communicating their experiences in their own voice and presenting 
them with the opportunity to be heard. Notably, most of the research interrogating the relation 
between stigma and genetic attribution in a mental illness has focused on the views of the 
general public or people caring for people living with the mental illness; this study is an 
exception to that trend. Participants in this study had also completed the UBACC scale (through 
the larger SAX study) investigating ability to consent to research, which meant that their 
responses were based on a basic understanding of genomics research and the research process. 
Additionally, many of the participants reported the research experience to be enriching as it 
was the first time some of them were presented with a space to meet, share and engage with 
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other individuals from similar backgrounds living with the same disease. They articulated that 
this fostered a feeling of “I am not alone in this”.  
 
10.7.6. Internalised stigma scale 
This study provided important evidence about the limited transportability of the ISMI to a 
South African SCZ and RHD Xhosa language speaking group. Despite a comprehensive 
translation design, psychometric properties showed very real limitations with the resultant 
tools. Further adaptations and psychometric testing is necessary to strengthen the usefulness of 
the scale for the two disease groups. More specifically, in future work, qualitative data on 
aspects relevant to RHD stigma would need to be included in an internalised stigma scale for 
people with RHD. We had hoped to use the ISMI and ISRHD-X scale data to determine if there 
is statistically significant differences in the two disease groups – however because of the 
limitations of the tools – this was not possible. Importantly, our qualitative data suggests that 
many of the important internalised stigma experiences unique to these two disease groups were 
not captured by the ISMI. Even though there are some overlaps with certain experiences of 
stigma across the two disease groups, there are also stark differences. These are identifiable in 
the rates of item endorsements presented in chapter 9 of this thesis. The endorsement rates 
provide valuable insights going forward in terms of which items should be considered and 
which should possibly not be considered when developing an internalised stigma scale for these 
disease groups. Important adaptation involving a thorough qualitative process,  needs to be 
done when preparing these types of scales for use in African languages and different disease 
groups.  
 
10.8. Recommendations 
 
The findings lend themselves to several recommendations. The findings of this study add to 
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African genomics literature and provide empirical evidence about what people of an African 
population group understand about genetics. Given the increase in genomics studies being 
conducted in the continent, and the challenges of engaging with African populations about 
genomics research (Tindana et al., 2012; Marsh et al., 2010; Marshall et al., 2014 & Masiye, 
2015) knowledge of what African people know and believe about genetics and disease is 
valuable for researchers designing genomic studies for African population groups. A second 
recommendation is that clinicians, genomic researchers, scientists and professionals working 
with or treating patients with RHD and those with SCZ, should be aware of the diverse and 
complex causal models that patients hold about their disease. This is important because it 
affects how, when and why they choose to take and adhere to Western medicine provided in 
local health facilities. In this case, decisions around treatment are important because they 
affect the recovery process of the patient, their lives in general and it also has implications for 
their families, communities and societies at large. Considering the South African context, and 
more so, other countries in Africa that are grossly under-resourced (e.g. availability of 
medication and poor infrastructure) and the limited capacity of health staff (i.e. doctors, 
nurses, psychiatrists and psychologists) in these facilities, it is important to ensure that when 
the opportunity arises, patients are engaged with in a sensitive manner. Furthermore, 
dialogues around diagnosis, cause of disease, prognosis and recovery should be considerate 
of patients’ cultural beliefs. This can be achieved by proposing and enrolling health staff in 
training programs which foster education in different cultural belief systems and how they 
understand and relate to the biomedical approach to disease (e.g. short courses, workshops, 
seminars, or conferences). Moreover, there is a clear need to think deeply about how to create 
improved accessibility for individuals who speak African languages to participate fully in 
health research. 
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Thirdly, this research has clearly indicated that ethics discussions that revolve around the risk 
of stigma arising as a consequence of genomics research, need to be more nuanced and take 
into consideration the complexity of this possible relation. Where stigma is raised as a concern 
in genomics research, this risk is often presented in linear terms: if you speak about diseases in 
terms of genetic attribution, then this increases the stigma associated with those conditions. 
This research – which presents the first purposively conducted study exploring this relation on 
the African continent – does not provide evidence of this linear relation. Going forward, where 
claims of stigma are made in the context of genomics, scholars need to be more specific about 
the circumstances in which this risk could be likely to affect African people.  
 
Fourthly, considering the translation and adaptation of the Internalised stigma scale process 
employed in this study, there are important insights to be considered in future research. The 
most obvious being that it seems more valuable to develop measures guided by qualitative data 
regarding real and relevant experiences within local communities. The richness of the data 
revealed in this study is evidence that there is much to be gained by conducting small-scale 
studies with individuals living with the particular disease of interest. And considering the push 
for biomedicine to use dominant biomedical instruments which have proven to be useful in 
Eurocentric contexts, these measures need to be applied sensitively in African contexts - with 
researchers having some knowledge of the context and cultural background of African 
populations. Insights gained from this study’s attempt to translate a measure developed in a 
Eurocentric context and to apply the measure to local populations has highlighted that there a 
real limitations which come with this process. In future, it is therefore important for researchers 
to weigh up the extensive costs of this traditional translation process and the limitations which 
the resultant scales may have and make a decision based on that whether it is a worthy process 
to follow.  
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Fifth and lastly, in relation to theory, it is critical for researchers to develop theories which 
consider the African paradigm and cultural belief models.  This means that cultural components 
such as beliefs around bewitchment and supernatural causes and idioms commonly used in the 
target language should be considered in attribution theories employed in future studies among 
African population groups. In essence, knowledge, awareness and consideration of these 
elements needs to be reflected in debates around the ethical aspects of African genomics 
research.  
 
In conclusion, empirical studies investigating the possible relation between genetic attribution 
on disease stigma are only beginning to be extended to the African context. To the best of our 
knowledge, there are very few published studies focusing on exploring stigma in relation to 
genomics in Africa. This study has therefore made a valuable contribution to the literature 
which explores this question among people in the African continent. The notion that genetic 
attribution could cause or increase stigma is simplistic and needs to be understood in the context 
of the nuanced and complex disease models used by African participants. As found in this 
study, these attribution models may be influenced by culture, personal and family history, 
social and economic reasons.  The referred to attribution models may in turn also have 
implications on experiences of internalised stigma and these complexities ought to be 
considered. 
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 Appendix C: Information sheet for focus group discussions with RHD/SCZ patients 
‘SAX/RHD’ to be replaced by the specific disease name relevant to the group of participants in each FGD. 
 
Title of the Study: Stigma in African genomics research on Schizophrenia and Rheumatic Heart Disease 
 
Introduction and summary 
We are researchers from the University of Cape Town and would like to speak with you about rheumatic heart 
disease/schizophrenia and how it affects your life. We are mostly interested in knowing whether having this 
disease causes you to feel like there is a stigma on you – that is, whether it makes other people look at you in a 
negative way. We would also like to talk with you about genetic research: what you understand about it, and if it 
could change stigma relating to your disease. We are asking you to take part in a group discussion on these topics. 
The other people  in the  group are patients with the same disease as you have. We will also ask you to answer 
some questions on paper. All the discussions will take place in Xhosa. We will take about two hours for the 
discussion. 
 
Intshayelelo nesishwankathelo 
Singabaphandi abaphuma kwiYDyunivesiti yase Kapa yaye sinqwenela ukuthetha nani malunga nesifo sentliziyo 
esondeleyo nesifo sokuphazamiseka kwengqondo needlela ezibuchaphazela ngayo ubomi benu. Sinomdla wokwazi 
ukuba ingaba xa unezizifo uziva unechaphaza elibi na okanye kwenza uluntu lukujonge ngokungamnkelekiyo. 
Sifuna kwakhona ukuthetha nani ngophando lofuzo, ukuba nazi ntonina ngalo yaye lungakutshintsha na 
ukujongwa komntu kakubi xa enesifo esithile. Sicela ukuba nithabathe kwingxoxo apho kuqwalaselwa ezi zihloko 
zibandakanywe ngasentla. Abanye abantu kulamaqela banazo nabo ezi zigulo njengani. Siyakunicela kwakho 
ukuba niphendule imibuzo ebhaliweyo. Zonke ezi ngxoxo zizakwenziwa ngesiXhosa yaye kuyakusithabatha 
ubuncinane iiyure ezimbini. 
 
Objective 
We hope to use the findings of this study to understand better if genetic research could influence the stigma 
relating to rheumatic heart disease schizophrenia. With stigma we mean whether your disease makes people look 
at you or treat you in a negative way. With genetic research, we talk about the kind of research that looks at the 
genetic material. Genetic material is like the building blocks of your body, and it is what makes people in families 
look like each other. Sometimes, genetic material is involved in the development of diseases. We want to discuss 
with you whether you think you would see your disease differently if you knew the cause was genetic. 
 
Injongo 
Sinethamba lokusebenzisa ziphumo zolu phando ukuqwalasela ukuba iziphumo zophando ngokuzalana azingebi 
nampembelelo na kwichabhaza elibekwa kwabo banophazamiseko lwengqondo. Ngechaphaza sithetha ukuba 
isigulo sakho asingebi senza abantu bakujonge ngeliso lokukweya kusini na. Ngophando lokuzalana sithetha 
sithetha ngesakhiwo sozalwano esithi senze umzimba lo wakho ufane nabakuni. Ngamanye amaxesha olufuzo 
luthilubene nxaxheba ekwenzekeni kwezifo emizimbeni yethu. Sifuna ukuqonda ukuba xa unokuyazi ukuba isigulo 
sakho senziwe lufuzo, ungasithatha ngendlela eyahlulaleyo kusinina. 
 
The Researchers 
This project is led by Drs. Jantina de Vries and Megan Campbell at the University of Cape Town (UCT). They work 
with other researchers at UCT and in the United States. 
 Abaphandi 
Oluphando lukhokelwe ngoogqirha uJantina de Vries no Megan Campbell beYunivesiti yaseKapa. Basebenza 
nabanye abaphandi kwiYunivesiti yaseKapa kwakunye nabase USA. 
 
Participants 
We will conduct this study with patients who have either schizophrenia or rheumatic heart disease (RHD). We 
hope to speak with 70 patients with RHD and 70 with schizophrenia. We contacted you because you also 
participated in the RHDGen/Schizophrenia genomics project. We would also like to interview 30 family members 
of patients who participated in the group discussions. 
 
Abathathi nxaxheba: 
Olu phando sizakulenza kubantu abanesifo esondeleyo sentliziyo kwanabo abanophazamiseko lwengqondo. 
Sinethemba lokuthetha nabantu abakumyinge wamashumi asixhenxe kwisigulo ngasinye. Sinichonge nina kuba 
benithabathe inxaxheba kuphando lwethu olungaphambili. Sizakucela kwakhona ukuba nodliwano ndlebe 
namalungu entsappho ezigulane ezithabatha inxaxheba kwezingxoxo abangamashumi amathathu. 
 
Methods 
If you agree to participate, you will be part of a group discussion with other patients that have the same 
disease as you do. The group will be small, about 6-10 people. The group discussion will consist of four components: 
Ukuba uyavuma uthabatha inxaxheba koluphando, sizakuthetha nawe kwakunye nabanye abantu abaso esisifo 
sakho (6-10 yabantu) kwinxoxo ngaxeshanye. Ezinxoxo zizakohlulwa kube kane: 
 
1. We will first ask you to answer some questions on paper. This will include questions about your disease experiences 
and whether you feel any stigma or discrimination because of your disease. 
Sizakubuza imibuzo esephepheni. Le mibuzo izakuthetha ngesifo sakho kunye namava akho okuphila nesisifo, 
kwaye izakubuza ngesenyeliso othe wasifumana ngenxa yokuphila nesisifo. 
 
2. We will then have a short group discussion about rheumatic heart disease/ schizophrenia and what you know 
about genetics. 
Sizakuthetha nabanye abantu abanaso esisifo unaso (RHD/SCZ) malunga no fuzo. 
 
3. We will then tell you a story about a patient with your disease, and what the doctor tells him about how he got 
it. 
Sizakukubalisela ibali lomntu onesisifo nawe unaso, kwaye ugqhira uzakumchazela lomntu ngezizatho zesifo sakhe. 
 
4. We will then conclude with a last group discussion where we talk about that story, and whether the story would 
change any of the stigma you may experience with your disease. 
Sizakugqibezela ngokuthetha malunga nebali eliye lavezwa koluphando, kwaye sibuze imibizo yokuba isenyeliso 
singatshintsha njani xa abantu besiva amava womntu onesisifo. 
 
Risks and benefits 
There are some risks relating to taking part in this study. Most of all, you could find it upsetting to talk about your 
disease and any stigma you feel. We will talk with you about how you feel after the group discussion, to make 
sure you are not upset. If you would like to talk to us after you’ve left, then you can call us on 021 650 5716 and 
we will make sure to put you in touch with people who can help. One of the members of our research team is a 
counselling psychologist. She will be able to counsel you about any negative aspects relating to your study 
participation. She can also direct you to people who can help longer-term. The benefit of this study is that it 
will help us understand whether genetic research can decrease stigma for rheumatic heart 
disease/schizophrenia. With the findings, we will be able to do better genetic research in the future. It may also 
be a benefit for you to be in a group of people who have the same disease as you do, to talk about how the disease 
makes you feel. 
 
Imingcipheko nobungozi  
Ikhona imingcipheko ethi inxulumane nokuthabatha inxaxheba kwesi sifundo. Abanye benu bangazifumana 
bekhathazekile ngokuthetha ngesifo sakho kwakunye nechaphaza othi uzive unalo. Kodwa ke siyakuthi sincokole 
malunga nendlela eniziva ngayo emva kwengxoxo mpikiswano ukuqinisekisa ukuba anikhathazekanga. Kwaye 
ukuba unqwenela ukuthetha nathi emva kokuba nimkile ningasitsalela umnxeba kule nombolo: 021 6505716 
kwaye siyakuthi siqinisekise ukuba sinidibanisa nabantu abayakuthi banincede. Esi sifundo siyakuthi sisincede 
ukuba sazi ukuba ingaba izifundo ngofuzo zingalicutha na ichaphaza okanye ibala ngesifo sentliziyo esondeleyo 
okanye isifo sengqondo. Ngeziphumo ke siyakukwazi ukuba sense izifundo ezingcono zofuzo kwilixa elizayo. Kwaye 
zinganalo negalelo xa umntu ekwiqumru lengxoxo mpikiswano nabantu abanesifo esifanayo nesakho xa nithetha 
ngendlela isifo esinenza nizive ngayo. 
 
Privacy 
We will record and write down the group discussion. At the start of the interview, we would like to get some 
information about you – including your name – but we will not share your name with anybody. When we write 
the discussion down it will not have your name on it. We will share the writings between all the researchers 
on the project. When we report on our research, we may use some of the sentences that you said. If we use one 
of your sentences, it will appear together with a brief description of you (for instance, ‘RHD/Schizophrenia 
patient’), and a code for the discussion (for instance, Focus Group 06). However, it is important to remember 
that the discussion will take place in a group. We will ask everybody in the group to keep the discussion 
confidential, but it is possible that somebody could talk to others about it. If you want, you can use another 
name for yourself during the discussion, so that nobody in the group will know your real name. It is up to you if 
you want to do that. 
 
Imfihlo  
Sizoshicilela, sibhale phantsi ingxoxo zeqela. Ekuqaleni kovavanyo, sizakucela ukufumana iincukacha ngawe, kunye 
negama lakho – kodwa igama lakho alizukwaziswa kumntu wonke. Igama lakho alizubonakaliswa kwingxixo 
esiyibhalileyo. Ingxelo ebhaliweyo izakwaziswa kubo bonke abaphandi bophulo. Xa sisenza inkcazelo ngophando, 
sisenokuzisebenzisa ezinye izivakalisi ozithethileyo. Apho sisebenzise esinye isivakalisi sakho, sizakubonakala kunye 
nengcaciso emfutshane yakho (umzekelo, `RHD/Schizophrenia) kunye ne nombolo yengxoxo (umzekelo iqela 
elikethekileyo 06). Yonke ingcombolo nenkcukacha efumaneka koluphando nemalunganawe iyakuba yimfihlo, 
kodwa kungenzeka ukuba omnye umntu oyewathatha inxaxheba koluphando athethe nabanye malungo 
noluphando. Ukuba uyathanda ungasebenzisa elinye igama xa uthatha inxaxheba koluphando. Oko Kkkuwe. 
 
Withdrawal 
You do not have to answer all the questions during the group discussion. For instance, if we ask a question 
and it makes you feel uncomfortable, you can just tell us. Also, you can decide to leave the discussion at any 
time. 
 
Ukurhoxa  
Awunyanzelekanga uphendule yonke imibuzo ngexesha lengxoxo yeqela. Umzekelo, uba sibuza umbuzo ube 
ukwenza uzive ungakhululekanga, angasixelela. Kwakhona, ungasithatha isigqibo uyishiye ingxoxo nangaliphi na 
ixesha. 
 
Compensation 
We would like to thank you for the time that you took to be part of our study. We will pay for the cost of your 
transport (R50) and give you a small voucher (R75) for your mobile phone. 
 
Imbuyekezo  
Sizakucela ukukubulela ngexesha olichithileyo waba nathi kwimfundo yethu. Sizakukuhlawula ngendleko 
ozihlawulileyo kwezothutho (R100) 
 
Contact Information 
If you have any questions or comments about this project, or if you want to speak more about the project, 
you can contact Olivia Matshabane on 084 293 6376. If you prefer, you can also send an email: 
olivia.matshabane@uct.ac.za@uct.ac.za. 
 
Inkcukacha zonxibelelwano  
Ukuba ngaba unemibuzo okanye ufuna ukuphawula ngoluphulo, okanye ukongeza malunga noluphulo, 
ungasitsalela ucingo kulomxeba 021 650 5716 (utsalele uJantina de Vries). Ungaphinde utsalele umxeba uOlivia 
Matshabane ku 084 293 6376 okanye ungasithumelelela i-email: olivia.matshabane@uct.ac.za. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Appendix D: Consent Form 
 
Title of the Study: Stigma in African genomics research on Schizophrenia 
and Rheumatic Heart Disease 
Informed Consent 
Key points to remember of this study: 
Imba ebalulekileyo ukuba uyikhumbule: 
 We are doing a project to explore whether genetic knowledge would change the stigma 
relating to schizophrenia (SCZ) and rheumatic heart disease (RHD) 
Senza Uphando lokuqondisisa ukuba ingaba ulwazi lwezinto zemfuzo lungazitshintsha njani 
na isenyeliso esinxulumene nokuphazamiseka engqondweni kunye nesifo esondelelo 
sentliziyo. 
 
 We will speak to RHD and SCZ patients about their experiences of stigma. 
Sizakuthetha nabantu abaphila nesigulo sokuphazamiseka engqondweni kunye nabantu 
abaphila nesifo sentliziyo malunga na mava abo esinyeliso esinyeliso esinxulumene 
nokuphazamiseka engqondweni.  
 
 You don’t have to give us your real name if you would prefer for us not to know it. 
Awunyanzelekanga ukuba usinike igama lakho ukuba awunqweneli silazi.  
 
 We would like to record the conversation. This is for us to keep good track of what was 
discussed. We will not tell anyone your name or let it be known it was you who participated. 
Singathanda ukuyishicilela incoko yethu. Lonto iyakukusinceda ukuqinisekisa ukuba konke 
okuthethiweyo kuselugcinweni. Siyagqinisekisa ukuba asiyikwazisa mntu ngegama lakho 
okanye ukuba ubukhe wathabatha inxaxheba koluphando.  
Please remember that your participation is voluntary, and there are no consequences if you do not 
want to participate. You can withdraw in the future if you want. Please contact Dr Jantina de Vries 
or Olivia Matshabane if you no longer want to participate, or if you would like to discuss any of the 
issues that came up when we spoke with you. 
Sicela ukhumbule ukuba inxaxheba yakho yintando yakho, kwaye akukho sinyanzeliso ukuba 
awunamnqweno wokuthabatha nxaxheba. Ungayeka na nini na xa uthanda. Sicela unxibelelane no 
Gqirha uJantina de Vries okanye uOlivia Matshabane, ukuba awusenamdla wokubayinxalenye 
yoluphando, okanye ukuba ufuna ukuncokola nangantoni na esithe sathetha ngayo koluphando.  
 
Consent Statement: 
 I agree to participate in the Stigma in Genomics research project; 
Ndiyavuma ukuthabatha inxaxheba kuphando lwezenyeliso zemfuzo. 
 
 I understand that my participation is voluntary and that I can withdraw at any moment; 
Ndiyayiqonda into yokuba inxaxheba yam kwesisifundo ayisosinyanzelo kwaye 
ndivumelekile ukuyeka xa ndithe ndathanda njalo. 
 
 I understand that I am participating in research, and that I will not benefit from this; except 
by receiving compensation for my travelling to the amount of R100. 
Ndiyayiqonda into yokuba ngokuthabatha inxaxheba koluphando akukho nzuzo endiya 
kuyifumana ngaphandle kwe mali engage R100 yokukhwela. 
 
 I have been given the opportunity to ask questions and these have been answered. 
Ndinikiwe ithuba lokubuza imibuzo, kwaye yaphenduleka. 
 
Participant name or pseudonym/Igama lomthathi nxaxheba__________________________________       
Participant Signature/ Umtyikityo________________________________________________________ 
Date/ Umhla________________________________________________________________________ 
 
Name of person taking consent/ Igama lomntu othabatha isivumelwano__________________________                      
Signature/ Utyikityo____________________________________________________________________                                  
Date/ Umhla_________________________________________________________________________ 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix E: Demographic Data Collection Sheet for FGDs  
 
 
Participant name or pseudonym/ Igama okanye igama lamaxoki: 
 
Age/ 
Iminyaka 
 
 
Sex/ Isini 
 Under 18 
 18-25 years 
 25-35 years 
 Over 35 years 
 
 Male 
 Female 
 
Highest level of education/ 
Ibanga lemfundo eliphezulu 
 No formal education 
 Grades 1-7 
 Grades 8-10 
 Grades 11-12 
 More than Grade 12 
Employment/ 
Ukuphangela 
 
 
Average income/ 
Umvuzo 
 Unemployed 
 Employed fulltime 
 Employed part-time 
 
 Less than R500 per week 
 R500-R1000 per week 
 R1000-R2000 per week 
 More than R2000 per week 
 
Government disability grant/ 
Uyasifumana isibonelelo sika 
rhulumente 
 Yes 
 No 
This section to be completed by Research Staff prior to distributing this form to participants 
FGD Number: 
Disease group (SCZ or RHD): 
 How old were you when your condition was first diagnosed? 
Wawuna ngaphi nokufumanisa kwakho ukuba unesisifo? 
 
Under 18 
 18-25 years 
 25-35 years 
 Over 35 years 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Appendix F: FGD Process 
Step Activity Approximat
e time (min) 
1 People enter the room and sit down 
 
2 Thank people for being there. Explain the study, ask if everything is clear 
and if everyone is happy. 
10 min 
3 Explain need for written informed consent and distribute signature 
pages; get informed consent 
15 min 
4 Administer the short questionnaire with demographic data 5-10 min 
5 Explain (repeat) what will happen next with regards to the video which 
will be watched and the discussion to follow in between  
  5 min 
6 Short debrief – is everybody ok? 5 min 
7 Start the FGD and its duration 60 min 
8 At the end, ask if there are any questions. Contain and debrief the group. 
Repeat/explain that the vignette is made-up and that the disease is 
caused by mixed genetic and environmental factors. 
 
 
30 min 
9 Thanks and small reimbursem nt for travel money 5 min 
 
 
 
 
 
 
 
 
 
 
 
 
 Appendix G: FGD topic guide and vignette RHD patients 
 
NOTES: The scenarios in these topic guides were translated to isiXhosa and then developed 
into short videos by a professional film maker. These videos were screened during the FGDs.  
 
Start FGD 
 Scope general understanding of genetics 
 You have all been involved in a genetics/genomics research project – can you tell us a little 
bit about what genetics/genomics is? Do you remember what the nurse told you? 
 First explore whether interviewees have any conception of genetics. 
 Then explain what this is, mentioning family inheritance, family members sharing physical and 
disease traits. Useful phrases are ‘things that run in the family’, things that are in the blood’, and 
also explanations about how particular features (e.g. shape of the face or the body) are often 
shared between family members – e.g. you can look like your mum or your dad. Also, diseases 
move in families in that same way. 
 
Vignette (turned into short video, with questions appearing on the screen)  
Story stage 1 
Andile is 26 years old and lives with his mother in an RDP house in Langa. He is unemployed 
and gets a government disability grant each month to support them. Andile has rheumatic 
heart disease or what is also called valve disease, and first became ill four years ago. He then 
became very tired and was often short of breath. He also went to the hospital many times 
for simple things that other people would not get very ill of, like flu. His mother found this 
very strange and worrying. She took him to the hospital where the doctor told them that 
Andile had rheumatic heart disease and began treating him. 
 What do you know about rheumatic heart disease? 
 What do you think causes it? 
 How will having rheumatic heart disease affect Andile’s life? 
 How do you think other people will respond to Andile when they know he has rheumatic heart 
disease? 
o Is it likely that Andile will be looked down on by others? 
 
What we want to get from the FGDs is a sense of whether genetic attribution would impact on 
stigma associated with the two diseases. 
 
Questions/purpose of FGDs: 
 Explore existing stigma relating to RHD and SAX 
 Explore knowledge about genetics and genomics 
 Explore whether genetic attribution could influence stigma surrounding SAX and RHD 
 Story stage 2 (all stages turned into very short videos, with questions appearing on the 
screen) 
(i) Genetic: Andile wanted to know what had caused his rheumatic heart disease. The doctor 
explained that although this disease is triggered by an infection, how likely a person is to develop it 
runs in the family/ is hereditary/in the genes, which means that it was passed down from his parents 
and previous generations in the family. He asked if Andile remembered anyone else in the family 
who had similar problems. Andile remembered having an uncle who also had heart problems. 
 So the doctor tells Andile that his rheumatic heart disease is caused by something passed 
down in his family. How will this affect Andile’s life? [After open-ended responses, follow up 
with specific probes below, if not already mentioned; to explore further ask “How?”] 
a. Will it change how his family relates to him? 
b. Will it change how his friends relate to him? 
c. Will it affect the chances that a boss would give him a job? 
d. Will it affect the chances that he’ll get married? 
e. Will it affect his decisions about having children? 
f. Will it change the chances that he will want treatment? 
g. How else might it change his life? 
 
(ii) Mixed environmental/genetic: Andile wanted to know what had caused his rheumatic heart 
disease. The doctor explained that although this disease is triggered by an infection, how likely a 
person is to develop it partly runs in the family/ is hereditary/in the genes, and partly depends on 
the circumstances the person lives in. The doctor asked where Andile grew up. Andile tells him that 
for most of his life, she lived in a shack they shared with his aunt. The doctor asked if Andile could 
remember whether he had ever had a really sore throat, followed by pain in his body. He remembered 
that he was very ill when he was about six, and then again in his early twenties. The doctor tells 
Andile that his disease is caused by a combination of things in his blood (his genes), the sore throat 
and where he grew up. 
 So the doctor tells Andile that his rheumatic heart disease is partly caused by something 
passed down in his family and partly by the circumstances in which he grew up. How will this 
affect Andile’s life? [After open-ended responses, follow up with specific probes below, if 
not already mentioned; to explore further ask “How?”] 
a. Will it change how his family relates to him? 
b. Will it change how his friends relate to him? 
c. Will it affect the chances that a boss would give him a job? 
d. Will it affect the chances that he’ll get married? 
e. Will it affect his decisions about having children? 
f. Will it change the chances that he will want treatment? 
g. How else might it change his life? 
 
(iii) Environmental: Andile wanted to know what had caused the rheumatic heart disease. The doctor 
explained that although this disease is triggered by an infection, how likely a person is to develop it 
partly depends on the circumstances the person lives in. For example, people who live in crowded, 
 poorly ventilated houses are more likely to get RHD. He asked if Andile could remember whether he 
had ever had a really sore throat, followed by pain in his body. He remembered that he was very ill 
when he was about six, and then again in his early twenties. 
 So the doctor tells Andile that his rheumatic heart disease is caused by the circumstances in 
which he grew up. How will this affect Andile’s life? [After open-ended responses, follow up 
with specific probes below, if not already mentioned; to explore further ask “How?”] 
a. Will it change how his family relates to him? 
b. Will it change how his friends relate to him? 
c. Will it affect the chances that a boss would give him a job? 
d. Will it affect the chances that he’ll get married? 
e. Will it affect his decisions about having children? 
f. Will it change the chances that he will want treatment? 
g. How else might it change his life? 
 
Story stage 3 (turned into short video with questions appearing on the screen)  
Andile’s mother is friendly with your parents and you all happen to meet up one day. Andile’s 
mother wants to introduce you to her son and hopes that the two of you would become friends. 
 How would you feel about becoming friends with Andile? 
 How would you feel about introducing Andile to other people in your family? 
 How would you feel if Andile wanted to date or marry your sister? 
 Do you think Andile’s children would also develop this disease? All of them, or just some of 
them? 
 Appendix H: FGD topic guide and vignette SCZ patients 
 
NOTES: Topic guides and vignettes were discussed with SCZ study recruiters to get their input on 
typical patient presentation. The scenarios in these topic guides were translated into isiXhosa 
and developed into short videos by a professional film maker. These videos were screened 
during the FGDs.  
 
Start FGD 
Scope general understanding of genetics 
 You have all been involved in a genetics/genomics research project – can you tell us a little bit 
about what genetics/genomics is? What do you remember about what the nurse told you? 
 First explore whether interviewees have any conception of genetics. 
 Then explain what this is, mentioning family inheritance, family members sharing physical and disease 
traits. Useful phrases are ‘things that run in the family’, things that are in the blood’, and also 
explanations about how particular features (e.g. shape of the face or the body) are often shared 
between family members – e.g. you can look like your mum or your dad. Also, diseases move in 
families in that same way. 
 
Vignette 
Story stage 1 (turned into short video with questions appearing on the screen) 
Andile is 26 years old and lives with his mother in an RDP house in Langa. He is unemployed and 
gets a  government  disability  grant  each  month  to  support  them.  Andile  has  schizophrenia  and 
first became ill four years ago. He started hearing strange voices that scared him and started 
believing that it was too dangerous to leave his house. His mother found his behaviour very strange 
and worrying. She took him to the hospital where the doctor told them that Andile had 
schizophrenia and began treating him. 
 What do you know about schizophrenia? 
 What do you think causes it? 
 How will having schizophrenia affect Andile’s life? 
 How do you think other people will respond to Andile when they know he has schizophrenia? 
o Is it likely that Andile will be looked down on by others? 
 
Story stage 2 (all story stages turned into short video with questions appearing on the screen) 
What we want to get from the FGDs is a sense of whether genetic attribution would impact on 
stigma associated with the two diseases. 
 
Questions/purpose of FGDs: 
 Explore existing stigma relating to RHD and SAX 
 Explore knowledge about genetics and genomics 
 Explore whether genetic attribution could influence stigma surrounding SAX and RHD 
 (i) Genetic: Andile wanted to know what had caused his schizophrenia. The doctor explained that 
schizophrenia runs in the family/ is hereditary/ in the genes, which means that it was passed down from 
his parents and previous generations in the family. He asked if Andile remembered anyone else in the family 
who had similar problems. Andile remembered an uncle who other family members said behaved in strange 
ways and reported hearing scary voices. 
 So the doctor tells Andile that his schizophrenia is caused by something passed down in his family. 
How will this affect Andile’s life? [After open-ended responses, follow up with specific probes below, 
if not already mentioned; to explore further ask “How?”] 
a. Will it change how his family relates to him? 
b. Will it change how his friends relate to him? 
c. Will it affect the chances that a boss would give him a job? 
d. Will it affect the chances that he’ll get married? 
e. Will it affect his decisions about having children? 
f. Will it change the chances that he will want treatment? 
g. How else might it change his life? 
 
(ii) Mixed environmental/genetic: Andile wanted to know what had caused his schizophrenia. The doctor 
explained that schizophrenia is partly hereditary/ in the genes, which means that it was passed down 
from his parents and previous generations in the family. But carrying the genes alone was not enough: it 
probably was also caused by the circumstances that Andile had been exposed to in his life. The doctor 
asked if Andile could remember anyone else in the family who had similar symptoms. Andile 
remembered an uncle who other family members said behaved in strange ways and reported hearing 
scary voices. The doctor also asked if he could remember anything very challenging, difficult or traumatic 
that happened in his life. Andile said that his father died when he was a baby, and that his mother had 
been unable to find fulltime employment. They often had little money and not enough food or a warm 
place to stay. Andile and his mother were alone without family to depend on. Andile was teased, bullied 
and beaten by older children in the community, and spent a lot of time alone. The doctor tells Andile that 
his disease is caused by a combination of things in his blood (his genes) and his experiences growing up. 
 So the doctor tells Andile that his schizophrenia is partly caused by something passed down in his 
family and partly by the circumstances in which he grew up. How will this affect Andile’s 
life? [After open-ended responses, follow up with specific probes below, if not already mentioned; 
to explore further ask “How?”] 
a. Will it change how his family relates to him? 
b. Will it change how his friends relate to him? 
c. Will it affect the chances that a boss would give him a job? 
d. Will it affect the chances that he’ll get married? 
e. Will it affect his decisions about having children? 
f. Will it change the chances that he will want treatment? 
g. How else might it change his life? 
 
(iii) Environmental: Andile wanted to know what had caused his schizophrenia. The doctor explained that 
schizophrenia was caused by the circumstances that Andile had been exposed to in his life. He asked if 
Andile could remember anything very challenging, difficult or traumatic that he had experienced. Andile 
said his father had died when he was a baby, and that his mother had been unable to find fulltime 
employment. They often had little money and not enough food or a warm place to stay. Andile and his 
mother were alone without family to depend on. Andile was teased, bullied and beaten by older children 
 in the community, and spent a lot of time alone. 
 So the doctor tells Andile that his schizophrenia is caused by the circumstances in which he grew 
up. How will this affect Andile’s life? [After open-ended responses, follow up with specific 
probes below, if not already mentioned; to explore further ask “How?”] 
a. Will it change how his family relates to him? 
b. Will it change how his friends relate to him? 
c. Will it affect the chances that a boss would give him a job? 
d. Will it affect the chances that he’ll get married? 
e. Will it affect his decisions about having children? 
f. Will it change the chances that he will want treatment? 
g. How else might it change his life? 
 
Story stage 3 (turned into short video with questions appearing on the screen) Andile’s mother is 
friendly with your parents and you all happen to meet up one day. Andile’s mother wants to introduce 
you to her son and hopes that the two of you would become friends. 
 How would you feel about becoming friends with Andile? 
 How would you feel about introducing Andile to other people in your family? 
 How would you feel if Andile wanted to date or marry your sister? 
 Do you think Andile’s children would also develop this disease? All of them, or just some of 
them. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Appendix I 
 
 Internalised Stigma of Mental Illness Xhosa Version (ISMI-X)  
Sex: Isini M / F 
Age: Iminyaka yakho  
Highest level of education: Ibanga lemfundo eliphezulu 
Where do you live? Uhlala phi URBAN / PERI-URBAN / RURAL 
 
 
 
 
 
 
 
 
 
 
 
 
1 2 3 4 
4  
Strongly 
disagree/ 
Andivumi 
kakhulu 
 
 
Disagree/ 
Andivumi 
 
Agree/ 
Ndiyavuma 
 
Strongly 
agree/ 
Ndiyavuma 
kakhulu 
         Alienation 
1 I feel out of place in the world 
because I have a mental illness 
Ndiziva ndingamkelekanga 
ehlabathini kuba ndiphazamiseke 
ngokwasengqondweni 
 
 
 
 
 
 
    
5 I am embarrassed or ashamed that 
I have a mental illness 
Ndiziva ndiphoxekile okanye 
ndinentloni kuba 
ndiphazamiseke 
ngokwasengqondweni 
 
 
    
8 I feel inferior to others who 
don’t have a mental illness 
Ndiziva ndizeya kubantu 
abangaphazamisekanga 
engqondweni 
 
    
16 I am disappointed in myself for 
having a mental illness 
Ndiziva ndinodano ngesiqu sam 
kuba ndiphazamiseke 
ngokwasengqondweni 
 
    
 17 Having a mental illness has 
spoiled my life  
Ukuba nesigulo sengqondo 
kubuphazamisile ubomi bam 
    
21 
People without mental illness 
could not possibly understand 
me 
Abantu 
abangaphazamisekanga 
engqondweni ngekhe 
bayiqonde imeko yam 
    
         Stereotype Endorsement 
2 Mentally ill people tend to be 
violent  
Abantu abaphazamisekileyo 
engqondweni bakholisa ukuba 
ndlongo-ndlongo 
 
  
    
6 Mentally ill people shouldn’t get 
married  
Abantu abaphazamisekileyo 
engqondweni abafanelanga 
ukutshata 
 
 
    
10 People with a mental illness cannot 
live a good, rewarding life 
Abantu abaphazamisekileyo 
engqondweni abanakho ukuphila 
ubomi obulungileyo 
nobunembuyekezo 
 
 
    
18 People can tell that I have a mental 
illness by the way I look 
Abantu bangatsho ukuba 
ndiphazamisekile engqondweni 
ngendlela endibonakala ngayo 
lwezigqibo 
 
    
19 Because I have a mental illness, I 
need others to make most 
decisions for me 
Kuba ndiphazamisekile 
engqondweni ndifuna abanye 
abantu bandithathele uninzi  
 
    
 23 I can’t contribute anything to 
society because I have a mental 
illness  
Andikwazi kuba nagalelo 
ekuhlaleni 
nakweyiphi na into kuba 
ndiphazamisekile engqondweni 
 
    
29 Stereotypes about the mentally ill 
apply to me 
Iingcamango ezingezizo zabantu 
malunga nesigulo sengqondo nam 
ziyandichaphazela 
 
 
    
         Discrimination Experience 
3 People discriminate against me 
because I have a mental illness 
Abantu bayandicalu-
calula kuba 
ndiphazamisekile 
engqondweni 
    
15 
People often patronize me, or treat 
me like a child, just because I have a 
mental illness  
Abantu bakholisa ukundiphatha 
okomntwana kuba ndiphazamisekile 
engqondweni 
    
22 People ignore me or take me less 
seriously 
just because I have a 
mental illness  
Abantu baye bangandihoyi 
okanye bangandithatheli 
ngqalelo kuba 
ndiphazamisekile 
engqondweni 
    
25 Nobody would be interested in 
getting close to me because I have a 
mental illness 
 Akukho mntu uyakuba nomdla 
wokusondela kum kuba 
ndiphazamisekile engqondweni 
    
 28 
Others think that I can’t achieve 
much in life because I have a mental 
illness 
Abanye abantu bacinga ukuba 
andinakuze ndiphumelele kangako 
ebomini kuba ndiphazamisekile 
engqondweni 
    
        Social Withdrawal 
4 
I avoid getting close to people who 
don’t have a mental illness to avoid 
rejection 
Ndiyazikhwebula ukuba kufutshane 
kubantu abangaphazamisekanga 
engqondweni ukuze ndingaziva 
ndingamkelekanga 
 
    
9 
I don’t socialize as much as I used to 
because my mental illness might 
make me look or behave weird 
Andisakonwabeli kakhulu ukuhlala 
nabanye abantu njengoko 
ndandiqhele ukwenza kuba isigulo 
sam sengqondo sindenza 
ndibonakale kwaye ndenze izinto 
ezingaqhelekanga 
    
11 I don’t talk about myself much 
because I don’t want to burden 
others with my mental illness 
Andithethi kakhulu ngam kuba 
andifuni ukwenzela abanye abantu 
uxanduva ngesigulo sam 
sokuphazamiseka engqondweni 
 
 
    
12 Negative stereotypes about mental 
illness keep me isolated from the 
‘normal’ World Ingcamango ezimbi 
ezithethwa ngophazamiseko 
lwengqondo zindenza ndiziguzule 
kwizinto eziqhubekayo ehlabathini 
'eliqhelekileyo' 
 
 
    
 13 Being around people who don’t 
have a mental illness makes me feel 
out of place or inadequate 
Ukuba phakathi kwabantu 
abangaphazamisekanga 
engqondweni kundenza ndizive 
ingathi ndilahlekile okanye 
ndimncinci 
    
20 I stay away from social situations in 
order to protect my family or friends 
from embarrassment 
Ndihlalela kude le kwindawo 
zolonwabo ukuze ndikhusele usapho 
lwam kunye nabahlobo bam kuhlazo 
    
        Stigma Resistance 
7 
People with mental illness make 
important contributions to society 
Abantu abaphazamisekileyo 
engqondweni banegalelo 
elibalulekileyo ekuhlaleni 
 
 
    
14 I feel comfortable being seen in 
public with an obviously mentally ill 
person 
Ndiziva ndikhululekile 
esidlangalaleni nomntu 
ocacileyo ukuba uphazamisekile 
engqondweni 
    
24 
Living with mental illness has 
made me a tough survivor 
Ukuphila ndinophazamiseko 
lwengqondo kundenze 
ndaphumelela kwimeko ezinzima 
 
    
26 In general, I am able to live life 
the way I want to 
Ngokuqhelekileyo, ndiyakwazi 
ukuphila ubomi ngendlela 
endifuna ngayo 
    
27 I can have a good, fulfilling life, 
despite my mental illness 
Ndingaba nobomi obuhle obanelisayo 
nangona ndiphazamisekile 
engqondweni 
 
    
  
                 Experiences of Abuse 
30 People call me names 
because I have a mental 
illness 
Abantu bandibiza 
ngamagama kuba 
ndiphazamisekile 
engqondweni 
    
31 
People have been physically abusive 
towards me because I have a 
mental illness 
Abantu bebendihlukumeza 
ngokwasemzimbeni kuba 
ndiphazamisekile engqondweni 
    
32 
People have been verbally abusive 
towards me because I have a 
mental illness 
Abantu bebethetha rhabaxa 
ngakum, kuba  ndiphazamisekile 
ngokwase ngqondweni 
    
33 
I find it difficult to attend clinic 
appointments because people will 
know that I have a mental illness 
Ndifumana kunzima ukuya ekliniki 
nje ngoko kumisiwe kuba abantu 
bazakwazi ukuba mna 
ndiphazamisekile engqondweni 
    
34 
I think the media has a negative 
influence on the way people 
perceive mental illness Ndicinga 
ukuba izinto ezisasaza iindaba 
zinempembelelo engeyiyo kwindlela 
abantu abajonga ngayo abantu 
abaphazamisekileyo engqondweni  
    
35 I find it difficult to take my tablets 
every day because they remind me 
that I have a mental illness 
Ndifumanisa kunzima ukusela 
ipilisi zam yonke imihla kuba 
zindikhumbuza ukuba 
ndiphazamisekile engqondweni 
    
 
 
  Internalised Stigma of Rheumatic Heart Disease Xhosa Version (ISRHD-X) 
Sex: Isini M / F 
Age: Iminyaka yakho  
Highest level of education: Ibanga lemfundo eliphezulu 
Where do you live? Uhlala phi URBAN / PERI-URBAN / RURAL 
Have you had an operation performed? Wakhe 
watyandwa na ngaphambili? 
 
 
Y / N 
If yes, date of operation: Ukuba kunjalo, umhla: 
 
  1 2 3 
 
Agree/ 
Ndiyavuma 
4 
Strongly 
disagree/ 
Andivumi 
kakhulu 
 
Disagree/ 
Andivumi 
Agree/ 
Ndiyavuma 
Strongly 
agree/ 
Ndiyavuma 
kakhulu 
Alienation 
1 I feel out of place in the world because I 
have a heart disease 
Ndiziva ndingamkelekanga ehlabathini 
kuba ndinesifo sentliziyo 
 
 
    
5 I am embarrassed or ashamed that I have a 
heart disease 
Ndiziva ndinodano okanye ndinentloni 
kuba ndinesifo sentliziyo 
 
    
8 I feel inferior to others who don’t have a 
heart disease 
Ndiziva ndizeya kubantu abangenasifo 
sentliziyo 
    
16 I am disappointed in myself for having a 
heart disease 
Ndiziva ndinodano ngesiqu sam kuba 
ndinesifo sentliziyo 
    
17 Having a heart disease has spoiled 
my life  
Ubomi bam bonakele ngenxa yesifo 
sentliziyo 
    
21 People without heart disease could not 
possibly understand me 
Abantu abangenasifo sentliziyo 
ngekhe bayiqonde imeko yam 
    
Stereotype Endorsement 
2 People with heart disease tend to be violent 
Abantu abanesifo sentliziyo bakholisa ukuba 
ndlongo-ndlongo 
 
 
   
 
 
 
 
 6 People with heart disease shouldn’t get 
married 
Abantu abanesifo sentliziyo abafanelanga 
ukutshata 
    
18 People with heart disease cannot live a 
good, rewarding life 
Abantu abanesifo sentliziyo abanakho 
ukuphila ubomi obulungileyo 
nobunembuyekezo 
    
19 Because I have a heart disease, I need others 
to make most decisions for me 
Kuba ndinesifo sentliziyo ndifuna 
abanye abantu bandithathele uninzi 
lwezigqibo 
    
23 I can’t contribute anything to society 
because I have a heart disease 
Andikwazi kuba nagalelo ekuhlaleni 
nakweyiphi na into kuba ndinesifo 
sentliziyo 
    
29 Stereotypes about people with heart disease 
apply to me 
Iingcamango ezingezizo zabantu 
malunga nesifo sentliziyo nam 
ziyandichapazela 
    
        Discrimination Experience 
3 People discriminate against me because I 
have a heart disease 
Abantu bayandicalu-calula kuba ndinesifo 
sentliziyo 
    
15 People often patronize me, or treat me like a 
child, just because I have a heart disease 
Abantu bakholisa ukundiphatha 
okomntwana kuba ndinesifo sentliziyo 
    
22 People ignore me or take me less seriously 
just because I have a heart disease Abantu 
baye bangandhoyi okanye bangandithatheli 
ngqalelo kuba ndinesifo sentliziyo 
    
 25 Nobody would be interested in getting close 
to me because I have a heart disease Akukho 
mntu uyakuba nomdla wokusondela kum 
kuba ndinesifo sentliziyo 
    
28 Others think that I can’t achieve much in life 
because I have a heart disease 
Abanye abantu bacinga ukuba andinakuze 
ndiphumelele kangako ebomini kuba 
ndinesifo sentliziyo 
    
       Social Withdrawal 
4 I avoid getting close to people who don’t 
have a heart disease to avoid rejection  
Ndiyazikhwebula ukuba kufutshane 
kubantu abangenasifo sentliziyo ukuze 
ndingaziva ndingamkelekanga 
 
    
9 I don’t socialize as much as I used to 
because my heart disease might make me 
look or behave weird 
Andisakonwabeli kakhulu ukuhlala 
nabanye abantu njengoko ndandiqhele 
ukwenza kuba isifo sam sentliziyo sindenza 
ndibonakale kwaye ndenze izinto 
ezingaqhelekanga 
    
11 I don’t talk about myself much because I 
don’t want to burden others with my heart 
disease 
Andithethi kakhulu ngam kuba andifuni 
ukwenzela abanye abantu uxanduva 
ngesifo sam sentliziyo 
    
12 Negative stereotypes about heart disease 
keep me isolated from the ‘normal’ World 
Ingcamango ezimbi ezithethwa ngesifo 
sentliziyo zindenza ndiziguzule kwizinto 
eziqhubekayo ehlabathini 'eliqhelekileyo' 
    
13 Being around people who don’t have a heart 
disease makes me feel out of place or 
inadequate 
Ukuba phakathi kwabantu abangenasifo 
sentliziyo kundenza ndizive ingathi 
ndilahlekile okanye ndimncinci 
    
  
          Experiences of Abuse 
30 People call me names because I have a 
heart disease 
Abantu bandibiza ngamagama 
kuba ndinesifo sentliziyo 
    
31 
People have been physically abusive 
towards me because I have a heart 
disease Abantu bebendihlukumeza 
ngokwasemzimbeni kuba ndinesifo 
sentliziyo 
    
20 I stay away from social situations in order to 
protect my family or friends from 
embarrassment 
Ndihlalela kude le kwindawo zolonwabo 
ukuze ndikhusele usapho lwam kunye 
nabahlobo bam kuhlazo 
    
        Stigma Resistance 
7 People with heart disease make important 
contributions to society 
Abantu abanesifo sentliziyo banegalelo 
elibalulekileyo ekuhlaleni 
    
14 I feel comfortable being seen in public 
with a person who obviously has heart 
disease 
Ndiziva ndikhululekile ukubonwa 
esidlangalaleni  nomntu ocacileyo ukuba 
unesifo sentliziyo 
    
24 Living with heart disease has made me a 
tough survivor 
Ukuphila nesifo sentliziyo kundenze 
ndaphumelela kwimeko ezinzima 
    
26 In general, I am able to live life the way I 
want to 
Ngokuqhelekileyo, ndiyakwazi ukuphila 
ubomi ngendlela endifuna ngayo 
    
27 I can have a good, fulfilling life, despite my 
heart disease 
Ndingaba nobomi obuhle obanelisayo 
nangona ndinesifo sentliziyo 
    
 32 People have been verbally abusive 
towards me because I have a heart 
disease 
Abantu bebethetha rhabaxa 
ngakum, kuba ndinesifo 
sentliziyo 
    
33 I find it difficult to attend clinic 
appointments because people will 
know that I have a heart disease 
Ndifumanisa kunzima ukuya ekliniki 
nje ngoko kumisiwe kuba abantu 
bazakwazi ukuba ndinesifo 
sentliziyo 
    
34 I think the media has a negative 
influence on the way people perceive 
heart disease  
Ndicinga ukuba izinto ezisasaza iindaba  
zinempembelelo engeyiyo kwindlela 
abantu abajonga ngayo abantu 
abanesifo sentliziyo  
    
35 I find it difficult to take my tablets 
every day because they remind me that 
I have a heart disease 
Ndifumanisa kunzima ukusela ipilisi 
zam yonke imihla kuba 
zindikhumbuza ukuba ndinesifo 
sentliziyo 
    
 
 
 
 
 
 
 
 
Appendix J: Back-translation 
 Original English Xhosa  Back-translation 
English 
 Strongy disagree 
Disagree 
Neither agree or disagree 
Agree 
Strongly agree 
Andivumi kakhulu 
Andivumi 
Ndivuma ndingavumi 
Ndiyavuma 
Ndiyavuma kakhulu 
Highly Disagree 
Disagree 
Partially Agree 
Agree 
Highly Agree 
   
I feel out of place in the 
world because I have a 
mental illness 
 
 
I feel out of place in the 
world because I have a 
heart disease                   
Ndiziva 
ndingamkelekanga 
emhlabeni kuba 
ndiphazamisekile 
engqonweni 
 
Ndiziva ndingenandawo 
ehlabathini kuba 
ndinesifo sentliziyo   
Due to my mental 
instability, I don't feel 
welcome in the 
world. 
 
 
I feel like I don't have 
a place on earth due 
to my heart disease 
Having a mental illness 
has spoiled my life   
                                                                                       
Having a heart disease 
has spoiled my life 
 
Ukuba nesigulo 
sengqondo 
kubuphazamisile ubomi 
bam 
 
Ubomi bam bonakele 
ngenxa yesifo sentliziyo 
Having a mental 
illness has disrupted 
my life 
 
My life has been 
ruined by having a 
heart disease 
People without mental 
illness could not possibly 
understand me   
                                             
People without heart 
disease could not possibly 
understand me                                                 
 
Abantu 
abangaphazamisekanga 
engqondweni ngekhe 
bayiqonde imeko yam 
 
Abantu abangenasifo 
sentliziyo ngekhe 
bayiqonde imeko yam 
People who do not 
suffer from a mental 
illness will never 
understand my 
situation 
 
People who do not 
suffer from heart 
problems 
I am embarrassed or 
ashamed that I have a 
mental illness           
                                                
I am embarrassed or 
ashamed that I have a 
heart disease                                                             
 
Ndiziva ndinodano 
okanye ndinentloni kuba 
ndiphazamisekile 
engqondweni 
 
Ndiziva ndinodano 
okanye ndinentloni kuba 
ndinesifo sentliziyo 
I feel embarrassed or 
ashamed because I 
suffer from mental 
illness 
 
I feel embarrased or 
ashamed because I 
suffer from heart 
disease 
 
 
 
 
 
I am disappointed in 
myself for having a 
mental illness     
                                                             
I am disappointed in 
myself for having a heart 
disease                                                                   
Ndiziva ndinodano 
ngesiqu sam kuba 
ndiphazamisekile 
engqondweni 
 
Ndiziva ndinodano 
ngesiqu sam kuba 
ndinesifo sentliziyo 
I feel ashamed of 
myself as a person 
due to having a 
mentall illness. 
 
I feel ashamed of 
myself as a person 
due to having a heart 
disease 
I feel inferior to others 
who don’t have a mental 
illness  
                                                                
I feel inferior to others  
who don’t have a heart 
disease                                                                    
Ndiziva ndizeya kubantu 
abangaphazamisekanga 
engqondweni 
 
Ndiziva ndizeya kubantu 
abangenasifo sentliziyo 
I feel inferior to 
people who are not 
mentally ill 
 
I feel inferior to 
people who don't 
suffer from heart 
diseases 
Stereotypes about the 
mentally ill apply to me  
 
Stereotypes about people 
with heart disease apply 
to me                                                   
Iingcamango ngabantu 
abagula ngengqondo 
ziquka nam 
 
Iingcamango ngabantu 
abanesifo sentliziyo 
ziquka nam 
I am included in the 
opinions society has 
on people with a 
mental illness 
I am included in the 
opinions society has 
on people with heart 
disease 
People can tell that I have 
a mental illness by the 
way I look       
                                                   
People can tell that I have 
a heart disease by the 
way I look                                                         
Abantu bangatsho ukuba 
ndiphazamisekile 
engqondweni ngendlela 
endibonakala ngayo 
 
Abantu bangatsho ukuba 
ndinesifo sentliziyo  
ngendlela endibonakala 
ngayo 
Its evident that I have 
a mental illness just 
by looking at me 
 
Its evident that I have 
a heart disease just 
by looking at me 
Mentally ill people tend to 
be violent        
                                                                                      
People with heart disease 
tend to be violent                                                                                       
 
Abantu 
abaphazamisekileyo 
engqondweni bakholisa 
ukuba ndlongo-ndlongo 
 
Abantu abanesifo 
sentliziyo bakholisa 
ukuba ndlongo-ndlongo 
People with a mental 
illness tend to be 
violent 
 
People with heart 
disease tend to be 
violent 
Because I have a mental 
illness, I need others to 
Kuba ndiphazamisekile 
engqondweni ndifuna 
I prefer people to 
make decisions on my 
 
 
 
 
 
make most decisions for 
me 
                                                                                      
Because I have a heart 
disease, I need others to 
make most decisions for 
me                               
abanye abantu 
bandithathele uninzi 
lwezigqibo
 
Kuba ndinesifo sentliziyo 
ndifuna abanye abantu 
bandithathele uninzi 
lwezigqibo 
behalf because I am 
mentally ill 
 
I prefer people to 
make decisions on my 
behalf because I have 
a heart disease  
People with a mental 
illness cannot live a good, 
rewarding life   
                                                           
People with heart disease 
cannot live a good, 
rewarding life                                                        
Abantu 
abaphazamisekileyo 
engqondweni abanakho 
ukuphila ubomi 
obulungileyo 
nobunembuyekezo 
 
Abantu abanesifo 
sentliziyo abanakho 
ukuphila ubomi 
obulungileyo 
nobunembuyekezo 
People with mental 
illness cannot live a 
good and peaceful life 
 
People with heart 
disease cannot live a 
good and peaceful life 
Mentally ill people 
shouldn’t get married    
                                                                                             
People with heart disease 
shouldn’t get married                                                                             
Abantu 
abaphazamisekileyo 
engqondweni  
abafanelanga  ukutshata 
 
Abantu abanesifo 
sentliziyo abafanelanga 
ukutshata 
People who are 
mentally ill arent 
suited for marriage 
 
People with heart 
disease arent suited 
for marriage. 
I can’t contribute 
anything to society 
because I have a mental 
illness    
                                                                                             
I can’t contribute anything 
to society because I have 
a heart disease                                     
Andikwazi kuba negalelo 
ekuhlaleni nakweyiphi na 
into kuba 
ndiphazamisekile 
engqondweni 
 
Andikwazi kuba nagalelo 
ekuhlaleni nakweyiphi na 
into kuba ndinesifo 
sentliziyo 
I cannot have any sort 
of contribution in 
society because I 
have mental illness 
 
I cannot have any sort 
of contribution in 
society because I 
have heart disease 
 
 
 
 
 
 
People discriminate 
against me because I have 
a mental illness                   
 
People discriminate 
against me because I have 
a heart disease                                                 
Abantu bayandicalu-
calula kuba 
ndiphazamisekile 
engqondweni 
 
Abantu bayandicalu-
calula kuba ndinesifo 
sentliziyo 
People discriminate 
against me because I 
am mentally ill 
 
People discriminate 
against me me 
because I have a 
heart disease 
Others think that I can’t 
achieve much in life 
because I have a mental 
illness         
                                                                              
Others think that I can’t 
achieve much in life 
because I have a heart 
disease                           
Abanye abantu bacinga 
ukuba andinakuze 
ndiphumelele kangako 
ebomini kuba 
ndiphazamisekile 
engqondweni 
 
Abanye abantu bacinga 
ukuba andinakuze 
ndiphumelele kangako 
ebomini kuba ndinesifo 
sentliziyo 
Some people think 
that I will never 
succeed in life 
because I am 
mentally ill 
 
Some people think 
that I will never 
succeed because I 
have a heart disease 
People ignore me or take 
me less seriously just 
because I have a mental 
illness                             
                                                           
People ignore me or take 
me less seriously just 
because I have a heart 
disease                        
 
Abantu baye 
bangandinaki okanye 
bangandithatheli 
ngqalelo kuba 
ndiphazamisekile 
engqondweni 
 
Abantu baye 
bangandinaki okanye 
bangandithatheli 
ngqalelo kuba ndinesifo 
sentliziyo 
People never take me 
seriously because of 
my mental illness 
 
People never take me 
seriously because I 
have a heart disease 
People often patronize 
me, or treat me like a 
child, just because I have 
a mental illness                                                                  
People often patronize 
me, or treat me like a 
child, just because I have 
a heart disease                                                                                                                                
Kumaxesha amaninzi 
abantu bandiphatha 
okomntwana kuba 
ndiphazamisekile 
engqondweni
 
Kumaxesha amaninzi 
abantu bandiphatha 
okomntwana kuba
ndinesifo sentliziyo 
Most of the time 
people treat me like a 
child because I have a 
mental illness. 
Most of the time 
people treat me like a 
child because I have 
heart disease 
Nobody would be 
interested in getting close 
Akukho mntu uyakuba 
nomdla wokusondela 
kum kuba 
Nobody would want 
to be near me 
 
 
 
 
 
to me because I have a 
mental illness                   
                                                                  
Nobody would be 
interested in getting close 
to me because I have a 
heart disease                                                                                                                                 
 
ndiphazamisekile 
engqondweni 
 
Akukho mntu uyakuba 
nomdla wokusondela 
kum kuba ndinesifo 
sentliziyo
because I have a 
mental illness 
 
Nobody would want 
to be near me 
because I have a 
heart disease 
I don’t talk about myself 
much because I don’t 
want to burden others 
with my mental illness              
                                        
I don’t talk about myself 
much because I don’t 
want to burden others 
with my heart disease                                                                                                                    
 
Andithethi  kakhulu 
ngam kwabanye abantu 
kuba andifuni ukubanika 
uxanduva  ngesigulo sam 
sokuphazamiseka 
engqondweni 
 
Andithethi  kakhulu 
ngam kwabanye abantu 
kuba andifuni ukubanika 
uxanduva  ngesifo sam 
sentliziyo 
I rarely talk about 
myself with other 
people because I 
don't want to burden 
them with my mental 
illness 
 
I rarely talk about 
myself with other 
people because I 
don't want to burden 
them with my heart 
disease. 
I don’t socialize as much 
as I used to because my 
mental illness might make 
me look or behave weird          
                                                                                                                                                        
I don’t socialize as much 
as I used to because my 
heart disease might make 
me look or behave weird                                                                                                                                         
Andisakonwabeli 
kakhulu ukuhlala 
nabanye abantu 
njengoko ndandiqhele 
ukwenza kuba isigulo 
sam sengqondo sindenza 
ndibonakale kwaye 
ndenze izinto 
ezingaqhelekanga 
 
Andisakonwabeli 
kakhulu ukuhlala 
nabanye abantu 
njengoko ndandiqhele
ukwenza kuba isifo sam 
sentliziyo sindenza 
ndibonakale kwaye 
ndenze izinto 
ezingaqhelekanga 
I no longer enjoy 
being around people 
as I used to because 
my mental illness 
makes me do things 
Im not used to 
 
I no longer enjoy 
being around people 
as I used to because
my heart disease 
makes me do things 
that I'm not used to. 
 
 
 
 
 
Negative stereotypes 
about mental illness keep 
me isolated from the 
‘normal’ World         
                               
                              
 
Negative stereotypes 
about heart dissease keep 
me isolated from the 
‘normal’ World                                                                                                                                 
 
Ingcamango ezimbi 
ezithethwa 
ngophazamiseko 
lwengqondo zindenza 
ndiziguzule kwizinto 
eziqhubekayo 
ehlabathini 
'eliqhelekileyo' 
 
Ingcamango ezimbi 
ezithethwa ngesifo 
sentliziyo zindenza 
ndiziguzule kwizinto 
eziqhubekayo 
ehlabathini 
'eliqhelekileyo' 
Negative opinions on 
mental illness make 
me distance myself 
from things that 
happen in the 
"normal" world 
 
 
 
Negative opinions on 
heart disease make 
me distance myself 
from things that 
happen in the 
"normal" world. 
I stay away from social 
situations in order to 
protect my family or 
friends from 
embarrassment    
                                                     
I stay away from social 
situations in order to 
protect my family or 
friends from 
embarrassment                                                                                                                
 
Ndihlalela kude le 
kwindawo zolonwabo 
ukuze ndikhusele usapho 
lwam  kunye nabahlobo 
bam kwihlazo 
 
Ndihlalela kude le 
kwindawo zolonwabo 
ukuze ndikhusele usapho 
lwam  kunye nabahlobo 
bam kwihlazo
I stay far away from 
places of leisure to 
protect myself and 
my family from 
embarrassment 
 
I stay far away from 
places of leisure to 
protect myself and 
my family from 
embarrassment. 
Being around people who 
don’t have a mental 
illness makes me feel out 
of place or inadequate           
                                               
Being around people who 
don’t have a heart disease 
makes me feel out of 
place or inadequate                                                                                                       
Ukuba phakathi 
kwabantu 
abangaphazamisekanga 
engqondweni kundenza 
ndizive  ingathi 
ndilahlekile okanye 
ndimncinci 
 
Ukuba phakathi 
kwabantu abangenasifo 
sentliziyo kundenza 
ndizive  ingathi 
ndilahlekile okanye 
ndimncinci 
Being among people 
who are not mentally 
ill makes me feel lost 
and inferior 
 
 
Being among people 
who don't have heart 
disease makes me 
feel lost and inferior. 
I avoid getting close to 
people who don’t have a 
Ndiyazikhwebula ukuba 
kufutshane kubantu 
abangaphazamisekanga 
I distance myself from 
being close to people 
who don't suffer from 
 
 
 
 
 
mental illness to avoid 
rejection 
                                                                    
I avoid getting close to 
people who don’t have a 
heart disease to avoid 
rejection                                                                                                                             
 
engqondweni ukuze 
ndingaziva 
ndingamkelekanga 
 
Ndiyazikhwebula ukuba 
kufutshane kubantu 
abangenasifo sentliziyo
ukuze ndingaziva 
ndingamkelekanga 
mental ilness so that I 
don't feel unwelcome 
 
I distance myself from 
being close to people 
who don't suffer from 
heart disease so that I 
don't feel unwelcome 
I feel comfortable being 
seen in public with an 
obviously mentally ill 
person  
                                                                                            
 
 
I feel comfortable being 
seen in public with a 
person who obviosuly has 
heart disease                                                                                                                                
Ndiziva ndikhululekile  
esidlangalaleni nomntu 
ocacileyo ukuba 
uphazamisekile 
engqondweni
 
Ndiziva ndikhululekile  
esidlangalaleni nomntu 
ocacileyo ukuba unesifo 
sentliziyo 
I feel at ease in the 
presence of a 
mentally ill person 
 
 
 
I feel at ease in the 
presence of a person 
who has heart 
disease. 
In general, I am able to 
live life the way I want to    
                                                                                 
In general, I am able to 
live life the way I want to                                                      
 
Ngokuqhelekileyo, 
ndiyakwazi ukuphila 
ubomi ngendlela 
endifuna ngayo 
 
Ngokuqhelekileyo 
,ndiyakwazi ukuphila 
ubomi ngendlela 
endifuna ngayo 
Normally, I am able to 
live my life the way I 
want to 
 
Normally, I am able to 
live my life the way I 
want to. 
I can have a good, 
fulfilling life, despite my 
mental illness                    
                                                  
I can have a good, 
fulfilling life, despite my 
heart disease                                                        
 
Ndingaba nobomi obuhle 
obanelisayo nangona 
ndiphazamisekile 
engqondweni 
 
Ndingaba nobomi obuhle 
obanelisayo nangona 
ndinesifo sentliziyo 
I can have a good and 
fulfilling life 
regardless of my 
mental illness 
 
I can have a good and 
fulfilling life 
regardless of my 
heart disease 
 
 
 
 
 
People with mental illness 
make important 
contributions to society    
                                                                                                             
People with heart disease 
make important 
contributions to society                                           
 
Abantu 
abaphazamisekileyo 
engqondweni banegalelo 
elibalulekileyo ekuhlaleni 
 
Abantu abanesifo 
sentliziyo banegalelo 
elibalulekileyo ekuhlaleni 
People with a mental 
illness play an 
important role in the 
community 
 
People with heart 
disease play an 
important role in the 
community 
Living with mental illness 
has made me a tough 
survivor                    
                
                                      
Living with heart disease 
has made me a tough 
survivor                                                            
Ukuphila 
ndinophazamiseko 
engqondweni kundenze 
ndaphumelela kwimeko 
ezinzima 
 
Ukuphila nesifo sentliziyo 
kundenze ndaphumelela 
kwimeko ezinzima 
Living with a mental 
disorder has seen me 
get out of difficult 
situations 
  
 
Living with a heart  
disease has seen me 
get out of difficult 
situations 
People call me names 
because I have a mental 
illness                                                                            
People call me names 
because I have a heart 
disease                                                                  
Abantu bandibiza 
ngamagama kuba 
ndiphazamisekile 
engqondweni
Abantu bandibiza 
ngamagama kuba 
ndinesifo sentliziyo 
People call me names 
because I am 
mentally ill 
 
People call me names 
because I have heart 
disease 
 
People have been 
physically abusive 
towards me because I 
have a mental illness                           
                                                             
People have been 
physically abusive 
towards me because I 
have a heart disease                                                                                                                              
Abantu 
bebendihlukumeza 
ngokwasemzimbeni kuba 
ndiphazamisekile 
engqondweni 
 
Abantu 
bebendihlukumeza 
ngokwasemzimbeni kuba 
ndinesifo sentliziyo 
People physically 
abused me because 
of my mental illness 
 
 
People physically 
abused me because I 
have a heart disease 
People have been verbally 
abusive towards me 
because I have a mental 
illness           
                                                                            
People have been verbally 
abusive towards me 
Abantu bebendithuka 
kuba ndiphazamisekile 
ngokwase ngqondweni 
 
 
Abantu bebendithuka 
kuba ndinesifo sentliziyo 
People swore at me 
because of my mental 
illness 
 
 
People swore at me 
because I have a 
heart disease 
 
 
 
 
 
because I have a heart 
disease                       
 
I find it difficult to attend 
clinic appointments 
because people will know 
that I have a mental 
illness            
                                                                                                                                                      
I find it difficult to attend 
clinic appointments 
because people will know 
that I have a heart disease                                                                                                                                             
Ndifumanisa kunzima 
ukuya ekliniki nje ngoko 
kumisiwe kuba abantu 
bazakwazi ukuba mna 
ndiphazamisekile 
engqondweni 
 
Ndifumanisa kunzima 
ukuya ekliniki nje ngoko 
kumisiwe kuba abantu 
bazakwazi ukuba 
ndinesifo sentliziyo 
I find it difficult to go 
to the clinic as 
required because 
people will know I 
have a mental 
disorder 
 
 
I find it difficult to go 
to the clinic as 
required because 
people will know I 
have a heart disease 
I think the media has a 
negative influence on the 
way people perceive  
mental illness     
                                                                 
I think the media has a 
negative influence on the 
way people perceive heart 
disease                                                                                                                                
 
Ndicinga ukuba 
abasasazi bendaba 
banempembelelo 
enegxeke ngendlela 
abantu abajonga ngayo 
abantu 
abaphazamisekile 
engqondweni 
 
Ndicinga ukuba 
abasasazi bendaba 
banempembelelo 
enegxeke ngendlela 
abantu abajonga ngayo 
abantu abanesifo 
sentliziyo 
I think that news 
reportes have a 
negative influence on 
how people percieve 
mentally ill patients 
  
I think that news 
reporters have a 
negative influence on 
how people perceive 
heart disease patients 
I find it difficult to take my 
tablets every day because 
they remind me that I 
have a mental illness  
                                                                                                                                                               
I find it difficult to take my 
tablets every day because 
they remind me that I 
have a heart disease                                                                                                                                             
Ndifumanisa kunzima 
ukusela ipilisi zam yonke 
imihla kuba 
zindikhumbuza ukuba 
mna ndiphazamisekile 
engqondweni 
 
Ndifumanisa kunzima 
ukusela ipilisi zam yonke 
imihla kuba 
zindikhumbuza ukuba 
mna ndinesifo sentliziyo 
I find it hard to take 
my medication daily 
because it reminds 
me of my mental 
illness 
 
I find it hard to take 
my medication daily 
because it reminds 
me of my heart 
disease. 
 
